WorldWideScience

Sample records for breast technical progress

  1. Preventing Breast Cancer: Making Progress

    Science.gov (United States)

    ... Navigation Bar Home Current Issue Past Issues Preventing Breast Cancer: Making Progress Past Issues / Fall 2006 Table of ... 000 women will have been diagnosed with invasive breast cancer, and nearly 41,000 women will die from ...

  2. Technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-10-01

    This report summarizes experimental and theoretical work in basic nuclear physics carried out between October 1, 1995, the closing of our last Progress Report, and September 30, 1996 at the Nuclear Physics Laboratory of the University of Colorado, Boulder, under contracts DE-FG03-93ER-40774 and DE-FG03-95ER-40913 with the United States Department of Energy. The experimental contract supports broadly-based experimental research in intermediate energy nuclear physics. This report includes results from studies of Elementary Systems involving the study of the structure of the nucleon via polarized high-energy positron scattering (the HERMES experiment) and lower energy pion scattering from both polarized and unpolarized nucleon targets. Results from pion- and kaon-induced reactions in a variety of nuclear systems are reported under the section heading Meson Reactions; the impact of these and other results on understanding the nucleus is presented in the Nuclear Structure section. In addition, new results from scattering of high-energy electrons (from CEBAF/TJNAF) and pions (from KEK) from a broad range of nuclei are reported in the section on Incoherent Reactions. Finally, the development and performance of detectors produced by the laboratory are described in the section titled Instrumentation.

  3. Progress in breast cancer: overview.

    Science.gov (United States)

    Arteaga, Carlos L

    2013-12-01

    This edition of CCR Focus titled Research in Breast Cancer: Frontiers in Genomics, Biology, and Clinical Investigation reviews six topics that cover areas of translational research of high impact in breast cancer. These topics represent areas of breast cancer research where significant progress has occurred but also where very important challenges remain. The papers in this CCR Focus section are contributed by experts in the respective areas of investigation. Herein, key aspects of these contributions and the research directions they propose are reviewed. ©2013 AACR.

  4. Technical efficiency, efficiency change, technical progress and ...

    African Journals Online (AJOL)

    In May 2006, the Ministers of Health of all the countries on the African continent, at a special session of the African Union, undertook to institutionalise efficiency monitoring within their respective national health information management systems. The specific objectives of this study were: (i) to assess the technical efficiency of ...

  5. Progress in breast cancer: overview

    National Research Council Canada - National Science Library

    Arteaga, Carlos L

    2013-01-01

    This edition of CCR Focus titled Research in Breast Cancer: Frontiers in Genomics, Biology, and Clinical Investigation reviews six topics that cover areas of translational research of high impact in breast cancer...

  6. Technical progress, market forms and unemployment

    Directory of Open Access Journals (Sweden)

    A. ASIMAKOPULOS A.

    2013-12-01

    Full Text Available The purpose of the present paper is threefold. The first purpose is to emphasise the importance of the insights to be found in Sylos Labini’s work. The second purpose is to expand upon it by distinguishing  between the different types of technical progress. Finally, the third purpose is to comment on Labini’s comparison of Ricardo and Keynes on the possibility of technological unemployment. Regarding his description of technological progress as “labour saving”, the author shows that a more comprehensive description would be more useful for his purposes.

  7. Works Technical Department progress report, August 1965

    Energy Technology Data Exchange (ETDEWEB)

    1965-09-17

    This document details the activities of the Savannah River Works Technical Department during the month of August 1965. Topics discussed are: Reactor Technology, Separations Technology, Engineering Assistance, Health Physics, Laboratories Overview, and Technical Papers Issued.

  8. Works Technical Department progress report, March 1961

    Energy Technology Data Exchange (ETDEWEB)

    None

    1961-04-19

    This document details the activities of the Savannah River Works Technical Department during the month of March 1961. Topics discussed are: Reactor Technology, Separations Technology, Engineering Assistance, Health Physics, Laboratories Overview, and Technical Papers Issued.

  9. Nerve Fibers in Breast Cancer Tissues Indicate Aggressive Tumor Progression

    OpenAIRE

    Huang, Di; Su, Shicheng; Cui, Xiuying; Shen, Ximing; Zeng, Yunjie; Wu, Wei; Chen, Jianing; Chen, Fei; He, Chonghua; Liu, Jiang; Huang, Wei; Liu, Qiang; Su, Fengxi; Song, Erwei; Ouyang, Nengtai

    2014-01-01

    Abstract Emerging evidence has indicated nerve fibers as a marker in the progression of various types of cancers, such as pancreatic cancer and prostate cancer. However, whether nerve fibers are associated with breast cancer progression remains unclear. In this study, we evaluated the presence of nerve fibers in 352 breast cancer specimens and 83 benign breast tissue specimens including 43 cases of cystic fibrosis and 40 cases of fibroadenoma from 2 independent breast tumor center using immun...

  10. Bedtime misalignment and progression of breast cancer.

    Science.gov (United States)

    Hahm, Bong-Jin; Jo, Booil; Dhabhar, Firdaus S; Palesh, Oxana; Aldridge-Gerry, Arianna; Bajestan, Sepideh N; Neri, Eric; Nouriani, Bita; Spiegel, David; Zeitzer, Jamie M

    2014-03-01

    Disruption of circadian rhythms, which frequently occurs during night shift work, may be associated with cancer progression. The effect of chronotype (preference for behaviors such as sleep, work, or exercise to occur at particular times of day, with an associated difference in circadian physiology) and alignment of bedtime (preferred vs. habitual), however, have not yet been studied in the context of cancer progression in women with breast cancer. Chronotype and alignment of actual bedtime with preferred chronotype were examined using the Morningness-Eveningness Scale (MEQ) and sleep-wake log among 85 women with metastatic breast cancer. Their association with disease-free interval (DFI) was retrospectively examined using the Cox proportional hazards model. Median DFI was 81.9 months for women with aligned bedtimes ("going to bed at preferred bedtime") (n = 72), and 46.9 months for women with misaligned bedtimes ("going to bed later or earlier than the preferred bedtime") (n = 13) (log rank p = 0.001). In a multivariate Cox proportional hazard model, after controlling for other significant predictors of DFI, including chronotype (morning type/longer DFI; HR = 0.539, 95% CI = 0.320-0.906, p = 0.021), estrogen receptor (ER) status at initial diagnosis (negative/shorter DFI; HR = 2.169, 95% CI = 1.124-4.187, p = 0.028) and level of natural-killer cell count (lower levels/shorter DFI; HR = 1.641, 95% CI = 1.000-2.695, p = 0.050), misaligned bedtimes was associated with shorter DFI, compared to aligned bedtimes (HR = 3.180, 95% CI = 1.327-7.616, p = 0.018). Our data indicate that a misalignment of bedtime on a daily basis, an indication of circadian disruption, is associated with more rapid breast cancer progression as measured by DFI. Considering the limitations of small sample size and study design, a prospective study with a larger sample is necessary to explore their causal relationship and underlying

  11. Solar lease grant program. Technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    1981-04-01

    Progress on a lease program for the installation of a solar water heater with no installation charge is reported. Information on the announcement of the program, the selection of participants, the contractural agreement, progress on installation of equipment, monitoring, and evaluation is summarized. The status of the budget concerned with the program is announced. Forms used for applications for the program and an announcement from Resource Alternatives for Cilco customers are presented.

  12. Grain boundaries: Annual technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    Balluffi, R.W.; Bristowe, P.D.

    1988-04-28

    The present document is a progress report describing the work accomplished on the study of grain of gold. The research that was proposed initially for this period consisted of studies of the atomistics structure of grain boundaries by means of combined x-ray diffraction and computer modeling and of grain boundary phase transitions by electron microscopy and computer modeling. Progress has been made on both of these areas which is described in more detail. A list of reports describing the research completely during the first year is presented.

  13. Technical progress and its factors in Russia’s economy

    Directory of Open Access Journals (Sweden)

    Simon György Jr.

    2010-01-01

    Full Text Available In this paper long-term growth in Russia’s economy is viewed in the context of technical progress, based on both neoclassical and endogenous theories. The dynamics of economic growth with some aspects of catch-up development are examined, as well as capital deepening. TFP is quantified in terms of both output and productivity increases to reveal the leading role of embodied technical progress in productivity growth. An endogenous growth model helped to discern three complex factors of technical progress in the Russian economy, to which at the macro level a factor related to natural wealth (oil and gas resources was added. This enabled the author to conclude that the most important macroeconomic factor of Russia’s technical progress in the half century from the early 1960s to the late 2000s was its immobile component. At the manufacturing level the situation was more complicated, as the initial leadership of creative technical progress was superseded by the dominance of the mobile factor. The collapse of the Soviet Union made the Russian economy more service-oriented and radically changed the conditions of economic modernization, in which technology transfer ensured by FDI began to play a more prominent part, particularly after the default of 1998.

  14. Final Technical Progress Report NANOSTRUCTURED MAGNETIC MATERIALS

    Energy Technology Data Exchange (ETDEWEB)

    Charles M. Falco

    2012-09-13

    This report describes progress made during the final phase of our DOE-funded program on Nanostructured Magnetic Materials. This period was quite productive, resulting in the submission of three papers and presentation of three talks at international conferences and three seminars at research institutions. Our DOE-funded research efforts were directed toward studies of magnetism at surfaces and interfaces in high-quality, well-characterized materials prepared by Molecular Beam Epitaxy (MBE) and sputtering. We have an exceptionally well-equipped laboratory for these studies, with: Thin film preparation equipment; Characterization equipment; Equipment to study magnetic properties of surfaces and ultra-thin magnetic films and interfaces in multi-layers and superlattices.

  15. Nerve fibers in breast cancer tissues indicate aggressive tumor progression.

    Science.gov (United States)

    Huang, Di; Su, Shicheng; Cui, Xiuying; Shen, Ximing; Zeng, Yunjie; Wu, Wei; Chen, Jianing; Chen, Fei; He, Chonghua; Liu, Jiang; Huang, Wei; Liu, Qiang; Su, Fengxi; Song, Erwei; Ouyang, Nengtai

    2014-12-01

    Emerging evidence has indicated nerve fibers as a marker in the progression of various types of cancers, such as pancreatic cancer and prostate cancer. However, whether nerve fibers are associated with breast cancer progression remains unclear. In this study, we evaluated the presence of nerve fibers in 352 breast cancer specimens and 83 benign breast tissue specimens including 43 cases of cystic fibrosis and 40 cases of fibroadenoma from 2 independent breast tumor center using immunohistochemical staining for specific peripheral nerve fiber markers.In all, nerve fibers were present in 130 out of 352 breast cancer tissue specimens, while none were detected in normal breast tissue specimens. Among 352 cases, we defined 239 cases from Sun Yat-Sen Memorial Hospital, Guangzhou, China, as the training set, and 113 cases from the First Affiliated Hospital of Shantou University, Guangdong, China, as the validation set. The thickness of tumor-involving nerve fibers is significantly correlated with poor differentiation, lymph node metastasis, high clinical staging, and triple negative subtype in breast cancer. More importantly, Cox multifactor analysis indicates that the thickness of tumor-involving nerve fibers is a previously unappreciated independent prognostic factors associated with shorter disease-free survival of breast cancer patients. Our findings are further validated by online Oncomine database. In conclusion, our results show that nerve fiber involvement in breast cancer is associated with progression of the malignancy and warrant further studies in the future.

  16. Nerve Fibers in Breast Cancer Tissues Indicate Aggressive Tumor Progression

    Science.gov (United States)

    Huang, Di; Su, Shicheng; Cui, Xiuying; Shen, Ximing; Zeng, Yunjie; Wu, Wei; Chen, Jianing; Chen, Fei; He, Chonghua; Liu, Jiang; Huang, Wei; Liu, Qiang; Su, Fengxi; Song, Erwei; Ouyang, Nengtai

    2014-01-01

    Abstract Emerging evidence has indicated nerve fibers as a marker in the progression of various types of cancers, such as pancreatic cancer and prostate cancer. However, whether nerve fibers are associated with breast cancer progression remains unclear. In this study, we evaluated the presence of nerve fibers in 352 breast cancer specimens and 83 benign breast tissue specimens including 43 cases of cystic fibrosis and 40 cases of fibroadenoma from 2 independent breast tumor center using immunohistochemical staining for specific peripheral nerve fiber markers. In all, nerve fibers were present in 130 out of 352 breast cancer tissue specimens, while none were detected in normal breast tissue specimens. Among 352 cases, we defined 239 cases from Sun Yat-Sen Memorial Hospital, Guangzhou, China, as the training set, and 113 cases from the First Affiliated Hospital of Shantou University, Guangdong, China, as the validation set. The thickness of tumor-involving nerve fibers is significantly correlated with poor differentiation, lymph node metastasis, high clinical staging, and triple negative subtype in breast cancer. More importantly, Cox multifactor analysis indicates that the thickness of tumor-involving nerve fibers is a previously unappreciated independent prognostic factors associated with shorter disease-free survival of breast cancer patients. Our findings are further validated by online Oncomine database. In conclusion, our results show that nerve fiber involvement in breast cancer is associated with progression of the malignancy and warrant further studies in the future. PMID:25501061

  17. Does Lactation Mitigate Triple Negative/Basal Breast Cancer Progression

    Science.gov (United States)

    2013-11-01

    Award Number: W81XWH-10-1-0679 TITLE: DOES LACTATION MITIGATE TRIPLE NEGATIVE/BASAL BREAST CANCER...2013 4. TITLE AND SUBTITLE 5a. CONTRACT NUMBER DOES LACTATION MITIGATE TRIPLE NEGATIVE/BASAL BREAST CANCER PROGRESSION? 5b. GRANT NUMBER...that this protective layer may be maintained by tumors formed during pregnancy lactation cycle, but may be preferentially compromised by tumors

  18. Molecular Mechanisms of Metastatic Progression in Breast Cancer

    National Research Council Canada - National Science Library

    Flanagan, Louise

    2003-01-01

    .... In our studies we have focused on determining whether clusterin plays a causative role in the progression of human breast carcinoma by promoting cell survival, increasing cell motility and resistance to cytotoxic drugs...

  19. Molecular Mechanisms of Metastatic Progression in Breast Cancer

    National Research Council Canada - National Science Library

    Flanagan, Louise A

    2004-01-01

    .... In our studies, we have focused on determining whether clusterin plays a causative role in the progression of human breast cancer by promoting cell survival, increasing cell motility and resistance to cytotoxic drugs...

  20. Technical Entrepreneurship and Technological Progress in Developing Countries.

    Science.gov (United States)

    Quevedo-Procel, Jose

    This paper describes the Mexican economic environment in terms of general economic conditions from the 1940s to the present, the role of science and technology in industrial progress, and the promotion and support of small companies. The technical entrepreneur is identified as the missing link that would play an important part in the technological…

  1. Gene Expression Analysis of Breast Cancer Progression

    National Research Council Canada - National Science Library

    Gerald, Wiliam L

    2004-01-01

    ... to identify genes, gene expression profiles and molecular pathways associated with metastatic BC we have performed genome-wide gene expression analysis of a large number of breast cancer samples...

  2. Swallowable Wireless Capsule Endoscopy: Progress and Technical Challenges

    Directory of Open Access Journals (Sweden)

    Guobing Pan

    2012-01-01

    Full Text Available Wireless capsule endoscopy (WCE offers a feasible noninvasive way to detect the whole gastrointestinal (GI tract and revolutionizes the diagnosis technology. However, compared with wired endoscopies, the limited working time, the low frame rate, and the low image resolution limit the wider application. The progress of this new technology is reviewed in this paper, and the evolution tendencies are analyzed to be high image resolution, high frame rate, and long working time. Unfortunately, the power supply of capsule endoscope (CE is the bottleneck. Wireless power transmission (WPT is the promising solution to this problem, but is also the technical challenge. Active CE is another tendency and will be the next geneion of the WCE. Nevertheless, it will not come true shortly, unless the practical locomotion mechanism of the active CE in GI tract is achieved. The locomotion mechanism is the other technical challenge, besides the challenge of WPT. The progress about the WPT and the active capsule technology is reviewed.

  3. Swallowable wireless capsule endoscopy: progress and technical challenges.

    Science.gov (United States)

    Pan, Guobing; Wang, Litong

    2012-01-01

    Wireless capsule endoscopy (WCE) offers a feasible noninvasive way to detect the whole gastrointestinal (GI) tract and revolutionizes the diagnosis technology. However, compared with wired endoscopies, the limited working time, the low frame rate, and the low image resolution limit the wider application. The progress of this new technology is reviewed in this paper, and the evolution tendencies are analyzed to be high image resolution, high frame rate, and long working time. Unfortunately, the power supply of capsule endoscope (CE) is the bottleneck. Wireless power transmission (WPT) is the promising solution to this problem, but is also the technical challenge. Active CE is another tendency and will be the next geneion of the WCE. Nevertheless, it will not come true shortly, unless the practical locomotion mechanism of the active CE in GI tract is achieved. The locomotion mechanism is the other technical challenge, besides the challenge of WPT. The progress about the WPT and the active capsule technology is reviewed.

  4. Pathogenesis and progression of fibroepithelial breast tumors

    NARCIS (Netherlands)

    Kuijper, Arno

    2006-01-01

    Fibroadenoma and phyllodes tumor are fibroepithelial breast tumors. These tumors are biphasic, i.e. they are composed of stroma and epithelium. The behavior of fibroadenomas is benign, whereas phyllodes tumors can recur and even metastasize. Classification criteria for both tumors show considerable

  5. Genomics and premalignant breast lesions: clues to the development and progression of lobular breast cancer.

    Science.gov (United States)

    Mastracci, Teresa L; Boulos, Fouad I; Andrulis, Irene L; Lam, Wan L

    2007-01-01

    Advances in genomic technology have improved our understanding of the genetic events that parallel breast cancer development. Because almost all mammary carcinomas develop in the terminal duct lobular units of the breast, understanding the events involved in mammary gland development make it possible to recognize those events that, when altered, contribute to breast neoplasia. In this review we focus on lobular carcinomas, discussing the pathology, development, and progression of premalignant lobular lesions from a genomic point of view. We highlight studies utilizing genomic approaches and describe how these investigations have furthered our understanding of the complexity of premalignant breast lesions.

  6. Analysis of breast cancer progression using principal component ...

    Indian Academy of Sciences (India)

    PRAKASH KUMAR

    Analysis of breast cancer progression using principal component analysis and clustering. 1027. J. Biosci. 32(5), August 2007. 1. Introduction. Microarrays have the potential to identify pathways that are altered in disease. This promise has resulted in this technology being aggressively pursued by researchers, hospitals and ...

  7. Analysis of breast cancer progression using principal component ...

    Indian Academy of Sciences (India)

    2007-07-07

    Jul 7, 2007 ... We identify the clusters and their pathways with distinct subtypes of breast cancer (Luminal, Basal and Her2+). We confirm that the cancer phenotype develops early (in early hyperplasia or ADH stage) and find from our analysis that each subtype progresses from ADH to DCIS to IDC along its own specific ...

  8. Solar thermal power systems. Annual technical progress report, FY 1979

    Energy Technology Data Exchange (ETDEWEB)

    Braun, Gerald W.

    1980-06-01

    The Solar Thermal Power Systems Program is the key element in the national effort to establish solar thermal conversion technologies within the major sectors of the national energy market. It provides for the development of concentrating mirror/lens heat collection and conversion technologies for both central and dispersed receiver applications to produce electricity, provide heat at its point of use in industrial processes, provide heat and electricity in combination for industrial, commercial, and residential needs, and ultimately, drive processes for production of liquid and gaseous fuels. This report is the second Annual Technical Progress Report for the Solar Thermal Power Systems Program and is structured according to the organization of the Solar Thermal Power Systems Program on September 30, 1979. Emphasis is on the technical progress of the projects rather than on activities and individual contractor efforts. Each project description indicates its place in the Solar Thermal Power Systems Program, a brief history, the significant achievements and real progress during FY 1979, also future project activities as well as anticipated significant achievements are forecast. (WHK)

  9. Genome evolution during progression to breast cancer

    KAUST Repository

    Newburger, D. E.

    2013-04-08

    Cancer evolution involves cycles of genomic damage, epigenetic deregulation, and increased cellular proliferation that eventually culminate in the carcinoma phenotype. Early neoplasias, which are often found concurrently with carcinomas and are histologically distinguishable from normal breast tissue, are less advanced in phenotype than carcinomas and are thought to represent precursor stages. To elucidate their role in cancer evolution we performed comparative whole-genome sequencing of early neoplasias, matched normal tissue, and carcinomas from six patients, for a total of 31 samples. By using somatic mutations as lineage markers we built trees that relate the tissue samples within each patient. On the basis of these lineage trees we inferred the order, timing, and rates of genomic events. In four out of six cases, an early neoplasia and the carcinoma share a mutated common ancestor with recurring aneuploidies, and in all six cases evolution accelerated in the carcinoma lineage. Transition spectra of somatic mutations are stable and consistent across cases, suggesting that accumulation of somatic mutations is a result of increased ancestral cell division rather than specific mutational mechanisms. In contrast to highly advanced tumors that are the focus of much of the current cancer genome sequencing, neither the early neoplasia genomes nor the carcinomas are enriched with potentially functional somatic point mutations. Aneuploidies that occur in common ancestors of neoplastic and tumor cells are the earliest events that affect a large number of genes and may predispose breast tissue to eventual development of invasive carcinoma.

  10. International Linear Collider-A Technical Progress Report

    Energy Technology Data Exchange (ETDEWEB)

    Elsen, Eckhard; /DESY; Harrison, Mike; /Brookhaven; Hesla, Leah; /Fermilab; Ross, Marc; /Fermilab; Royole-Degieux, Perrine; /Paris, IN2P3; Takahashi, Rika; /KEK, Tsukuba; Walker, Nicholas; /DESY; Warmbein, Barbara; /DESY; Yamamoto, Akira; /KEK, Tsukuba; Yokoya, Kaoru; /KEK, Tsukuba; Zhang, Min; /Beijing, Inst. High Energy Phys.

    2011-11-04

    The International Linear Collider: A Technical Progress Report marks the halfway point towards the Global Design Effort fulfilling its mandate to follow up the ILC Reference Design Report with a more optimised Technical Design Report (TDR) by the end of 2012. The TDR will be based on much of the work reported here and will contain all the elements needed to propose the ILC to collaborating governments, including a technical design and implementation plan that are realistic and have been better optimised for performance, cost and risk. We are on track to develop detailed plans for the ILC, such that once results from the Large Hadron Collider (LHC) at CERN establish the main science goals and parameters of the next machine, we will be in good position to make a strong proposal for this new major global project in particle physics. The two overriding issues for the ILC R&D programme are to demonstrate that the technical requirements for the accelerator are achievable with practical technologies, and that the ambitious physics goals can be addressed by realistic ILC detectors. This GDE interim report documents the impressive progress on the accelerator technologies that can make the ILC a reality. It highlights results of the technological demonstrations that are giving the community increased confidence that we will be ready to proceed with an ILC project following the TDR. The companion detector and physics report document likewise demonstrates how detector designs can meet the ambitious and detailed physics goals set out by the ILC Steering Committee. LHC results will likely affect the requirements for the machine design and the detectors, and we are monitoring that very closely, intending to adapt our design as those results become available.

  11. Environmental Research Division technical progress report, January 1984-December 1985

    Energy Technology Data Exchange (ETDEWEB)

    1986-05-01

    Technical progress in the various research and assessment activities of Argonne National Laboratory's Environmental Research Division is reported for the period 1984 to 1985. Textual, graphic, and tabular information is used to briefly summarize (in separate chapters) the work of the Division's Atmospheric Physics, Environmental Effects Research, Environmental Impacts, Fundamental Molecular Physics and Chemistry, and Waste Management Programs. Information on professional qualifications, awards, and outstanding professional activities of staff members, as well as lists of publications, oral presentations, special events organized, and participants in educational programs, are provided in appendices at the end of each chapter.

  12. CCN5/WISP-2: A micromanager of breast cancer progression.

    Science.gov (United States)

    Banerjee, Sushanta K; Banerjee, Snigdha

    2012-06-01

    The gain of plasticity by a subset of cancer cells is a unique but common sequence of cancer progression from epithelial phenotype to mesenchymal phenotype (EMT) that is followed by migration, invasion and metastasis to a distant organ, and drug resistance. Despite multiple studies, it is still unclear how cancer cells regulate plasticity. Recent studies from our laboratory and others' proposed that CCN5/WISP-2, which is found intracellularly (in the nucleus and cytoplasm) and extracellularly, plays a negative regulator of plasticity. It prevents the EMT process in breast cancer cells as well as pancreatic cancer cells. Multiple genetic insults, including the gain of p53 mutations that accumulate over the time, may perturb CCN5 expression in non-invasive breast cancer cells, which ultimately helps cells to gain invasive phenotypes. Moreover, emerging evidence indicates that several oncogenic lesions such as miR-10b upregulation and activation of TGF-β-signaling can accumulate during CCN5 crisis in breast cancer cells. Collectively, these studies indicate that loss of CCN5 activity may promote breast cancer progression; application of CCN5 protein may represent a novel therapeutic intervention in breast cancer and possibly pancreatic cancer.

  13. Morphine Promotes Tumor Angiogenesis and Increases Breast Cancer Progression

    Directory of Open Access Journals (Sweden)

    Sabrina Bimonte

    2015-01-01

    Full Text Available Morphine is considered a highly potent analgesic agent used to relieve suffering of patients with cancer. Several in vitro and in vivo studies showed that morphine also modulates angiogenesis and regulates tumour cell growth. Unfortunately, the results obtained by these studies are still contradictory. In order to better dissect the role of morphine in cancer cell growth and angiogenesis we performed in vitro studies on ER-negative human breast carcinoma cells, MDA.MB231 and in vivo studies on heterotopic mouse model of human triple negative breast cancer, TNBC. We demonstrated that morphine in vitro enhanced the proliferation and inhibited the apoptosis of MDA.MB231 cells. In vivo studies performed on xenograft mouse model of TNBC revealed that tumours of mice treated with morphine were larger than those observed in other groups. Moreover, morphine was able to enhance the neoangiogenesis. Our data showed that morphine at clinical relevant doses promotes angiogenesis and increases breast cancer progression.

  14. Second harmonic generation reveals matrix alterations during breast tumor progression

    Science.gov (United States)

    Burke, Kathleen; Tang, Ping; Brown, Edward

    2013-03-01

    Alteration of the extracellular matrix in tumor stroma influences efficiency of cell locomotion away from the primary tumor into surrounding tissues and vasculature, thereby affecting metastatic potential. We study matrix changes in breast cancer through the use of second harmonic generation (SHG) of collagen in order to improve the current understanding of breast tumor stromal development. Specifically, we utilize a quantitative analysis of the ratio of forward to backward propagating SHG signal (F/B ratio) to monitor collagen throughout ductal and lobular carcinoma development. After detection of a significant decrease in the F/B ratio of invasive but not in situ ductal carcinoma compared with healthy tissue, the collagen F/B ratio is investigated to determine the evolution of fibrillar collagen changes throughout tumor progression. Results are compared with the progression of lobular carcinoma, whose F/B signature also underwent significant evolution during progression, albeit in a different manner, which offers insight into varying methods of tissue penetration and collagen manipulation between the carcinomas. This research provides insights into trends of stromal reorganization throughout breast tumor development.

  15. Ror2 Signaling and Its Relevance in Breast Cancer Progression

    Directory of Open Access Journals (Sweden)

    Michaela Bayerlová

    2017-06-01

    Full Text Available Breast cancer is a heterogeneous disease and has been classified into five molecular subtypes based on gene expression profiles. Signaling processes linked to different breast cancer molecular subtypes and different clinical outcomes are still poorly understood. Aberrant regulation of Wnt signaling has been implicated in breast cancer progression. In particular Ror1/2 receptors and several other members of the non-canonical Wnt signaling pathway were associated with aggressive breast cancer behavior. However, Wnt signals are mediated via multiple complex pathways, and it is clinically important to determine which particular Wnt cascades, including their domains and targets, are deregulated in poor prognosis breast cancer. To investigate activation and outcome of the Ror2-dependent non-canonical Wnt signaling pathway, we overexpressed the Ror2 receptor in MCF-7 and MDA-MB231 breast cancer cells, stimulated the cells with its ligand Wnt5a, and we knocked-down Ror1 in MDA-MB231 cells. We measured the invasive capacity of perturbed cells to assess phenotypic changes, and mRNA was profiled to quantify gene expression changes. Differentially expressed genes were integrated into a literature-based non-canonical Wnt signaling network. The results were further used in the analysis of an independent dataset of breast cancer patients with metastasis-free survival annotation. Overexpression of the Ror2 receptor, stimulation with Wnt5a, as well as the combination of both perturbations enhanced invasiveness of MCF-7 cells. The expression–responsive targets of Ror2 overexpression in MCF-7 induced a Ror2/Wnt module of the non-canonical Wnt signaling pathway. These targets alter regulation of other pathways involved in cell remodeling processing and cell metabolism. Furthermore, the genes of the Ror2/Wnt module were assessed as a gene signature in patient gene expression data and showed an association with clinical outcome. In summary, results of this study

  16. Hanford Engineer Works technical progress letter No. 137, February 9--15, [1947

    Energy Technology Data Exchange (ETDEWEB)

    Greninger, A.B.

    1947-02-20

    This technical progress letter contains reports from six Technical Department divisions at the Hanford Engineer Works for February 9, through February 15, 1947. The six reporting divisions are: 100 Areas, 300 Area, 200 Areas, Chemical Development, Laboratories, and Statistical Studies.

  17. Nuclear and cytoplasmic LIMK1 enhances human breast cancer progression

    Directory of Open Access Journals (Sweden)

    Gutierrez-Hartmann Arthur

    2011-06-01

    Full Text Available Abstract Background LIM kinase 1 (LIMK1 is expressed in both cytoplasmic and nuclear compartments, and is a key regulator of cytoskeletal organization involved in cell migration and proliferation. LIMK1 levels are increased in several human cancers, with LIMK1 over-expression in prostate and breast cancer cells leading to tumor progression. While it has been presumed that the mechanism by which LIMK1 promotes cancer progression is via its cytoplasmic effects, the role of nuclear vs cytoplasmic LIMK1 in the tumorigenic process has not been examined. Results To determine if cytoplasmic or nuclear LIMK1 expression correlated with breast cancer, we performed immunohistochemical (IHC analysis of breast tissue microarrays (TMAs, The IHC analysis of breast TMAs revealed that 76% of malignant breast tissue samples strongly expressed LIMK1 in the cytoplasm, with 52% of these specimens also expressing nuclear LIMK1. Only 48% of benign breast samples displayed strong cytoplasmic LIMK1 expression and 27% of these expressed nuclear LIMK1. To investigate the respective roles of cytoplamsic and nuclear LIMK1 in breast cancer progression, we targeted GFP-LIMK1 to cytoplasmic and nuclear subcellular compartments by fusing nuclear export signals (NESs or nuclear localization sequences (NLS, respectively, to the amino-terminus of GFP-LIMK1. Stable pools of MDA-MB-231 cells were generated by retroviral transduction, and fluorescence microscopy revealed that GFP alone (control and GFP-LIMK1 were each expressed in both the cytoplasm and nucleus of MDA-MB-231 cells, whereas NLS-GFP-LIMK1 was expressed in the nucleus and NES-GFP-LIMK1 was expressed in the cytoplasm. Western blot analyses revealed equal expression of GFP-LIMK1 and NES-GFP-LIMK1, with NLS-GFP-LIMK1 expression being less but equal to endogenous LIMK1. Also, Western blotting revealed increased levels of phospho-cofilin, phospho-FAK, phospho-paxillin, phospho-Src, phospho-AKT, and phospho-Erk1/2 in cells

  18. Parameter estimates for invasive breast cancer progression in the Canadian National Breast Screening Study.

    Science.gov (United States)

    Taghipour, S; Banjevic, D; Miller, A B; Montgomery, N; Jardine, A K S; Harvey, B J

    2013-02-19

    The aim of screening is to detect a cancer in the preclinical state. However, a false-positive or a false-negative test result is a real possibility. We describe invasive breast cancer progression in the Canadian National Breast Screening Study and construct progression models with and without covariates. The effect of risk factors on transition intensities and false-negative probability is investigated. We estimate the transition rates, the sojourn time and sensitivity of diagnostic tests for women aged 40-49 and 50-59. Although younger women have a slower transition rate from healthy state to preclinical, their screen-detected tumour becomes evident sooner. Women aged 50-59 have a higher mortality rate compared with younger women. The mean sojourn times for women aged 40-49 and 50-59 are 2.5 years (95% CI: 1.7, 3.8) and 3.0 years (95% CI: 2.1, 4.3), respectively. Sensitivity of diagnostic procedures for older women is estimated to be 0.75 (95% CI: 0.55, 0.88), while women aged 40-49 have a lower sensitivity (0.61, 95% CI: 0.42, 0.77). Age is the only factor that affects the false-negative probability. For women aged 40-49, 'age at entry', 'history of breast disease' and 'families with breast cancer' are found to be significant for some of the transition rates. For the age-group 50-59, 'age at entry', 'history of breast disease', 'menstruation length' and 'number of live births' are found to affect the transition rates. Modelling and estimating the parameters of cancer progression are essential steps towards evaluating the effectiveness of screening policies. The parameters include the transition rates, the preclinical sojourn time, the sensitivity, and the effect of different risk factors on cancer progression.

  19. The role of S100 genes in breast cancer progression.

    LENUS (Irish Health Repository)

    McKiernan, Eadaoin

    2011-06-01

    The S100 gene family encode low molecular weight proteins implicated in cancer progression. In this study, we analyzed the expression of four S100 genes in one cohort of patients with breast cancer and 16 S100 genes in a second cohort. In both cohorts, the expression of S100A8 and S1009 mRNA level was elevated in high-grade compared to low-grade tumors and in estrogen receptor-negative compared to estrogen receptor-positive tumors. None of the S100 transcripts investigated were significantly associated with the presence of lymph node metastasis. Notably, multiple S100 genes, including S100A1, S100A2, S100A4, S100A6, S100A8, S100A9, S100A10, S100A11, and S100A14 were upregulated in basal-type breast cancers compared to non-basal types. Using Spearman\\'s correlation analysis, several S100 transcripts correlated significantly with each other, the strongest correlation has been found between S100A8 and S100A9 (r = 0.889, P < 0.001, n = 295). Of the 16 S100 transcripts investigated, only S100A11 and S100A14 were significantly associated with patient outcome. Indeed, these two transcripts predicted outcome in the cohort of patients that did not receive systemic adjuvant therapy. Based on our findings, we conclude that the different S100 genes play varying roles in breast cancer progression. Specific S100 genes are potential targets for the treatment of basal-type breast cancers.

  20. The role of S100 genes in breast cancer progression.

    LENUS (Irish Health Repository)

    McKiernan, Eadaoin

    2012-02-01

    The S100 gene family encode low molecular weight proteins implicated in cancer progression. In this study, we analyzed the expression of four S100 genes in one cohort of patients with breast cancer and 16 S100 genes in a second cohort. In both cohorts, the expression of S100A8 and S1009 mRNA level was elevated in high-grade compared to low-grade tumors and in estrogen receptor-negative compared to estrogen receptor-positive tumors. None of the S100 transcripts investigated were significantly associated with the presence of lymph node metastasis. Notably, multiple S100 genes, including S100A1, S100A2, S100A4, S100A6, S100A8, S100A9, S100A10, S100A11, and S100A14 were upregulated in basal-type breast cancers compared to non-basal types. Using Spearman\\'s correlation analysis, several S100 transcripts correlated significantly with each other, the strongest correlation has been found between S100A8 and S100A9 (r = 0.889, P < 0.001, n = 295). Of the 16 S100 transcripts investigated, only S100A11 and S100A14 were significantly associated with patient outcome. Indeed, these two transcripts predicted outcome in the cohort of patients that did not receive systemic adjuvant therapy. Based on our findings, we conclude that the different S100 genes play varying roles in breast cancer progression. Specific S100 genes are potential targets for the treatment of basal-type breast cancers.

  1. FY 1992 work plan and technical progress reports

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1992-11-01

    The Desert Research Institute (DRI) is a division of the University of Nevada System devoted to multidisciplinary scientific research. For more than 25 years, DRI has conducted research for the US Department of Energy`s Nevada Field Office (DOE/NV) in support of operations at the Nevada Test Site (NTS). During that time, the research program has grown from an early focus on hydrologic studies to include the areas of geology, archaeology, environmental compliance and monitoring, statistics, database management, public education, and community relations. The range of DRI`s activities has also expanded to include a considerable amount of management and administrative support in addition to scientific investigations. DRI`s work plan for FY 1992 reflects a changing emphasis in DOE/NV activities from nuclear weapons testing to environmental restoration and monitoring. Most of the environmental projects from FY 1991 are continuing, and several new projects have been added to the Environmental Compliance Program. The Office of Technology Development Program, created during FY 1991, also includes a number of environmental projects. This document contains the FY 1992 work plan and quarterly technical progress reports for each DRI project.

  2. Inventors Center of Michigan Technical Assessment Program. Final progress report

    Energy Technology Data Exchange (ETDEWEB)

    1992-12-31

    The Technical Assessment Program at the Inventors Center of Michigan is designed to provide independent inventors with a reliable assessment of the technical merits of their proposed inventions. Using faculty from within Ferris State University`s College of Technology an assessment process examines the inventor`s assumptions, documentation, and prototypes, as well as, reviewing patent search results and technical literature to provide the inventor with a written report on the technical aspects of the proposed invention. The forms for applying for a technical assessment of an invention are included.

  3. Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study

    DEFF Research Database (Denmark)

    von Minckwitz, Gunter; du Bois, Andreas; Schmidt, Marcus

    2009-01-01

    PURPOSE: Trastuzumab shows clinical activity in human epidermal growth factor receptor 2 (HER-2)-positive early and advanced breast cancer. In the German Breast Group 26/Breast International Group 03-05 trial, we investigated if trastuzumab treatment should be continued beyond progression. METHODS......: Patients with HER-2-positive breast cancer that progresses during treatment with trastuzumab were randomly assigned to receive capecitabine (2,500 mg/m(2) body-surface area on days 1 through 14 [1,250 mg/m(2) semi-daily]) alone or with continuation of trastuzumab (6 mg/kg body weight) in 3-week cycles...... with increased toxicity. CONCLUSION: Continuation of trastuzumab plus capecitabine showed a significant improvement in overall response and time to progression compared with capecitabine alone in women with HER-2-positive breast cancer who experienced progression during trastuzumab treatment....

  4. Verification of Steelmaking Slags Iron Content Final Technical Progress Report

    Energy Technology Data Exchange (ETDEWEB)

    J.Y. Hwang

    2006-10-04

    The steel industry in the United States generates about 30 million tons of by-products each year, including 6 million tons of desulfurization and BOF/BOP slag. The recycling of BF (blast furnace) slag has made significant progress in past years with much of the material being utilized as construction aggregate and in cementitious applications. However, the recycling of desulfurization and BOF/BOP slags still faces many technical, economic, and environmental challenges. Previous efforts have focused on in-plant recycling of the by-products, achieving only limited success. As a result, large amounts of by-products of various qualities have been stockpiled at steel mills or disposed into landfills. After more than 50 years of stockpiling and landfilling, available mill site space has diminished and environmental constraints have increased. The prospect of conventionally landfilling of the material is a high cost option, a waste of true national resources, and an eternal material liability issue. The research effort has demonstrated that major inroads have been made in establishing the viability of recycling and reuse of the steelmaking slags. The research identified key components in the slags, developed technologies to separate the iron units and produce marketable products from the separation processes. Three products are generated from the technology developed in this research, including a high grade iron product containing about 90%Fe, a medium grade iron product containing about 60% Fe, and a low grade iron product containing less than 10% Fe. The high grade iron product contains primarily metallic iron and can be marketed as a replacement of pig iron or DRI (Direct Reduced Iron) for steel mills. The medium grade iron product contains both iron oxide and metallic iron and can be utilized as a substitute for the iron ore in the blast furnace. The low grade iron product is rich in calcium, magnesium and iron oxides and silicates. It has a sufficient lime value and

  5. Molecular pathogenesis of progression and recurrence in breast phyllodes tumors

    Science.gov (United States)

    Jara-Lazaro, Ana Richelia; Tan, Puay Hoon

    2009-01-01

    Breast phyllodes tumors are rare fibroepithelial neoplasms that need to be distinguished from the common morphologically similar fibroadenomas, because phyllodes tumors can recur and progress to malignancy. Their potentially recurring and metastasizing behavior is attributed to their stromal characteristics, for which categorization between benign, borderline and malignant tumors have not been universally established. Previous clonality studies revealing monoclonal stromal cells versus a polyclonal epithelial component theorized that phyllodes tumors are mainly stromal neoplasms, possibly arising from fibroadenomas. More recent chromosomal imbalances in both epithelium and stroma have challenged this theory to favor neoplasia of both epithelium and stroma, with initial interdependence between the two components. Inverse correlations between epithelial and stromal overexpression for various biological markers like estrogen receptor, p53, c-kit, Ki-67, endothelin-1, epidermal growth factor receptor, heparan sulfate, in addition to findings of epithelial Wnt signalling with stromal insulin growth factors and beta-catenin expression, suggest an initial epithelial-stromal interdependence at the benign phase. Upon progression to malignancy, the stroma is hypothesized to assume an autonomous growth overriding any epithelial influence. Frequent genetic alterations are chromosomal gains of 1q and losses at chromosome 13. Acquisition of new genetic imbalances within the tumor consistent with intratumoral heterogeneity, and subclones within histologically benign phyllodes tumors that recur or metastasize are the current theories explaining these tumors' unpredictable clinical behavior. PMID:19966935

  6. Progress in diagnosis of breast cancer: Advances in radiology technology

    Directory of Open Access Journals (Sweden)

    J Mari Beth Linder

    2015-01-01

    Full Text Available Breast cancer is the leading cause of cancer in females between the ages of 15 and 54, and the second leading cause of cancer death in women in the United States. Diagnosis begins with detection by breast examination (clinical breast exam or breast self-exam or by radiologic studies, like mammography. Many advances in the diagnosis of breast cancer have taken place in recent years. This article will review the history of radiologic advances in the diagnosis of breast cancer. Use of technological advancements in digital breast tomosynthesis, magnetic resonance imaging, and ultrasound in breast cancer diagnosis will be presented. Advantages and disadvantages of these diagnostic interventions when compared to older, traditional X-ray films will be discussed. It is important for all nurses, including radiology and oncology nurses, to be well informed about these varied diagnostic modalities, and appreciate the fact that advances in radiologic imaging technologies can yield improved outcomes for breast cancer patients.

  7. Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as "equipment for your health"

    OpenAIRE

    Frank R Lichtenberg; Suchin Virabhak

    2002-01-01

    Several econometric studies have concluded that technical progress embodied in equipment is a major source of manufacturing productivity growth. Other research has suggested that, over the long run, growth in the U.S. economy's 'health output' has been at least as large as the growth in non-health goods and services. One important input in the production of health pharmaceuticals is even more R&D- intensive than equipment. In this paper we test the pharmaceutical-embodied technical progress h...

  8. Hanford Engineer Works technical progress letter No. 138, February 16--22, [1947

    Energy Technology Data Exchange (ETDEWEB)

    Greninger, A.B.

    1947-02-27

    This technical progress letter contains reports from six Technical Department divisions at the Hanford Engineer Works for February 16 through February 22, 1947. The six reporting divisions are: 100 Areas, 300 Area, 200 Areas, Chemical Development, Laboratories, and Statistical Studies. (JL)

  9. Cadmium, arsenic, selenium and iron- Implications for tumor progression in breast cancer.

    Science.gov (United States)

    Jablonska, E; Socha, K; Reszka, E; Wieczorek, E; Skokowski, J; Kalinowski, L; Fendler, W; Seroczynska, B; Wozniak, M; Borawska, M H; Wasowicz, W

    2017-07-01

    The aim of this study was to determine Cd (cadmium) and As (arsenic) contents in human breast cancer tissues, investigate their interactions with Se (selenium) and Fe (iron), and assess their further implications for tumor progression. Metal contents were determined in 42 tissue sets (tumor and adjacent tissue) collected from 42 women diagnosed with primary breast cancer. Analytical methods included AAS and ICP-MS techniques. Significantly higher contents of Cd (p=0.0003), Se (psupport the role of Cd in breast cancer risk and progression. The possible link between As exposure and breast cancer is still not clear. Copyright © 2017 Elsevier B.V. All rights reserved.

  10. Does Lactation Mitigate Triple Negative/Basal Breast Cancer Progression?

    Science.gov (United States)

    2012-09-01

    Breast Cancer Res Treat, 2008. 109(1): p. 123-39. 2. Palmer, J.R., et al., Parity and lactation in relation to estrogen receptor negative breast ...Xue F, Michels KB: Lactation and incidence of premenopausal breast cancer : a longitudinal study. Arch Intern Med 2009, 169(15):1364-1371. 19...Palmer JR, Boggs DA, Wise LA, Ambrosone CB, Adams-Campbell LL, Rosenberg L: Parity and lactation in relation to estrogen receptor negative breast cancer

  11. Evaporation by mechanical vapor recompression. Technical progress report, September 1-December 31, 1979

    Energy Technology Data Exchange (ETDEWEB)

    Iverson, C.H.; Coury, G.E.

    1979-01-01

    Progress to date in the development of a study of the application of the technologies of mechanical vapor recompression and falling film evaporators as applied to the beet sugar industry is reported. Progress is reported in the following areas: technical literature search and plant visitations of existing applications of VR/FFE.

  12. Thermal Energy Storage technical progress report, April 1984-March 1985

    Energy Technology Data Exchange (ETDEWEB)

    Martin, J.F.

    1986-01-01

    Progress in the development of Thermal Energy Storage (TES) technology under the Oak Ridge National Laboratory Thermal Energy Storage Program for the period April 1984-March 1985 is reported. The program goals and project structure are presented. Each of the areas of TES research active in the program is discussed, and a discussion of technology efforts is included.

  13. Pro-oncogene Pokemon promotes breast cancer progression by upregulating survivin expression

    OpenAIRE

    ZU, XUYU; Ma, Jun; Liu, Hongxia; Liu, Feng; Tan, Chunyan; Yu, Lingling; Wang, Jue; Xie, Zhenhua; Cao, Deliang; Jiang, Yuyang

    2011-01-01

    Introduction Pokemon is an oncogenic transcription factor involved in cell growth, differentiation and oncogenesis, but little is known about its role in human breast cancer. In this study, we aimed to reveal the role of Pokemon in breast cancer progression and patient survival and to understand its underlying mechanisms. Methods Tissue microarray analysis of breast cancer tissues from patients with complete clinicopathological data and more than 20 years of follow-up were used to evaluate Po...

  14. Quarterly technical progress report, February 1, 1996--April 30, 1996

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-05-28

    This report from the Amarillo National REsource Center for PLutonium provides research highlights and provides information regarding the public dissemination of information. The center is a a scientific resource for information regarding the issues of the storage, disposition, potential utilization and transport of plutonium, high explosives, and other hazardous materials generated from nuclear weapons dismantlement. The center responds to informational needs and interpretation of technical and scientific data raised by interested parties and advisory groups. Also, research efforts are carried out on remedial action programs and biological/agricultural studies.

  15. Technical progress report, 1 April-30 June 1981

    Energy Technology Data Exchange (ETDEWEB)

    None

    1981-01-01

    This report describes the technical accomplishments during the quarter ending June 1981, on the commercial nuclear waste management programs under the direction of the Office of Nuclear Waste Isolation (ONWI). The ONWI program is organized into 8 tasks entitled: systems, waste package, site, repository, regulatory and institutional, test facilities and excavations, land acquisition, and program management. Principal investigators in each of these areas have submitted summaries of quarterly highlights for inclusion in this report. Separate abstracts have been prepared for 5 of these tasks for inclusion in the Energy Data Base. (DMC)

  16. Environmental Research Division technical progress report: January 1986--October 1987

    Energy Technology Data Exchange (ETDEWEB)

    1988-07-01

    Technical process in the various research activities of Argonne National Laboratory's Environmental Research Division is reported for the period 1986-1987. Textual, graphic, and tabular information is used to briefly summarize (in separate chapters) the work of the Division's Atmospheric Physics, Environmental Effects Research, Fundamental Molecular Physics and Chemistry, and Organic Geochemistry and Environmental Instrumentation Programs. Information on professional qualifications, awards, and outstanding professional activities of staff members, as well as lists of publications, oral presentations, special events organized, and participants in educational programs, are provided in appendices at the end of each chapter. Individual projects under each division are processed separately for the data bases.

  17. ADAM12 produced by tumor cells rather than stromal cells accelerates breast tumor progression

    DEFF Research Database (Denmark)

    Frohlich, Camilla; Nehammer, Camilla; Albrechtsen, Reidar

    2011-01-01

    Expression of ADAM12 is low in most normal tissues, but is markedly increased in numerous human cancers, including breast carcinomas. We have previously shown that overexpression of ADAM12 accelerates tumor progression in a mouse model of breast cancer (PyMT). In the present study, we found...

  18. Solar hot water space heating system. Technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    Van Dam, T

    1979-08-13

    A retrofit solar heating system was installed on Madison Hall at Jordan College, Cedar Springs, Michigan. The system provides heating and domestic water preheating for a campus dormitory. Freeze protection is provided by a draindown system. The building and solar system, construction progress, and design changes are described. Included in appendices are: condensate trap design, structural analysis, pictures of installation, operating instructions, maintenance instructions, and as-built drawings. (MHR)

  19. Rotational flaps in oncologic breast surgery. Anatomical and technical considerations.

    Science.gov (United States)

    Acea Nebril, Benigno; Builes Ramírez, Sergio; García Novoa, Alejandra; Varela Lamas, Cristina

    2016-01-01

    Local flaps are a group of surgical procedures that can solve the thoracic closure of large defects after breast cancer surgery with low morbidity. Its use in skin necrosis complications after conservative surgery or skin sparing mastectomies facilitates the initiation of adjuvant treatments and reduces delays in this patient group. This article describes the anatomical basis for the planning of thoracic and abdominal local flaps. Also, the application of these local flaps for closing large defects in the chest and selective flaps for skin coverage by necrosis in breast conserving surgery. Copyright © 2016 AEC. Publicado por Elsevier España, S.L.U. All rights reserved.

  20. Total RNA Sequencing Analysis of DCIS Progressing to Invasive Breast Cancer

    Science.gov (United States)

    2016-09-01

    epigenetic alterations of pre-invasive DCIS that did or did not progress to invasive breast cancer, with an in-depth...NIH- funded study of genetic and epigenetic alterations of pre-invasive DCIS that either progressed to invasive breast cancer IBC (cases) or had no...Hill, NC 27599 8. Special Reporting Requirements N/A 9. Appendices 19 References 1. R-Core-Team: R: A language and environment

  1. Advanced thermally stable jet fuels. Technical progress report, 1995

    Energy Technology Data Exchange (ETDEWEB)

    Schobert, H.H.; Eser, S.; Song, C. [and others

    1996-04-01

    The Penn State program in advanced thermally stable jet fuels has five components:(1) development of mechanisms of degradation and solids formation; (2) quantitative measurement of growth of sub- micrometer and micrometer sized particles suspended in fuels during thermal stressing; (3) characterization of carbonaceous deposits by various instrumental and microscopic methods; (4) elucidation of the role of additives in retarding the formation of carbonaceous solids; and (5) assessment of the potential of producing high yields of cycloalkanes and hydroaromatics by direct liquefaction of coal. Progress reports for these tasks are presented.

  2. Technical, Psychological, and Economic Aspects of DIEP Flap Breast Reconstruction

    NARCIS (Netherlands)

    T.H.C. Damen (Tim)

    2011-01-01

    textabstractIn the Western world the incidence of breast cancer (BC) is high. In the Netherlands the lifetime risk for women to develop BC is around 13%, making it the most common form of cancer among women with approximately 12.000 women being diagnosed annually. Also, increasing numbers of women

  3. TECHNICAL TRAINING SEMINAR: High Temperature Superconductors: Progress and Issues

    CERN Multimedia

    Davide Vitè

    2002-01-01

    Monday 24 June from 14:30 to 15:30 - Training Centre Auditorium - bldg. 593-11 High Temperature Superconductors: Progress and Issues Prof. Jan Evetts / UNIVERSITY OF CAMBRIDGE, Department of Materials Science and Metallurgy, UK Grappling with grain boundaries: Current transport processes in granular High Temperature Superconductors (HTS) The development of High Temperature Superconductors, seen from a materials scientist's point of view, is relevant to the superconductivity community at CERN: their possible high current applications can include high performance magnets for future accelerators. There is an urgent need to develop a quantitative description of HTS conductors in terms of their complex anisotropy, inhomogeneity and dimensionality. This is essential both for the practical specification of a conductor and for charting routes to conductor optimisation. The critical current, the n-value, dissipation and quenching characteristics are amongst most important parameters that make up an engineering specifi...

  4. Texas Experimental Tokamak. Technical progress report, April 1990--April 1993

    Energy Technology Data Exchange (ETDEWEB)

    Wootton, A.J.

    1993-04-01

    This progress report covers the period from November 1, 1990 to April 30, 1993. During that period, TEXT was operated as a circular tokamak with a material limiter. It was devoted to the study of basic plasma physics, in particular to study of fluctuations, turbulence, and transport. The purpose is to operate and maintain TEXT Upgrade as a complete facility for applied tokamak physics, specifically to conduct a research program under the following main headings: (1) to elucidate the mechanisms of working gas, impurity, and thermal transport in tokamaks, in particular to understand the role of turbulence; (2) to study physics of the edge plasma, in particular the turbulence; (3) to study the physics or resonant magnetic fields (ergodic magnetic divertors, intra island pumping); and (4) to study the physics of electron cyclotron heating (ECRH). Results of studies in each of these areas are reported.

  5. Tight junctions: a barrier to the initiation and progression of breast cancer?

    LENUS (Irish Health Repository)

    Brennan, Kieran

    2010-01-01

    Breast cancer is a complex and heterogeneous disease that arises from epithelial cells lining the breast ducts and lobules. Correct adhesion between adjacent epithelial cells is important in determining the normal structure and function of epithelial tissues, and there is accumulating evidence that dysregulated cell-cell adhesion is associated with many cancers. This review will focus on one cell-cell adhesion complex, the tight junction (TJ), and summarize recent evidence that TJs may participate in breast cancer development or progression. We will first outline the protein composition of TJs and discuss the functions of the TJ complex. Secondly we will examine how alterations in these functions might facilitate breast cancer initiation or progression; by focussing on the regulatory influence of TJs on cell polarity, cell fate and cell migration. Finally we will outline how pharmacological targeting of TJ proteins may be useful in limiting breast cancer progression. Overall we hope to illustrate that the relationship between TJ alterations and breast cancer is a complex one; but that this area offers promise in uncovering fundamental mechanisms linked to breast cancer progression.

  6. A role for ADAM12 in breast tumor progression and stromal cell apoptosis

    DEFF Research Database (Denmark)

    Kveiborg, Marie; Frohlich, Camilla; Albrechtsen, Reidar

    2005-01-01

    of stromal fibroblasts in tumor initiation and progression has been elucidated. Here, we show that stromal cell apoptosis occurs in human breast carcinoma but is only rarely seen in nonmalignant breast lesions. Furthermore, we show that ADAM12, a disintegrin and metalloprotease up-regulated in human breast...... cancer, accelerates tumor progression in a mouse breast cancer model. ADAM12 does not influence tumor cell proliferation but rather confers both decreased tumor cell apoptosis and increased stromal cell apoptosis. This dual role of ADAM12 in governing cell survival is underscored by the finding that ADAM......12 increases the apoptotic sensitivity of nonneoplastic cells in vitro while rendering tumor cells more resistant to apoptosis. Together, these results show that the ability of ADAM12 to influence apoptosis may contribute to tumor progression....

  7. Technical Division quarterly progress report, January 1--March 31, 1977

    Energy Technology Data Exchange (ETDEWEB)

    Slansky, C.M. (ed.)

    1977-05-01

    Progress is reported in three categories: Fuel Cycle Research and Development, special materials production, and projects supporting energy development. Results are presented on the fluidized-bed calcination of high-level radioactive waste from the reprocessing of spent commercial nuclear fuel, on the post treatment of the calcine, and on the removal of actinide elements from the waste prior to calcination. Other projects include the development of storage technology for /sup 85/Kr waste; a study of the hydrogen mordenite catalyzed reaction between NO/sub x/ and NH/sub 3/; the adsorption and storage of /sup 129/I on silver exchanged mordenite; physical properties, materials of construction, and unit operations studies on the evaporation of high-level waste; the behavior of volatile radionuclides during the combustion of HTGR graphite-based fuel; and the use of fission product ruthenium in age-dating uranium ore bodies. The long-term management of defense waste from the ICPP covers post-calcination treatment of ICPP calcined waste. Improvements are reported on the Fluorinel head end process for Zircaloy-clad fuels. Studies are included on nuclear materials security; application of a liquid-solid fluidized-bed heat exchanger to the recovery of geothermal heat; inplant reactor source term measurements; burnup methods for fast breeder reactor fuels; research on analytical methods; and the behavior of environmental species of iodine.

  8. Texas Experimental Tokamak, a plasma research facility: Technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    Wootton, A.J.

    1995-08-01

    In the year just past, the authors made major progress in understanding turbulence and transport in both core and edge. Development of the capability for turbulence measurements throughout the poloidal cross section and intelligent consideration of the observed asymmetries, played a critical role in this work. In their confinement studies, a limited plasma with strong, H-mode-like characteristics serendipitously appeared and received extensive study though a diverted H-mode remains elusive. In the plasma edge, they appear to be close to isolating a turbulence drive mechanism. These are major advances of benefit to the community at large, and they followed from incremental improvements in diagnostics, in the interpretation of the diagnostics, and in TEXT itself. Their general philosophy is that the understanding of plasma physics must be part of any intelligent fusion program, and that basic experimental research is the most important part of any such program. The work here demonstrates a continuing dedication to the problems of plasma transport which continue to plague the community and are an impediment to the design of future devices. They expect to show here that they approach this problem consistently, systematically, and effectively.

  9. Breast Reconstruction: A Century of Controversies and Progress.

    Science.gov (United States)

    Homsy, Antoine; Rüegg, Eva; Montandon, Denys; Vlastos, Georges; Modarressi, Ali; Pittet, Brigitte

    2018-01-31

    Breast cancer treatment has dramatically changed over the past century. Since Halsted's first description of radical mastectomy in 1882, breast reconstruction has evolved slowly from being considered as a useless or even dangerous procedure by surgeons to the possibility nowadays of reconstructing almost any kind of defect. In this review on the development of breast reconstruction, we outline the historical milestone innovations that led to the current management of the mastectomy defect in an attempt to understand the economic, social and psychological factors, which contributed to slow down its acceptance for several decades.

  10. Immune Suppression and Inflammation in the Progression of Breast Cancer

    Science.gov (United States)

    2008-03-01

    DAMD-17-01-1- 0312 grants. SKB is supported by a pre-doctoral fellowship from the DOD Breast Cancer Research Program (W81XWH-05-1-0276). P 2...Susan G. Komen Grant for the Cure BCTR0503885. SKB is supported by a pre-doctoral fellowship from the DOD Breast Cancer Research Program (W81XWH-05-1...the Cure BCTR0503885. SKB is supported by a pre-doctoral fellowship from the DOD Breast Cancer Research Program (W81XWH-05-1-0276). 136 REFERENCES

  11. Technical Division quarterly progress report, April 1--June 30, 1978

    Energy Technology Data Exchange (ETDEWEB)

    Plung, D.L. (ed.)

    1978-12-01

    Fuel cycle research and development: results are presented on fluidized-bed calcination and on post-treatment of commercial wastes; study was done on the use of microwave energy in processing wastes and on the use of bidentate compounds for separation of actinides from commercial power reactor reprocessing waste. Work on the krypton-85 storage development program, including the results of rubidium corrosion tests, is reported. In the HTGR fuel reprocessing section, the results of x-ray and Auger spectroscopy analysis of CO oxidation catalyst are reported. Special materials production: the long-term management of high-level ICPP wastes is reported: development of a calcine pelletizing pilot plant, actinide removal, actinide extraction by DHDECMP, and calcined solids retrieval and handling. Design work was completed for the fluorinel pilot-plant upgrade. Other development results reported are on the progress of the Rover plant, and on flowsheet development for electrolytic and second-cycle waste, for Fluorinel waste, and for Tank WM-183. Other results reported include: assistance to the Waste Calcining Facility and to the New Waste Calcining Facility, methods for the monitoring of gaseous effluents, and a mathematical model to describe chloride buildup in the waste calcining scrubbing solution. Other projects supporting energy developments: results are reported on nuclear materials safety, the installation and operation of a geothermal fluidized-bed dryer, the in-plant source-term measurement at the Turkey Point station, burnup methods for fast breeder reactor fuels, absolute thermal fission yields, analytical support to light-water breeder reactor developments, cerium analysis of actinide removal project solutions, a spark source mass spectrometric computer program, and on environmental iodine species behavior.

  12. An imbalance in progenitor cell populations reflects tumour progression in breast cancer primary culture models.

    LENUS (Irish Health Repository)

    Donatello, Simona

    2011-01-01

    Many factors influence breast cancer progression, including the ability of progenitor cells to sustain or increase net tumour cell numbers. Our aim was to define whether alterations in putative progenitor populations could predict clinicopathological factors of prognostic importance for cancer progression.

  13. ERIP invention 637. Technical progress report 2nd quarter, April 1997--June 1997

    Energy Technology Data Exchange (ETDEWEB)

    Thacker, G.W.

    1997-07-22

    This technical report describes progress in the development of the Pegasus plow, a stalk and root embedding apparatus. Prototype testing is reported, and includes the addition of precision tillage. Disease data, organic matter, and nitrogen levels results are very briefly described. Progress in marketing is also reported. Current marketing issues include test use by cotton and wheat growers, establishment of dealer relationships, incorporation of design modifications, expansion of marketing activities, and expansion of loan and lease program.

  14. Hypofractionated Adjuvant Whole Breast Radiotherapy: Progress and Prospects

    Energy Technology Data Exchange (ETDEWEB)

    Yarnold, John (Section of Radiotherapy, Inst. of Cancer Research, Royal Marsden Hospital, Sutton (United Kingdom)), E-mail: john.yarnold@icr.ac.uk; Haviland, Joanne (Clinical Trials and Statistics Unit (ICR-CTSU), Section of Clinical Trials, Inst. of Cancer Research, Sutton (United Kingdom))

    2010-11-15

    Published results of randomised trials involving >7000 women confirm the safety and efficacy of hypofractionated schedules of adjuvant radiotherapy for women with early breast cancer using fraction sizes between 2 and 3 Gy assuming appropriate downward adjustments to total dose. Unnecessary concerns relating to heart tolerance, suboptimal dose distribution and duration of follow up need not discourage the routine adoption of 15- or 16-fraction schedules in women treated by breast conservation surgery for early breast cancer. Regardless of fractionation regimen, dose escalation to the index quadrant in high risk subgroups will result in a greater relative increase in late adverse effects than tumour control, a therapeutic disadvantage that can only be overcome by exploiting a marked dose-volume effect. A 15-fraction schedule of whole breast radiotherapy is unlikely to represent the lower limits of hypofractionation, and the preliminary results of a 5-fraction regimen are encouraging

  15. MONOCLONAL ANTIBODIES AND BREAST CANCER. CURRENT THERAPEUTIC PROGRESS

    OpenAIRE

    Collignon, Joëlle; Gennigens, Christine; Rorive, Andrée; Coucke, Philippe; Lifrange, Eric; Maweja, Sylvie; Fillet, Georges; Jerusalem, Guy

    2009-01-01

    About 9,500 new breast cancers are diagnosed in Belgium every year. Improvement of our knowledge of altered molecular events leading to the proliferation of tumor cells has resulted in the development of targeted therapies in subgroups of cancers. One of the first validation of targeted therapy is the anti-HER-2 monoclonal antibody trastuzumab (Herceptin) in patients with overexpression of human epidermal growth factor receptor type 2 (HER2) occurring in 20 to 25% of invasive breast carcinoma...

  16. Kinesin family member 11 contributes to the progression and prognosis of human breast cancer.

    Science.gov (United States)

    Pei, Yuan-Yuan; Li, Gao-Chi; Ran, Jian; Wei, Feng-Xiang

    2017-12-01

    The present study aimed to clarify the association between kinesin family member 11 (KIF11) and human breast cancer, and the effect of KIF11 on breast cancer cell progression. Western blot analysis, reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis, retroviral infection, immunohistochemistry staining, MTT assay, anchorage-independent growth ability assay and tumorigenicity assay were all used in the present study. Western blot and RT-qPCR analysis revealed that the expression of KIF11 was markedly increased in malignant cells compared with that in non-tumorous cells at the mRNA and protein level. Immunohistochemical analysis revealed that KIF11 expression was upregulated in 256/268 (95.8%) paraffin-embedded archival breast cancer biopsies. Statistical analysis demonstrated a significant association between the upregulation of KIF11 expression and the progression of breast cancer. Multivariate analysis revealed that KIF11 upregulation represents an independent prognostic indicator for the survival of patients with breast cancer. Tumorigenicity experiments were further used to evaluate the effect of KIF11 in non-obese diabetic/severe combined immunodeficient mice. Silencing endogenous KIF11 by short hairpin RNAs inhibited the proliferation of breast cancer cells in vitro and in vivo . The present results suggest that KIF11 may serve an important function in the proliferation of breast cancer and may represent a novel and useful prognostic marker for breast cancer.

  17. PREFACE: Scientific and Technical Challenges in the Well Drilling Progress

    Science.gov (United States)

    2015-02-01

    departments - Technologies in Mineral Exploration and Technologies in Mineral Exploration were merged into one department. In 2003 the newly merged Department of Drilling was established within the Institute of Petroleum Engineering, now the Institute of Natural Resources and is located in Building № 6 where it began its life. During these 60 years more than 3000 specialists have graduated the Department of Drilling, many whom are highly-qualified and dedicated professionals. There is no doubt that this Conference involved comprehensive advanced engineering problems in drilling and issues on relevant personnel training. It is extremely important to understand how the 60-year progress and contribution in the field of drilling has left its trace in the history of this Department; and, that, now, it is necessary to move further and seek new and new horizons in drilling.

  18. Amarillo National Resource Center for Plutonium. Quarterly technical progress report, May 1--July 31, 1998

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1998-09-01

    Progress is reported on research projects related to the following: Electronic resource library; Environment, safety, and health; Communication, education, training, and community involvement; Nuclear and other materials; and Reporting, evaluation, monitoring, and administration. Technical studies investigate remedial action of high explosives-contaminated lands, radioactive waste management, nondestructive assay methods, and plutonium processing, handling, and storage.

  19. FAST FLUX TEST FACILITY MONTHLY INFORMAL TECHNICAL PROGRESS REPORT: MARCH 1969

    Energy Technology Data Exchange (ETDEWEB)

    Astley, E. R.

    1969-04-07

    This report was prepared by Battelle-Northwest under Contract No. AT(4S-l)-1830 for the Atomic Energy Commission, Division of Reactor Development and Technology, to summarize technical progress made in the Fast Flux Test Facility Program during March 1969.

  20. FAST FLUX TEST FACILITY MONTHLY INFORMAL TECHNICAL PROGRESS REPORT MAY 1969

    Energy Technology Data Exchange (ETDEWEB)

    Astley, E. R.; Cabell, C. P.

    1969-06-06

    This report was prepared by Battelle-Northwest under Contract No. AT(45-1)-1830 for the Atomic Energy Commission, Division of Reactor Development and Technology, to summarize technical progress made in the Fast Flux Test Facility Program during May 1969 .

  1. FAST FLUX TEST FACILITY MONTHLY INFORMAL TECHNICAL PROGRESS REPORT SEPTEMBER 1969

    Energy Technology Data Exchange (ETDEWEB)

    Astely, E. R.; Cabell, C. P.

    1969-10-07

    This report was prepared by Battelle-Northwest under Contract No. AT(45-1)-1830 for the Atomic Energy Commission, Division of Reactor Development and Technology, to summarize technical progress made in the Fast Flux Test Facility Program during September 1969.

  2. FAST FLUX TEST FACILITY MONTHLY INFORMAL TECHNICAL PROGRESS REPORT FEBRUARY 1969

    Energy Technology Data Exchange (ETDEWEB)

    Astley, E. R.

    1969-03-07

    This report was prepared by Battelle-Northwest under Contract No. AT (45-1)-1830 for the Atomic Energy Commission, Division of Reactor Development and Technology, to summarize technical progress made in the Fast Flux Test Facility Program during February 1969.

  3. Development of superior asphalt recycling agency: Phase 1, Technical feasibility. Technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    Bullin, J.A.; Glover, C.J.; Davison, R.R.; Lin, Moon-Sun; Chaffin, J.; Liu, Meng; Eckhardt, C.

    1996-04-01

    About every 12 years, asphalt roads must be reworked, and this is usually done by placing thick layers (hot-mix overlays) of new material on top of failed material, resulting in considerable waste of material and use of new asphalt binder. A good recycling agent is needed, not only to reduce the viscosity of the aged material but also to restore compatibility. Objective is to establish the technical feasibility (Phase I) of determining the specifications and operating parameters for producing high quality recycling agents which will allow most/all the old asphalt-based road material to be recycled. It is expected that supercritical fractionation can be used. The advanced road aging simulation procedure will be used to study aging of blends of old asphalt and recycling agents.

  4. Development of Ultrasound Tomography for Breast Imaging: Technical Assessment

    Energy Technology Data Exchange (ETDEWEB)

    Duric, N; Littrup, P; Babkin, A; Chambers, D; Azevedo, S; Arkady, K; Pevzner, R; Tokarev, M; Holsapple, E

    2004-09-30

    Ultrasound imaging is widely used in medicine because of its benign characteristics and real-time capabilities. Physics theory suggests that the application of tomographic techniques may allow ultrasound imaging to reach its full potential as a diagnostic tool allowing it to compete with other tomographic modalities such as X-ray CT and MRI. This paper describes the construction and use of a prototype tomographic scanner and reports on the feasibility of implementing tomographic theory in practice and the potential of US tomography in diagnostic imaging. Data were collected with the prototype by scanning two types of phantoms and a cadaveric breast. A specialized suite of algorithms was developed and utilized to construct images of reflectivity and sound speed from the phantom data. The basic results can be summarized as follows: (1) A fast, clinically relevant US tomography scanner can be built using existing technology. (2) The spatial resolution, deduced from images of reflectivity, is 0.4 mm. The demonstrated 10 cm depth-of-field is superior to that of conventional ultrasound and the image contrast is improved through the reduction of speckle noise and overall lowering of the noise floor. (3) Images of acoustic properties such as sound speed suggest that it is possible to measure variations in the sound speed of 5 m/s. An apparent correlation with X-ray attenuation suggests that the sound speed can be used to discriminate between various types of soft tissue. (4) Ultrasound tomography has the potential to improve diagnostic imaging in relation to breast cancer detection.

  5. Progress in the Biological Understanding and Management of Breast Cancer-Associated Central Nervous System Metastases

    Science.gov (United States)

    Gonzalez-Angulo, Ana M.

    2013-01-01

    Metastasis to the central nervous system (CNS) is a devastating neurological complication of systemic cancer. Brain metastases from breast cancer have been documented to occur in approximately 10%–16% of cases over the natural course of the disease with leptomeningeal metastases occurring in approximately 2%–5% of cases of breast cancer. CNS metastases among women with breast cancer tend to occur among those who are younger, have larger tumors, and have a more aggressive histological subtype such as the triple negative and HER2-positive subtypes. Treatment of CNS metastases involves various combinations of whole brain radiation therapy, surgery, stereotactic radiosurgery, and chemotherapy. We will discuss the progress made in the treatment and prevention of breast cancer-associated CNS metastases and will delve into the biological underpinnings of CNS metastases including evaluating the role of breast tumor subtype on the incidence, natural history, prognostic outcome, and impact of therapeutic efficacy. PMID:23740934

  6. Epigenetic regulator RBP2 is critical for breast cancer progression and metastasis

    Science.gov (United States)

    Cao, Jian; Liu, Zongzhi; Cheung, William K.C.; Zhao, Minghui; Chen, Sophia Y.; Chan, Siew Wee; Booth, Carmen J.; Nguyen, Don X.; Yan, Qin

    2014-01-01

    Summary Metastasis is a major clinical challenge for cancer treatment. Emerging evidence suggests that epigenetic aberrations contribute significantly to tumor formation and progression. However, the drivers and roles of such epigenetic changes in tumor metastasis are still poorly understood. Using bioinformatic analysis of human breast cancer gene expression datasets, we identified histone demethylase RBP2 as a putative mediator of metastatic progression. By using both human breast cancer cells and genetically engineered mice, we demonstrated that RBP2 is critical for breast cancer metastasis to the lung in multiple in vivo models. Mechanistically, RBP2 promotes metastasis as a pleiotropic positive regulator of many metastasis genes. In addition, RBP2 loss suppresses tumor formation in the MMTV-neu transgenic mice. These results suggest that therapeutically targeting RBP2 is a potential strategy to inhibit tumor progression and metastasis. PMID:24582965

  7. Discovery of Genomic Breakpoints Affecting Breast Cancer Progression and Prognosis

    Science.gov (United States)

    2010-10-01

    19a. NAME OF RESPONSIBLE PERSON USAMRMC a. REPORT U b. ABSTRACT U c. THIS PAGE U UU 34 19b. TELEPHONE NUMBER (include area code...Predki, P., Martin, C., Wernick , M., et al. 2001. Comprehensive genome sequence analysis of a breast cancer amplicon. Genome Res. 11: 1034–1042. Hahn, Y

  8. Development of superior asphalt recycling agents. Phase 1, Technical feasibility. Technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    Bullin, J.A.; Glover, C.J.; Davison, R.R.; Chaffin, J.; Lin, Moon-Sun

    1995-07-01

    About 27 million tons of asphalt and nearly twenty times this much aggregate are consumed each year to build and maintain over two million miles of roads in this country. Over a cycle of about 12 years on the average, these roads must be reworked and much of these millions of tons of rock and asphalt cannot be reused with present recycling technology. Instead, much of the maintenance is accomplished by placing thick layers (hot-mix overlays) of new material on top of the failed material. This results in considerable waste of material, both in terms of quality aggregate and in terms of asphalt binder. In addition, the new asphalt binder represents a significant source of potential energy. The main impediment to recycling asphalt binder is the poorly developed science of recycling agent composition and, as a result, optimum recycling agents are not available. An excellent recycling agent should not only be able to reduce the viscosity of the aged material, but it must also be able to restore compatibility. The properties of the old material and recycling agent must be compatible to give both good initial properties and aging characteristics, and this must be understood. The agent must also be inexpensive and easily manufactured. A large quantity of potential feedstock for the production of recycling agents is available and much of it is now fed to cokers. This material could be recovered by supercritical extraction which is an existing refinery technology. A supercritical pilot plant is available at Texas A&M and has been used to produce fractions for study. The objective of this research is to establish the technical feasibility of determining the specifications and operating parameters necessary to produce high quality recycling agents which will allow most old asphalt-based road material to be recycled.

  9. Technical analysis support for Transportation Energy Conservation Division of DOE. Tenth progress report for May 1979

    Energy Technology Data Exchange (ETDEWEB)

    1979-06-10

    The work to be performed by the Aerospace Corporation for the DOE/TEC is confined to the following basic task areas: (1) technical support of ongoing research and development programs in energy efficient transportation systems; (2) analysis for the future commercialization of transportation technologies; (3) new concept evaluation program support; (4) technical evaluation of new concepts, inventions, and ideas; (5) assessment of technological and other factors on the implementation and utilization of transportation in the United States; and (6) program planning analysis and documentation. The status of achieved progress through the period ending May 31, 1979 is presented; and the expenditure status is summarized. (WHK)

  10. FoxD3 deficiency promotes breast cancer progression by induction of epithelial–mesenchymal transition

    Energy Technology Data Exchange (ETDEWEB)

    Chu, Tian-Li [Department of General Surgery, The People’s Hospital of Wuqing, Tianjin (China); Zhao, Hong-Meng [Key Laboratory of Breast Cancer Prevention and Treatment of the Ministry of Education, Tianjin Medical University Cancer Institute and Hospital, Tianjin (China); Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin (China); Li, Yue [Department of Respiration, Affiliated Hospital of Medical College of Chinese People’s Armed Police Force, Tianjin (China); Chen, Ao-Xiang; Sun, Xuan [Key Laboratory of Breast Cancer Prevention and Treatment of the Ministry of Education, Tianjin Medical University Cancer Institute and Hospital, Tianjin (China); Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin (China); Ge, Jie, E-mail: gejie198003@163.com [Key Laboratory of Breast Cancer Prevention and Treatment of the Ministry of Education, Tianjin Medical University Cancer Institute and Hospital, Tianjin (China); Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin (China)

    2014-04-04

    Highlights: • FOXD3 is down-regulated in breast cancer tissues. • FOXD3 inhibits breast cancer cell proliferation and invasion. • FoxD3 deficiency induces epithelial–mesenchymal transition. - Abstract: The transcription factor forkhead box D3 (FOXD3) plays an important role in the development of neural crest and gastric cancer cells. However, the function and mechanisms of FOXD3 in the breast tumorigenesis and progression is still limited. Here, we report that FOXD3 is a tumor suppressor of breast cancer tumorigenicity and aggressiveness. We found that FOXD3 is down-regulated in breast cancer tissues. Patients with low FOXD3 expression have a poor outcome. Depletion of FOXD3 expression promotes breast cancer cell proliferation and invasion in vitro, whereas overexpression of FOXD3 inhibits breast cancer cell proliferation and invasion both in vitro and in vivo. In addition, depletion of FOXD3 is linked to epithelial–mesenchymal transition (EMT)-like phenotype. Our results indicate FOXD3 exhibits tumor suppressive activity and may be useful for breast therapy.

  11. Fuels, materials, and coolant chemistry programs. Annual technical progress report, GFY 1969

    Energy Technology Data Exchange (ETDEWEB)

    Murbach, E. W.; Atkins, D. F.

    1970-09-01

    The objectives of the project are to (1) manage a source of stock systems quality sodium for the program, (2) monitor the compositions of sodium and of gas atmospheres in use on all the subtasks in the program; and provide a management system for ensuring the use of proper procedures in sampling, transferring, and analyzing of sodium, and (3) procure, characterize and manage a supply of cladding materials for the program. The report provides technical progress during fiscal year 1969.

  12. TERTIARY ECONOMIC ACTIVITIES UNDER THE IMPACT OF SCIENTIFIC AND TECHNICAL PROGRESS IN ROMANIA

    Directory of Open Access Journals (Sweden)

    PAUL-BOGDAN ZAMFIR

    2015-06-01

    Full Text Available The scientific and technical progress put its mark in a different manner on all activities that occur within contemporary economy and it was present in the entire evolution of human society, but its implications and effects were never so strong and extensive. There is no area of activity in which progress not to interfere, both as important mutations that they are happening in the all area of production factors, as well as the place and role of the human factor in the deployment of production processes. In the current period the progress has exceeded certain human limits, operating in other areas which until more now it seems unattainable by the achievements of new technology. In this paradigm are successfully integrated tertiary activities in which the scientific and technical progress entered with great difficulty.Nowadays we are witnessing spectacular evolutions whether we talk about movement of goods, education, research, health, transportation, arts and culture, etc. The purpose of this paper is to determine the degree in which scientific and technical progress. In this paper we proposed to determine the level in which the scientific and technical progress, had a decisive impact on the development of the tertiary sector in general and in Romania in particular , we shall specify which are the economic tertiary activities that adapt fast to new changes occurred in the system of informational society. In this context we have to mention the systems of intelligent transport, electronic governance, medical system based on ICT online educational systems, as a possible response of the tertiary sector to the adaptation of technological progress benefits. In the first part of this paper we focused on the conceptual delimitation of scientific concepts at which we refer often such as: technological progress and innovative services which inevitably determine the evolution of tertiary sector under the impact of new modern technologies. On this background

  13. Decontamination Systems Information and Research Program. Quarterly technical progress report, January 1--March 31, 1994

    Energy Technology Data Exchange (ETDEWEB)

    1994-05-01

    West Virginia University (WVU) and the US DOE Morgantown Energy Technology Center (METC) entered into a Cooperative Agreement on August 29, 1992 entitled ``Decontamination Systems Information and Research Programs.`` Stipulated within the Agreement is the requirement that WVU submit to METC a series of Technical Progress Reports on a quarterly basis. This report comprises the first Quarterly Technical Progress Report for Year 2 of the Agreement. This report reflects the progress and/or efforts performed on the sixteen (16) technical projects encompassed by the Year 2 Agreement for the period of January 1 through March 31, 1994. In situ bioremediation of chlorinated organic solvents; Microbial enrichment for enhancing in-situ biodegradation of hazardous organic wastes; Treatment of volatile organic compounds (VOCs) using biofilters; Drain-enhanced soil flushing (DESF) for organic contaminants removal; Chemical destruction of chlorinated organic compounds; Remediation of hazardous sites with steam reforming; Soil decontamination with a packed flotation column; Use of granular activated carbon columns for the simultaneous removal of organics, heavy metals, and radionuclides; Monolayer and multilayer self-assembled polyion films for gas-phase chemical sensors; Compact mercuric iodide detector technology development; Evaluation of IR and mass spectrometric techniques for on-site monitoring of volatile organic compounds; A systematic database of the state of hazardous waste clean-up technologies; Dust control methods for insitu nuclear and hazardous waste handling; Winfield Lock and Dam remediation; and Socio-economic assessment of alternative environmental restoration technologies.

  14. Immune Suppression and Inflammation in the Progression of Breast Cancer

    National Research Council Canada - National Science Library

    Bunt, Stephanie K

    2007-01-01

    .... Tumor progression in many patients and experimental animals with cancer is frequently associated with the expansion of a population of myeloid cells, termed Myeloid-derived Suppressor Cells (MDSC...

  15. Genomic analyses of breast cancer progression reveal distinct routes of metastasis emergence

    DEFF Research Database (Denmark)

    Krøigård, Anne Bruun; Larsen, Martin Jakob; Brasch-Andersen, Charlotte

    2017-01-01

    A main controversy in cancer research is whether metastatic abilities are present in the most advanced clone of the primary tumor or result from independently acquired aberrations in early disseminated cancer cells as suggested by the linear and the parallel progression models, respectively. The ...... clinical implications and provides substantial novel molecular insights into the timing and mutational evolution of breast cancer metastasis....

  16. Analysis of the progression of fibroepithelial tumours of the breast by PCR-based clonality assay

    NARCIS (Netherlands)

    Kuijper, Arno; Buerger, H.; Simon, R.; Schaefer, K-L.; Croonen, A.; Boecker, W.; Wall, E. van der; Diest, P.J. van

    2002-01-01

    Fibroadenoma and phyllodes tumour of the breast are both fibroepithelial tumours. Although progression to epithelial malignancy has been described, the behaviour of most fibroadenomas is benign. Phyllodes tumours, on the other hand, can display locally destructive growth and can even metastasize. A

  17. Three-Dimensional Breast Cancer Models Mimic Hallmarks of Size-Induced Tumor Progression.

    Science.gov (United States)

    Singh, Manjulata; Mukundan, Shilpaa; Jaramillo, Maria; Oesterreich, Steffi; Sant, Shilpa

    2016-07-01

    Tumor size is strongly correlated with breast cancer metastasis and patient survival. Increased tumor size contributes to hypoxic and metabolic gradients in the solid tumor and to an aggressive tumor phenotype. Thus, it is important to develop three-dimensional (3D) breast tumor models that recapitulate size-induced microenvironmental changes and, consequently, natural tumor progression in real time without the use of artificial culture conditions or gene manipulations. Here, we developed size-controlled multicellular aggregates ("microtumors") of subtype-specific breast cancer cells by using non-adhesive polyethylene glycol dimethacrylate hydrogel microwells of defined sizes (150-600 μm). These 3D microtumor models faithfully represent size-induced microenvironmental changes, such as hypoxic gradients, cellular heterogeneity, and spatial distribution of necrotic/proliferating cells. These microtumors acquire hallmarks of tumor progression in the same cell lines within 6 days. Of note, large microtumors of hormone receptor-positive cells exhibited an aggressive phenotype characterized by collective cell migration and upregulation of mesenchymal markers at mRNA and protein level, which was not observed in small microtumors. Interestingly, triple-negative breast cancer (TNBC) cell lines did not show size-dependent upregulation of mesenchymal markers. In conclusion, size-controlled microtumor models successfully recapitulated clinically observed positive association between tumor size and aggressive phenotype in hormone receptor-positive breast cancer while maintaining clinically proven poor correlation of tumor size with aggressive phenotype in TNBC. Such clinically relevant 3D models generated under controlled experimental conditions can serve as precise preclinical models to study mechanisms involved in breast tumor progression as well as antitumor drug effects as a function of tumor progression. Cancer Res; 76(13); 3732-43. ©2016 AACR. ©2016 American

  18. Progressive APOBEC3B mRNA expression in distant breast cancer metastases.

    Directory of Open Access Journals (Sweden)

    Anieta M Sieuwerts

    Full Text Available APOBEC3B was recently identified as a gain-of-function enzymatic source of mutagenesis, which may offer novel therapeutic options with molecules that specifically target this enzyme. In primary breast cancer, APOBEC3B mRNA is deregulated in a substantial proportion of cases and its expression is associated with poor prognosis. However, its expression in breast cancer metastases, which are the main causes of breast cancer-related death, remained to be elucidated.RNA was isolated from 55 primary breast cancers and paired metastases, including regional lymph node (N = 20 and distant metastases (N = 35. APOBEC3B mRNA levels were measured by RT-qPCR. Expression levels of the primary tumors and corresponding metastases were compared, including subgroup analysis by estrogen receptor (ER/ESR1 status.Overall, APOBEC3B mRNA levels of distant metastases were significantly higher as compared to the corresponding primary breast tumor (P = 0.0015, an effect that was not seen for loco-regional lymph node metastases (P = 0.23. Subgroup analysis by ER-status showed that increased APOBEC3B levels in distant metastases were restricted to metastases arising from ER-positive primary breast cancers (P = 0.002. However, regarding ER-negative primary tumors, only loco-regional lymph node metastases showed increased APOBEC3B expression when compared to the corresponding primary tumor (P = 0.028.APOBEC3B mRNA levels are significantly higher in breast cancer metastases as compared to the corresponding ER-positive primary tumors. This suggests a potential role for APOBEC3B in luminal breast cancer progression, and consequently, a promising role for anti-APOBEC3B therapies in advanced stages of this frequent form of breast cancer.

  19. Multimodal Analgesia in Breast Surgical Procedures: Technical and Pharmacological Considerations for Liposomal Bupivacaine Use

    Directory of Open Access Journals (Sweden)

    Anoushka M. Afonso, MD

    2017-09-01

    Full Text Available Enhanced recovery after surgery is a multidisciplinary perioperative clinical pathway that uses evidence-based interventions to improve the patient experience as well as increase satisfaction, reduce costs, mitigate the surgical stress response, accelerate functional recovery, and decrease perioperative complications. One of the most important elements of enhanced recovery pathways is multimodal pain management. Herein, aspects relating to multimodal analgesia following breast surgical procedures are discussed with the understanding that treatment decisions should be individualized and guided by sound clinical judgment. A review of liposomal bupivacaine, a prolonged-release formulation of bupivacaine, in the management of postoperative pain following breast surgical procedures is presented, and technical guidance regarding optimal administration of liposomal bupivacaine is provided.

  20. The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression.

    Directory of Open Access Journals (Sweden)

    Sandra Dupouy

    Full Text Available BACKGROUND: The neurotensin (NTS and its specific high affinity G protein coupled receptor, the NT1 receptor (NTSR1, are considered to be a good candidate for one of the factors implicated in neoplastic progression. In breast cancer cells, functionally expressed NT1 receptor coordinates a series of transforming functions including cellular migration and invasion. METHODS AND RESULTS: we investigated the expression of NTS and NTSR1 in normal human breast tissue and in invasive ductal breast carcinomas (IDCs by immunohistochemistry and RT-PCR. NTS is expressed and up-regulated by estrogen in normal epithelial breast cells. NTS is also found expressed in the ductal and invasive components of IDCs. The high expression of NTSR1 is associated with the SBR grade, the size of the tumor, and the number of metastatic lymph nodes. Furthermore, the NTSR1 high expression is an independent factor of prognosis associated with the death of patients. CONCLUSION: these data support the activation of neurotensinergic deleterious pathways in breast cancer progression.

  1. Network analysis of breast cancer progression and reversal using a tree-evolving network algorithm.

    Directory of Open Access Journals (Sweden)

    Ankur P Parikh

    2014-07-01

    Full Text Available The HMT3522 progression series of human breast cells have been used to discover how tissue architecture, microenvironment and signaling molecules affect breast cell growth and behaviors. However, much remains to be elucidated about malignant and phenotypic reversion behaviors of the HMT3522-T4-2 cells of this series. We employed a "pan-cell-state" strategy, and analyzed jointly microarray profiles obtained from different state-specific cell populations from this progression and reversion model of the breast cells using a tree-lineage multi-network inference algorithm, Treegl. We found that different breast cell states contain distinct gene networks. The network specific to non-malignant HMT3522-S1 cells is dominated by genes involved in normal processes, whereas the T4-2-specific network is enriched with cancer-related genes. The networks specific to various conditions of the reverted T4-2 cells are enriched with pathways suggestive of compensatory effects, consistent with clinical data showing patient resistance to anticancer drugs. We validated the findings using an external dataset, and showed that aberrant expression values of certain hubs in the identified networks are associated with poor clinical outcomes. Thus, analysis of various reversion conditions (including non-reverted of HMT3522 cells using Treegl can be a good model system to study drug effects on breast cancer.

  2. Overexpression of L1 cell adhesion molecule correlates with aggressive tumor progression of patients with breast cancer and promotes motility of breast cancer cells

    OpenAIRE

    Zhang, Jian; Yang, Fei; Ding, Yong; Zhen, Linlin; Han, Xuedong; Jiao, Feng; Tang, Jinhai

    2015-01-01

    Background and purpose: L1 cell adhesion molecule (L1CAM) has been observed to be aberrantly expressed and implicated in progression of several types of human cancers. However, its roles in breast cancer have not been fully elucidated. In this study, we aimed to investigate the clinical significance of L1CAM in human breast cancer and to validate whether it participates in cancer cell migration and invasion. Methods: Immunohistochemical analysis of 100 breast cancer and matched non-cancerous ...

  3. Alterations in Galectin-3 Expression and Distribution Correlate with Breast Cancer Progression : Functional Analysis of Galectin-3 in Breast Epithelial-Endothelial Interactions

    OpenAIRE

    Shekhar, Malathy P.V.; Nangia-Makker, Pratima; Tait, Larry; Miller, Fred; Raz, Avraham

    2004-01-01

    To define the role of galectin-3 in breast cancer progression, we have used a novel three-dimensional co-culture system that recapitulates in vivo reciprocal functional breast epithelial-endothelial cell-cell and cell-matrix interactions, and examined the expression of galectin-3 mRNA and protein in human breast tumors and xenografts. Galectin-3 is required for the stabilization of epithelial-endothelial interaction networks because immunoneutralization with galectin-3 antibodies abolishes th...

  4. Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis

    DEFF Research Database (Denmark)

    Krøigård, Anne Bruun; Larsen, Martin Jakob; Lænkholm, Anne-Vibeke

    2015-01-01

    Evolution of the breast cancer genome from pre-invasive stages to asynchronous metastasis is complex and mostly unexplored, but highly demanded as it may provide novel markers for and mechanistic insights in cancer progression. The increasing use of personalized therapy of breast cancer...... necessitates knowledge of the degree of genomic concordance between different steps of malignant progression as primary tumors often are used as surrogates of systemic disease. Based on exome sequencing we performed copy number profiling and point mutation detection on successive steps of breast cancer...... progression from one breast cancer patient, including two different regions of Ductal Carcinoma In Situ (DCIS), primary tumor and an asynchronous metastasis. We identify a remarkable landscape of somatic mutations, retained throughout breast cancer progression and with new mutational events emerging at each...

  5. Pro-oncogene Pokemon promotes breast cancer progression by upregulating survivin expression.

    Science.gov (United States)

    Zu, Xuyu; Ma, Jun; Liu, Hongxia; Liu, Feng; Tan, Chunyan; Yu, Lingling; Wang, Jue; Xie, Zhenhua; Cao, Deliang; Jiang, Yuyang

    2011-03-10

    Pokemon is an oncogenic transcription factor involved in cell growth, differentiation and oncogenesis, but little is known about its role in human breast cancer. In this study, we aimed to reveal the role of Pokemon in breast cancer progression and patient survival and to understand its underlying mechanisms. Tissue microarray analysis of breast cancer tissues from patients with complete clinicopathological data and more than 20 years of follow-up were used to evaluate Pokemon expression and its correlation with the progression and prognosis of the disease. DNA microarray analysis of MCF-7 cells that overexpress Pokemon was used to identify Pokemon target genes. Chromatin immunoprecipitation (ChIP) and site-directed mutagenesis were utilized to determine how Pokemon regulates survivin expression, a target gene. Pokemon was found to be overexpressed in 158 (86.8%) of 182 breast cancer tissues, and its expression was correlated with tumor size (P = 0.0148) and lymph node metastasis (P = 0.0014). Pokemon expression led to worse overall (n = 175, P = 0.01) and disease-related (n = 79, P = 0.0134) patient survival. DNA microarray analyses revealed that in MCF-7 breast cancer cells, Pokemon regulates the expression of at least 121 genes involved in several signaling and metabolic pathways, including anti-apoptotic survivin. In clinical specimens, Pokemon and survivin expression were highly correlated (n = 49, r = 0.6799, P Pokemon induces survivin expression by binding to the GT boxes in its promoter. Pokemon promotes breast cancer progression by upregulating survivin expression and thus may be a potential target for the treatment of this malignancy.

  6. Progress with palbociclib in breast cancer: latest evidence and clinical considerations.

    Science.gov (United States)

    Rocca, Andrea; Schirone, Alessio; Maltoni, Roberta; Bravaccini, Sara; Cecconetto, Lorenzo; Farolfi, Alberto; Bronte, Giuseppe; Andreis, Daniele

    2017-02-01

    Deregulation of the cell cycle is a hallmark of cancer, and research on cell cycle control has allowed identification of potential targets for anticancer treatment. Palbociclib is a selective inhibitor of the cyclin-dependent kinases 4 and 6 (CDK4/6), which are involved, with their coregulatory partners cyclin D, in the G1-S transition. Inhibition of this step halts cell cycle progression in cells in which the involved pathway, including the retinoblastoma protein (Rb) and the E2F family of transcription factors, is functioning, although having been deregulated. Among breast cancers, those with functioning cyclin D-CDK4/6-Rb-E2F are mainly hormone-receptor (HR) positive, with some HER2-positive and rare triple-negative cases. Deregulation results from genetic or otherwise occurring hyperactivation of molecules subtending cell cycle progression, or inactivation of cell cycle inhibitors. Based on results of randomized clinical trials, palbociclib was granted accelerated approval by the US Food and Drug Administration (FDA) for use in combination with letrozole as initial endocrine-based therapy for metastatic disease in postmenopausal women with HR-positive, HER2-negative breast cancer, and was approved for use in combination with fulvestrant in women with HR-positive, HER2-negative advanced breast cancer with disease progression following endocrine therapy. This review provides an update of the available knowledge on the cell cycle and its regulation, on the alterations in cyclin D-CDK4/6-Rb-E2F axis in breast cancer and their roles in endocrine resistance, on the preclinical activity of CDK4/6 inhibitors in breast cancer, both as monotherapy and as partners of combinatorial synergic treatments, and on the clinical development of palbociclib in breast cancer.

  7. Delineating an Epigenetic Continuum for Initiation, Transformation and Progression to Breast Cancer

    Energy Technology Data Exchange (ETDEWEB)

    Chen, Kang Mei; Stephen, Josena K. [Department of Otolaryngology/Head and Neck Surgery, Henry Ford Hospital, 1 Ford Place, 1D, Detroit, MI 48202 (United States); Raju, Usha [Department of Pathology, Henry Ford Hospital, Detroit, 1 Ford Place, 1D, Detroit, MI 48202 (United States); Worsham, Maria J., E-mail: mworsha1@hfhs.org [Department of Otolaryngology/Head and Neck Surgery, Henry Ford Hospital, 1 Ford Place, 1D, Detroit, MI 48202 (United States)

    2011-03-29

    Aberrant methylation of promoter CpG islands is a hallmark of human cancers and is an early event in carcinogenesis. We examined whether promoter hypermethylation contributes to the pathogenesis of benign breast lesions along a progression continuum to invasive breast cancer. The exploratory study cohort comprised 17 breast cancer patients with multiple benign and/or in situ lesions concurrently present with invasive carcinoma within a tumor biopsy. DNA from tumor tissue, normal breast epithelium when present, benign lesions (fibroadenoma, hyperplasia, papilloma, sclerosing adenosis, apocrine metaplasia, atypical lobular hyperplasia or atypical ductal hyperplasia), and in situ lesions of lobular carcinoma and ductal carcinoma were interrogated for promoter methylation status in 22 tumor suppressor genes using the multiplex ligation-dependent probe amplification assay (MS-MLPA). Methylation specific PCR was performed to confirm hypermethylation detected by MS-MLPA. Promoter methylation was detected in 11/22 tumor suppressor genes in 16/17 cases. Hypermethylation of RASSF1 was most frequent, present in 14/17 cases, followed by APC in 12/17, and GSTP1 in 9/17 cases with establishment of an epigenetic monocloncal progression continuum to invasive breast cancer. Hypermethylated promoter regions in normal breast epithelium, benign, and premalignant lesions within the same tumor biopsy implicate RASSF1, APC, GSTP1, TIMP3, CDKN2B, CDKN2A, ESR1, CDH13, RARB, CASP8, and TP73 as early events. DNA hypermethylation underlies the pathogenesis of step-wise transformation along a monoclonal continuum from normal to preneoplasia to invasive breast cancer.

  8. Three-dimensional cultures modeling premalignant progression of human breast epithelial cells: role of cysteine cathepsins.

    Science.gov (United States)

    Mullins, Stefanie R; Sameni, Mansoureth; Blum, Galia; Bogyo, Matthew; Sloane, Bonnie F; Moin, Kamiar

    2012-12-01

    The expression of the cysteine protease cathepsin B is increased in early stages of human breast cancer.To assess the potential role of cathepsin B in premalignant progression of breast epithelial cells, we employed a 3D reconstituted basement membrane overlay culture model of MCF10A human breast epithelial cells and isogenic variants that replicate the in vivo phenotypes of hyper plasia(MCF10AneoT) and atypical hyperplasia (MCF10AT1). MCF10A cells developed into polarized acinar structures with central lumens. In contrast, MCF10AneoT and MCF10AT1 cells form larger structures in which the lumens are filled with cells. CA074Me, a cell-permeable inhibitor selective for the cysteine cathepsins B and L,reduced proliferation and increased apoptosis of MCF10A, MCF10AneoT and MCF10AT1 cells in 3D culture. We detected active cysteine cathepsins in the isogenic MCF10 variants in 3D culture with GB111, a cell-permeable activity based probe, and established differential inhibition of cathepsin B in our 3D cultures. We conclude that cathepsin B promotes proliferation and premalignant progression of breast epithelial cells. These findings are consistent with studies by others showing that deletion of cathepsin B in the transgenic MMTV-PyMT mice, a murine model that is predisposed to development of mammary cancer, reduces malignant progression.

  9. HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells.

    Directory of Open Access Journals (Sweden)

    Sandeep N Shah

    Full Text Available Emerging evidence suggests that tumor cells metastasize by co-opting stem cell transcriptional networks, although the molecular underpinnings of this process are poorly understood. Here, we show for the first time that the high mobility group A1 (HMGA1 gene drives metastatic progression in triple negative breast cancer cells (MDA-MB-231, Hs578T by reprogramming cancer cells to a stem-like state. Silencing HMGA1 expression in invasive, aggressive breast cancer cells dramatically halts cell growth and results in striking morphologic changes from mesenchymal-like, spindle-shaped cells to cuboidal, epithelial-like cells. Mesenchymal genes (Vimentin, Snail are repressed, while E-cadherin is induced in the knock-down cells. Silencing HMGA1 also blocks oncogenic properties, including proliferation, migration, invasion, and orthotopic tumorigenesis. Metastatic progression following mammary implantation is almost completely abrogated in the HMGA1 knock-down cells. Moreover, silencing HMGA1 inhibits the stem cell property of three-dimensional mammosphere formation, including primary, secondary, and tertiary spheres. In addition, knock-down of HMGA1 depletes cancer initiator/cancer stem cells and prevents tumorigenesis at limiting dilutions. We also discovered an HMGA1 signature in triple negative breast cancer cells that is highly enriched in embryonic stem cells. Together, these findings indicate that HMGA1 is a master regulator of tumor progression in breast cancer by reprogramming cancer cells through stem cell transcriptional networks. Future studies are needed to determine how to target HMGA1 in therapy.

  10. Technical progress report for application of numerical simulation methodology to automotive combustion

    Energy Technology Data Exchange (ETDEWEB)

    None

    1980-03-01

    The third quarterly technical progress report is presented for DOE Contract No. DE-AC-03-79-ET15397.001 entitled, Application of Numerical Simulation Methodology to Automotive Combustion. Work during the period has concentrated on completing the model development and validation for in-cylinder fluid dynamics via: simulation (and data comparison) for piston induced vortex roll-up at high Reynolds number; simulation (and data comparison) for the decay of swirl in the Sandia DISC engine; and definition of compression cycle parametric cycle simulations. The results of these studies are described.

  11. Decontamination Systems Information and Research Program. Quarterly technical progress report, January 1--March 31, 1993

    Energy Technology Data Exchange (ETDEWEB)

    1993-04-01

    This reports reports the progress/efforts performed on six technical projects: 1. systematic assessment of the state of hazardous waste clean-up technologies; 2. site remediation technologies (SRT):drain- enhanced soil flushing for organic contaminants removal; 3. SRT: in situ bio-remediation of organic contaminants; 4. excavation systems for hazardous waste sites: dust control methods for in-situ nuclear waste handling; 5. chemical destruction of polychlorinated biphenyls; and 6. development of organic sensors: monolayer and multilayer self-assembled films for chemical sensors.

  12. [Experimental and theoretical plasma physics program]. Technical progress [in FY 1981

    Energy Technology Data Exchange (ETDEWEB)

    Griem, H.

    1981-12-31

    In recent years, members of the Maryland Theory Group have made significant contributions to the national fusion theory programs and in many cases these theoretical development helped to interpret experimental results and to design new experimental programs. In the following, the authors summarize the technical progress in five major areas: (1) rf interaction with plasmas including wave propagation, rf heating, rf induced runaways and current drive; (2) spheromak -- formation, equilibrium, and stability; (3) stability of nonaxisymmetric systems (EBT, mirror, etc.); (4) stability theory of toroidal plasmas -- tokamak, RFP, etc.; and (5) nonlinear theory.

  13. Western Research Institute: Annual technical progress report, October 1987--September 1988

    Energy Technology Data Exchange (ETDEWEB)

    1988-12-01

    This report describes the technical progress made by the Western Research Institute of the University of Wyoming Research Institute of the University of Wyoming Research Corporation on work performed for the period October 1, 1987 through September 30, 1988. This research involves five resource areas: oil shale, tar sand, underground coal gasification, advanced process technology, and advanced fuels research. Under the terms of the cooperative agreement, an annual project plan has been approved by DOE. The work reported herein reflects the implementation of the research in the plan and follows the structure used therein. 49 refs., 32 figs., 87 tabs.

  14. Clinical Significance of HER-2 Splice Variants in Breast Cancer Progression and Drug Resistance

    Directory of Open Access Journals (Sweden)

    Claire Jackson

    2013-01-01

    Full Text Available Overexpression of human epidermal growth factor receptor (HER-2 occurs in 20–30% of breast cancers and confers survival and proliferative advantages on the tumour cells making HER-2 an ideal therapeutic target for drugs like Herceptin. Continued delineation of tumour biology has identified splice variants of HER-2, with contrasting roles in tumour cell biology. For example, the splice variant 16HER-2 (results from exon 16 skipping increases transformation of cancer cells and is associated with treatment resistance; conversely, Herstatin (results from intron 8 retention and p100 (results from intron 15 retention inhibit tumour cell proliferation. This review focuses on the potential clinical implications of the expression and coexistence of HER-2 splice variants in cancer cells in relation to breast cancer progression and drug resistance. “Individualised” strategies currently guide breast cancer management; in accordance, HER-2 splice variants may prove valuable as future prognostic and predictive factors, as well as potential therapeutic targets.

  15. Overexpression of L1 cell adhesion molecule correlates with aggressive tumor progression of patients with breast cancer and promotes motility of breast cancer cells.

    Science.gov (United States)

    Zhang, Jian; Yang, Fei; Ding, Yong; Zhen, Linlin; Han, Xuedong; Jiao, Feng; Tang, Jinhai

    2015-01-01

    L1 cell adhesion molecule (L1CAM) has been observed to be aberrantly expressed and implicated in progression of several types of human cancers. However, its roles in breast cancer have not been fully elucidated. In this study, we aimed to investigate the clinical significance of L1CAM in human breast cancer and to validate whether it participates in cancer cell migration and invasion. Immunohistochemical analysis of 100 breast cancer and matched non-cancerous breast tissues was performed to detect the expression and sub-cellular localization of L1CAM protein. Its associations with clinicopathological characteristics of breast cancer patients were statistically analyzed and its phenotypic effects were also evaluated in vitro. Of the 100 breast cancer patients, 89 (89.0%) were positive for L1CAM immunostaining localized in the membrane of cancer cells. The immunoreactive scores of L1CAM protein in breast cancer tissues were significantly higher than those in matched non-cancerous breast tissues (Pbreast cancer patients. Moreover, we found that RNA interference-mediated knockdown of L1CAM could inhibit the migration and invasion abilities of breast cancer cells in vitro. Our results suggest that the overexpression of L1CAM may be related to several established markers of poor prognosis in breast cancer patients. L1CAM might be a potential therapeutic target against metastatic breast cancer.

  16. Heber geothermal binary demonstration project quarterly technical progress report, October 1, 1982--December 31, 1982

    Energy Technology Data Exchange (ETDEWEB)

    Lacy, R.G.; Allen, R.F.; Dixon, J.R.; Hsiao, W.P.; Liparidis, G.S.; Lombard, G.L.; Nelson, T.T.; Van De Mark, G.D.

    1983-05-01

    The purpose of this quarterly technical progress report is to document work completed on the nominal 65 Megawatt (Mwe gross) Heber Geothermal Binary Demonstration Project, located at Heber, California, during the period of October 1, 1982--December 31, 1982. The work was performed by San Diego Gas and Electric Company under the support and cooperation of the U.S. Department of Energy, the Electric Power Research Institute, the Imperial Irrigation District, the California Department of Water Resources, and the Southern California Edison Company. Topics covered in this quarterly report include progress made in the areas of Wells and Fluid Production and Injection Systems, Power Plant Design and Construction, Power Plant Demonstration, and Data Acquisition and Dissemination.

  17. Heber geothermal binary demonstration project quarterly technical progress report, July 1, 1981--September 30, 1981

    Energy Technology Data Exchange (ETDEWEB)

    Lacy, R.G.; Allen, R.F.; Alsup, R.A.; Liparidis, G.S.; Van De Mark, G.D.

    1983-08-01

    The purpose of this quarterly technical progress report is to document work completed on the nominal 65 Megawatt (Mwe gross) Heber Geothermal Binary Demonstration Project, located at Heber, California, during the period of July 1, 1981, through September 30, 1981. The work was performed by San Diego Gas and Electric Company under the support and cooperation of the US Department of Energy, the Electric Power Research Institute, the Imperial Irrigation District, the California Department of Water Resources, and the Southern California Edison Company. Topics covered in this quarterly report include progress made in the areas of Wells and Fluid production and Injection Systems, Power Plant Design and Construction, Power Plant Demonstration, and Data Acquisition and Dissemination.

  18. Joint modelling of longitudinal CEA tumour marker progression and survival data on breast cancer

    Science.gov (United States)

    Borges, Ana; Sousa, Inês; Castro, Luis

    2017-06-01

    This work proposes the use of Biostatistics methods to study breast cancer in patients of Braga's Hospital Senology Unit, located in Portugal. The primary motivation is to contribute to the understanding of the progression of breast cancer, within the Portuguese population, using a more complex statistical model assumptions than the traditional analysis that take into account a possible existence of a serial correlation structure within a same subject observations. We aim to infer which risk factors aect the survival of Braga's Hospital patients, diagnosed with breast tumour. Whilst analysing risk factors that aect a tumour markers used on the surveillance of disease progression the Carcinoembryonic antigen (CEA). As survival and longitudinal processes may be associated, it is important to model these two processes together. Hence, a joint modelling of these two processes to infer on the association of these was conducted. A data set of 540 patients, along with 50 variables, was collected from medical records of the Hospital. A joint model approach was used to analyse these data. Two dierent joint models were applied to the same data set, with dierent parameterizations which give dierent interpretations to model parameters. These were used by convenience as the ones implemented in R software. Results from the two models were compared. Results from joint models, showed that the longitudinal CEA values were signicantly associated with the survival probability of these patients. A comparison between parameter estimates obtained in this analysis and previous independent survival[4] and longitudinal analysis[5][6], lead us to conclude that independent analysis brings up bias parameter estimates. Hence, an assumption of association between the two processes in a joint model of breast cancer data is necessary. Results indicate that the longitudinal progression of CEA is signicantly associated with the probability of survival of these patients. Hence, an assumption of

  19. Human breast adipose tissue: characterization of factors that change during tumor progression in human breast cancer.

    Science.gov (United States)

    Fletcher, Sabrina Johanna; Sacca, Paula Alejandra; Pistone-Creydt, Mercedes; Coló, Federico Andrés; Serra, María Florencia; Santino, Flavia Eliana; Sasso, Corina Verónica; Lopez-Fontana, Constanza Matilde; Carón, Rubén Walter; Calvo, Juan Carlos; Pistone-Creydt, Virginia

    2017-02-07

    Adipose microenvironment is involved in signaling pathways that influence breast cancer. We aim to characterize factors that are modified: 1) in tumor and non tumor human breast epithelial cell lines when incubated with conditioned media (CMs) from human breast cancer adipose tissue explants (hATT) or normal breast adipose tissue explants (hATN); 2) in hATN-CMs vs hATT-CMs; 3) in the tumor associated adipocytes vs. non tumor associated adipocytes. We used hATN or hATT- CMs on tumor and non-tumor breast cancer cell lines. We evaluated changes in versican, CD44, ADAMTS1 and Adipo R1 expression on cell lines or in the different CMs. In addition we evaluated changes in the morphology and expression of these factors in slices of the different adipose tissues. The statistical significance between different experimental conditions was evaluated by one-way ANOVA. Tukey's post-hoc tests were performed within each individual treatment. hATT-CMs increase versican, CD44, ADAMTS1 and Adipo R1 expression in breast cancer epithelial cells. Furthermore, hATT-CMs present higher levels of versican expression compared to hATN-CMs. In addition, we observed a loss of effect in cellular migration when we pre-incubated hATT-CMs with chondroitinase ABC, which cleaves GAGs chains bound to the versican core protein, thus losing the ability to bind to CD44. Adipocytes associated with the invasive front are reduced in size compared to adipocytes that are farther away. Also, hATT adipocytes express significantly higher amounts of versican, CD44 and Adipo R1, and significantly lower amounts of adiponectin and perilipin, unlike hATN adipocytes. We conclude that hATT secrete a different set of proteins compared to hATN. Furthermore, versican, a proteoglycan that is overexpressed in hATT-CMs compared to hATN-CMs, might be involved in the tumorogenic behavior observed in both cell lines employed. In addition, we may conclude that adipocytes from the tumor microenvironment show a less differentiated

  20. IκB kinases increase Myc protein stability and enhance progression of breast cancer cells

    Directory of Open Access Journals (Sweden)

    Ou Da-Liang

    2011-05-01

    Full Text Available Abstract Background Both IκB kinase (IKK complex and oncgenic protein Myc play important roles in cancer progression, including cancer cell invasiveness and metastasis. The levels of Myc is regulated by the phosphorylation of Myc at Thr58 and Ser62. Results In this study, we show that the expression of Myc is associated with IKKα and IKKβ in breast cancers and that Myc is an IKKs substrate. Suppression of IKK activity by either chemical inhibitor or transfection of kinase-dead mutants decreases the phosphorylation of Myc at Ser62 and enhances the degradation of Myc. Consequently, these treatments decrease the tumorigenic and invasive ability of breast cancer cells. Furthermore, doxorubicin, a frequently used anticancer drug in breast cancer, activates IKKs and Myc, thereby increasing invasiveness and tumorigenesis of breast carcinoma MCF7 cells. Inhibition of IKKs prevents these doxorubicin-induced effects. Conclusions Our study indicates that IKKs tightly regulate Myc expression through prolonging protein stability, and suggests that IKKs are potentially therapeutic targets and that suppression of IKKs may be used following chemotherapy to reduce the risk of treatment-induced tumor progression.

  1. AMOTL1 Promotes Breast Cancer Progression and Is Antagonized by Merlin

    Directory of Open Access Journals (Sweden)

    Christophe Couderc

    2016-01-01

    Full Text Available The Hippo signaling network is a key regulator of cell fate. In the recent years, it was shown that its implication in cancer goes well beyond the sole role of YAP transcriptional activity and its regulation by the canonical MST/LATS kinase cascade. Here we show that the motin family member AMOTL1 is an important effector of Hippo signaling in breast cancer. AMOTL1 connects Hippo signaling to tumor cell aggressiveness. We show that both canonical and noncanonical Hippo signaling modulates AMOTL1 levels. The tumor suppressor Merlin triggers AMOTL1 proteasomal degradation mediated by the NEDD family of ubiquitin ligases through direct interaction. In parallel, YAP stimulates AMOTL1 expression. The loss of Merlin expression and the induction of Yap activity that are frequently observed in breast cancers thus result in elevated AMOTL1 levels. AMOTL1 expression is sufficient to trigger tumor cell migration and stimulates proliferation by activating c-Src. In a large cohort of human breast tumors, we show that AMOTL1 protein levels are upregulated during cancer progression and that, importantly, the expression of AMOTL1 in lymph node metastasis appears predictive of the risk of relapse. Hence we uncover an important mechanism by which Hippo signaling promotes breast cancer progression by modulating the expression of AMOTL1.

  2. Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment.

    Science.gov (United States)

    Panagopoulos, Vasilios; Leach, Damien A; Zinonos, Irene; Ponomarev, Vladimir; Licari, Giovanni; Liapis, Vasilios; Ingman, Wendy V; Anderson, Peter; DeNichilo, Mark O; Evdokiou, Andreas

    2017-04-01

    Myeloperoxidase (MPO) and eosinophil peroxidase (EPO) are heme-containing enzymes, well known for their antimicrobial activity, are released in high quantities by infiltrating immune cells in breast cancer. However, the functional importance of their presence within the tumour microenvironment is unclear. We have recently described a new role for peroxidases as key regulators of fibroblast and endothelial cell functionality. In the present study, we investigate for the first time, the ability of peroxidases to promote breast cancer development and progression. Using the 4T1 syngeneic murine orthotopic breast cancer model, we examined whether increased levels of peroxidases in developing mammary tumours influences primary tumour growth and metastasis. We showed that MPO and EPO stimulation increased mammary tumour growth and enhanced lung metastases, effects that were associated with reduced tumour necrosis, increased collagen deposition and neo-vascularisation within the primary tumour. In vitro, peroxidase treatment, robustly stimulated human mammary fibroblast migration and collagen type I and type VI secretion. Mechanistically, peroxidases induced the transcription of pro-tumorigenic and metastatic MMP1, MMP3 and COX-2 genes. Taken together, these findings identify peroxidases as key contributors to cancer progression by augmenting pro-tumorigenic collagen production and angiogenesis. Importantly, this identifies inflammatory peroxidases as therapeutic targets in breast cancer therapy.

  3. Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis.

    Directory of Open Access Journals (Sweden)

    Nigel P S Crawford

    2007-11-01

    Full Text Available A novel candidate metastasis modifier, ribosomal RNA processing 1 homolog B (Rrp1b, was identified through two independent approaches. First, yeast two-hybrid, immunoprecipitation, and functional assays demonstrated a physical and functional interaction between Rrp1b and the previous identified metastasis modifier Sipa1. In parallel, using mouse and human metastasis gene expression data it was observed that extracellular matrix (ECM genes are common components of metastasis predictive signatures, suggesting that ECM genes are either important markers or causal factors in metastasis. To investigate the relationship between ECM genes and poor prognosis in breast cancer, expression quantitative trait locus analysis of polyoma middle-T transgene-induced mammary tumor was performed. ECM gene expression was found to be consistently associated with Rrp1b expression. In vitro expression of Rrp1b significantly altered ECM gene expression, tumor growth, and dissemination in metastasis assays. Furthermore, a gene signature induced by ectopic expression of Rrp1b in tumor cells predicted survival in a human breast cancer gene expression dataset. Finally, constitutional polymorphism within RRP1B was found to be significantly associated with tumor progression in two independent breast cancer cohorts. These data suggest that RRP1B may be a novel susceptibility gene for breast cancer progression and metastasis.

  4. Expression of ANO1/DOG1 is associated with shorter survival and progression of breast carcinomas.

    Science.gov (United States)

    Bae, Jun Sang; Park, Jeong Yeol; Park, See-Hyoung; Ha, Sang Hoon; An, Ae Ri; Noh, Sang Jae; Kwon, Keun Sang; Jung, Sung Hoo; Park, Ho Sung; Kang, Myoung Jae; Jang, Kyu Yun

    2018-01-02

    The expression of ANO1 is considered to have diagnostic specificity for gastrointestinal stromal tumors. However, its function as a calcium-activated chloride channel suggests that the expression of ANO1 is not restricted to gastrointestinal stromal tumors. Recently, it has been reported that ANO1 has roles in the progression of human malignant tumors. However, the role of ANO1 in breast carcinoma has been controversial. Therefore, we investigated the expression of ANO1 in 139 breast carcinoma patients and the role of ANO1 in vitro . The immunohistochemical expression of ANO1 was significantly associated with the expression of β-catenin, cyclin D1, MMP9, snail, and E-cadherin. Especially, ANO1 expression was an independent indicator of poor prognosis of shorter overall survival and relapse-free survival of breast carcinoma patients by multivariate analysis. In MCF7 and MDA-MB-231 breast carcinoma cells, inhibition of ANO1 with T16Ainh-A01 or siRNA for ANO1 significantly suppressed the proliferation of cells. Knock-down of ANO1 with siRNA induced G0/G1 cell cycle arrest and significantly inhibited the invasiveness of breast carcinoma cells. Knock-down of ANO1 decreased the expression of β-catenin, cyclin D1, MMP9, snail, and N-cadherin, and increased the expression of E-cadherin. In conclusion, this study demonstrates that ANO1 expression is an indicator of poor prognosis of breast carcinoma patients and suggests that ANO1 might be a therapeutic target for breast carcinoma patients with ANO1-positive tumors and poor prognosis.

  5. Breast cancer associated a2 isoform vacuolar ATPase immunomodulates neutrophils: potential role in tumor progression

    Science.gov (United States)

    Ibrahim, Safaa A.; Katara, Gajendra K.; Kulshrestha, Arpita; Jaiswal, Mukesh K.; Amin, Magdy A.; Beaman, Kenneth D.

    2015-01-01

    In invasive breast cancer, tumor associated neutrophils (TAN) represent a significant portion of the tumor mass and are associated with increased angiogenesis and metastasis. Identifying the regulatory factors that control TAN behavior will help in developing ideal immunotherapies. Vacuolar ATPases (V-ATPases), multi-subunit proton pumps, are highly expressed in metastatic breast cancer cells. A cleaved peptide from a2 isoform V-ATPase (a2NTD) has immunomodulatory role in tumor microenvironment. Here, we report for the first time the role of V-ATPase in neutrophils modulation. In invasive breast cancer cells, a2NTD was detected and a2V was highly expressed on the surface. Immunohistochemical analysis of invasive breast cancer tissues revealed that increased neutrophil recruitment and blood vessel density correlated with increased a2NTD levels. In order to determine the direct regulatory role of a2NTD on neutrophils, recombinant a2NTD was used for the treatment of neutrophils isolated from the peripheral blood of healthy volunteers. Neutrophils treated with a2NTD (a2Neuɸ) showed increased secretion of IL-1RA, IL-10, CCL-2 and IL-6 that are important mediators in cancer related inflammation. Moreover, a2Neuɸ exhibited an increased production of protumorigenic factors including IL-8, matrix metaloprotinase-9 and vascular endothelial growth factor. Further, functional characterization of a2Neuɸ revealed that a2Neuɸ derived products induce in vitro angiogenesis as well as increase the invasiveness of breast cancer cells. This study establishes the modulatory effect of breast cancer associated a2V on neutrophils, by the action of a2NTD, which has a positive impact on tumor progression, supporting that a2V can be a potential selective target for breast cancer therapy. PMID:26460736

  6. miR-410-3p suppresses breast cancer progression by targeting Snail.

    Science.gov (United States)

    Zhang, Ya-Feng; Yu, Yue; Song, Wang-Zhao; Zhang, Rui-Ming; Jin, Shan; Bai, Jun-Wen; Kang, Hong-Bin; Wang, Xin; Cao, Xu-Chen

    2016-07-01

    miR-410-3p acts as an oncogene or tumor-suppressor gene in various types of cancer. However, its role in breast cancer remains unknown. In the present study, expression of miR-410-3p in 30 breast cancer and paired adjacent normal tissues was detected by RT-qPCR. The expression of miR-410-3p was downregulated in 76.7% of the breast cancer samples. To further validate the expression of miR-410-3p in breast cancer, we analyzed miR-410-3p expression profiling data set from The Cancer Genome Atlas (TCGA) including 683 breast cancer and 87 normal breast tissues. We observed that the expression of miR-410-3p was downregulated in breast cancer tissues. Next, we investigated the influence of miR-410-3p on cell proliferation by transiently transfecting the miR-410-3p mimic or inhibitor, as well as their corresponding controls in the MDA-MB-231 and MCF7 cell lines. miR-410-3p overexpression reduced cell growth, colony formation and the number of EdU-positive cells in the MDA-MB-231 cells. In contrast, inhibition of miR-410-3p in the MCF7 cells resulted in a higher proliferation rate as assessed by MTT assay, plate colony formation and EdU assays. Furthermore, miR-410-3p inhibited epithelial-mesenchymal transition. In addition, Snail was found to be a direct target of miR-410-3p based on a luciferase assay. Overexpression of Snail was able to rescue the effect of miR-410-3p in breast cancer cells. Moreover, miR‑410-3p was inversely expressed with Snail in breast cancer samples. Our data provide new knowledge regarding the role of miR-410-3p in breast cancer progression.

  7. Self-efficacy and fear of cancer progression during the year following diagnosis of breast cancer.

    Science.gov (United States)

    Melchior, Hanne; Büscher, Cathrin; Thorenz, Andrea; Grochocka, Anna; Koch, Uwe; Watzke, Birgit

    2013-01-01

    The aim of this study was to investigate fear of disease progression (FoP) during the year following diagnosis of breast cancer and its association with general self-efficacy (SE). In a prospective study, 118 breast cancer patients were recruited shortly after diagnosis disclosure (response rate: 54%) and at 1-year follow-up (follow-up rate: 90%). Participants completed self-report measures of general self-efficacy (General Self-Efficacy Scale) and fear of progression (short form of the Fear of Progression Questionnaire). Cross-sectional regression analysis revealed that high FoP is significantly associated with low SE, even when controlling for demographic and medical characteristics (total R² = 0.17). Having children and a relatively short time since diagnosis also significantly predicted higher FoP. Longitudinal analyses showed that FoP decreased significantly over time (p = 0.001; d = 0.25), but a significant decrease was only observed for patients with high initial FoP (p fears in breast cancer patients. As FoP changes only slightly over time, treatment to enhance SE and reduce FoP should be initiated soon after disease disclosure. Copyright © 2011 John Wiley & Sons, Ltd.

  8. Role of deregulated microRNAs in breast cancer progression using FFPE tissue.

    Directory of Open Access Journals (Sweden)

    Liang Chen

    Full Text Available MicroRNAs (miRNAs contribute to cancer initiation and progression by silencing the expression of their target genes, causing either mRNA molecule degradation or translational inhibition. Intraductal epithelial proliferations of the breast are histologically and clinically classified into normal, atypical ductal hyperplasia (ADH, ductal carcinoma in situ (DCIS and invasive ductal carcinoma (IDC. To better understand the progression of ductal breast cancer development, we attempt to identify deregulated miRNAs in this process using Formalin-Fixed, Paraffin-Embedded (FFPE tissues from breast cancer patients. Following tissue microdissection, we obtained 8 normal, 4 ADH, 6 DCIS and 7 IDC samples, which were subject to RNA isolation and miRNA expression profiling analysis. We found that miR-21, miR-200b/c, miR-141, and miR-183 were consistently up-regulated in ADH, DCIS and IDC compared to normal, while miR-557 was uniquely down-regulated in DCIS. Interestingly, the most significant miRNA deregulations occurred during the transition from normal to ADH. However, the data did not reveal a step-wise miRNA alteration among discrete steps along tumor progression, which is in accordance with previous reports of mRNA profiling of different stages of breast cancer. Furthermore, the expression of MSH2 and SMAD7, two important molecules involving TGF-β pathway, was restored following miR-21 knockdown in both MCF-7 and Hs578T breast cancer cells. In this study, we have not only identified a number of potential candidate miRNAs for breast cancer, but also found that deregulation of miRNA expression during breast tumorigenesis might be an early event since it occurred significantly during normal to ADH transition. Consequently, we have demonstrated the feasibility of miRNA expression profiling analysis using archived FFPE tissues, typically with rich clinical information, as a means of miRNA biomarker discovery.

  9. Surgical resident technical skill self-evaluation: increased precision with training progression.

    Science.gov (United States)

    Quick, Jacob A; Kudav, Vishal; Doty, Jennifer; Crane, Megan; Bukoski, Alex D; Bennett, Bethany J; Barnes, Stephen L

    2017-10-01

    Surgical resident ability to accurately evaluate one's own skill level is an important part of educational growth. We aimed to determine if differences exist between self and observer technical skill evaluation of surgical residents performing a single procedure. We prospectively enrolled 14 categorical general surgery residents (six post-graduate year [PGY] 1-2, three PGY 3, and five PGY 4-5). Over a 6-month period, following each laparoscopic cholecystectomy, residents and seven faculty each completed the Objective Structured Assessment of Technical Skills (OSATS). Spearman's coefficient was calculated for three groups: senior (PGY 4-5), PGY3, and junior (PGY 1-2). Rho (ρ) values greater than 0.8 were considered well correlated. Of the 125 paired assessments (resident-faculty each evaluating the same case), 58 were completed for senior residents, 54 for PGY3 residents, and 13 for junior residents. Using the mean from all OSATS categories, trainee self-evaluations correlated well to faculty (senior ρ 0.97, PGY3 ρ 0.9, junior ρ 0.9). When specific OSATS categories were analyzed, junior residents exhibited poor correlation in categories of respect for tissue (ρ -0.5), instrument handling (ρ 0.71), operative flow (ρ 0.41), use of assistants (ρ 0.05), procedural knowledge (ρ 0.32), and overall comfort with the procedure (ρ 0.73). PGY3 residents lacked correlation in two OSATS categories, operative flow (ρ 0.7) and procedural knowledge (ρ 0.2). Senior resident self-evaluations exhibited strong correlations to observers in all areas. Surgical residents improve technical skill self-awareness with progressive training. Less-experienced trainees have a tendency to over-or-underestimate technical skill. Copyright © 2017 Elsevier Inc. All rights reserved.

  10. Projects at the Component Development and Integration Facility. Quarterly technical progress report, January 1, 1994--March 31, 1994

    Energy Technology Data Exchange (ETDEWEB)

    1994-08-01

    This quarterly technical progress report presents progress on the projects at the Component Development and Integration Facility (CDIF) during the second quarter of FY94. The CDIF is a major US Department of Energy test facility in Butte, Montana, operated by MSE, Inc. Projects in progress include: Biomass Remediation Project; Heavy Metal-Contaminated Soil Project; MHD Shutdown; Mine Waste Technology Pilot Program; Plasma Projects; Resource Recovery Project; Sodium Sulfide/Ferrous Sulfate Project; and Spray Casting Project.

  11. An Improved Syngeneic Orthotopic Murine Model of Human Breast Cancer Progression

    Science.gov (United States)

    Rashid, Omar M.; Nagahashi, Masayuki; Ramachandran, Suburamaniam; Dumur, Catherine; Schaum, Julia; Yamada, Akimitsu; Terracina, Krista P.; Milstien, Sheldon; Spiegel, Sarah; Takabe, Kazuaki

    2014-01-01

    Purpose Breast cancer drug development costs nearly $610 million and 37 months in preclinical mouse model trials with minimal success rates. Despite these inefficiencies, there are still no consensus breast cancer preclinical models. Methods Murine mammary adenocarcinoma 4T1-luc2 cells were implanted subcutaneous (SQ) or orthotopically percutaneous injection in the area of the nipple (OP), or surgically into the chest 2nd mammary fat pad under direct vision (ODV) in Balb/c immunocompetent mice. Tumor progression was followed by in vivo bioluminescence and direct measurements, pathology and survival determined, and tumor gene expression analyzed by genome-wide microarrays. Results ODV produced less variable sized tumors and was a reliable method of implantation. ODV implantation into the chest 2nd mammary pad rather than into the abdominal 4th mammary pad, the most common implantation site, better mimicked human breast cancer progression pattern, which correlated with bioluminescent tumor burden and survival. Compared to SQ, ODV produced tumors that differentially expressed genes whose interaction networks are of importance in cancer research. qPCR validation of 10 specific target genes of interest in ongoing clinical trials demonstrated significant differences in expression. Conclusions ODV implantation into the chest 2nd mammary pad provides the most reliable model that mimics human breast cancer compared from subcutaneous implantation that produces tumors with different genome expression profiles of clinical significance. Increased understanding of the limitations of the different preclinical models in use will help guide new investigations and may improve the efficiency of breast cancer drug development. PMID:25200444

  12. [Aspects of progesterone receptor (PR) activity regulation - impact on breast cancer progression].

    Science.gov (United States)

    Piasecka, Dominika; Składanowski, Andrzej C; Kordek, Radzisław; Romańska, Hanna M; Sądej, Rafał

    2015-01-01

    Progesterone receptor (PR) and its specific ligand play a key role in development and physiology of mammary gland. The role of PR in initiation and progression of breast carcinoma (BCa) is unquestionable, although molecular mechanism of PR action is complex and not fully understood. It is known that increased risk of breast cancer is associated with progestin-based (synthetic ligands of progesterone) hormonal contraception or hormone replacement therapies. It is estimated that ER/PR-positive tumours represent approximately 50-70% of all BCa cases, and the loss of PR is associated with resistance to hormonal therapy and increased tumour invasiveness. In classical, genomic signalling pathway cytoplasmic PR, following ligand binding, translocates to the nucleus and regulates expression of genes with the PRE sequence. PR is also involved in a large number of alternative, non-genomic signalling cascades, e.g. PR is able to activate MAPK and PI3K/AKT pathways, which leads to regulation of gene expression. The cross-talk between PR and Growth Factors Receptors (GFR) results in progesterone-independent activation of PR as well as PR-regulated GFR expression and activation. Growth factors signalling promotes formation of a pool of hypersensitive PR responsive to even very low ligand concentration. Transcriptional activity of PR as well as its dynamic impact on processes such as cell migration and adhesion are crucial for BCa progression. Further studies of multifaceted mechanisms of PR action may contribute to new PR-targeting therapeutic strategies for breast cancer patients.

  13. Identification of metastasis driver genes by massive parallel sequencing of successive steps of breast cancer progression

    DEFF Research Database (Denmark)

    Krøigård, Anne Bruun; Larsen, Martin Jakob; Lænkholm, Anne-Vibeke

    2018-01-01

    Cancer results from alterations at essential genomic sites and is characterized by uncontrolled cell proliferation, invasion and metastasis. Identification of driver genes of metastatic progression is essential, as metastases, not primary tumors, are fatal. To gain insight into the mutational...... concordance between different steps of malignant progression we performed exome sequencing and validation with targeted deep sequencing of successive steps of malignant progression from pre-invasive stages to asynchronous distant metastases in six breast cancer patients. Using the ratio of non......-synonymous to synonymous mutations, a surprisingly large number of cancer driver genes, ranging between 3 and 145, were estimated to confer a selective advantage in the studied primary tumors. We report a substantial amount of metastasis specific mutations and a number of novel putative metastasis driver genes. Most...

  14. Power systems development facility. Quarterly technical progress report, January 1, 1994--March 31, 1994

    Energy Technology Data Exchange (ETDEWEB)

    1994-07-01

    This quarterly technical progress report summarizes work completed during the last quarter of the Second Budget Period, January 1 through March 31, 1994, entitled {open_quotes}Hot Gas Cleanup Test Facility for Gasification and Pressurized Combustion.{close_quotes} The objective of this project is to evaluate hot gas particulate control technologies using coal-derived gas streams. This will entail the design, construction, installation, and use of a flexible test facility which can operate under realistic gasification and combustion conditions. The major particulate control device issues to be addressed include the integration of the particulate control devices into coal utilization systems, on-line cleaning techniques, chemical and thermal degradation of components, fatigue or structural failures, blinding, collection efficiency as a function of particle size, and scale-up of particulate control systems to commercial size.

  15. Spray forming -- Aluminum: Third annual report (Phase 2). Technical progress -- Summary

    Energy Technology Data Exchange (ETDEWEB)

    Kozarek, R.L.

    1998-04-20

    Commercial production of aluminum sheet and plate by spray atomization and deposition is a potentially attractive manufacturing alternative to conventional ingot metallurgy/hot-milling and to continuous casting processes because of reduced energy requirements and reduced cost. To realize the full potential of the technology, the Aluminum Company of America (Alcoa), under contract by the US Department of Energy, is investigating currently available state-of-the-art atomization devices to develop nozzle design concepts whose spray characteristics are tailored for continuous sheet production. This third technical progress report will summarize research and development work conducted during the period 1997 October through 1998 March. Included are the latest optimization work on the Alcoa III nozzle, results of spray forming runs with 6111 aluminum alloy and preliminary rolling trials of 6111 deposits.

  16. Fiber-optic, anti-cycling, high pressure sodium street light control. Final technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1995-05-01

    This is the Final Technical Progress Report on a project to develop and market a Fiber-Optic Anti-Cycling High Pressure Sodium Street Light Control. The field test units are now being made with a single vertical PC board design and contains a computer-on-a-chip or PROM IC to take the place of the majority of the components previously contained on the upper logic board. This will reduce the final costs of the unit when it is in production and increase the control`s flexibility. The authors have finished the soft tooling and have made the 400 plastic cases for the field test units. The new configuration of the cases entails a simplified design of the control shell which will have the lenses cast in place. The shell and base plastics are now finished and in final assembly awaiting the completion of the PC boards.

  17. Energy conservation in citrus processing. Technical progress report, October 1, 1979-March 31, 1980

    Energy Technology Data Exchange (ETDEWEB)

    1980-06-15

    The Sunkist Citrus Plant in Ontario, California, processes about 6 million pounds of citrus fruit per day to make products which include frozen concentrated juice; chilled, pasteurized, natural strength juice; molasses from peel; dried meal from peel; pectin; citrus oil; and bioflavonoids. The energy intensive operations at the plant include concentration, drying, and refrigeration. The objective of the two-year two-phase project is to identify an economically viable alternative to the existing method of meeting energy requirements. Progress on the technical work of Phase I is reported. The following are summarized: requirements (energy price projection, atmospheric emission requirements, citrus juice quality constraints, economic evaluations); characterization (basic citrus processing operations, energy consumption and fruit processed vs time, identification and measurement of energy uses, energy balance for a typical citrus juice evaporator); and thermodynamic analysis (heat pump model, thermal evaporator, and co-generation model).

  18. Solar heating and hot water system for the central administrative office facility. Technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    1978-11-01

    Progress on the solar heating and hot water system for the central administrative office facility of the Lincoln Housing Authority, Lincoln, NE is covered. An acceptance test plan is presented and the results of the test are tabulated. A complete blueprint of the system as built is provided. The monitoring system is drawn and settings and installation are described. An operation and maintenance manual discusses procedures for start up, shut down and seasonal changeover and include a valve list and pictures and specifications of components and materials used. Photographs of the final installation are included, and technical data and performance data are given. Finally, there is a brief description of system design and operation and a discussion of major maintenance problems encountered and their solutions. (LEW)

  19. Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy

    Science.gov (United States)

    Gordon, Andrew C.; Gradishar, William J.; Kaklamani, Virginia G.; Thuluvath, Avesh J.; Ryu, Robert K.; Sato, Kent T.; Gates, Vanessa L.; Salem, Riad; Lewandowski, Robert J.

    2016-01-01

    PURPOSE The purpose of this open-label, retrospective report was to determine the safety and effectiveness of locoregional therapy with yttrium-90 (90Y) radioembolization for patients with progressing breast cancer liver metastases (BCLM) despite polychemotherapy. MATERIALS & METHODS Seventy-five patients with progressing BCLM and stable extrahepatic disease were treated with radioembolization at our institution. Retrospective review of a prospectively collected database was performed to evaluate clinical and biochemical toxicities, tumor response, overall survival (OS), and time to progression (TTP). Radiologic response assessments included Response Evaluation Criteria in Solid Tumors in primary index lesions and metabolic activity on positron emission tomography. Univariate and multivariate analyses were performed. RESULTS 30-day mortality was 4% (n=3). Grade 3+ clinical toxicity and hyperbilirubinemia occurred in 7.6% (n=5) and 5.9% (n=4), respectively. The rate of partial response was 35.3% (n=24), 63.2% (n=43) had stable disease, and progressive disease occurred in 1.5% (n=1). PET imaging was available in 25 patients and 21 (84%) had a complete or partial response or stable disease. The median OS was 6.6mo (95% CI, 5.0 to 9.2mo). The hazard ratio (HR) for OS was .39 (95% CI, .23 to .66) for tumor burden <25% compared to greater tumor burden in multivariate analysis. Elevated bilirubin reduced OS. The HR for hepatic progression was .22 (95% CI, .05 to .98) for solitary compared to multifocal disease. CONCLUSIONS Locoregional therapy with 90Y radioembolization is safe and stops or delays the progression of targeted chemorefractory breast cancer liver metastases. Adverse prognosticators are identified. PMID:25156827

  20. Transposon mutagenesis identifies genes that cooperate with mutant Pten in breast cancer progression

    Science.gov (United States)

    Rangel, Roberto; Lee, Song-Choon; Hon-Kim Ban, Kenneth; Guzman-Rojas, Liliana; Mann, Michael B.; Newberg, Justin Y.; McNoe, Leslie A.; Selvanesan, Luxmanan; Ward, Jerrold M.; Rust, Alistair G.; Chin, Kuan-Yew; Black, Michael A.; Jenkins, Nancy A.; Copeland, Neal G.

    2016-01-01

    Triple-negative breast cancer (TNBC) has the worst prognosis of any breast cancer subtype. To better understand the genetic forces driving TNBC, we performed a transposon mutagenesis screen in a phosphatase and tensin homolog (Pten) mutant mice and identified 12 candidate trunk drivers and a much larger number of progression genes. Validation studies identified eight TNBC tumor suppressor genes, including the GATA-like transcriptional repressor TRPS1. Down-regulation of TRPS1 in TNBC cells promoted epithelial-to-mesenchymal transition (EMT) by deregulating multiple EMT pathway genes, in addition to increasing the expression of SERPINE1 and SERPINB2 and the subsequent migration, invasion, and metastasis of tumor cells. Transposon mutagenesis has thus provided a better understanding of the genetic forces driving TNBC and discovered genes with potential clinical importance in TNBC. PMID:27849608

  1. Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression.

    Science.gov (United States)

    Lambein, Kathleen; Van Bockstal, Mieke; Vandemaele, Lies; Van den Broecke, Rudy; Cocquyt, Veronique; Geenen, Sofie; Denys, Hannelore; Libbrecht, Louis

    2017-11-01

    Although the prognostic and predictive significance of human epidermal growth factor receptor 2 (HER2) in invasive breast cancer is well established, its role in ductal carcinoma in situ (DCIS) remains unclear. Reports on combined evaluation of both HER2 protein expression and HER2 amplification status in pure DCIS and DCIS adjacent to invasive ductal carcinoma (i.e., admixed DCIS) are scarce. In this study, immunohistochemistry and fluorescence in situ hybridization (FISH) were used to assess HER2 status in 72 cases of pure DCIS, 73 cases of DCIS admixed with invasive ductal carcinoma (IDC), and 60 cases of pure IDC. HER2 copy number-based amplification was present in 49% of pure DCIS, 16% of admixed DCIS, 18% of admixed IDC, and 8% of pure IDC. Amplified pure DCIS with clusters of HER2 signals showed a significantly lower HER2 copy number than amplified admixed DCIS with clusters. Whereas pure DCIS and admixed DCIS presented significant differences, the in situ and invasive component of admixed tumors showed striking similarities regarding mean HER2 and chromosome 17 centromere (CEP17) copy number, grade, and estrogen and progesterone receptor expression. The discrepant prevalence of HER2 amplification among breast cancer subgroups indirectly suggests that HER2 may not play a crucial role in the transition of in situ to invasive breast cancer. The similarities in HER2 amplification status between the in situ and invasive component of admixed tumors hint at a common biological pathway for both components. Our data support the theory that pure DCIS, pure IDC, and admixed lesions have a common progenitor, but can progress as separate lineages.

  2. MHD Integrated Topping Cycle Project. Fourteenth quarterly technical progress report, November 1, 1990-- January 31, 1991

    Energy Technology Data Exchange (ETDEWEB)

    1992-02-01

    This fourteenth quarterly technical progress report of the MHD Integrated Topping Cycle Project presents the accomplishments during the period November 1, 1990 to January 31, 1991. Testing of the High Pressure Cooling Subsystem electrical isolator was completed. The PEEK material successfully passed the high temperature, high pressure duration tests (50 hours). The Combustion Subsystem drawings were CADAM released. The procurement process is in progress. An equipment specification and RFP were prepared for the new Low Pressure Cooling System (LPCS) and released for quotation. Work has been conducted on confirmation tests leading to final gas-side designs and studies to assist in channel fabrication.The final cathode gas-side design and the proposed gas-side designs of the anode and sidewall are presented. Anode confirmation tests and related analyses of anode wear mechanisms used in the selection of the proposed anode design are presented. Sidewall confirmation tests, which were used to select the proposed gas-side design, were conducted. The design for the full scale CDIF system was completed. A test program was initiated to investigate the practicality of using Avco current controls for current consolidation in the power takeoff (PTO) regions and to determine the cause of past current consolidation failures. Another important activity was the installation of 1A4-style coupons in the 1A1 channel. A description of the coupons and their location with 1A1 channel is presented herein.

  3. Biochemical removal of HAP precursors from coal. Quarterly technical progress report, 1996

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-12-31

    Shake flask tests were completed of microbial pyrite and HAP precursor removal from Rosebud subbituminous coal. Significant amounts of Ni, F, Mn, Cd, Co and Be were removed from this coal. Analyses in connection with leach column tests of Pittsburgh coal were completed and confirmed significant removal of Ni, F, Mn, Cd, Co and As from this coal. Although Hg was not removed from Pittsburgh coal by microbial attack, there was a correlation between HCl leaching of Hg from this coal and the extent of depyritization. Since HgS is soluble in HCl, the results suggest HgS is exposed by chemical and microbial dissolution of coal pyrite. Column tests with cleaned Indiana No. 5 coal are in progress and show significant early dissolution of Ni, Mn, Cd, Co and As. A final shake flask test with Kentucky No. 9 coal was begun. Pittsburgh coal with a low content of fines was shipped to the Idaho National Engineering Laboratory (INEL) in preparation for slurry column tests of HAP precursor removal. Project results were presented at the PETC contractor`s conference held in Pittsburgh. A project progress review meeting was also held with the PETC technical project monitor.

  4. An imbalance in progenitor cell populations reflects tumour progression in breast cancer primary culture models

    LENUS (Irish Health Repository)

    Donatello, Simona

    2011-04-26

    Abstract Background Many factors influence breast cancer progression, including the ability of progenitor cells to sustain or increase net tumour cell numbers. Our aim was to define whether alterations in putative progenitor populations could predict clinicopathological factors of prognostic importance for cancer progression. Methods Primary cultures were established from human breast tumour and adjacent non-tumour tissue. Putative progenitor cell populations were isolated based on co-expression or concomitant absence of the epithelial and myoepithelial markers EPCAM and CALLA respectively. Results Significant reductions in cellular senescence were observed in tumour versus non-tumour cultures, accompanied by a stepwise increase in proliferation:senescence ratios. A novel correlation between tumour aggressiveness and an imbalance of putative progenitor subpopulations was also observed. Specifically, an increased double-negative (DN) to double-positive (DP) ratio distinguished aggressive tumours of high grade, estrogen receptor-negativity or HER2-positivity. The DN:DP ratio was also higher in malignant MDA-MB-231 cells relative to non-tumourogenic MCF-10A cells. Ultrastructural analysis of the DN subpopulation in an invasive tumour culture revealed enrichment in lipofuscin bodies, markers of ageing or senescent cells. Conclusions Our results suggest that an imbalance in tumour progenitor subpopulations imbalances the functional relationship between proliferation and senescence, creating a microenvironment favouring tumour progression.

  5. Circadian disruption and biomarkers of tumor progression in breast cancer patients awaiting surgery.

    Science.gov (United States)

    Cash, E; Sephton, S E; Chagpar, A B; Spiegel, D; Rebholz, W N; Zimmaro, L A; Tillie, J M; Dhabhar, F S

    2015-08-01

    Psychological distress, which can begin with cancer diagnosis and continue with treatment, is linked with circadian and endocrine disruption. In turn, circadian/endocrine factors are potent modulators of cancer progression. We hypothesized that circadian rest-activity rhythm disruption, distress, and diurnal cortisol rhythms would be associated with biomarkers of tumor progression in the peripheral blood of women awaiting breast cancer surgery. Breast cancer patients (n=43) provided actigraphic data on rest-activity rhythm, cancer-specific distress (IES, POMS), saliva samples for assessment of diurnal cortisol rhythm, cortisol awakening response (CAR), and diurnal mean. Ten potential markers of tumor progression were quantified in serum samples and grouped by exploratory factor analysis. Analyses yielded three factors, which appear to include biomarkers reflecting different aspects of tumor progression. Elevated factor scores indicate both high levels and strong clustering among serum signals. Factor 1 included VEGF, MMP-9, and TGF-β; suggesting tumor invasion/immunosuppression. Factor 2 included IL-1β, TNF-α, IL-6R, MCP-1; suggesting inflammation/chemotaxis. Factor 3 included IL-6, IL-12, IFN-γ; suggesting inflammation/TH1-type immunity. Hierarchical regressions adjusting age, stage and socioeconomic status examined associations of circadian, distress, and endocrine variables with these three factor scores. Patients with poor circadian coordination as measured by rest-activity rhythms had higher Factor 1 scores (R(2)=.160, p=.038). Patients with elevated CAR also had higher Factor 1 scores (R(2)=.293, p=.020). These relationships appeared to be driven largely by VEGF concentrations. Distress was not related to tumor-relevant biomarkers, and no other significant relationships emerged. Women with strong circadian activity rhythms showed less evidence of tumor promotion and/or progression as indicated by peripheral blood biomarkers. The study was not equipped to

  6. PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment.

    Science.gov (United States)

    Guerrero-Zotano, Angel; Mayer, Ingrid A; Arteaga, Carlos L

    2016-12-01

    Anti-cancer cancer-targeted therapies are designed to exploit a particular vulnerability in the tumor, which in most cases results from its dependence on an oncogene and/or loss of a tumor suppressor. Mutations in the phosphoinositide 3-kinase (PI3K)/AKT/mTOR pathway are freqcuently found in breast cancers and associated with cellular transformation, tumorigenesis, cancer progression, and drug resistance. Several drugs targeting PI3K/ATK/mTOR are currently in clinical trials, mainly in combination with endocrine therapy and anti-HER2 therapy. These drugs are the focus of this review.

  7. [Chemical risk in operating rooms and technical progress: the obligations and responsibilities of law].

    Science.gov (United States)

    Oddo, Antonio

    2013-01-01

    We are going to consider the specific applications of the new legal system and of the most recent body of laws to those work environments of particular risk, such as healthcare facilities and in particular operating rooms. In such environments, volatile chemicals classified as "dangerous" are used with consequent exposure to "chemical risk", both of those persons professionally involved, depending on the type of activity, and of the patients to whom such activities are addressed in the same environment. Once the chemical risk is framed in the existing regulatory system, it must be specifically evaluated the application of the same principle to the particular chemical risk arising from the use of anesthetic agents in the operating room, for example sevoflurane and desflurane, being careful to test wether and how much this risk can be eliminated or reduced to minimum in relation to the new achievements of the technical progress. So, as soon as the quality of "dangerous chemical agent" of the "volatile chemicals" and of the "volatile liquid anesthetic" (sevoflurane and desflurane) as well--which are characterized by a lower degree of toxicity and for this reason are mostly used in current chemical practice, preferable to some anesthetic gases such as nitrous oxide--is legally verified, it is necessary to relate the scientific and technical data which result from the current "state of art" also to the other binding regulations that are imposed for the "prevention and protection from chemical agents", according to the relative Title IX of the TUSL (Unique text for Safety and Health at Work).

  8. Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression.

    Science.gov (United States)

    Giussani, Marta; Merlino, Giuseppe; Cappelletti, Vera; Tagliabue, Elda; Daidone, Maria Grazia

    2015-12-01

    Several evidences support the concept that cancer development and progression are not entirely cancer cell-autonomous processes, but may be influenced, and possibly driven, by cross-talk between cancer cells and the surrounding microenvironment in which, besides immune cells, stromal cells and extracellular matrix (ECM) play a major role in regulating distinct biologic processes. Stroma and ECM-related signatures proved to influence breast cancer progression, and to contribute to the identification of tumor phenotypes resistant to cytotoxic and hormonal treatments. The possible clinical implications of the interplay between tumor cells and the microenvironment, with special reference to ECM remodelling, will be discussed in this review. Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

  9. What can be learnt about disease progression in breast cancer dormancy from relapse data?

    Science.gov (United States)

    Willis, Lisa; Graham, Trevor A; Alarcón, Tomás; Alison, Malcolm R; Tomlinson, Ian P M; Page, Karen M

    2013-01-01

    Breast cancer patients have an anomalously high rate of relapse many years--up to 25 years--after apparently curative surgery removed the primary tumour. Disease progression during the intervening years between resection and relapse is poorly understood. There is evidence that the disease persists as dangerous, tiny metastases that remain at a growth restricted, clinically undetectable size until a transforming event restarts growth. This is the starting point for our study, where patients who have metastases that are all tiny and growth-restricted are said to have cancer dormancy. Can long-term follow-up relapse data from breast cancer patients be used to extract knowledge about the progression of the undetected disease? Here, we evaluate whether this is the case by introducing and analysing four simple mathematical models of cancer dormancy. These models extend the common assumption that a random transforming event, such as a mutation, can restart growth of a tiny, growth-restricted metastasis; thereafter, cancer dormancy progresses to detectable metastasis. We find that physiopathological details, such as the number of random transforming events that metastases must undergo to escape from growth restriction, cannot be extracted from relapse data. This result is unsurprising. However, the same analysis suggested a natural question that does have a surprising answer: why are interesting trends in long-term relapse data not more commonly observed? Further, our models indicate that (a) therapies which induce growth restriction among metastases but do not prevent increases in metastases' tumourigenicity may introduce a time post-surgery when more patients are prone to relapse; and (b), if a number of facts about disease progression are first established, how relapse data might be used to estimate clinically relevant variables, such as the likely numbers of undetected growth-restricted metastases. This work is a necessary, early step in building a quantitative

  10. What can be learnt about disease progression in breast cancer dormancy from relapse data?

    Directory of Open Access Journals (Sweden)

    Lisa Willis

    Full Text Available Breast cancer patients have an anomalously high rate of relapse many years--up to 25 years--after apparently curative surgery removed the primary tumour. Disease progression during the intervening years between resection and relapse is poorly understood. There is evidence that the disease persists as dangerous, tiny metastases that remain at a growth restricted, clinically undetectable size until a transforming event restarts growth. This is the starting point for our study, where patients who have metastases that are all tiny and growth-restricted are said to have cancer dormancy. Can long-term follow-up relapse data from breast cancer patients be used to extract knowledge about the progression of the undetected disease? Here, we evaluate whether this is the case by introducing and analysing four simple mathematical models of cancer dormancy. These models extend the common assumption that a random transforming event, such as a mutation, can restart growth of a tiny, growth-restricted metastasis; thereafter, cancer dormancy progresses to detectable metastasis. We find that physiopathological details, such as the number of random transforming events that metastases must undergo to escape from growth restriction, cannot be extracted from relapse data. This result is unsurprising. However, the same analysis suggested a natural question that does have a surprising answer: why are interesting trends in long-term relapse data not more commonly observed? Further, our models indicate that (a therapies which induce growth restriction among metastases but do not prevent increases in metastases' tumourigenicity may introduce a time post-surgery when more patients are prone to relapse; and (b, if a number of facts about disease progression are first established, how relapse data might be used to estimate clinically relevant variables, such as the likely numbers of undetected growth-restricted metastases. This work is a necessary, early step in building a

  11. Does Skeletal Muscle Mass Influence Breast Cancer? Evaluating Mammary Tumorigenesis and Progression Genetically Hyper-Muscular Mice

    Science.gov (United States)

    2006-07-01

    the skeletal muscle-specific muscle growth inhibitor myostatin and mice expressing a dominant negative form of the myostatin receptor, Activin...and rates of breast cancer initiation and progression. 15. SUBJECT TERMS Breast cancer, skeletal muscle, myostatin , MPA, DMBA, Activin receptor 16...including interleukins, Insulin-like Growth Factor (IGF) isoforms, IGF-binding proteins and myostatin . To determine the effect of skeletal muscle mass

  12. Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis

    DEFF Research Database (Denmark)

    Krøigård, Anne Bruun; Larsen, Martin Jakob; Lænkholm, Anne Vibeke

    2015-01-01

    Evolution of the breast cancer genome from pre-invasive stages to asynchronous metastasis is complex and mostly unexplored, but highly demanded as it may provide novel markers for and mechanistic insights in cancer progression. The increasing use of personalized therapy of breast cancer...... the different stages of tumor evolution in this patient emphasizes the importance of molecular profiling of metastatic tissue directing molecularly targeted therapy at recurrence....

  13. Final Technical Progress Report: Development of Low-Cost Suspension Heliostat; December 7, 2011 - December 6, 2012

    Energy Technology Data Exchange (ETDEWEB)

    Bender, W.

    2013-01-01

    Final technical progress report of SunShot Incubator Solaflect Energy. The project succeeded in demonstrating that the Solaflect Suspension Heliostat design is viable for large-scale CSP installations. Canting accuracy is acceptable and is continually improving as Solaflect improves its understanding of this design. Cost reduction initiatives were successful, and there are still many opportunities for further development and further cost reduction.

  14. Importance of transcript levels of caspase-2 isoforms S and L for breast carcinoma progression.

    Science.gov (United States)

    Brynychová, Veronika; Hlaváč, Viktor; Ehrlichová, Marie; Václavíková, Radka; Pecha, Václav; Trnková, Markéta; Wald, Martin; Mrhalová, Marcela; Kubáčková, Kateřina; Pikus, Tomáš; Kodet, Roman; Kovář, Jan; Souček, Pavel

    2013-03-01

    A role of caspase-2 in chemotherapy-induced apoptosis has been suggested. Our study aimed to evaluate the prognostic and predictive importance of caspase-2 isoforms in breast cancer patients. Caspase-2L and -2S transcript levels were determined in paired tumor and non-malignant control tissues from 64 patients after neoadjuvant chemotherapy and 100 pretreatment patients (general set) by real-time PCR with absolute quantification. Low but statistically significant upregulation of caspase-2L in tumor versus control tissues was observed in both sets. Significant associations of the levels of caspase-2L, -2S or S/L ratio with clinical prognostic factors were observed. However, none of these associations were confirmed in both sets. Levels of caspase-2 isoforms or the S/L ratio did not significantly associate with progression-free survival in the general set or with chemotherapy response in the neoadjuvant set. Our results suggest that the role of caspase-2 isoforms in the progression of breast cancer may considerably differ between pre- and post-chemotherapy patients.

  15. Effects of progressive relaxation exercises on anxiety and comfort of Turkish breast cancer patients receiving chemotherapy.

    Science.gov (United States)

    Yilmaz, Seher Gurdil; Arslan, Sevban

    2015-01-01

    Breast cancer is the second most common cancer in the world and by far the most frequent cancer among women. This study was conducted to observe the effect of progressive relaxation exercises on anxiety and comfort level of breast cancer patients receiving chemotherapy. A control group pre-test/post-test quasi-experimental model was applied with experimental (30) and control (30) groups, who agreed to participate in this study. Data collection was with the "Personnel Information Form, State-Trait Anxiety Inventory and General Comfort Scale". The average age of the patients that participated in the study was 49.1±7.96 years. Eighty-three point three percent (n=25) of the patients in the experiment group and 86.7 (n=26) percent of patients in control group were married. Patient state of anxiety post-test mean scores were 36.2±8.21 in the experimental group and 43.4±7.96 in the control group, the difference being statistically significant (pProgressive relaxation exercises positively affect patient comfort and anxiety levels in Turkey.

  16. Hormonally up-regulated neu-associated kinase: A novel target for breast cancer progression.

    Science.gov (United States)

    Zambrano, Joelle N; Neely, Benjamin A; Yeh, Elizabeth S

    2017-05-01

    Hormonally up-regulated neu-associated Kinase (Hunk) is a protein kinase that was originally identified in the murine mammary gland and has been shown to be highly expressed in Human Epidermal Growth Factor Receptor 2 positive (HER2 + /ErbB2 + ) breast cancer cell lines as well as MMTV-neu derived mammary tumor cell lines. However, the physiological role of Hunk has been largely elusive since its identification. Though Hunk is predicted to be a Serine/Threonine (Ser/Thr) protein kinase with homology to the SNF1/AMPK family of protein kinases, there are no known Hunk substrates that have been identified to date. Recent work demonstrates a role for Hunk in HER2 + /ErbB2 + breast cancer progression, including drug resistance to HER2/ErbB2 inhibitors, with Hunk potentially acting downstream of HER2/ErbB2 and the PI3K/Akt pathway. These studies have collectively shown that Hunk plays a vital role in promoting mammary tumorigenesis, as Hunk knockdown via shRNA in xenograft tumor models or crossing MMTV-neu or Pten-deficient genetically engineered mouse models into a Hunk knockout (Hunk-/-) background impairs mammary tumor growth in vivo. Because the majority of HER2 + /ErbB2 + breast cancer patients acquire drug resistance to HER2/ErbB2 inhibitors, the characterization of novel drug targets like Hunk that have the potential to simultaneously suppress tumorigenesis and potentially enhance efficacy of current therapeutics is an important facet of drug development. Therefore, work aimed at uncovering specific regulatory functions for Hunk that could contribute to this protein kinase's role in both tumorigenesis and drug resistance will be informative. This review focuses on what is currently known about this under-studied protein kinase, and how targeting Hunk may prove to be a potential therapeutic target for the treatment of breast cancer. Copyright © 2017 Elsevier Ltd. All rights reserved.

  17. Real-time motion analysis reveals cell directionality as an indicator of breast cancer progression.

    Directory of Open Access Journals (Sweden)

    Michael C Weiger

    Full Text Available Cancer cells alter their migratory properties during tumor progression to invade surrounding tissues and metastasize to distant sites. However, it remains unclear how migratory behaviors differ between tumor cells of different malignancy and whether these migratory behaviors can be utilized to assess the malignant potential of tumor cells. Here, we analyzed the migratory behaviors of cell lines representing different stages of breast cancer progression using conventional migration assays or time-lapse imaging and particle image velocimetry (PIV to capture migration dynamics. We find that the number of migrating cells in transwell assays, and the distance and speed of migration in unconstrained 2D assays, show no correlation with malignant potential. However, the directionality of cell motion during 2D migration nicely distinguishes benign and tumorigenic cell lines, with tumorigenic cell lines harboring less directed, more random motion. Furthermore, the migratory behaviors of epithelial sheets observed under basal conditions and in response to stimulation with epidermal growth factor (EGF or lysophosphatitic acid (LPA are distinct for each cell line with regard to cell speed, directionality, and spatiotemporal motion patterns. Surprisingly, treatment with LPA promotes a more cohesive, directional sheet movement in lung colony forming MCF10CA1a cells compared to basal conditions or EGF stimulation, implying that the LPA signaling pathway may alter the invasive potential of MCF10CA1a cells. Together, our findings identify cell directionality as a promising indicator for assessing the tumorigenic potential of breast cancer cell lines and show that LPA induces more cohesive motility in a subset of metastatic breast cancer cells.

  18. Highly specific role of the insulin receptor in breast cancer progression.

    Science.gov (United States)

    Rostoker, Ran; Abelson, Sagi; Bitton-Worms, Keren; Genkin, Inna; Ben-Shmuel, Sarit; Dakwar, Maria; Orr, Zila Shen; Caspi, Avishay; Tzukerman, Maty; LeRoith, Derek

    2015-04-01

    Accumulating evidence from clinical trials indicates that specific targeting of the IGF1 receptor (IGF1R) is not efficient as an anti-breast cancer treatment. One possible reason is that the mitogenic signals from the insulin receptor (IR) can be processed independently or as compensation to inhibition of the IGF1R. In this study, we highlight the role of the IR in mediating breast tumor progression in both WT mice and a hyperinsulinemic MKR mouse model by induction of Ir (Insr) or Igf1r knockdown (KD) in the mammary carcinoma Mvt-1 cell line. By using the specific IR antagonist-S961, we demonstrated that Igf1r-KD induces elevated responses by the IR to IGF1. On the other hand, Ir-KD cells generated significantly smaller tumors in the mammary fat pads of both WT and MKR mice, as opposed to control cells, whereas the Igf1r-KD cells did not. The tumorigenic effects of insulin on the Mvt-1 cells were also demonstrated using microarray analysis, which indicates alteration of genes and signaling pathways involved in proliferation, the cell cycle, and apoptosis following insulin stimulation. In addition, the correlation between IR and the potential prognostic marker for aggressive breast cancer, CD24, was examined in the Ir-KD cells. Fluorescence-activated cell sorting (FACS) analysis revealed more than 60% reduction in CD24 expression in the Ir-KD cells when compared with the control cells. Our results also indicate that CD24-expressing cells can restore, at least in part, the tumorigenic capacity of Ir-KD cells. Taken together, our results highlight the mitogenic role of the IR in mammary tumor progression with a direct link to CD24 expression. © 2015 Society for Endocrinology.

  19. The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancer.

    Science.gov (United States)

    Magnani, Luca; Patten, Darren K; Nguyen, Van T M; Hong, Sung-Pil; Steel, Jennifer H; Patel, Naina; Lombardo, Ylenia; Faronato, Monica; Gomes, Ana R; Woodley, Laura; Page, Karen; Guttery, David; Primrose, Lindsay; Fernandez Garcia, Daniel; Shaw, Jacqui; Viola, Patrizia; Green, Andrew; Nolan, Christopher; Ellis, Ian O; Rakha, Emad A; Shousha, Sami; Lam, Eric W-F; Győrffy, Balázs; Lupien, Mathieu; Coombes, R Charles

    2015-09-08

    Over 30% of ERα breast cancer patients develop relapses and progress to metastatic disease despite treatment with endocrine therapies. The pioneer factor PBX1 translates epigenetic cues and mediates estrogen induced ERα binding. Here we demonstrate that PBX1 plays a central role in regulating the ERα transcriptional response to epidermal growth factor (EGF) signaling. PBX1 regulates a subset of EGF-ERα genes highly expressed in aggressive breast tumours. Retrospective stratification of luminal patients using PBX1 protein levels in primary cancer further demonstrates that elevated PBX1 protein levels correlate with earlier metastatic progression. In agreement, PBX1 protein levels are significantly upregulated during metastatic progression in ERα-positive breast cancer patients. Finally we reveal that PBX1 upregulation in aggressive tumours is partly mediated by genomic amplification of the PBX1 locus. Correspondingly, ERα-positive breast cancer patients carrying PBX1 amplification are characterized by poor survival. Notably, we demonstrate that PBX1 amplification can be identified in tumor derived-circulating free DNA of ERα-positive metastatic patients. Metastatic patients with PBX1 amplification are also characterized by shorter relapse-free survival. Our data identifies PBX1 amplification as a functional hallmark of aggressive ERα-positive breast cancers. Mechanistically, PBX1 amplification impinges on several critical pathways associated with aggressive ERα-positive breast cancer.

  20. Tumor-Associated Macrophages Promote Malignant Progression of Breast Phyllodes Tumors by Inducing Myofibroblast Differentiation.

    Science.gov (United States)

    Nie, Yan; Chen, Jianing; Huang, Di; Yao, Yandan; Chen, Jiewen; Ding, Lin; Zeng, Jiayi; Su, Shicheng; Chao, Xue; Su, Fengxi; Yao, Herui; Hu, Hai; Song, Erwei

    2017-07-01

    Myofibroblast differentiation plays an important role in the malignant progression of phyllodes tumor, a fast-growing neoplasm derived from periductal stromal cells of the breast. Macrophages are frequently found in close proximity with myofibroblasts, but it is uncertain whether they are involved in the myofibroblast differentiation during phyllodes tumor progression. Here we show that increased density of tumor-associated macrophage (TAM) correlates with malignant progression of phyllodes tumor. We found that TAMs stimulated myofibroblast differentiation and promoted the proliferation and invasion of phyllodes tumor cells. Furthermore, we found that levels of the chemokine CCL18 in TAM was an independent prognostic factor of phyllodes tumor. Mechanistic investigations showed that CCL18 promoted expression of α-smooth muscle actin, a hallmark of myofibroblast, along with the proliferation and invasion of phyllodes tumor cells, and that CCL18-driven myofibroblast differentiation was mediated by an NF-κB/miR-21/PTEN/AKT signaling axis. In murine xenograft models of human phyllodes tumor, CCL18 accelerated tumor growth, induced myofibroblast differentiation, and promoted metastasis. Taken together, our findings indicated that TAM drives myofibroblast differentiation and malignant progression of phyllodes tumor through a CCL18-driven signaling cascade amenable to antibody disruption. Cancer Res; 77(13); 3605-18. ©2017 AACR . ©2017 American Association for Cancer Research.

  1. Coal liquefaction process streams characterization and evaluation. Quarterly technical progress report, January 1--March 31, 1992

    Energy Technology Data Exchange (ETDEWEB)

    Robbins, G.A.; Brandes, S.D.; Winschel, R.A.; Burke, F.P.

    1992-08-01

    This is the tenth Quarterly Technical Progress Report under DOE Contract DE-AC22-89PC89883. Process oils from Wilsonville Run 262 were analyzed to provide information on process performance. Run 262 was operated from July 10 through September 30, 1991, in the thermal/catalytic Close-Coupled Integrated Two-Stage Liquefaction (CC-ITSL) configuration with ash recycle. The feed coal was Black Thunder Mine subbituminous coal. The high/low temperature sequence was used. Each reactor was operated at 50% of the available reactor volume. The interstage separator was in use throughout the run. The second-stage reactor was charged with aged Criterion 324 catalyst (Ni/Mo on 1/16 inch alumina extrudate support). Slurry catalysts and sulfiding agent were fed to the first-stage reactor. Molyvan L is an organometallic compound which contains 8.1% Mo, and is commercially available as an oil-soluble lubricant additive. It was used in Run 262 as a dispersed hydrogenation catalyst precursor, primarily to alleviate deposition problems which plagued past runs with Black Thunder coal. One test was made with little supported catalyst in the second stage. The role of phenolic groups in donor solvent properties was examined. In this study, four samples from direct liquefaction process oils were subjected to O-methylation of the phenolic groups, followed by chemical analysis and solvent quality testing.

  2. MHD Integrated Topping Cycle Project. Sixteenth quarterly technical progress report, May 1991--July 1991

    Energy Technology Data Exchange (ETDEWEB)

    1992-03-01

    The Magnetohydrodynamics (MHD) Integrated Topping Cycle (ITC) Project represents the culmination of the proof-of-concept (POC) development stage in the US Department of Energy (DOE) program to advance MHD technology to early commercial development stage utility power applications. The project is a joint effort, combining the skills of three topping cycle component developers: TRW, Avco/TDS, and Westinghouse. TRW, the prime contractor and system integrator, is responsible for the 50 thermal megawatt (50 MW{sub t}) slagging coal combustion subsystem. Avco/TDS is responsible for the MHD channel subsystem (nozzle, channel, diffuser, and power conditioning circuits), and Westinghouse is responsible for the current consolidation subsystem. The ITC Project will advance the state-of-the-art in MHD power systems with the design, construction, and integrated testing of 50 MW{sub t} power train components which are prototypical of the equipment that will be used in an early commercial scale MHD utility retrofit. Long duration testing of the integrated power train at the Component Development and Integration Facility (CDIF) in Butte, Montana will be performed, so that by the early 1990`s, an engineering data base on the reliability, availability, maintainability and performance of the system will be available to allow scaleup of the prototypical designs to the next development level. This Sixteenth Quarterly Technical Progress Report covers the period May 1, 1991 to July 31, 1991.

  3. Coal liquefaction process streams characterization and evaluation. Quarterly technical progress report, April 1--June 30, 1992

    Energy Technology Data Exchange (ETDEWEB)

    Brandes, S.D.; Lancet, M.S.; Robbins, G.A.; Winschel, R.A.; Burke, F.P.

    1992-11-01

    This is the eleventh Quarterly Technical Progress Report under DOE Contract DE-AC22-89PC89883. Major topics reported are: (1) The results of a study designed to determine the effects of the conditions employed at the Wilsonville slurry preheater vessel on coal conversion is described. (2) Stable carbon isotope ratios were determined and used to source the carbon of three product samples from Period 49 of UOP bench-scale coprocessing Run 37. The results from this coprocessing run agree with the general trends observed in other coprocessing runs that we have studied. (3) Microautoclave tests and chemical analyses were performed to ``calibrate`` the reactivity of the standard coal used for determining donor solvent quality of process oils in this contract. (4) Several aspects of Wilsonville Close-Coupled Integrated Two-Stage Liquefaction (CC-ITSL) resid conversion kinetics were investigated; results are presented. Error limits associated with calculations of deactivation rate constants previously reported for Runs 258 and 261 are revised and discussed. A new procedure is described that relates the conversions of 850{degrees}F{sup +} , 1050{degrees}F{sup +}, and 850 {times} 1050{degrees}F material. Resid conversions and kinetic constants previously reported for Run 260 were incorrect; corrected data and discussion are found in Appendix I of this report.

  4. PFBC HGCU Test Facility. Technical progress report No. 24, Third quarter, CY 1995

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1995-10-01

    This is the twenty-fourth and final Technical Progress Report submitted to the Department of Energy (DOE) in connection with the cooperative agreement between the DOE and Ohio Power Company for the Tidd PFBC Hot Gas Clean Up Test Facility. This report covers the work completed during the Third Quarter of CY 1995. All activity this quarter was directed toward the completion of the program final report. A draft copy of the final report was forwarded to DOE during this quarter, and DOE submitted their comments on the report to AEPSC. DOE requested that Westinghouse write an appendix to the report covering the performance of the fail-safe regenerator devices during Tad operation, and Westinghouse subsequently prepared the appendix. Additional DOE comments were incorporated into the report, and it will be issued in camera-ready form by the end of October, 1995, which is the program end date. Appendix 1 presents the results of filter candle posttest examination by Westinghouse performed on selected filter candles following final shutdown of the system.

  5. Jointly sponsored research program quarterly technical progress report, January--March 1994

    Energy Technology Data Exchange (ETDEWEB)

    1994-08-01

    Progress reports are presented for the following tasks: Development and demonstration of a practical electric downhole steam generator for thermal recovery of heavy oil and tar; wetting behavior of selected crude oil/brine/rock systems; coal gasification, power generation, and product market study; impact of leachate from clean coal technology waste on the stability of clay liners; investigation of coprocessing of heavy oil, automobile shredder residue, and coal; injection into coal seams for simultaneous CO{sub 2} mitigation and enhanced recovery of coalbed methane; optimization of carbonizer operations in the FMC coke process; chemical sensor and field screening technology development; demonstration of the Koppelman ``Series C`` Power River Basin coal as feed; remote chemical sensor development; market assessment and technical feasibility study of PFBC ash use; solid-state NMR analysis and interpretation of naturally and artificially matured kerogens; Crow{trademark} field demonstration with Bell Lumber and Pole; ``B`` series pilot plant tests; and in-situ treatment of manufactured gas plant contaminated soils demonstration program.

  6. Unfiltered sulfur colloid and sentinel node biopsy for breast cancer: technical and kinetic considerations.

    Science.gov (United States)

    Moffat, F L; Gulec, S A; Sittler, S Y; Serafini, A N; Sfakianakis, G N; Boggs, J E; Franceschi, D; Pruett, C S; Pop, R; Gurkok, C; Livingstone, A S; Krag, D N

    1999-12-01

    There are few clinical data on technical limitations and radiocolloid kinetics related to sentinel lymph node (SLN) biopsy for breast cancer. In 70 clinical node-negative patients, unfiltered 99mTc sulfur-colloid was injected peritumorally and cutaneous hot spots were mapped with a gamma probe. SLN biopsy was performed followed by axillary lymph node dissection. Missed radioactive nodes (nodes not under hot spots) were removed from axillary lymph node dissection specimens and submitted separately. At least one hot spot was mapped in 69 patients (98%) and SLNs were retrieved in 62 (89%). No radiolabeled nodes were found in five (7%) and only nodes not under hot spots were retrieved in three patients (4%). Residual nodes not under hot spots were retrieved in 17 patients (24%) in whom at least one SLN specimen had been found. Diffuse radioactivity around the radiocolloid injection site impeded identification of all radiolabeled nodes during SLN biopsy, and was responsible for one of two false negatives (20 node-positive patients; false-negative rate 10%). Hot spot radioactivity, number of radiolabeled nodes, and nodal radioactivity did not change with time interval from radiocolloid injection to surgery (0.75-6.25 hours). Although SLN localization rate is high, intraparenchymal injection may predispose to failure of radiocolloid migration, failure to identify SLNs because of high radiation background, and false-negative outcomes. Alternative routes of radiocolloid administration should be explored.

  7. High SO{sub 2} removal efficiency testing. Technical progress report, [October 1--December 31, 1992

    Energy Technology Data Exchange (ETDEWEB)

    Blythe, G.

    1993-01-20

    Baseline testing at the ``base`` site. Tampa Electric Company`s (TECo`s) Big Bend Station, commenced on September 28 and was completed on October 2. Initial results from this testing were presented in the previous Technical Progress Report, but a more complete discussion is provided in this report. Parametric testing was conducted at the Big Bend site during this quarter to evaluate the effects of dibasic acid (DBA) addition on system SO{sub 2} removal performance. The parametric tests were conducted from November 2 through 19. A DBA consumption rate test was also conducted, after the parametric tests were completed. The DBA consumption test was conducted from November 21 through 25. Options I and II to the base program were exercised by DOE/PETC at the end of the previous quarter. These options involve testing at Hoosier Energy Rural Electric Cooperative Inc.`s Merom Station and Southwestern Electric Power Company`s Pirkey Station, respectively. Testing was conducted at Merom Station during November. Previously, Radian Corporation was the test contractor for EPRI-funded performance additive testing at this site. This EPRI-funded testing involved the equivalent of baseline testing, parametric testing with both DBA and sodium formate performance additives, and an additive consumption test with the DBA additive. The results of the prior testing will be available to support the objectives of this DOE project Consequently, the only testing required at the Merom site was to conduct consumption tests with the sodium formate additive. After a brief baseline repeat test, two sodium formate consumption tests were conducted during the time period from November 11 through 23. Results from the consumption tests are presented and discussed in this report.

  8. Power systems development facility. Quarterly technical progress report, July 1--September 30, 1993

    Energy Technology Data Exchange (ETDEWEB)

    1993-12-31

    This quarterly technical progress report summarizes work completed during the Second Quarter of the Second Budget Period, July 1 through September 30, 1993, under the Department of Energy (DOE) Cooperative Agreement No. DE-FC21-90MC25140 entitled ``Hot Gas Cleanup Test Facility for Gasification and Pressurized Combustion.`` The objective of this project is to evaluate hot gas particle control technologies using coal-derived gas streams. This will entail the design, construction, installation, and use of a flexible test facility which can operate under realistic gasification and combustion conditions. The major particulate control device issues to be addressed include the integration of the particulate control devices into coal utilization systems, on-line cleaning techniques, chemical and thermal degradation of components, fatigue or structural failures, blinding, collection efficiency as a function of particle size, and scaleup of particulate control systems to commercial size. The conceptual design of the facility was extended to include a within scope, phased expansion of the existing Hot Gas Cleanup Test Facility Cooperative Agreement to also address systems integration issues of hot particulate removal in advanced coal-based power generation systems. This expansion included the consideration of the following modules at the test facility in addition to the existing Transport Reactor gas source and Hot Gas Cleanup Units: Carbonizer/Pressurized Circulating Fluidized Bed Gas Source. Hot Gas Cleanup Units to mate to all gas streams; Combustion Gas Turbine; and Fuel Cell and associated gas treatment. This expansion to the Hot Gas Cleanup Test Facility is herein referred to as the Power Systems Development Facility (PSDF). The major emphasis during this reporting period was continuing the detailed design of the facility.

  9. Randomized controlled trial to evaluate the effects of progressive resistance training compared to progressive muscle relaxation in breast cancer patients undergoing adjuvant radiotherapy: the BEST study.

    Science.gov (United States)

    Potthoff, Karin; Schmidt, Martina E; Wiskemann, Joachim; Hof, Holger; Klassen, Oliver; Habermann, Nina; Beckhove, Philipp; Debus, Juergen; Ulrich, Cornelia M; Steindorf, Karen

    2013-03-28

    Cancer-related fatigue (CRF) is one of the most common and distressing side effects of cancer and its treatment. During and after radiotherapy breast cancer patients often suffer from CRF which frequently impairs quality of life (QoL). Despite the high prevalence of CRF in breast cancer patients and the severe impact on the physical and emotional well-being, effective treatment methods are scarce.Physical activity for breast cancer patients has been reported to decrease fatigue, to improve emotional well-being and to increase physical strength. The pathophysiological and molecular mechanisms of CRF and the molecular-biologic changes induced by exercise, however, are poorly understood.In the BEST trial we aim to assess the effects of resistance training on fatigue, QoL and physical fitness as well as on molecular, immunological and inflammatory changes in breast cancer patients during adjuvant radiotherapy. The BEST study is a prospective randomized, controlled intervention trial investigating the effects of a 12-week supervised progressive resistance training compared to a 12-week supervised muscle relaxation training in 160 patients with breast cancer undergoing adjuvant radiotherapy. To determine the effect of exercise itself beyond potential psychosocial group effects, patients in the control group perform a group-based progressive muscle relaxation training. Main inclusion criterion is histologically confirmed breast cancer stage I-III after lumpectomy or mastectomy with indication for adjuvant radiotherapy. Main exclusion criteria are acute infectious diseases, severe neurological, musculosceletal or cardiorespiratory disorders. The primary endpoint is cancer-related fatigue; secondary endpoints include immunological and inflammatory parameters analyzed in peripheral blood, saliva and urine. In addition, QoL, depression, physical performance and cognitive capacity will be assessed. The BEST study is the first randomized controlled trial comparing progressive

  10. First-line capecitabine monotherapy for slowly progressing metastatic breast cancer: do we need aggressive treatment?

    Science.gov (United States)

    Debled, Marc; Madranges, Nicolas; Trainaud, Alexandra; Floquet, Anne; Donamaria, Catherine; Brouste, Véronique; Durand, Michel; Mauriac, Louis

    2009-01-01

    Primary treatment goals in less aggressive metastatic breast cancer (MBC) are prolonged survival, good quality of life and control of the disease and its symptoms. High activity, oral administration and no alopecia make capecitabine monotherapy attractive in slowly evolving disease. We retrospectively analysed 226 patients who had received single-agent capecitabine as 1st-line chemotherapy at our institution. The median interval between breast cancer diagnosis and MBC was 52 months (range 0-479); 76% had received endocrine therapy for MBC, 58% had visceral involvement and 30% had 3 or more metastatic sites. The median starting dose was 1,000 mg/m(2) twice daily. Disease was improved in 56% of the patients (median duration: 13.2 months) and stabilised in 20%. Median time to treatment failure was 8.8 months (95% CI: 7.1-10.5); median overall survival from initiating capecitabine was 23.6 months (95% CI: 19.7-27.4). Prior adjuvant chemotherapy, endocrine therapy for MBC, visceral disease, hormone receptor status and initial capecitabine dose did not influence time to treatment failure. Among 161 patients <75 years, 90% received further chemotherapy. Based on these findings, 1st-line capecitabine should be considered in slowly progressing disease, offering an active, well-tolerated oral treatment with minimal toxicity and no alopecia. More toxic treatments may be reserved for more aggressive disease. Copyright 2009 S. Karger AG, Basel.

  11. Neural Analyses Validate and Emphasize the Role of Progesterone Receptor in Breast Cancer Progression and Prognosis.

    Science.gov (United States)

    Caronongan, Arturo; Venturini, Barbara; Canuti, Debora; Dlay, Satnam; Naguib, Raouf N G; Sherbet, Gajanan V

    2016-04-01

    Oestrogen receptor (ER) expression is routinely measured in breast cancer management, but the clinical merits of measuring progesterone receptor (PR) expression have remained controversial. Hence the major objective of this study was to assess the potential of PR as a predictor of response to endocrine therapy. We report on analyses of the relative importance of ER and PR for predicting prognosis using robust multilayer perceptron artificial neural networks. Receptor determinations use immunohistochemical (IHC) methods or radioactive ligand binding assays (LBA). In view of the heterogeneity of intratumoral receptor distribution, we examined the relative merits of the IHC and LBA methods. Our analyses reveal a more significant correlation of IHC-determined PR than ER with both nodal status and 5-year disease-free survival (DFS). In LBA, PR displayed higher correlation with survival and ER with nodal status. There was concordance of correlation of PR with DFS by both IHC and LBA. This study suggests a clear distinction between PR and ER, with PR displaying greater correlation than ER with disease progression and prognosis, and emphasizes the marked superiority of the IHC method over LBA. These findings may be valuable in the management of patients with breast cancer. Copyright© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

  12. Role and therapeutic potential of G-protein coupled receptors in breast cancer progression and metastases.

    Science.gov (United States)

    Singh, Anukriti; Nunes, Jessica J; Ateeq, Bushra

    2015-09-15

    G-protein-coupled receptors (GPCRs) comprise a large family of cell-surface receptors, which have recently emerged as key players in tumorigenesis, angiogenesis and metastasis. In this review, we discussed our current understanding of the many roles played by GPCRs in general, and particularly Angiotensin II type I receptor (AGTR1), a member of the seven-transmembrane-spanning G-protein coupled receptor superfamily, and its significance in breast cancer progression and metastasis. We have also discussed different strategies for targeting AGTR1, and its ligand Angiotension II (Ang II), which might unravel unique opportunities for breast cancer prevention and treatment. For example, AGTR1 blockers (ARBs) which are already in clinical use for treating hypertension, merit further investigation as a therapeutic strategy for AGTR1-positive cancer patients and may have the potential to prevent Ang II-AGTR1 signalling mediated cancer pathogenesis and metastases. Copyright © 2015 The Authors. Published by Elsevier B.V. All rights reserved.

  13. Initiators and promoters for the occurrence of screen-detected breast cancer and the progression to clinically-detected interval breast cancer.

    Science.gov (United States)

    Yen, Amy Ming-Fang; Wu, Wendy Yi-Ying; Tabar, Laszlo; Duffy, Stephen W; Smith, Robert A; Chen, Hsiu-Hsi

    2017-03-01

    The risk factors responsible for breast cancer have been well documented, but the roles of risk factors as initiators, causing the occurrence of screen-detected breast cancer, or promoters, responsible for the progression of the screen-detected to the clinically-detected breast cancer, have been scarcely evaluated. We used data from women in a cohort in Kopparberg (Dalarna), Sweden between 1977 and 2010. Conventional risk factors, breast density, and tumor-specific biomarkers are superimposed to the temporal course of the natural history of the disease. The results show that older age at first full-term pregnancy, dense breast, and a family history of breast cancer increased the risk of entering the preclinical screen-detectable phase of breast cancer by 23%, 41%, and 89%, respectively. Overweight/obesity (body mass index ≥25 kg/m 2 ) was a significant initiator (adjusted relative risk [aRR] 1.15; 95% confidence interval [CI], 0.99-1.33), but was inversely associated with the role of promoter (aRR 0.65; 95% CI, 0.51-0.82). Dense breast (aRR 1.46; 95% CI, 1.12-1.91), triple-negative (aRR 2.07; 95% CI, 1.37-3.15), and Ki-67 positivity (aRR 1.66; 95% CI, 1.19-2.30) were statistically significant promoters. When the molecular biomarkers were considered collectively as one classification, the basal-like subtype was the most influential subtype on promoters (aRR 4.24; 95% CI, 2.56-7.02) compared with the Luminal A subtype. We ascertained state-dependent covariates of initiators and promoters to classify the risk of the two-step progression of breast cancer. The results of the current study are useful for individually-tailored screening and personalized clinical surveillance of patients with breast cancer that was detected at an early stage. Copyright © 2016 The Authors. Production and hosting by Elsevier B.V. All rights reserved.

  14. An "elite hacker": breast tumors exploit the normal microenvironment program to instruct their progression and biological diversity.

    Science.gov (United States)

    Boudreau, Aaron; van't Veer, Laura J; Bissell, Mina J

    2012-01-01

    The year 2011 marked the 40 year anniversary of Richard Nixon signing the National Cancer Act, thus declaring the beginning of the "War on Cancer" in the United States. Whereas we have made tremendous progress toward understanding the genetics of tumors in the past four decades, and in developing enabling technology to dissect the molecular underpinnings of cancer at unprecedented resolution, it is only recently that the important role of the stromal microenvironment has been studied in detail. Cancer is a tissue-specific disease, and it is becoming clear that much of what we know about breast cancer progression parallels the biology of the normal breast differentiation, of which there is still much to learn. In particular, the normal breast and breast tumors share molecular, cellular, systemic and microenvironmental influences necessary for their progression. It is therefore enticing to consider a tumor to be a "rogue hacker"--one who exploits the weaknesses of a normal program for personal benefit. Understanding normal mammary gland biology and its "security vulnerabilities" may thus leave us better equipped to target breast cancer. In this review, we will provide a brief overview of the heterotypic cellular and molecular interactions within the microenvironment of the developing mammary gland that are necessary for functional differentiation, provide evidence suggesting that similar biology--albeit imbalanced and exaggerated--is observed in breast cancer progression particularly during the transition from carcinoma in situ to invasive disease. Lastly we will present evidence suggesting that the multigene signatures currently used to model cancer heterogeneity and clinical outcome largely reflect signaling from a heterogeneous microenvironment-a recurring theme that could potentially be exploited therapeutically.

  15. Hydrogen production by supercritical water gasification of biomass. Phase 1 -- Technical and business feasibility study, technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1997-12-01

    The nine-month Phase 1 feasibility study was directed toward the application of supercritical water gasification (SCWG) for the economical production and end use of hydrogen from renewable energy sources such as sewage sludge, pulp waste, agricultural wastes, and ultimately the combustible portion of municipal solid waste. Unique in comparison to other gasifier systems, the properties of supercritical water (SCW) are ideal for processing biowastes with high moisture content or contain toxic or hazardous contaminants. During Phase I, an end-to-end SCWG system was evaluated. A range of process options was initially considered for each of the key subsystems. This was followed by tests of sewage sludge feed preparation, pumping and gasification in the SCW pilot plant facility. Based on the initial process review and successful pilot-scale testing, engineering evaluations were performed that defined a baseline system for the production, storage and end use of hydrogen. The results compare favorably with alternative biomass gasifiers currently being developed. The results were then discussed with regional wastewater treatment facility operators to gain their perspective on the proposed commercial SCWG systems and to help define the potential market. Finally, the technical and business plans were developed based on perceived market needs and the projected capital and operating costs of SCWG units. The result is a three-year plan for further development, culminating in a follow-on demonstration test of a 5 MT/day system at a local wastewater treatment plant.

  16. Aberrant nocturnal cortisol and disease progression in women with breast cancer.

    Science.gov (United States)

    Zeitzer, Jamie M; Nouriani, Bita; Rissling, Michelle B; Sledge, George W; Kaplan, Katherine A; Aasly, Linn; Palesh, Oxana; Jo, Booil; Neri, Eric; Dhabhar, Firdaus S; Spiegel, David

    2016-07-01

    While a relationship between disruption of circadian rhythms and the progression of cancer has been hypothesized in field and epidemiologic studies, it has never been unequivocally demonstrated. We determined the circadian rhythm of cortisol and sleep in women with advanced breast cancer (ABC) under the conditions necessary to allow for the precise measurement of these variables. Women with ABC (n = 97) and age-matched controls (n = 24) took part in a 24-h intensive physiological monitoring study involving polysomnographic sleep measures and high-density plasma sampling. Sleep was scored using both standard clinical metrics and power spectral analysis. Three-harmonic regression analysis and functional data analysis were used to assess the 24-h and sleep-associated patterns of plasma cortisol, respectively. The circadian pattern of plasma cortisol as described by its timing, timing relative to sleep, or amplitude was indistinguishable between women with ABC and age-matched controls (p's > 0.11, t-tests). There was, however, an aberrant spike of cortisol during the sleep of a subset of women, during which there was an eightfold increase in the amount of objectively measured wake time (p sleep disruption. A greater understanding of this sleep-related cortisol abnormality, possibly a vulnerability trait, is likely important in our understanding of individual variation in the progression of cancer.

  17. Evidence for a Role of Tumor-Derived Laminin-511 in the Metastatic Progression of Breast Cancer

    Science.gov (United States)

    Chia, Jenny; Kusuma, Nicole; Anderson, Robin; Parker, Belinda; Bidwell, Bradley; Zamurs, Laura; Nice, Edouard; Pouliot, Normand

    2007-01-01

    Most studies investigating laminins (LMs) in breast cancer have focused on LM-111 or LM-332. Little is known, however, about the expression and function of α5 chain-containing LM-511/521 during metastatic progression. Expression of LM-511/521 subunits was examined in genetically related breast tumor lines and corresponding primary tumors and metastases in a syngeneic mouse model using real-time quantitative polymerase chain reaction, in situ hybridization, and immunohistochemistry. The results from our investigation indicate that LM-511 rather than LM-111, -332, or -521 correlates with metastatic potential in mouse mammary tumors. LM-511 was a potent adhesive substrate for both murine and human breast carcinoma cells and promoted strong haptotactic responses in metastatic lines. Haptotaxis was mediated by α3 integrin in both MCF-7 and MDA-MB-231 cells and was strongly inhibited by blocking antibodies against this integrin subunit. However, whereas nonmetastatic MCF-7 cells migrated toward LM-511 primarily via α3β1 integrin, results from antibody perturbation experiments and flow cytometry analysis suggest that this response is mediated by an as yet unidentified α3β integrin heterodimer (other than α3β1) in MDA-MB-231 cells. These results are consistent with earlier reports implicating α3 integrins in breast cancer progression and support the role of LM-511 as a functional substrate regulating breast cancer metastasis. PMID:17525279

  18. Changes in keratin expression during metastatic progression of breast cancer: impact on the detection of circulating tumor cells.

    Science.gov (United States)

    Joosse, Simon A; Hannemann, Juliane; Spötter, Julia; Bauche, Andreas; Andreas, Antje; Müller, Volkmar; Pantel, Klaus

    2012-02-15

    Circulating tumor cells (CTC) might function as early markers for breast cancer metastasis or monitoring therapy efficacy. Enrichment and identification of CTCs are based on epithelial markers that might be modulated during epithelial-mesenchymal transition. Little is known about the expression of keratins in CTCs and whether all CTCs can be detected with antibodies directed against a limited panel of keratins. Protein expression of keratin 2, 4-10, 13-16, 18, and 19 were assessed by a cocktail of antibodies (C11, AE1, AE3, and K7) and keratin antibodies C11 and A45-B/B3 alone in 11 breast cancer cell lines and 50 primary breast carcinomas and their lymph node metastases. Furthermore, CTCs were assessed in blood of 70 metastatic breast cancer patients. Claudin-low cell lines did not show expression of normal breast epithelial keratins but were positive for K14 and K16, detected by the cocktail only. Primary breast carcinomas showed changes in keratin expression during metastatic progression to the lymph nodes. In 35 of 70 patients CTCs were identified, of which 83%, 40%, and 57% were identified by the cocktail, C11 and A45-B/B3, respectively. Identification of CTCs by the cocktail was associated with shorter survival (P keratin expression with potential biologic relevance. Individual keratin antibodies recognizing only a limited set of keratins inherit the risk to miss biologically relevant CTCs in cancer patients, and antibody cocktails including these keratins are therefore recommended. ©2012 AACR.

  19. Progressive increase of glucose transporter-3 (GLUT-3) expression in estrogen-induced breast carcinogenesis.

    Science.gov (United States)

    Kocdor, M A; Kocdor, H; Pereira, J S; Vanegas, J E; Russo, I H; Russo, J

    2013-01-01

    Increased glucose uptake and glycolysis are main metabolic characteristics of malignant cells. A family of glucose transporters (GLUTs) facilitates glucose movement across the plasma membranes in a tumor-specific manner. Glucose transporter-1 (GLUT-1), GLUT-3 and recently GLUT-12, have been previously shown in breast cancer cells and are found to be associated with poor prognosis. In addition, it has been shown that estrogen plays critical roles in GLUT regulation, however, the stage-specific GLUT regulation of mammary carcinogenesis is unclear. GLUT expression patterns were investigated in an in vitro-in vivo progressive, estrogen-induced, mammary carcinogenesis model which consisted of four cell lines, with same genetic background. In this model, different stages of tumor initiation and progression are represented, MCF-10F being the normal stage, E2 cells the transformed stage by estrogen, C5 cells, the invasive stage, and T4 cells the tumorigenic stage. In addition, loss of ductulogenesis and solid mass formation in collagen matrix and invasiveness of the cells were counted. Real time PCR showed that GLUT1 expression was downregulated in MCF10F after treatment with 17β-estradiol (E2), and in the invasive cell type (C5), but not in the tumor cells (T4), which had no changes compared to MCF10F. C5 and T4 cells showed the highest rate of GLUT-3 expression. These cells were also found to be associated with loss of ductulogenesis, solid mass formation and higher invasive capacity, whereas, GLUT-12 was downregulated in C5 and T4 cells. Estrogen-induced malignant transformation is associated with remarkable and progressive GLUT-3 expression, GLUT-1 re-expression at further stages, as well as GLUT-12 downregulation.

  20. Progressive strength training to prevent LYmphoedema in the first year after breast CAncer - the LYCA feasibility study

    DEFF Research Database (Denmark)

    Ammitzbøll, Gunn; Lanng, Charlotte; Kroman, Niels

    2017-01-01

    BACKGROUND: Lymphoedema is a common late effect after breast cancer (BC) that has no effective cure once chronic. Accumulating evidence supports progressive strength training (PRT) as a safe exercise modality in relation to the onset and exacerbation of lymphoedema. In the 'preventive intervention...... against LYmphoedema after breast CAncer' (LYCA) feasibility study we examined the feasibility of a program of PRT in the first year after BC to inform a planned randomised controlled trial (RCT). MATERIAL AND METHODS: LYCA was a one-group prospective pilot trial inviting women operated with axillary lymph...

  1. Ski regulates Hippo and TAZ signaling to suppress breast cancer progression.

    Science.gov (United States)

    Rashidian, Juliet; Le Scolan, Erwan; Ji, Xiaodan; Zhu, Qingwei; Mulvihill, Melinda M; Nomura, Daniel; Luo, Kunxin

    2015-02-10

    Ski, the transforming protein of the avian Sloan-Kettering retrovirus, inhibits transforming growth factor-β (TGF-β)/Smad signaling and displays both pro-oncogenic and anti-oncogenic activities in human cancer. Inhibition of TGF-β signaling is likely responsible for the pro-oncogenic activity of Ski. We investigated the mechanism(s) underlying the tumor suppressor activity of Ski and found that Ski suppressed the activity of the Hippo signaling effectors TAZ and YAP to inhibit breast cancer progression. TAZ and YAP are transcriptional coactivators that can contribute to cancer by promoting proliferation, tumorigenesis, and cancer stem cell expansion. Hippo signaling activates the the Lats family of kinases, which phosphorylate TAZ and YAP, resulting in cytoplasmic retention and degradation and inhibition of their transcriptional activity. We showed that Ski interacted with multiple components of the Hippo pathway to facilitate activation of Lats2, resulting in increased phosphorylation and subsequent degradation of TAZ. Ski also promoted the degradation of a constitutively active TAZ mutant that is not phosphorylated by Lats, suggesting the existence of a Lats2-independent degradation pathway. Finally, we showed that Ski repressed the transcriptional activity of TAZ by binding to the TAZ partner TEAD and recruiting the transcriptional co-repressor NCoR1 to the TEAD-TAZ complex. Ski effectively reversed transformation and epithelial-to-mesenchyme transition in cultured breast cancer cells and metastasis in TAZ-expressing xenografted tumors. Thus, Ski inhibited the function of TAZ through multiple mechanisms in human cancer cells. Copyright © 2015, American Association for the Advancement of Science.

  2. Development and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progression.

    Directory of Open Access Journals (Sweden)

    Lora C Bailey-Downs

    Full Text Available Most cancer patients die with metastatic disease, thus, good models that recapitulate the natural process of metastasis including a dormancy period with micrometastatic cells would be beneficial in developing treatment strategies. Herein we report a model of natural metastasis that balances time to complete experiments with a reasonable dormancy period, which can be used to better study metastatic progression. The basis for the model is a 4T1 triple negative syngeneic breast cancer model without resection of the primary tumor. A cell titration from 500 to 15,000 GFP tagged 4T1 cells implanted into fat pad number four of immune proficient eight week female BALB/cJ mice optimized speed of the model while possessing metastatic processes including dormancy and beginning of reactivation. The frequency of primary tumors was less than 50% in animals implanted with 500-1500 cells. Although implantation with over 10,000 cells resulted in 100% primary tumor development, the tumors and macrometastases formed were highly aggressive, lacked dormancy, and offered no opportunity for treatment. Implantation of 7,500 cells resulted in >90% tumor take by 10 days; in 30-60 micrometastases in the lung (with many animals also having 2-30 brain micrometastases two weeks post-implantation, with the first small macrometastases present at five weeks; many animals displaying macrometastases at five weeks and animals becoming moribund by six weeks post-implantation. Using the optimum of 7,500 cells the efficacy of a chemotherapeutic agent for breast cancer, doxorubicin, given at its maximal tolerated dose (MTD; 1 mg/kg weekly was tested for an effect on metastasis. Doxorubicin treatment significantly reduced primary tumor growth and lung micrometastases but the number of macrometastases at experiment end was not significantly affected. This model should prove useful for development of drugs to target metastasis and to study the biology of metastasis.

  3. Savannah River Plant Works Technical Department monthly progress report for May 1958: Deleted Version

    Energy Technology Data Exchange (ETDEWEB)

    1958-06-17

    This progress report by the Atomic Energy Division of the Savannah River Plant covers: Reactor Technology; Separation Technology; Engineering Assistance; Health Physics; and General Laboratory Work. (JT)

  4. Savannah River Ecology Laboratory, Annual Technical Progress Report of Ecological Research, June 30, 2002

    Energy Technology Data Exchange (ETDEWEB)

    Paul M. Bertsch, (Director)

    2002-06-30

    The Savannah River Ecology Laboratory (SREL) is a research unit of The University of Georgia (UGA) and has been conducting ecological research on the Savannah River Site (SRS) near Aiken, South Carolina for 50 years. The overall mission of the Laboratory is to acquire and communicate knowledge of ecological processes and principles. SREL conducts fundamental and applied ecological research, as well as education and outreach programs, under a Cooperative Agreement with the U.S. Department of Energy (DOE). The Laboratory's research mission during the 2002 fiscal year was fulfilled with the publication of 76 journal articles and book chapters by faculty, technical staff, students, and visiting scientists. An additional 50 journal articles have been submitted or are in press. Other noteworthy events took place as faculty members, staff, and graduate students received awards. These are described in the section titled Special Accomplishments of Faculty, Staff, Students, and Administration on page 51. Notable scientific accomplishments include work conducted on contaminant transport, stable isotopes, sandhills ecology, and phytoremediation: (1) A collaborative study between Dr. Tom Hinton at SREL and scientists at SRTC demonstrated the feasibility of using illite clay to sequester 137Cs in sediments along the P and R reactor cooling canal system, where approximately 3,000 acres of land are contaminated. Overall, the study showed significant decreases in cesium concentrations and bioavailability following the addition of illite with no sign of harm to the ecosystem. While the cesium remains sequestered from the biosphere, its radioactivity decays and the process progresses from contaminant immobilization to remediation. (2) SREL's stable isotope laboratory is now fully functional. Stable isotope distributions in nature can provide important insights into many historical and current environmental processes. Dr. Christopher Romanek is leading SREL's research

  5. Proceedings of the technical review on advances in geothermal reservoir technology---Research in progress

    Energy Technology Data Exchange (ETDEWEB)

    Lippmann, M.J. (ed.)

    1988-09-01

    This proceedings contains 20 technical papers and abstracts describing most of the research activities funded by the Department of Energy (DOE's) Geothermal Reservoir Technology Program, which is under the management of Marshall Reed. The meeting was organized in response to several requests made by geothermal industry representatives who wanted to learn more about technical details of the projects supported by the DOE program. Also, this gives them an opportunity to personally discuss research topics with colleagues in the national laboratories and universities.

  6. Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer

    Directory of Open Access Journals (Sweden)

    Beauchemin C

    2014-06-01

    Full Text Available Catherine Beauchemin,1 Dan Cooper,2 Marie-Ève Lapierre,1 Louise Yelle,3 Jean Lachaine11Université de Montréal, Faculté de pharmacie, Montreal, 2Institut national d'excellence en santé et en services sociaux (INESSS, 3Centre Hospitalier de l'Université de Montréal – Hôpital Notre-Dame, Département de médecine, Université de Montréal, Montreal, QC, CanadaBackground: Progression-free survival (PFS and time to progression (TTP are frequently used to establish the clinical efficacy of anti-cancer drugs. However, the surrogacy of PFS/TTP for overall survival (OS remains a matter of uncertainty in metastatic breast cancer (mBC. This study assessed the relationship between PFS/TTP and OS in mBC using a trial-based approach.Methods: We conducted a systematic literature review according to the PICO method: 'Population' consisted of women with mBC; 'Interventions' and 'Comparators' were standard treatments for mBC or best supportive care; 'Outcomes' of interest were median PFS/TTP and OS. We first performed a correlation analysis between median PFS/TTP and OS, and then conducted subgroup analyses to explore possible reasons for heterogeneity. Then, we assessed the relationship between the treatment effect on PFS/TTP and OS. The treatment effect on PFS/TTP and OS was quantified by the absolute difference of median values. We also conducted linear regression analysis to predict the effects of a new anti-cancer drug on OS on the basis of its effects on PFS/TTP.Results: A total of 5,041 studies were identified, and 144 fulfilled the eligibility criteria. There was a statistically significant relationship between median PFS/TTP and OS across included trials (r=0.428; P<0.01. Correlation coefficient for the treatment effect on PFS/TTP and OS was estimated at 0.427 (P<0.01. The obtained linear regression equation was ΔOS =−0.088 (95% confidence interval [CI] −1.347–1.172 + 1.753 (95% CI 1.307–2.198 × ΔPFS (R2=0.86.Conclusion: Results of

  7. Hypoxia-inducible factor-mediated induction of WISP-2 contributes to attenuated progression of breast cancer.

    Science.gov (United States)

    Fuady, Jerry H; Bordoli, Mattia R; Abreu-Rodríguez, Irene; Kristiansen, Glen; Hoogewijs, David; Stiehl, Daniel P; Wenger, Roland H

    2014-01-01

    Hypoxia and the hypoxia-inducible factor (HIF) signaling pathway trigger the expression of several genes involved in cancer progression and resistance to therapy. Transcriptionally active HIF-1 and HIF-2 regulate overlapping sets of target genes, and only few HIF-2 specific target genes are known so far. Here we investigated oxygen-regulated expression of Wnt-1 induced signaling protein 2 (WISP-2), which has been reported to attenuate the progression of breast cancer. WISP-2 was hypoxically induced in low-invasive luminal-like breast cancer cell lines at both the messenger RNA and protein levels, mainly in a HIF-2α-dependent manner. HIF-2-driven regulation of the WISP2 promoter in breast cancer cells is almost entirely mediated by two phylogenetically and only partially conserved functional hypoxia response elements located in a microsatellite region upstream of the transcriptional start site. High WISP-2 tumor levels were associated with increased HIF-2α, decreased tumor macrophage density, and a better prognosis. Silencing WISP-2 increased anchorage-independent colony formation and recovery from scratches in confluent cell layers of normally low-invasive MCF-7 cancer cells. Interestingly, these changes in cancer cell aggressiveness could be phenocopied by HIF-2α silencing, suggesting that direct HIF-2-mediated transcriptional induction of WISP-2 gene expression might at least partially explain the association of high HIF-2α tumor levels with prolonged overall survival of patients with breast cancer.

  8. n-Butyl benzyl phthalate promotes breast cancer progression by inducing expression of lymphoid enhancer factor 1.

    Directory of Open Access Journals (Sweden)

    Tsung-Hua Hsieh

    Full Text Available Environmental hormones play important roles in regulating the expression of genes involved in cell proliferation, drug resistance, and breast cancer risk; however, their precise role in human breast cancer cells during cancer progression remains unclear. To elucidate the effect of the most widely used industrial phthalate, n-butyl benzyl phthalate (BBP, on cancer progression, we evaluated the results of BBP treatment using a whole human genome cDNA microarray and MetaCore software and selected candidate genes whose expression was changed by more than ten-fold by BBP compared with controls to analyze the signaling pathways in human breast cancer initiating cells (R2d. A total of 473 genes were upregulated, and 468 were downregulated. Most of these genes are involved in proliferation, epithelial-mesenchymal transition, and angiogenesis signaling. BBP induced the viability, invasion and migration, and tube formation in vitro, and Matrigel plug angiogenesis in vivo of R2d and MCF-7. Furthermore, the viability and invasion and migration of these cell lines following BBP treatment was reduced by transfection with a small interfering RNA targeting the mRNA for lymphoid enhancer-binding factor 1; notably, the altered expression of this gene consistently differentiated tumors expressing genes involved in proliferation, epithelial-mesenchymal transition, and angiogenesis. These findings contribute to our understanding of the molecular impact of the environmental hormone BBP and suggest possible strategies for preventing and treating human breast cancer.

  9. Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients.

    Directory of Open Access Journals (Sweden)

    Caroline Bergenfelz

    Full Text Available Myeloid-derived suppressor cells (MDSCs are highly immunosuppressive myeloid cells, which increase in cancer patients. The molecular mechanism behind their generation and function is unclear. Whereas granulocytic-MDSCs correlate with poor overall survival in breast cancer, the presence and relevance of monocytic-MDSCs (Mo-MDSCs is unknown. Here we report for the first time an enrichment of functional blood Mo-MDSCs in breast cancer patients before they acquire a typical Mo-MDSC surface phenotype. A clear population of Mo-MDSCs with the typical cell surface phenotype (CD14(+HLA-DR(low/-CD86(low/-CD80(low/-CD163(low/- increased significantly first during disease progression and correlated to metastasis to lymph nodes and visceral organs. Furthermore, monocytes, comprising the Mo-MDSC population, from patients with metastatic breast cancer resemble the reprogrammed immunosuppressive monocytes in patients with severe infections, both by their surface and functional phenotype but also at their molecular gene expression profile. Our data suggest that monitoring the Mo-MDSC levels in breast cancer patients may represent a novel and simple biomarker for assessing disease progression.

  10. Technical feasibility proof for high-resolution low-dose photon-counting CT of the breast

    Energy Technology Data Exchange (ETDEWEB)

    Kalender, Willi A.; Kolditz, Daniel; Lueck, Ferdinand [University of Erlangen-Nuernberg, Institute of Medical Physics (IMP), Erlangen (Germany); CT Imaging GmbH, Erlangen (Germany); Steiding, Christian [University of Erlangen-Nuernberg, Institute of Medical Physics (IMP), Erlangen (Germany); CT Imaging GmbH, Erlangen (Germany); University Hospital of Erlangen, Institute of Radiology, Erlangen (Germany); Ruth, Veikko; Roessler, Ann-Christin [University of Erlangen-Nuernberg, Institute of Medical Physics (IMP), Erlangen (Germany); Wenkel, Evelyn [University Hospital of Erlangen, Institute of Radiology, Erlangen (Germany)

    2017-03-15

    X-ray computed tomography (CT) has been proposed and evaluated multiple times as a potentially alternative method for breast imaging. All efforts shown so far have been criticized and partly disapproved because of their limited spatial resolution and higher patient dose when compared to mammography. Our concept for a dedicated breast CT (BCT) scanner therefore aimed at novel apparatus and detector design to provide high spatial resolution of about 100 μm and average glandular dose (AGD) levels of 5 mGy or below. Photon-counting technology was considered as a solution to reach these goals. The complete concept was previously evaluated and confirmed by simulations and basic experiments on laboratory setups. We here present measurements of dose, technical image quality parameters and surgical specimen results on such a scanner. For comparison purposes, the specimens were also imaged with digital mammography (DM) and breast tomosynthesis (BT) apparatus. Results show that photon-counting BCT (pcBCT) at 5 mGy AGD offers sufficiently high 3D spatial resolution for reliable detectability of calcifications and soft tissue delineation. (orig.)

  11. Data on the putative role of p53 in breast cancer cell adhesion: Technical information for adhesion assay

    Directory of Open Access Journals (Sweden)

    Kallirroi Voudouri

    2016-12-01

    Full Text Available In this data article, the potential role of p53 tumor suppressor gene (p53 on the attachment ability of MCF-7 breast cancer cells was investigated. In our main article, “IGF-I/ EGF and E2 signaling crosstalk through IGF-IR conduit point affect breast cancer cell adhesion” (K. Voudouri, D. Nikitovic, A. Berdiaki, D. Kletsas, N.K. Karamanos, G.N. Tzanakakis, 2016 [1], we describe the key role of IGF-IR in breast cancer cell adhesion onto fibronectin (FN. p53 tumor suppressor gene is a principal regulator of cancer cell proliferation. Various data have demonstrated an association between p53 and IGF-IR actions on cell growth through its’ putative regulation of IGF-IR expression. According to our performed experiments, p53 does not modify IGF-IR expression and does not affect basal MCF-7 cells adhesion onto FN. Moreover, technical details about the performance of adhesion assay onto the FN substrate were provided.

  12. Developing Technical Writing Skills in the Physical Chemistry Laboratory: A Progressive Approach Employing Peer Review

    Science.gov (United States)

    Gragson, Derek E.; Hagen, John P.

    2010-01-01

    Writing formal "journal-style" lab reports is often one of the requirements chemistry and biochemistry students encounter in the physical chemistry laboratory. Helping students improve their technical writing skills is the primary reason this type of writing is a requirement in the physical chemistry laboratory. Developing these skills is an…

  13. Technical progress report for the quarter 1 October-31 December 1980

    Energy Technology Data Exchange (ETDEWEB)

    1981-01-01

    This report describes the technical accomplishments on the commercial nuclear waste management programs and on the geologic disposal of nuclear wastes. The program is organized into eight tasks: systems, waste package, site, repository, regulatory and institutional, test facilities and excavations, land acquisition, and program management. (DLC)

  14. Association Euratom - DTU, Technical University of Denmark, Department of Physics - Annual Progress Report 2012

    DEFF Research Database (Denmark)

    The programme of the Research Unit of the Fusion Association Euratom – DTU, Technical University of Denmark covers work in fusion plasma physics and in fusion technology. The fusion plasma physics research focuses on turbulence and transport, and its interaction with the plasma equilibrium...

  15. Association Euratom - DTU, Technical University of Denmark, Department of Physics - Annual Progress Report 2013

    DEFF Research Database (Denmark)

    The programme of the Research Unit of the Fusion Association Euratom – DTU, Technical University of Denmark covers work in fusion plasma physics and in fusion technology. The fusion plasma physics research focuses on turbulence and transport, and its interaction with the plasma equilibrium...

  16. Health literacy and fear of cancer progression in elderly women newly diagnosed with breast cancer--A longitudinal analysis.

    Science.gov (United States)

    Halbach, Sarah Maria; Enders, Anna; Kowalski, Christoph; Pförtner, Timo-Kolja; Pfaff, Holger; Wesselmann, Simone; Ernstmann, Nicole

    2016-05-01

    This study aims to investigate the distribution of health literacy levels and the association of health literacy with fear of cancer progression (FoP) over the course of cancer treatment in a sample of elderly women newly diagnosed with breast cancer. The analyses are part of a prospective, multicenter cohort-study (PIAT) that took place in Germany between 2013 and 2014. Elderly women (aged 65 years and older) newly diagnosed with breast cancer completed validated measures of health literacy and FoP directly after the breast cancer surgery and 40 weeks later. Multivariate random-effects regression analysis for longitudinal data was applied to estimate the association of health literacy with FoP considering socio-demographic, clinical and psychosocial characteristics of the patients. About half of the elderly breast cancer patients in our sample were classified as having limited health literacy (inadequate and problematic levels). Inadequate and problematic health literacy were significantly associated with higher levels of FoP in the elderly breast cancer patients. Limited health literacy is an independent risk factor for increased FoP. Enhancing health literacy could contribute to reducing patients' cancer-related fears. Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

  17. [List and drag forces on droplets and particles in wall-bounded shear flows]. Technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    McLaughlin, J.B.

    1992-11-01

    This project has two goals, to calculate the lift force on a spherical droplet or particle that translates through a shear flow, and to measure the inertial migration velocity that is caused by the lift force. The focus of the study is on a range of Reynolds numbers that has been shown to be of importance in the inertial deposition of aerosols from turbulent shear flows. Aspects of current technical progress summarized are the asymptotic analysis, computer simulations, and experimental measurements. Future plans and resulting publications are given.

  18. NRL Technical Year End Progress Report for MCSC PM-ICE FY11 SOW Tasks 1 and 2 - Hearing Loss

    Science.gov (United States)

    2012-05-18

    2 — Hearing Loss Research May 18, 2012 Approved for public release; distribution is unlimited. Peter C. HerdiC James W. mCmaHon daniel l. amon...Technical Year End Progress Report for MCSC PM-ICE FY11 SOW Tasks 1 and 2 — Hearing Loss Research Peter C. Herdic, James W. McMahon, Daniel L. Amon...deemed relevant to the warfighter. 18-05-2012 Memorandum Report Hearing loss Human ear Small weapons fire Shooter’s notch Program Manager, Infantry Combat

  19. [A clinical trial of neutron capture therapy for brain tumors]. Technical progress report 1988

    Energy Technology Data Exchange (ETDEWEB)

    Zamenhof, R.G.

    1988-12-31

    This report describes progress made in refining of neutron-induced alpha tract autoradiography, in designing epithermal neutron bean at MITR-II and in planning treatment dosimetry using Monte Carlo techniques.

  20. University of Florida, University research program in robotics. Annual technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    Crane, C.D. III; Tulenko, J.S.

    1994-05-01

    Progress is reported in the areas of environmental hardening, database, world modeling, vision, man-machine interface, advanced liquid metal reactor inspection robot, and articulated transporter/manipulator system (ATMS) development.

  1. Amarillo National Resource Center for Plutonium. Quarterly technical progress report, May 1, 1997--July 31, 1997

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1997-09-01

    Progress summaries are provided from the Amarillo National Center for Plutonium. Programs include the plutonium information resource center, environment, public health, and safety, education and training, nuclear and other material studies.

  2. High-temperature molten-carbonate fuel cells. Technical progress report, January-March 1979

    Energy Technology Data Exchange (ETDEWEB)

    1979-05-01

    Progress on the design, development, fabrication, performance testing, and modeling of molten carbonate fuel cells is reported. Component development including electrode structures, electrolyte powder, electrolyte tiles, and cell frame and current collectors is described. (WHK)

  3. Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress.

    Directory of Open Access Journals (Sweden)

    Tiziana Triulzi

    Full Text Available We recently showed that differential expression of extracellular matrix (ECM genes delineates four subgroups of breast carcinomas (ECM1, -2, -3- and -4 with different clinical outcome. To further investigate the characteristics of ECM signature and its impact on tumor progression, we conducted unsupervised clustering analyses in 6 additional independent datasets of invasive breast tumors from different platforms for a total of 643 samples. Use of four different clustering algorithms identified ECM3 tumors as an independent group in all datasets tested. ECM3 showed a homogeneous gene pattern, consisting of 58 genes encoding 43 structural ECM proteins. From 26 to 41% of the cases were ECM3-enriched, and analysis of datasets relevant to gene expression in neoplastic or corresponding stromal cells showed that both stromal and breast carcinoma cells can coordinately express ECM3 genes. In in vitro experiments, β-estradiol induced ECM3 gene production in ER-positive breast carcinoma cell lines, whereas TGFβ induced upregulation of the genes leading to ECM3 gene classification, especially in ER-negative breast carcinoma cells and in fibroblasts. Multivariate analysis of distant metastasis-free survival in untreated breast tumor patients revealed a significant interaction between ECM3 and histological grade (p = 0.001. Cox models, estimated separately in grade I-II and grade III tumors, indicated a highly significant association between ECM3 and worse survival probability only in grade III tumors (HR = 3.0, 95% CI = 1.3-7.0, p = 0.0098. Gene Set Enrichment analysis of ECM3 compared to non-ECM3 tumors revealed significant enrichment of epithelial-mesenchymal transition (EMT genes in both grade I-II and grade III subsets of ECM3 tumors. Thus, ECM3 is a robust cluster that identifies breast carcinomas with EMT features but with accelerated metastatic potential only in the undifferentiated (grade III phenotype. These findings support the

  4. Association Euratom - Risø National Laboratory, Technical University of Denmark - Annual Progress Report 2007

    DEFF Research Database (Denmark)

    Michelsen, Poul; Korsholm, Søren Bang; Juul Rasmussen, Jens

    The programme of the Research Unit of the Fusion Association Euratom - Risø National Laboratory, Technical University of Denmark, covers work in fusion plasma physics and in fusion technology. The fusion plasma physics research focuses on turbulence and transport, and its interaction with the pla......The programme of the Research Unit of the Fusion Association Euratom - Risø National Laboratory, Technical University of Denmark, covers work in fusion plasma physics and in fusion technology. The fusion plasma physics research focuses on turbulence and transport, and its interaction...... phased out during 2007. Minor activities are system analysis, initiative to involve Danish industry in ITER contracts and public information. A summary is presented of the results obtained in the Research Unit during 2007....

  5. Index to Nuclear Safety: a technical progress review by chrology, permuted title, and author, Volume 11(1) through Volume 20(6)

    Energy Technology Data Exchange (ETDEWEB)

    Cottrell, W B; Passiakos, M

    1980-06-01

    This index to Nuclear Safety, a bimonthly technical progress review, covers articles published in Nuclear Safety, Volume II, No. 1 (January-February 1970), through Volume 20, No. 6 (November-December 1979). It is divided into three sections: a chronological list of articles (including abstracts) followed by a permuted-title (KWIC) index and an author index. Nuclear Safety, a bimonthly technical progress review prepared by the Nuclear Safety Information Center (NSIC), covers all safety aspects of nuclear power reactors and associated facilities. Over 600 technical articles published in Nuclear Safety in the last ten years are listed in this index.

  6. Experimental Program Final Technical Progress Report: 15 February 2007 to 30 September 2012

    Energy Technology Data Exchange (ETDEWEB)

    Kinney, Edward R. [University of Colorado, Boulder, CO

    2014-09-12

    This is the final technical report of the grant DE-FG02-04ER41301 to the University of Colorado at Boulder entitled "Intermediate Energy Nuclear Physics" and describes the results of our funded activities during the period 15 February 2007 to 30 September 2012. These activities were primarily carried out at Fermilab, RHIC, and the German lab DESY. Significant advances in these experiments were carried out by members of the Colorado group and are described in detail.

  7. Amarillo National Resource Center for Plutonium. Quarterly technical progress report, November 1, 1997--January 31, 1998

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1998-03-01

    This report provides information on projects conducted by the Amarillo National Resource Center for Plutonium, a consortium of Texas A&M University, Texas Tech University, and the University of Texas. Progress is reported for four major areas: (1) plutonium information resource; (2) environmental, safety, and health; (3) communication, education, training, and community involvement; and (4) nuclear and other material studies. Environmental, safety, and health projects reported include a number of studies on high explosives. Progress reported for nuclear material studies includes storage and waste disposal investigations.

  8. Basic Facts of Breast Cancer in Korea in 2014: The 10-Year Overall Survival Progress.

    Science.gov (United States)

    Park, Eun Hwa; Min, Sun Young; Kim, Zisun; Yoon, Chan Seok; Jung, Kyu-Won; Nam, Seok Jin; Oh, Se Jeong; Lee, Seeyoun; Park, Byeong-Woo; Lim, Woosung; Hur, Min Hee

    2017-03-01

    We, the Korean Breast Cancer Society (KBCS), present the facts and the trends of breast cancer in Korea in 2014. Data on the total number of newly diagnosed patients was obtained from the Korea Central Cancer Registry database, other data were collected from the KBCS online registry database, and the overall survival data of patients were updated from Statistics Korea. A total of 21,484 female patients were newly diagnosed with breast cancer in 2014. The crude incidence rate and the age-standardized incidence rate (ASR) of breast cancer in female patients, including carcinoma in situ, were 83.4 cases and 63.9 cases per 100,000 women, respectively. The ASR showed an annual increase of 6.1% from 1999 to 2014; however, although the increase of the ASR had slowed since 2008, the incidence rate itself continuously increased. The proportion of early breast cancer increased consistently, and the pathological features changed accordingly. While breast-conserving surgery was mainly performed, the proportion of total mastectomy was slightly increased. The total number of breast reconstruction surgeries increased rapidly. The 5-year and 10-year overall survival rates for all stages of breast cancer patients were 91.2% and 84.8%, respectively. The overall survival rate of Korean patients with breast cancer was extremely high, compared with other developed countries. Thus, we consider that the clinical characteristics of breast cancer have changed over the past decade. A nationwide registry data will contribute to a better understanding of the characteristics of breast cancer in Korea.

  9. The Gαh-PLCδ1 signaling axis drives metastatic progression in triple-negative breast cancer.

    Science.gov (United States)

    Huang, Shang-Pen; Liu, Pei-Yao; Kuo, Chih-Jung; Chen, Chi-Long; Lee, Wei-Jiunn; Tsai, Yu-Hui; Lin, Yuan-Feng

    2017-06-02

    Distant metastasis of triple-negative breast cancer (TNBC) to other organs, e.g., the lungs, has been correlated with poor survival rates among breast cancer patients. Therefore, the identification of useful therapeutic targets to prevent metastasis or even inhibit tumor growth of TNBC is urgently needed. Gαh is a novel GTP-binding protein and known as an inactive form of calcium-dependent tissue transglutaminase. However, the functional consequences of transamidating and G-protein activities of tissue transglutaminase in promoting cancer metastasis are still controversial. Kaplan-Meier analyses were performed to estimate the prognostic values of Gαh and PLCδ1 by utilizing public databases and performing immunohistochemical staining experiments. Cell-based invasion assays and in vivo lung colony-forming and orthotropic lung metastasis models were established to evaluate the effectiveness of interrupting the protein-protein interaction (PPI) between Gαh and PLCδ1 in inhibiting the invasive ability and metastatic potential of TNBC cells. Here, we showed that the increased level of cytosolic, not extracellular, Gαh is a poor prognostic marker in breast cancer patients and correlates with the metastatic evolution of TNBC cells. Moreover, clinicopathological analyses revealed that the combined signature of high Gαh/PLCδ1 levels indicates worse prognosis in patients with breast cancer and correlates with lymph node metastasis of ER-negative breast cancer. Blocking the PPI of the Gαh/PLCδ1 complex by synthetically myristoylated PLCδ1 peptide corresponding to the Gαh-binding interface appeared to significantly suppress cellular invasiveness in vitro and inhibit lung metastatic colonies of TNBC cells in vivo. This study establishes Gαh/PLCδ1 as a poor prognostic factor for patients with estrogen receptor-negative breast cancers, including TNBCs, and provides therapeutic value by targeting the PPI of the Gαh/PLCδ1 complex to combat the metastatic progression

  10. Association between changes in body fat and disease progression after breast cancer surgery is moderated by menopausal status.

    Science.gov (United States)

    Liu, Li-Ni; Lin, Yung-Chang; Miaskowski, Christine; Chen, Shin-Cheh; Chen, Mei-Ling

    2017-12-18

    Obesity is linked to poor disease outcomes in breast cancer patients. However, this link was mostly based on body weight or BMI rather than body-fat. The purpose of this study was to evaluate the relationship between body-fat gain and disease progression in Taiwanese women after breast cancer surgery and how this relationship is influenced by menopausal status. Body fat percentage was measured 1 day before and 6 months after surgery in 131 women with stages 0-III breast cancer. Disease outcomes (metastasis and death) were assessed by chart review and telephone contact 7 to 8 years after diagnosis. These data were analyzed by multivariate Cox proportional hazard model analysis. The percentage of women with over 5% gain in body-fat was 56% for premenopausal and 42% for postmenopausal. Rates of distant metastasis and all-cause mortality were 17.6 and 9.9%, respectively over the follow-up period. Distant metastases were predicted in postmenopausal but not premenopausal women with breast cancer by increased body fat percentage (HR = 1.3, p = 0.035), after controlling other potential covariates, including disease severity, estrogen receptor expression, progesterone receptors expression, age, and exercise habit before diagnosis. Survival was not significantly associated with body-fat percentage gains. Our results suggest that increased body fat percentage 6 months after breast surgery is an important predictor of distant metastasis in postmenopausal Taiwanese women with breast cancer. Clinicians may need to measure patients' body fat periodically. Our findings should be validated in studies with a longer follow-up time.

  11. Great Basin paleoenvironmental studies project; Technical progress report: First quarter (January--August 1993)

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1993-12-31

    Project goals, project tasks, progress on tasks, and problems encountered are described and discussed for each of the studies that make up the Great Basin Paleoenvironmental Studies Project for Yucca Mountain. These studies are: Paleobotany, Paleofauna, Geomorphology, and Transportation. Budget summaries are also given for each of the studies and for the overall project.

  12. Savannah River Ecology Laboratory annual technical progress report of ecological research, period ending July 31, 1993

    Energy Technology Data Exchange (ETDEWEB)

    Vaitkus, M.R.; Wein, G.R. [eds.; Johnson, G.

    1993-11-01

    This progress report gives an overview of research programs at the Savannah River Site. Topics include; environmental operations support, wood stork foraging and breeding, defense waste processing, environmental stresses, alterations in the environment due to pollutants, wetland ecology, biodiversity, pond drawdown studies, and environmental toxicology.

  13. Progression criteria for cancer antigen 15.3 and carcinoembryonic antigen in metastatic breast cancer compared by computer simulation of marker data

    DEFF Research Database (Denmark)

    Sölétormos, G; Hyltoft Petersen, P; Dombernowsky, P

    2000-01-01

    BACKGROUND: We investigated the utility of computer simulation models for performance comparisons of different tumor marker assessment criteria to define progression or nonprogression of metastatic breast cancer. METHODS: Clinically relevant values for progressive cancer antigen 15...... of progression. CONCLUSIONS: The computer simulation model is a fast, effective, and inexpensive approach for comparing the diagnostic potential of assessment criteria during clinically relevant conditions of steady-state and progressive disease. The model systems can be used to generate tumor marker assessment...

  14. Licochalcone B Arrests Cell Cycle Progression and Induces Apoptosis in Human Breast Cancer MCF-7 Cells.

    Science.gov (United States)

    Yu, Lina; Ma, Jun; Han, Jichun; Wang, Bo; Chen, Xiaoyu; Gao, Caixia; Li, Defang; Zheng, Qiusheng

    2016-01-01

    Recent patent of licochalcone B (LCB) as an antiinflammatory agent has been developed. Emerging evidence shows that LCB may be a promising alternative compound with anti-cancer activities. However, the anticancer mechanism of LCB in MCF-7 cells has not been fully investigated. We aimed to unearth the anti-cancer effect and mechanism of LCB in MCF-7 cells. Cell proliferation activity and cell-cycle progression were determined by sulforhodamine B assay and flow cytometry, respectively. The mRNA and protein levels of cell cycle-related proteins and apoptosis-associated proteins were examined by RT-qPCR and western blot, respectively. Mitochondrial membrane potential (MMP) was measured by flow cytometry after JC-1 staining. We found that LCB inhibited MCF-7 cells proliferation in a concentration- and time-dependent manner. Moreover, LCB-treatment led to S phase arrest in MCF-7 cells, which could be elucidated by the decreased mRNA and protein levels of Cyclin A, Cdk2 and Cdc25 A, and the increased protein level of p21. LCB also induced such apoptosis morphology as phosphatidylserine externalization, chromatin condensation and DNA fragmentation. Moreover, LCB led to the loss of MMP, resulting in the release of cytochrome C. The above apoptotic events were supported by the fact that LCB upregulated the mRNA and protein levels of Caspase 3, Caspase 9 and Bax, and downregulated the mRNA and protein level of Bcl-2, which was triggered by the increased p53 protein level in LCB-treated MCF-7 cells. These findings suggested that LCB could be a promising agent for treatment of human breast cancer.

  15. Solar-powered irrigation systems. Technical progress report, July 1977--January 1978

    Energy Technology Data Exchange (ETDEWEB)

    None

    1978-02-28

    Dispersed solar thermal power systems applied to farm irrigation energy needs are analyzed. The 17 western states, containing 84% of nationwide irrigated croplands and consuming 93% of nationwide irrigation energy, have been selected to determine were solar irrigation systems can compete most favorably with conventional energy sources. Financial analysis of farms, according to size and ownership, was accomplished to permit realistic comparative analyses of system lifetime costs. Market potential of optimized systems has been estimated for the 17-state region for near-term (1985) and intermediate-term (2000) applications. Technical, economic, and institutional factors bearing on penetration and capture of this market are being identified.

  16. Molecular biological enhancement of coal biodesulfurization. Ninth quarterly technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    Litchfield, J.H.; Zupancic, T.J.; Baker, B.; Palmer, D.T.; Fry, I.J.; Tranuero, C.G.; Wyza, R.E.; Schweitzer, A.; Conkle, H.N. [Battelle, Columbus, OH (United States); Chakravanty, L.; Tuovinen, O.H. [Ohio State Univ., Columbus, OH (United States)

    1991-09-13

    The objective of this project is to produce one or more microorganisms capable of removing the organic and inorganic sulfur in coal. The original specific technical objectives of the project were to: clone and characterize the genes encoding the enzymes of the ``4S`` pathway (sulfoxide/sulfone/sulfonate/sulfate) for release of organic sulfur from coal; return multiple copies of genes to the original host to enhance the biodesulfurization activity of that organism; transfer this pathway into a fast-growing chemolithotropic bacterium; conduct a batch-mode optimization/analysis of scale-up variables.

  17. Association Euratom - DTU, Technical University of Denmark, Department of Physics - Annual Progress Report 2011

    DEFF Research Database (Denmark)

    The programme of the Research Unit of the Fusion Association Euratom – DTU, Technical University of Denmark (until 31-12- 2011: Association Euratom – Risø DTU) covers work in fusion plasma physics and in fusion technology. The fusion plasma physics research focuses on turbulence and transport......, and its interaction with the plasma equilibrium and particles. The effort includes both first principles based modelling, and experimental observations of turbulence and of fast ion dynamics by collective Thomson scattering. Within fusion technology there are activities related to development of high...

  18. [Tampa Electric Company IGCC project]. Final public design report; Technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-07-01

    This final Public Design Report (PDR) provides completed design information about Tampa Electric Company`s Polk Power Station Unit No. 1, which will demonstrate in a commercial 250 MW unit the operating parameters and benefits of the integration of oxygen-blown, entrained-flow coal gasification with advanced combined cycle technology. Pending development of technically and commercially viable sorbent for the Hot Gas Cleanup System, the HGCU also is demonstrated. The report is organized under the following sections: design basis description; plant descriptions; plant systems; project costs and schedule; heat and material balances; general arrangement drawings; equipment list; and miscellaneous drawings.

  19. Interleukin 8 in progression of hormone-dependent early breast cancer

    Indian Academy of Sciences (India)

    Many studies have confirmed high levels ofinterleukin 8 (IL8) in HER2-enriched and basal-like (ER–) primary breast tumours, but less is known about thesignificance of IL8 in hormone-dependent breast cancer. The aim of this study was to evaluate the prognostic significance of IL8 and clinicopathological parameters in ...

  20. Interleukin 8 in progression of hormone-dependent early breast cancer

    Indian Academy of Sciences (India)

    2017-04-18

    Apr 18, 2017 ... significance of IL8 and clinicopathological parameters in hormone-dependent breast cancer, and to examine possible associations between them that might imply possible biological dependence. The study included 91 early-stage breast cancer patients with detectable levels of hormone receptors (ER>0, ...

  1. Loss of cadherin-based cell adhesion and the progression of Invasive Lobular Breast Cancer

    NARCIS (Netherlands)

    Vlug, E.J.

    2015-01-01

    Lobular breast cancer is a type of breast cancer that is histologically characterized by a noncohesive growth pattern of small regular cells, where single cells infiltrate as one-layered strands of cells. This noncohesive growth pattern is due to inactivation of the E-cadherin complex and a

  2. HER family kinase domain mutations promote tumor progression and can predict response to treatment in human breast cancer

    KAUST Repository

    Boulbes, Delphine R.

    2014-11-11

    Resistance to HER2-targeted therapies remains a major obstacle in the treatment of HER2-overexpressing breast cancer. Understanding the molecular pathways that contribute to the development of drug resistance is needed to improve the clinical utility of novel agents, and to predict the success of targeted personalized therapy based on tumor-specific mutations. Little is known about the clinical significance of HER family mutations in breast cancer. Because mutations within HER1/EGFR are predictive of response to tyrosine kinase inhibitors (TKI) in lung cancer, we investigated whether mutations in HER family kinase domains are predictive of response to targeted therapy in HER2-overexpressing breast cancer. We sequenced the HER family kinase domains from 76 HER2-overexpressing invasive carcinomas and identified 12 missense variants. Patients whose tumors carried any of these mutations did not respond to HER2 directed therapy in the metastatic setting. We developed mutant cell lines and used structural analyses to determine whether changes in protein conformation could explain the lack of response to therapy. We also functionally studied all HER2 mutants and showed that they conferred an aggressive phenotype and altered effects of the TKI lapatinib. Our data demonstrate that mutations in the finely tuned HER kinase domains play a critical function in breast cancer progression and may serve as prognostic and predictive markers.

  3. Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling.

    Science.gov (United States)

    Britschgi, Adrian; Bill, Anke; Brinkhaus, Heike; Rothwell, Christopher; Clay, Ieuan; Duss, Stephan; Rebhan, Michael; Raman, Pichai; Guy, Chantale T; Wetzel, Kristie; George, Elizabeth; Popa, M Oana; Lilley, Sarah; Choudhury, Hedaythul; Gosling, Martin; Wang, Louis; Fitzgerald, Stephanie; Borawski, Jason; Baffoe, Jonathan; Labow, Mark; Gaither, L Alex; Bentires-Alj, Mohamed

    2013-03-12

    The calcium-activated chloride channel anoctamin 1 (ANO1) is located within the 11q13 amplicon, one of the most frequently amplified chromosomal regions in human cancer, but its functional role in tumorigenesis has remained unclear. The 11q13 region is amplified in ∼15% of breast cancers. Whether ANO1 is amplified in breast tumors, the extent to which gene amplification contributes to ANO1 overexpression, and whether overexpression of ANO1 is important for tumor maintenance have remained unknown. We have found that ANO1 is amplified and highly expressed in breast cancer cell lines and primary tumors. Amplification of ANO1 correlated with disease grade and poor prognosis. Knockdown of ANO1 in ANO1-amplified breast cancer cell lines and other cancers bearing 11q13 amplification inhibited proliferation, induced apoptosis, and reduced tumor growth in established cancer xenografts. Moreover, ANO1 chloride channel activity was important for cell viability. Mechanistically, ANO1 knockdown or pharmacological inhibition of its chloride-channel activity reduced EGF receptor (EGFR) and calmodulin-dependent protein kinase II (CAMKII) signaling, which subsequently attenuated AKT, v-src sarcoma viral oncogene homolog (SRC), and extracellular signal-regulated kinase (ERK) activation in vitro and in vivo. Our results highlight the involvement of the ANO1 chloride channel in tumor progression and provide insights into oncogenic signaling in human cancers with 11q13 amplification, thereby establishing ANO1 as a promising target for therapy in these highly prevalent tumor types.

  4. Development of a low-noise 10 K J-T refrigeration system. Technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    Little, W.A.

    1990-02-15

    This report summarizes work done on the development of a low noise Joule-Thomson, microminiature refrigeration system design for 10K operation. Good progress has been made on the compressor and on the waterknife to be used for the fabrication of the refrigerators. Work on the refrigerator itself is progressing well. Difficulties which had been experienced previously resulting in the warming of the nitrogen stage precooler appear to be due to inefficiency of the final stage laminar flow heat exchanger. This inefficiency is strongly dependent upon the mass flow through this stage, and difficulty in controlling this to the required precision caused the wide range of variations in the performance of otherwise similar coolers.

  5. GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis.

    Science.gov (United States)

    Shahi, P; Wang, C-Y; Chou, J; Hagerling, C; Gonzalez Velozo, H; Ruderisch, A; Yu, Y; Lai, M-D; Werb, Z

    2017-10-05

    Semaphorin 3B (SEMA3B) is a secreted axonal guidance molecule that is expressed during development and throughout adulthood. Recently, SEMA3B has emerged as a tumor suppressor in non-neuronal cells. Here, we show that SEMA3B is a direct target of GATA3 transcriptional activity. GATA3 is a key transcription factor that regulates genes involved in mammary luminal cell differentiation and tumor suppression. We show that GATA3 relies on SEMA3B for suppression of tumor growth. Loss of SEMA3B renders GATA3 inactive and promotes aggressive breast cancer development. Overexpression of SEMA3B in cells lacking GATA3 induces a GATA3-like phenotype and higher levels of SEMA3B are associated with better cancer patient prognosis. Moreover, SEMA3B interferes with activation of LIM kinases (LIMK1 and LIMK2) to abrogate breast cancer progression. Our data provide new insights into the role of SEMA3B in mammary gland and provides a new branch of GATA3 signaling that is pivotal for inhibition of breast cancer progression and metastasis.

  6. U.C. Davis high energy particle physics research: Technical progress report -- 1990

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1990-12-31

    Summaries of progress made for this period is given for each of the following areas: (1) Task A--Experiment, H1 detector at DESY; (2) Task C--Experiment, AMY detector at KEK; (3) Task D--Experiment, fixed target detectors at Fermilab; (4) Task F--Experiment, PEP detector at SLAC and pixel detector; (5) Task B--Theory, particle physics; and (6) Task E--Theory, particle physics.

  7. Integrins in mammary-stem-cell biology and breast-cancer progression – a role in cancer stem cells?

    Science.gov (United States)

    Pontier, Stephanie M.; Muller, William J.

    2009-01-01

    Summary Cancer cells with stem cell-like properties (cancer stem cells) are believed to drive cancer and are associated with poor prognosis. Data from mouse models have demonstrated that integrins, the major cellular receptors for extracellular-matrix components, have essential roles both during cancer initiation and progression, and during cell differentiation in normal development. By presenting an overview of the role of integrins in stem-cell biology and in cancer progression, this Commentary aims to present evidence for a role of integrins in the biology of cancer stem cells. Given the recent interest in the role of integrins in breast-cancer initiation and progression, we focus on the role of the members of the integrin family and their coupled signaling pathways in mammary-gland development and tumorigenesis. PMID:19118213

  8. Integrins in mammary-stem-cell biology and breast-cancer progression--a role in cancer stem cells?

    Science.gov (United States)

    Pontier, Stephanie M; Muller, William J

    2009-01-15

    Cancer cells with stem cell-like properties (cancer stem cells) are believed to drive cancer and are associated with poor prognosis. Data from mouse models have demonstrated that integrins, the major cellular receptors for extracellular-matrix components, have essential roles both during cancer initiation and progression, and during cell differentiation in normal development. By presenting an overview of the role of integrins in stem-cell biology and in cancer progression, this Commentary aims to present evidence for a role of integrins in the biology of cancer stem cells. Given the recent interest in the role of integrins in breast-cancer initiation and progression, we focus on the role of the members of the integrin family and their coupled signaling pathways in mammary-gland development and tumorigenesis.

  9. Measurements of scattering processes in negative ion-atom collisions. Technical progress report, 1 September 1991--31 August 1992

    Energy Technology Data Exchange (ETDEWEB)

    Kvale, T.J.

    1992-04-01

    This Technical Progress Report describes the progress made on the research objectives during the past twelve months. This research project is designed to provide measurements of various scattering processes which occur in H{sup {minus}} collisions with atomic (specifically, noble gas and atomic hydrogen) targets at intermediate energies. These processes include: elastic scattering,single- and double-electron detachment, and target excitation/ionization. For the elastic and target inelastic processes where H{sup {minus}} is scattered intact, the experimental technique of Ion Energy-Loss Spectroscopy (IELS) will be employed to identify the final target state(s). In most of the above processes, cross sections are unknown both experimentally and theoretically. The measurements in progress will provide either experimentally-determined cross sections or set upper limits to those cross sections. In either case, these measurements will be stringent tests of our understanding in energetic negative ion-atom collisions. This series of experiments required the construction of a new facility and the initial ion beam was accelerated through the apparatus in April 1991.

  10. The Progression of Podcasting/Vodcasting in a Technical Physics Class

    Science.gov (United States)

    Glanville, Y. J.

    2010-11-01

    Technology such as Microsoft PowerPoint presentations, clickers, podcasting, and learning management suites is becoming prevalent in classrooms. Instructors are using these media in both large lecture hall settings and small classrooms with just a handful of students. Traditionally, each of these media is instructor driven. For instance, podcasting (audio recordings) provided my technical physics course with supplemental notes to accompany a traditional algebra-based physics lecture. Podcasting is an ideal tool for this mode of instruction, but podcasting/vodcasting is also an ideal technique for student projects and student-driven learning. I present here the various podcasting/vodcasting projects my students and I have undertaken over the last few years.

  11. Advanced direct liquefaction concepts for PETC generic units. Quarterly technical progress report, April 1994--June 1994

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1994-09-01

    The technical approach of the contract has been expanded to provide additional economic evaluation of related process options. Additional data will be developed in the following areas to facilitate these evaluations. The effect of several modified pretreatments on liquefaction will be investigated. These include catalytic and thermal dewaxing of distillate solvents, the effect that adding light resid to distillate solvent has on hydrotreating and dewaxing, the liquefaction behavior of dense-media separated low-rank coals, and methods of selectively removing oxygen from low-rank coals. Additional chemical, physical, and performance information on improved first-stage catalysts will be developed. Upgrading of ash concentrate to recover catalysts and improve low-rank coals will be assessed. The conversion of residual fractions to distillate by hydropyrolysis will be evaluated. The economic impact of these processes will be determined.

  12. Association Euratom - Risoe National Laboratory, Technical Univ. of Denmark. Annual progress report 2007

    Energy Technology Data Exchange (ETDEWEB)

    Michelsen, P.K.; Korsholm, S.B.; Rasmussen, J.J. (eds.)

    2008-04-15

    The programme of the Research Unit of the Fusion Association Euratom - Risoe National Laboratory, Technical University of Denmark, covers work in fusion plasma physics and in fusion technology. The fusion plasma physics research focuses on turbulence and transport, and its interaction with the plasma equilibrium and particles. The effort includes both first principles based modelling, and experimental observations of turbulence and of fast ion dynamics by collective Thomson scattering. The activities in technology on investigations of radiation damage of fusion reactor materials have been phased out during 2007. Minor activities are system analysis, initiative to involve Danish industry in ITER contracts and public information. A summary is presented of the results obtained in the Research Unit during 2007. (Author)

  13. Association Euratom - Risoe National Laboratory for Sustainable Energy, Technical University of Denmark. Annual progress report 2008

    Energy Technology Data Exchange (ETDEWEB)

    Korsholm, S.B.; Michelsen, P.K.; Rasmussen, J.J.; Westergaard, C.M. (eds.)

    2009-04-15

    The programme of the Research Unit of the Fusion Association Euratom - Risoe National Laboratory for Sustainable Energy, Technical University of Denmark, covers work in fusion plasma physics and in fusion technology. The fusion plasma physics research focuses on turbulence and transport, and its interaction with the plasma equilibrium and particles. The effort includes both first principles based modelling, and experimental observations of turbulence and of fast ion dynamics by collective Thomson scattering. New activities in technology related to development of high temperature superconductors have been initiated in 2008. Minor activities are system analysis, initiative to involve Danish industry in ITER contracts and public information. A summary is presented of the results obtained in the Research Unit during 2008. (Author)

  14. Association Euratom - Risoe National Laboratory for Sustainable Energy, Technical University of Denmark. Annual progress report 2010

    Energy Technology Data Exchange (ETDEWEB)

    Korsholm, S.B.; Michelsen, P.K.; Rasmussen, J.J.; Westergaard, C.M. (eds.)

    2011-04-15

    The programme of the Research Unit of the Fusion Association Euratom - Risoe National Laboratory for Sustainable Energy, Technical University of Denmark, covers work in fusion plasma physics and in fusion technology. The fusion plasma physics research focuses on turbulence and transport, and its interaction with the plasma equilibrium and particles. The effort includes both first principles based modelling, and experimental observations of turbulence and of fast ion dynamics by collective Thomson scattering. Within fusion technology there are activities related to development of high temperature superconductors. Other activities are system analysis, initiative to involve Danish industry in ITER contracts and public information. A summary is presented of the results obtained in the Research Unit during 2010. (Author)

  15. Association Euratom - Risoe National Laboratory for Sustainable Energy, Technical University of Denmark. Annual progress report 2009

    Energy Technology Data Exchange (ETDEWEB)

    Korsholm, S.B.; Michelsen, P.K.; Rasmussen, J.J.; Westergaard, C.M. (eds.)

    2010-04-15

    The programme of the Research Unit of the Fusion Association Euratom - Risoe National Laboratory for Sustainable Energy, Technical University of Denmark, covers work in fusion plasma physics and in fusion technology. The fusion plasma physics research focuses on turbulence and transport, and its interaction with the plasma equilibrium and particles. The effort includes both first principles based modelling, and experimental observations of turbulence and of fast ion dynamics by collective Thomson scattering. Within fusion technology there are activities related to development of high temperature superconductors. Minor activities are system analysis, initiative to involve Danish industry in ITER contracts and public information. A summary is presented of the results obtained in the Research Unit during 2009. (Author)

  16. Decontamination Systems Information and Research Program. Quarterly technical progress report, July 1--September 30, 1993

    Energy Technology Data Exchange (ETDEWEB)

    1993-10-01

    Progress reports are presented for the following projects: systematic assessment of the state of hazardous waste clean-up technologies; site remediation technologies--drain-enhanced soil flushing (DESF) for organic contaminants removal; excavation systems for hazardous waste sites; chemical destruction of polychlorinated biphenyls; development of organic sensors--monolayer and multilayer self-assembled films for chemical sensors; Winfield Lock and Dam remediation; Winfield cleanup survey; assessment of technologies for hazardous waste site remediation--non-treatment technologies and pilot scale test facility implementation; assessment of environmental remediation storage technology; assessment of environmental remediation excavation technology; assessment of environmental remediation monitoring technology; and remediation of hazardous sites with steam reforming.

  17. Enthalpy and phase behavior of coal derived liquid mixtures. Technical progress report, January-March 1986

    Energy Technology Data Exchange (ETDEWEB)

    Yesavage, V.F.; Kidnay, A.J.

    1986-04-30

    On July 15, 1984, work was initiated on a program to study the enthalpy and phase behavior of coal derived liquid model compound mixtures. During the seventh quarter, preliminary enthalpy measurements for the 5/6:1/6 m-cresol/tetralin binary mixture have been completed and are included in Appendix A at the end of this report. Vapor liquid equilibria VLE measurements for the m-cresol/tetralin system have been completed for four isotherms; 250, 275, 300, 325/sup 0/C. These results and a summary of progress to date for the VLE apparatus are in the appendix at the end of this report. 10 refs., 15 figs., 6 tabs.

  18. Coolside waste management research. Quarterly technical progress report, October 1, 1991--October 31, 1991

    Energy Technology Data Exchange (ETDEWEB)

    1991-12-31

    Objective was to produce sufficient information on physical and chemical nature of Coolside waste (Coolside No.1, 3 at Edgewater power plant) to design and construct stable, environmentally safe landfills. Progress during this period was centered on analytical method development, elemental and mineralogical analysis of samples, and field facilities preparation to receive lysimeter fill. Sample preparation techniques for thick target PIXE/PIGE were investigated; good agreement between measured and actual values for standard fly ash were obtained for all elements except Fe, Ba, K (PIXE).

  19. Using Simulation to Model and Validate Invasive Breast Cancer Progression in Women in the Study and Control Groups of the Canadian National Breast Screening Studies I and II.

    Science.gov (United States)

    Taghipour, Sharareh; Caudrelier, Laurent N; Miller, Anthony B; Harvey, Bart

    2017-02-01

    Modeling breast cancer progression and the effect of various risk is helpful in deciding when a woman should start and end screening, and how often the screening should be undertaken. We modeled the natural progression of breast cancer using a hidden Markov process, and incorporated the effects of covariates. Patients are women aged 50-59 (older) and 40-49 (younger) years from the Canadian National Breast Screening Studies. We included prevalent cancers, estimated the screening sensitivities and rates of over-diagnosis, and validated the models using simulation. We found that older women have a higher rate of transition from a healthy to preclinical state and other causes of death but a lower rate of transition from preclinical to clinical state. Reciprocally, younger women have a lower rate of transition from a healthy to preclinical state and other causes of death but a higher rate of transition from a preclinical to clinical state. Different risk factors were significant for the age groups. The mean sojourn times for older and younger women were 2.53 and 2.96 years, respectively. In the study group, the sensitivities of the initial physical examination and mammography for older and younger women were 0.87 and 0.81, respectively, and the sensitivity of the subsequent screens were 0.78 and 0.53, respectively. In the control groups, the sensitivities of the initial physical examination for older and younger women were 0.769 and 0.671, respectively, and the sensitivity of the subsequent physical examinations for the control group aged 50-59 years was 0.37. The upper-bounds for over-diagnosis in older and younger women were 25% and 27%, respectively. The present work offers a basis for the better modeling of cancer incidence for a population with the inclusion of prevalent cancers.

  20. Hypoxia-inducible factor-mediated induction of WISP-2 contributes to attenuated progression of breast cancer

    Directory of Open Access Journals (Sweden)

    Fuady JH

    2014-03-01

    Full Text Available Jerry H Fuady,1,* Mattia R Bordoli,1,* Irene Abreu-Rodríguez,1,* Glen Kristiansen,2 David Hoogewijs,1,** Daniel P Stiehl,1,** Roland H Wenger1,**1Institute of Physiology and Zurich Center for Human Physiology, University of Zurich, Zurich, Switzerland; 2University Hospital Bonn, Institute of Pathology, Bonn, Germany*,**These authors contributed equally to this workAbstract: Hypoxia and the hypoxia-inducible factor (HIF signaling pathway trigger the expression of several genes involved in cancer progression and resistance to therapy. Transcriptionally active HIF-1 and HIF-2 regulate overlapping sets of target genes, and only few HIF-2 specific target genes are known so far. Here we investigated oxygen-regulated expression of Wnt-1 induced signaling protein 2 (WISP-2, which has been reported to attenuate the progression of breast cancer. WISP-2 was hypoxically induced in low-invasive luminal-like breast cancer cell lines at both the messenger RNA and protein levels, mainly in a HIF-2α-dependent manner. HIF-2-driven regulation of the WISP2 promoter in breast cancer cells is almost entirely mediated by two phylogenetically and only partially conserved functional hypoxia response elements located in a microsatellite region upstream of the transcriptional start site. High WISP-2 tumor levels were associated with increased HIF-2α, decreased tumor macrophage density, and a better prognosis. Silencing WISP-2 increased anchorage-independent colony formation and recovery from scratches in confluent cell layers of normally low-invasive MCF-7 cancer cells. Interestingly, these changes in cancer cell aggressiveness could be phenocopied by HIF-2α silencing, suggesting that direct HIF-2-mediated transcriptional induction of WISP-2 gene expression might at least partially explain the association of high HIF-2α tumor levels with prolonged overall survival of patients with breast cancer.Keywords: invasion, metastasis, motility, oxygen, tumor, transcriptional

  1. Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer

    DEFF Research Database (Denmark)

    von Minckwitz, Gunter; Schwedler, Kathrin; Schmidt, Marcus

    2011-01-01

    Continuation of trastuzumab plus capecitabine (XH) showed a significantly improved overall response rate and time to progression compared with capecitabine (X) alone in women with HER2-positive breast cancer progressing during trastuzumab treatment. Here, we report the final analysis on overall...

  2. Technical Note: Robust measurement of the slice-sensitivity profile in breast tomosynthesis.

    Science.gov (United States)

    Maki, Aili K; Mainprize, James G; Yaffe, Martin J

    2016-08-01

    The purpose of this work is to improve the repeatability of the measurement of the slice-sensitivity profile (SSP) in reconstructed breast tomosynthesis volumes. A grid of aluminum ball-bearings (BBs) within a PMMA phantom was imaged on breast tomosynthesis systems from three different manufacturers. The full-width half-maximum (FWHM) values were measured for the SSPs of the BBs in the reconstructed volumes. The effect of transforming the volumes from a Cartesian coordinate system (CCS) to a cone-beam coordinate system (CBCS) on the variability in the FWHM values was assessed. Transforming the volumes from a CCS to a CBCS before measuring the SSPs reduced the coefficient of variation (COV) in the measurements of FWHM in repeated measurements by 56% and reduced the dependence of the FWHM values on the location of the BBs within the reconstructed volume by 76%. Measuring the SSP in the volumes in a CBCS improves the robustness of the measurement.

  3. Dissolved organic matter and lake metabolism. Technical progress report, 1 July 1979-30 June 1980

    Energy Technology Data Exchange (ETDEWEB)

    Wetzel, R.G.

    1980-01-01

    Progress in research to evaluate the impact of utilization of fossil fuels on surface water is reported. Analyses of regulatory mechanisms of growth and rates of carbon cycling center on evaluation of quantitative control interactions among the microflora of the pelagial zones of several lakes of progressively greater eutrophy, littoral photosynthetic producer-decomposer complex, and allochthonous inorganic-organic influxes and their biotic processing. The underlying thesis is that quantification of the dynamic carbon fluxes among these components and their rate control mechanisms by physical and chemical factors are fundamental to elucidation of the rate functions of lake eutrophication. A major portion of the research has been directed towards the fate and nutrient mechanisms regulating qualitative and quantitative utilization and losses of organic carbon synthesized within lakes and their drainage basins. It has become increasingly apparent that the wetland and littoral flora, and attendant epiphytic and benthic microflora, have major regulatory controls on biogeochemical cycling of whole lake systems. A major effort on factors regulating the metabolism of littoral macrophytes and attached algae has been coupled to integrated studies on their decomposition and the fate of detrital dissolved and particulate organic matter. These organic products are being coupled to influences on enzymatic activity and inorganic nutrient cycling.

  4. Superconducting fault current limiter. Fifth quarterly technical progress report, August 8, 1978-November 7, 1979

    Energy Technology Data Exchange (ETDEWEB)

    1979-01-01

    Progress in the development of fault current limiters for superconducting power transmission systems is reported. The analysis and design of a magnetically switched resistive device and the experimental program were emphasized and reported. A transient heat transfer model was developed which indicates the parameters which are important in determining the thermal heating and recovery of the superconduting film. Designs for the switching coil and the S/C element were also carried out and are reported. A four-pole magnetic coil is recommended; this generates a magnetic field which is nearly perpendicular to spiral or helical S/C film geometrics. A spirally-designed, 3000 ohm limiter is shown to be able to fit within a .5 to 1m inner radius, .05 to .03 m wide, 1.3 to 3.9 m long annualr region. The experimental program has included work on materials development and on prepartion of the switching and thermal recovery experimental facility. The material development program has uncovered several serious short-comings of NbN as the S/C film material. Macroscopic holes and surface debris, and microscopic imperfections reduce the critical current density below the expected value and, in addition, cause nonuniform switching. Reasons for these effects are postulated, and a continuing, vigorous materials program is suggested in hopes of alleviating these problems. Virtually all of the experimental equipment had been installed, and so the magnetic switching and thermal recovery experiments can begin and progress during the next quarter. (LCL)

  5. Methyl chloride via oxyhydrochlorination of methane. Quarterly technical progress report No. 6, January--March 1993

    Energy Technology Data Exchange (ETDEWEB)

    1993-11-01

    The purpose of this contract is to develop a process for converting light alkane gases to methyl chloride via oxyhydrochlorination using highly selective, stable catalysts in fixed-bed reactors designed to remove the large amount of heat generated, so as to control the reaction temperature. Further, the objective is to obtain the engineering data base necessary for developing a commercially feasible process and to evaluate the economics of the process. This document reports significant progress this quarter toward the development of a stable heterogeneous packed bed catalyst for the oxyhydrochlorination of methane. This quarter`s data shows a catalyst which gave an average 18% methane conversion and 78% MeCl selectivity for a 12 day period of time. The PDU (Process Development Unit) design engineering effort made significant progress this quarter. A bid on a modular unit by Xytel Corp. was received and evaluated. The pre-engineering estimate showed that costs were considerably higher than the original project capital estimates. A rigorous effort was made to eliminate all non-essential equipment and scope of work. A reduced scope was agreed upon and in the second round both Xytel and the Dow Corning in-house facilities engineering team were allowed to bid on the package.

  6. Understanding the dual nature of CD44 in breast cancer progression

    National Research Council Canada - National Science Library

    Louderbough, Jeanne M V; Schroeder, Joyce A

    2011-01-01

    CD44 has been the subject of extensive research for more than 3 decades because of its role in breast cancer, in addition to many physiological processes, but interestingly, conflicting data implicate...

  7. Metastic Progression of Breast Cancer by Allelic Loss on Chromosome 18q21

    National Research Council Canada - National Science Library

    Thiagalingam, Sam

    2006-01-01

    Genetic and epigenetic inactivation of SMAD4 are rare occurrences in breast tumors despite it is localized to chromosome 18q and serves as a frequent target for inactivation in advanced gastrointestinal cancers...

  8. The Role of Myoepithelial Maspin in Breast Carcinoma Progression, Diagnosis and Screening

    National Research Council Canada - National Science Library

    Barsky, Sanford

    2002-01-01

    In glandular organs a precancerous stale precedes invasive carcinoma. in the breast this state is recognized as DGIS and consists of an epithelial cell proliferation confined by myoepithelial cells...

  9. Investigation of Metastatic Breast Tumor Heterogeneity and Progression Using Dual Optical/SPECT Imaging

    National Research Council Canada - National Science Library

    Antich, Peter P

    2006-01-01

    .... The proposed training plan will lead to advanced skills in research design, data management and analysis and in working with interdisciplinary research teams to improve outcomes of care of patients with breast cancer...

  10. Homocysteine Is an Oncometabolite in Breast Cancer, Which Promotes Tumor Progression and Metastasis

    Science.gov (United States)

    2017-01-01

    ANGPTL-4 and MMP-9 in breast cancer cell lines. TASK 5: Analyze the influence of homocysteine and ANGPTL-4 on the permeability of lung...of protein lysates for western blotting, and preparation of RNA for qPCR. Lungs were perfused with India ink and Fekete solution to visualize... permeability of lung microvascular endothelial cells. Lung is the one of the primary sites for breast cancer metastasis, and it is believed that the

  11. The role of dietary factors in prevention and progression of breast cancer.

    Science.gov (United States)

    Rossi, Roberta Elisa; Pericleous, Marinos; Mandair, Dalvinder; Whyand, Tara; Caplin, Martyn Evan

    2014-12-01

    Breast cancer (BC) is the leading global cause of cancer-related death in women. There is growing evidence for a role for dietary factors in BC pathophysiology. The aim of the present review was to evaluate the impact of dietary factors in BC risk. Bibliographical searches were performed in PubMed, using the following terms: "nutrition and breast cancer", "nutrition and breast carcinoma", "dietary factors and breast cancer", "risk factors and breast cancer", "diet and breast cancer, "breast cancer epidemiology", "breast cancer and prevention". Consumption of well-done red meat appears to be associated with increased risk of BC, whereas fish may be protective. Total cholesterol, triglyceride levels and glycaemic load should be monitored and controlled in at risk populations because they may be associated with increased risk of BC, although the exact mechanisms involved are not clear. Alcohol intake should be minimized since it is a risk factor for BC. High intake of polyphenol/phyto-oestrogen -rich food (i.e. flavonoids, soya products), as well as fibres, fruits and vegetables, may have potential protective effects against BC occurrence but the results might vary according to hormonal status. Vitamin D supplements appear protective against BC development and similarly other vitamins and oligo-elements might decrease BC risk, although further large prospective studies are required. There exist increasing evidence that dietary factors can play an important role in both the development and prevention of BC. Large randomized clinical and epidemiological studies are required but are difficult to design due to the number of variable factors. Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

  12. Management of dry flue gas desulfurization by-products in underground mines. Quarterly technical progress report, April 1995--June 1995

    Energy Technology Data Exchange (ETDEWEB)

    Chugh, Y.P.; Dutta, D.; Esling, S. [and others

    1995-07-01

    On September 30, 1993, the U.S. Department of Energy-Morgantown Energy Technology Center and Southern Illinois University at Carbondale (SIUC) entered into a cooperative research agreement entitled {open_quotes}Management of Dry Flue Gas Desulfurization By-Products in Underground Mines{close_quotes} (DE-FC21-93MC30252). Under the agreement Southern Illinois University at Carbondale will develop and demonstrate several technologies for the placement of coal combustion residues in abandoned coal mines, and will assess the environmental impact of such underground residues placement. Previous quarterly Technical Progress Reports have set forth the specific objectives of the program, and a discussion of these is not repeated here. Rather, this report discusses the technical progress made during the period April 1 - June 30, 1995. A final topical report on the SEEC, Inc. demonstration of its technology for the transporting of coal combustion residues was completed during the quarter, although final printing of the report was accomplished early in July, 1995. The SEEC technology involves the use of Collapsible Intermodal Containers (CIC`s) developed by SEEC, and the transportation of such containers - filled with fly ash or other coal combustion residues - on rail coal cars or other transportation means. Copies of the final topical report, entitled {open_quotes}The Development and Testing of Collapsible Intermodal Containers for the Handling and Transport of Coal Combustion Residues{close_quotes} were furnished to the Morgantown Energy Technology Center. The Rapid Aging Test colums were placed in operation during the quarter. This test is to determine the long-term reaction of both the pneumatic and hydraulic mixtures to brine as a leaching material, and simulates the conditions that will be encountered in the actual underground placement of the coal combustion residues mixtures. The tests will continue for about one year.

  13. Technical Progress Report on Application and Development of Appropriate Tools and Technologies for Cost-Effective Carbon Sequestration

    Energy Technology Data Exchange (ETDEWEB)

    Bill Stanley; Patrick Gonzalez; Sandra Brown; Jenny Henman; Ben Poulter; Sarah Woodhouse Murdock; Neil Sampson; Tim Pearson; Sarah Walker; Zoe Kant; Miguel Calmon; Gilberto Tiepolo

    2006-06-30

    The Nature Conservancy is participating in a Cooperative Agreement with the Department of Energy (DOE) National Energy Technology Laboratory (NETL) to explore the compatibility of carbon sequestration in terrestrial ecosystems and the conservation of biodiversity. The title of the research project is ''Application and Development of Appropriate Tools and Technologies for Cost-Effective Carbon Sequestration''. The objectives of the project are to: (1) improve carbon offset estimates produced in both the planning and implementation phases of projects; (2) build valid and standardized approaches to estimate project carbon benefits at a reasonable cost; and (3) lay the groundwork for implementing cost-effective projects, providing new testing ground for biodiversity protection and restoration projects that store additional atmospheric carbon. This Technical Progress Report discusses preliminary results of the six specific tasks that The Nature Conservancy is undertaking to answer research needs while facilitating the development of real projects with measurable greenhouse gas reductions. The research described in this report occurred between April 1st and July 30th 2006. The specific tasks discussed include: Task 1: carbon inventory advancements; Task 2: emerging technologies for remote sensing of terrestrial carbon; Task 3: baseline method development; Task 4: third-party technical advisory panel meetings; Task 5: new project feasibility studies; and Task 6: development of new project software screening tool. Work is being carried out in Brazil, Belize, Chile, Peru and the USA.

  14. Current status of gene therapy for breast cancer: progress and challenges

    Directory of Open Access Journals (Sweden)

    McCrudden CM

    2014-11-01

    Full Text Available Cian M McCrudden, Helen O McCarthySchool of Pharmacy, Queen’s University Belfast, Belfast, UKAbstract: Breast cancer is characterized by a series of genetic mutations and is therefore ideally placed for gene therapy intervention. The aim of gene therapy is to deliver a nucleic acid-based drug to either correct or destroy the cells harboring the genetic aberration. More recently, cancer gene therapy has evolved to also encompass delivery of RNA interference technologies, as well as cancer DNA vaccines. However, the bottleneck in creating such nucleic acid pharmaceuticals lies in the delivery. Deliverability of DNA is limited as it is prone to circulating nucleases; therefore, numerous strategies have been employed to aid with biological transport. This review will discuss some of the viral and nonviral approaches to breast cancer gene therapy, and present the findings of clinical trials of these therapies in breast cancer patients. Also detailed are some of the most recent developments in nonviral approaches to targeting in breast cancer gene therapy, including transcriptional control, and the development of recombinant, multifunctional bio-inspired systems. Lastly, DNA vaccines for breast cancer are documented, with comment on requirements for successful pharmaceutical product development.Keywords: breast cancer, gene therapy, nonviral, clinical trial

  15. Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem?

    Science.gov (United States)

    Sacchini, Virgilio; Pinotti, José A; Barros, Alfredo C S D; Luini, Alberto; Pluchinotta, Alfonso; Pinotti, Marianne; Boratto, Marcelo G; Ricci, Marco D; Ruiz, Carlos A; Nisida, Antonio C; Veronesi, Paolo; Petit, Jean; Arnone, Paolo; Bassi, Fabio; Disa, Joseph J; Garcia-Etienne, Carlos A; Borgen, Patrick I

    2006-11-01

    We evaluated the risks and benefits of nipple-sparing mastectomy in a multiinstitutional experience in the settings of risk-reducing surgery and breast cancer treatment. We analyzed data on 123 patients who had undergone nipple-sparing mastectomy with breast reconstruction for prophylaxis (n=55), treatment of breast cancer (n=41), or both (n=27) at four large centers. Median patient age was 45 years (range 22 to 70 years). There were 192 procedures (69 bilateral, 54 unilateral). Forty-four patients had invasive cancer; 20 had ductal carcinoma in situ (DCIS); 4 had phyllodes tumor. In all of these patients, the nipple tissue was cancer free on pathologic review. Median followup was 24.6 months (range 2.0 to 570.4 months). Local recurrence developed in two patients: one had DCIS in the upper-outer quadrant, with 71.8 months of followup; the other's cancer was invasive, in the upper-outer quadrant, with 6 months of followup. Distant metastasis developed in a third patient, who died 50 months after the procedure. Breast cancer developed in two patients after prophylactic mastectomy: one in the upper-outer quadrant at 61.8 months; one in the axillary tail at 24.4 months. No patients had recurrences in the nipple-areolar complex. Necrosis of the nipple was reported in 22 of 192 patients (11%) and it was judged minimal (less than one-third total skin of nipple) in 13 of 22 patients (59%). Overall cosmesis was judged by the patient and surgeon as good to excellent in the majority of patients. Level of satisfaction with cosmetic results was similar between prophylactic and treatment patients. The risk of local relapse was very low in our series of nipple-sparing mastectomies performed for DCIS or invasive cancer. Nipple-sparing mastectomy in the risk-reducing and breast cancer-treatment settings may be feasible in selected patients and should be the subject of additional prospective clinical trials.

  16. Savannah River Ecology Laboratory. Annual technical progress report of ecological research

    Energy Technology Data Exchange (ETDEWEB)

    Smith, M.H.

    1996-07-31

    The Savannah River Ecology Laboratory (SREL) is a research unit of the University of Georgia (UGA). The overall mission of the Laboratory is to acquire and communicate knowledge of ecological processes and principles. SREL conducts basic and applied ecological research, as well as education and outreach programs, under a contract with the U.S. Department of Energy (DOE) at the Savannah River Site (SRS) near Aiken, South Carolina. Significant accomplishments were made during the past year in the areas of research, education and service. The Laboratory`s research mission was fulfilled with the publication of two books and 143 journal articles and book chapters by faculty, technical and students, and visiting scientists. An additional three books and about 80 journal articles currently are in press. Faculty, technician and students presented 193 lectures, scientific presentations, and posters to colleges and universities, including minority institutions. Dr. J Vaun McArthur organized and conducted the Third Annual SREL Symposium on the Environment: New Concepts in Strewn Ecology: An Integrative Approach. Dr. Michael Newman conducted a 5-day course titled Quantitative Methods in Ecotoxicology, and Dr. Brian Teppen of The Advanced Analytical Center for Environmental Sciences (AACES) taught a 3-day short course titled Introduction to Molecular Modeling of Environmental Systems. Dr. I. Lehr Brisbin co-hosted a meeting of the Crocodile Special Interest Group. Dr. Rebecca Sharitz attended four symposia in Japan during May and June 1996 and conducted meetings of the Executive Committee and Board of the International Association for Ecology (ENTECOL).

  17. Risk factors for disease progression in HER2-positive breast cancer patients based on the location of metastases

    Directory of Open Access Journals (Sweden)

    Joanna Huszno

    2015-09-01

    Full Text Available Introduction : Trastuzumab therapy significantly improves progression-free and overall survival in HER2-positive [HER2(+] breast cancer (BC patients. However, in most patients with HER2(+ metastatic BC, the disease progress occurred. The aim of this study was to evaluate the clinicopathological risk factors for progression in HER2-positive breast cancer patients during trastuzumab therapy. Material and methods : The analysis included medical records of HER2(+ metastatic BC patients treated with trastuzumab between 2006 and 2013. Results : The most common site of progression during trastuzumab therapy were lungs 25 (39%, central nervous system (CNS 8 (13%, skin 9 (14%, locoregional lymph nodes 19 (30%, liver 18 (28% and bone 17 (27%. Patients with lung metastases significantly more often had a history of cancer in the family than women with other metastasis sites (24% vs. 2.6%, p = 0.048. Metastases to lungs occurred also more often during therapy containing trastuzumab with chemotherapy than trastuzumab alone 17/8 (58% vs. 41%, p = 0.043. Central nervous system metastases were observed insignificantly more frequently in postmenopausal women than premenopausal patients 8/0 (22% vs. 0%, p = 0.093. There was reported a tendency to liver metastases in ER-negative tumors 13/20 (72% vs. 44%, p = 0.053. Bone metastases were associated with the positive steroid receptor status (p = 0.019 and second neoplasm in history (p = 0.06. Conclusions : Risk factors for disease progression were the menopausal status (CNS metastases, steroid receptor status (liver, lymph nodes and bone metastases, history of cancer in the family (lung metastases and history of cigarette smoking (liver metastases.

  18. Accelerator research studies. Technical progress report, June 1, 1991--May 31, 1992

    Energy Technology Data Exchange (ETDEWEB)

    1992-02-01

    The Accelerator Research Studies program at the University of Maryland, sponsored by the Department of Energy under grant number DE-FG05-91ER40642, is currently in the first year of a three-year funding cycle. The program consists of the following three tasks: TASK A, Study of Transport and Longitudinal Compression of Intense, High-Brightness Beams, TASK B, Study of Collective Ion Acceleration by Intense Electron Beams and Pseudospark Produced High Brightness Electron Beams; TASK C, Study of a Gyroklystron High-power Microwave Source for Linear Colliders. In this report we document the progress that has been made during the past year for each of the three tasks.

  19. Dissolved organic matter and lake metabolism. Technical progress report, 1 July 1976--30 June 1977

    Energy Technology Data Exchange (ETDEWEB)

    Wetzel, R.G.

    1977-01-01

    Progress is reported on investigations on the qualitative and quantitative cycling of particulate and dissolved organic matter within lakes and their drainage basins. Interactions of dissolved organic matter with inorganic nutrient cycling and regulation of the photosynthetic and decompositional metabolism of micro- and macroflora remain the focal point of these studies. Major efforts were directed towards the sources fates, pathways, and interactions of dissolved organic matter in inorganic chemical cycling; allochthonous sources, metabolism en route, and inputs to the lake systems of increasing stages of eutrophication; and the relationships of these compounds to the nutrient physiology and metabolism of phytoplankton, sessile algae, macrophytes, and bacterial populations. Results of studies carried out in a freshwater lake in Michigan (Lawrence Lake) are reported. 165 references.

  20. Automotive Stirling Engine Development Program. Quarterly technical progress report, October--December 1977

    Energy Technology Data Exchange (ETDEWEB)

    Kitzner, E.W.

    1978-01-01

    This report covers the first 3 months effort of the Ford/DOE Automotive Stirling Engine Development Program, specifically Task I which is Fuel Economy Assessment. At the beginning of this contract effort the projected fuel economy of the 4-215 Stirling engine was 21.16 MPG with a confidence level of 29 percent. Since that date, the fuel economy improvement projection of the 4-215 Stirling engine has been increased to 22.11 MPG, with a confidence level of 29 percent. Collection of fuel economy improvement data is directly related to engine durability. Engine durability has been limited. Since September 19, 1977 a total of 47.7 hours of engine running time has been accumulated using two engine builds. Progress is reported in sub-task studies of burners, preheaters, engine drive, blower system, power control, air-fuel ratio control, cooling system, and cycle control. (LCL)

  1. Waste Isolation Safety Assessment Program. Technical progress report for FY-1978

    Energy Technology Data Exchange (ETDEWEB)

    Brandstetter, A.; Harwell, M.A.; Howes, B.W.; Benson, G.L.; Bradley, D.J.; Raymond, J.R.; Serne, R.J.; Schilling, A.H.

    1979-07-01

    Associated with commercial nuclear power production in the United States is the generation of potentially hazardous radioactive wastes. The Department of Energy (DOE) is seeking to develop nuclear waste isolation systems in geologic formations that will preclude contact with the biosphere of waste radionuclides in concentrations which are sufficient to cause deleterious impact on humans or their environments. Comprehensive analyses of specific isolation systems are needed to assess the expectations of meeting that objective. The Waste Isolation Safety Assessment Program (WISAP) has been established at the Pacific Northwest Laboratory (operated by Battelle Memorial Institute) for developing the capability of making those analyses. Progress on the following tasks is reported: release scenario analysis, waste form release rate analysis, release consequence analysis, sorption-desorption analysis, and societal acceptance analysis. (DC)

  2. Enthalpy and phase behavior of coal derived liquid mixtures. Technical progress report, April-June 1986

    Energy Technology Data Exchange (ETDEWEB)

    Yesavage, V.F.; Kidnay, A.J.

    1986-07-31

    Enthalpy measurements for the m-cresol/tetralin binary system, and the quinoline/tertralin binary system have been completed and are included. A calibration check on the calorimeter was performed and is presented in Appendix C. Vapor liquid equilibria measurements for the quinoline/tetralin system have been completed for four isotherms; 250, 275, 300, and 325/sup 0/C. These results and a summary of progress to date for the VLE apparatus are in the appendix at the end of this report. Also, preliminary work has begun on the quinoline/m-cresol/tetralin ternary system. Correlational work has consisted of the development of mathematical expressions for fugacity and enthalpy using various combinations of mixing rules and equations of state discussed in earlier reports. Also maximum likelihood routines has been written to determine the necessary parameters for binary data obtained in this investigation.

  3. AFCT/TFCT/ISFS Program. Technical progress report, July 1, 1978-September 30, 1978

    Energy Technology Data Exchange (ETDEWEB)

    Hill, O.F. (comp.)

    1978-09-01

    This is the last in a series of quarterly progress reports on research and development studies performed for the Alternate Fuel Cycle Technologies/Thorium Fuel Cycle Technologies/International Spent Fuel Receipt and Storage (AFCT/TFCT/ISFS) Program. This program provided information needed by industry to close the back end of the power reactor fuel cycle. During the last quarter. studies were conducted on the following task: Thorium Resource Price Analyses; Investigation of Air Cleaning Processes for Removing Tributyl Phosphate from Off-Gas Streams; Study of Iodine Chemistry in Process Solutions; High-Level Waste Treatment; Electropolishing to Decontaminate Metallic Waste from Alternate and Thorium Converter Fuel Cycles; US Scale Transport, Dispersion and Removal Model Comparison; Safety Criticality Experiments; and Criticality Research in Support of Thorium Fuel Cycle Technology Program.

  4. Index to Nuclear Safety. A technical progress review by chronology, permuted title, and author. Vol. 11, No. 1--Vol. 17, No. 6

    Energy Technology Data Exchange (ETDEWEB)

    Cottrell, W.B.; Klein, A.

    1977-02-23

    This index to Nuclear Safety covers articles in Nuclear Safety Vol. 11, No. 1 (Jan.-Feb. 1970), through Vol. 17, No. 6 (Nov.-Dec. 1976). The index includes a chronological list of articles (including abstract) followed by KWIC and Author Indexes. Nuclear Safety, a bimonthly technical progress review prepared by the Nuclear Safety Information Center, covers all safety aspects of nuclear power reactors and associated facilities. The index lists over 350 technical articles in the last six years of publication.

  5. Technical progress report for the magnetohydrodynamics Coal-Fired Flow Facility for the period April 1, 1993--June 30, 1993

    Energy Technology Data Exchange (ETDEWEB)

    1993-10-01

    In this quarterly technical progress report, UTSI reports on progress on a multitask contract to develop the necessary technology for the steam bottoming plant of the MHD Steam Combined Cycle power plant. A Proof-Of-Concept (POC) test was conducted during the quarter and the results are reported. This POC test was terminated after 88 hours of operation due to the failure of the coal pulverizer main shaft. Preparations for the test and post-test activities are summarized. Modifications made to the dry electrostatic precipitator (ESP) are described and measurements of its performance are reported. The baghouse performance is summarized, together with actions being taken to improve bag cleaning using reverse air. Data on the wet ESP performance is included at two operating conditions, including verification that it met State of Tennessee permit conditions for opacity with all the flow through it. The results of experiments to determine the effect of potassium seed on NO{sub x} emissions and secondary combustion are reported. The status of efforts to quantify the detailed mass balance for all POC testing is summarized. The work to develop a predictive ash deposition model is discussed and results compared with deposition actually encountered during the test. Plans to measure the kinetics of potassium and sulfur on flames like the secondary combustor, are included. Advanced diagnostic work by both UTSI and MSU is reported. Efforts to develop the technology for a high temperature air heater using ceramic tubes are summarized.

  6. GPHS-RTGs in support of the Cassini RTG Program. Semi annual technical progress report, September 26, 1994--April 2, 1995

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1995-04-20

    The technical progress achieved during the period 26 September 1994 through 2 April 1995 on Contract DE-AC03-91SF18852 Radioisotope Thermoelectric Generators and Ancillary Activities is described herein. Monthly technical activity for the period 27 February 1995 through 2 April 1995 is included in this progress report. The report addresses tasks, including: spacecraft integration and liaison; engineering support; safety; qualified unicouple production; ETG Fabrication, assembly, and test; ground support equipment; RTG shipping and launch support; designs, reviews, and mission applications; project management, quality assurance, reliability, contract changes, CAGO acquisition (operating funds), and CAGO maintenance and repair; and CAGO acquisition (capital funds).

  7. Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions Vitamin D pathways unbalanced in breast lesions

    Directory of Open Access Journals (Sweden)

    Lopes Nair

    2010-09-01

    Full Text Available Abstract Background Breast cancer is a heterogeneous disease associated with different patient prognosis and responses to therapy. Vitamin D has been emerging as a potential treatment for cancer, as it has been demonstrated that it modulates proliferation, apoptosis, invasion and metastasis, among others. It acts mostly through the Vitamin D receptor (VDR and the synthesis and degradation of this hormone are regulated by the enzymes CYP27B1 and CYP24A1, respectively. We aimed to study the expression of these three proteins by immunohistochemistry in a series of breast lesions. Methods We have used a cohort comprising normal breast, benign mammary lesions, carcinomas in situ and invasive carcinomas and assessed the expression of the VDR, CYP27B1 and CYP24A1 by immunohistochemistry. Results The results that we have obtained show that all proteins are expressed in the various breast tissues, although at different amounts. The VDR was frequently expressed in benign lesions (93.5% and its levels of expression were diminished in invasive tumours (56.2%. Additionally, the VDR was strongly associated with the oestrogen receptor positivity in breast carcinomas. CYP27B1 expression is slightly lower in invasive carcinomas (44.6% than in benign lesions (55.8%. In contrast, CYP24A1 expression was augmented in carcinomas (56.0% in in situ and 53.7% in invasive carcinomas when compared with that in benign lesions (19.0%. Conclusions From this study, we conclude that there is a deregulation of the Vitamin D signalling and metabolic pathways in breast cancer, favouring tumour progression. Thus, during mammary malignant transformation, tumour cells lose their ability to synthesize the active form of Vitamin D and respond to VDR-mediated Vitamin D effects, while increasing their ability to degrade this hormone.

  8. Capillary electrokinetic separations with optical detection. Technical progress report, February 1, 1993--January 31, 1994

    Energy Technology Data Exchange (ETDEWEB)

    Sepaniak, M.J.

    1993-10-01

    This program seeks the development of capillary electrokinetic separation techniques and associated optical methods of detection. Fundamental studies of pertinent separation and band broadening mechanisms are being conducted, with the emphasis on understanding systems that include highly-ordered assemblies as running buffer additives. The additives include cyclodextrins, affinity reagents, and soluble (entangled) polymers and are employed with capillary electrophoresis, CE and/or micellar electrokinetic capillary chromatography, MECC modes of separation. The utility of molecular modeling techniques for predicting the effects of highly ordered assemblies on the retention behavior of isomeric compounds is under investigation. The feasibility of performing separations using a non-aqueous solvent/fullerene electrochromatographic system is being explored. The analytical methodologies associated with these capillary separation techniques are being advanced through the development of retention programming instumentation/techniques and new strategies for performing optical detection. The advantages of laser fluorimetry are extended through the inclusion of fluorogenic, reagents in the running buffer. These reagents include oligonucleotide intercalation reagents for detecting DNA fragments. Chemiluminescence detection using post-capillary reactors/flow cells is also in progress. Successful development of these separation and detection systems will fill current voids in the capabilities of capillary separation techniques.

  9. Dissolved organic matter and lake metabolism. Technical progress report, 1 July 1977--30 June 1978

    Energy Technology Data Exchange (ETDEWEB)

    Wetzel, R.G.

    1978-01-01

    Interactions of dissolved organic matter with inorganic nutrient cycling and regulation of the photosynthetic and decompositional metabolism of micro- and macroflora remains the focal point of these studies. Major efforts are directed towards the sources, fates, pathways, and interactions of dissolved organic matter in inorganic chemical cycling; allochthonous sources, metabolism en route, and inputs to the lake systems of increasing stages of eutrophication; and the relationships of these compounds to the nutrient physiology and metabolism of phytoplankton, sessile algae, macrophytes, and bacterial populations of the littoral zones and wetlands of the drainage basin. Analyses of regulatory mechanisms of growth and rates of carbon cycling center on evaluation of quantitative control interactions among the microflora of the pelagial zones of seversal lakes of progressively greater eutrophy, littoral photosynthetic producer-decomposer complex, and allochthonous inorganic--organic influxes and their biotic processing. The underlying thesis is that quantification of the dynamic carbon fluxes among these components and their rate control mechanisms by physical and chemical factors are fundamental to elucidation of the rate functions of lake eutrophication.

  10. Dissolved organic matter and lake metabolism. Technical progress report, 1 July 1978--30 Jun 1979

    Energy Technology Data Exchange (ETDEWEB)

    Wenzel, R.G.

    1979-01-01

    Progress is reported in continuing investigations focused on integrated studies of the qualitative and quantitative cycling and metabolism of particulate and dissolved organic carbon in lakes and their inflow sources (surface and subsurface). Emphasis is placed on the sources, fates, and interactions of dissolved and particulate organic matter in relation to: (a) inorganic chemical cycling, (b) allochthonous loading to the lake system, and (c) the coupled nutrient physiology and metabolism of phytoplankton, bacterial populations, macrophytes, and attendant sessile algal-bacterial communities. Regulatory mechanisms of growth and rates of carbon and nutrient cycling are being evaluated among the (a) inorganic-organic influxes of allochthonous sources as they are controlled by wetland-littoral communities, (b) the littoral photosynthetic producer-decomposer complex, and (c) the microflora of the pelagial zone. Quantification of carbon fluxes among these components and control mechanisms is fundamental to elucidation of the rate functions of lake eutrophication. The integrated studies addressing these multifacted objectives are summarized in three summary diagrams.

  11. Supramolecular structures for photochemical energy conversion. Technical progress report, 1993--1996

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-06-01

    This research project is concerned with the design, synthesis and study by photochemical and spectroscopic methods of complex molecular devices that mimic some important aspects of photosynthetic electron and energy transfer. Properly engineered molecules of this type can functionally mimic photosynthetic light harvesting (singlet-singlet energy transfer between chromophores), photoprotection from light-initiated singlet oxygen damage (triplet-triplet energy transfer from chlorophylls to carotenoid polyenes), and, most importantly, photoinduced multistep electron transfer to generate charge-separated states that preserve some of the photon energy as chemical potential. During the last three years, progress has been made on several fronts, all of which are related to the overall goal. A biomimetic system based on carotenoid-porphyrin-quinone triads has been constructed that demonstrates photoinduced transmembrane charge separation which in turn drives transmembrane proton transfer. Another investigation has focused on the use of proton transfer reactions to stabilize the initial products of photoinduced electron transfer and thereby increase the yield of long-lived charge separation. A third study has investigated the influence of rigid molecular geometries and short donor-acceptor separations on photoinduced electron transfer reactions. Finally, generation and quenching of singlet molecular oxygen by chlorophyll aggregates has been studied. All four studies are described and results are discussed.

  12. Technical progress report during Phase 1 of the continuous fiber ceramic composites program

    Energy Technology Data Exchange (ETDEWEB)

    Richerson, D.W.

    1994-03-15

    United States industry has a critical need for materials that are lightweight, strong, tough, corrosion resistant and capable of performing at high temperatures; such materials will enable substantial increase in energy efficiency and reduction in emissions of pollutants. Continuous fiber ceramic composites (CFCCs) are an emerging class of materials which have the potential for the desired combination of properties to meet the industrial needs. A $10 billion annual market has been estimated for CFCC products by the year 2010, which equates to over 100,000 industrial sector jobs. The CFCC program began in the spring of 1992 as a three-phase 10-year effort to assess potential applications of CFCC materials, develop the necessary supporting technologies to design, analyze and test CFCC materials, conduct materials and process development guided by the applications assessment input, fabricate test samples and representative components to evaluate CFCC material capabilities under application conditions, and analyze scaleability and manufacturability plus demonstrate pilot-scale production engineering. DOE awarded 10 Phase I cooperative agreements to industry-lead teams plus identified generic supporting technology projects. This document highlights the broad progress and accomplishments on these contracts and support technology projects during Phase I.

  13. Great Basin paleoenvironmental studies project; Technical progress report, second quarter, September--November, 1993

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1993-12-31

    Progress is described in the four tasks associated with this project. Task 1, Paleobotanical studies in the Great Basin, has as its objective the reconstruction of the response of vegetation to climate in order to identify periods of mesic climate at Yucca Mountain during the last 20,000 to 50,000 years. Past extremes in infiltration rates are expected to serve as estimates of climate that may be expected during the next 10,000 years at Yucca Mtn. Task 2, Paleofaunas, will construct a history of Great Basin vertebrates that will provide empirical evidence of past environmental and climatic conditions. The objective of Task 3, Geomorphology, is to document the responses of surficial processes and landforms to the climatic changes documented by studies of packrat middens, pollen, and faunal distributions. The goal of Task 4, Transportation, is to compare the results from three models that have been suggested as appropriate for evaluating flood flows on alluvial fans with the results obtained from the traditional one-dimensional, stochastic model used in previous research for Yucca Mountain. This research looked at three alluvial fans with rail transportation alignments crossing them.

  14. Advanced thermally stable jet fuels: Technical progress report, July 1994--September 1994

    Energy Technology Data Exchange (ETDEWEB)

    Schobert, H.H.; Eser, S.; Song, C.; Hatcher, P.G.; Boehman, A.; Coleman, M.M.

    1994-07-01

    There are five tasks within this project on thermally stable coal-based jet fuels. Progress on each of the tasks is described. Task 1, Investigation of the quantitative degradation chemistry of fuels, has 3 subtasks which are described: Pyrolysis of n-alkylbenzenes; Thermal decomposition of n-tetradecane in near-critical region; and Re-examining the effects of reactant and inert gas pressure on tetradecane pyrolysis--Effect of cold volume in batch reactor. Under Task 2, Investigation of incipient deposition, the subtask reported is Uncertainty analysis on growth and deposition of particles during heating of coal-derived aviation gas turbine fuels; under Task 3, Investigation of the quantitative degradation chemistry of fuels, is subtask, Effects of high surface area activated carbon and decalin on thermal degradation of jet A-1 fuel and n-dodecane; under Task 4, Coal-based fuel stabilization studies, is subtask, Screening potential jet fuel stabilizers using the model compound dodecane; and under Task 5, Exploratory studies on the direct conversion of coal to high quality jet fuels, is subtask, Shape-selective naphthalene hydrogenation for production of thermally stable jet fuels. 25 refs., 64 figs., 22 tabs.

  15. Progress in digestive endoscopy: Flexible Spectral Imaging Colour Enhancement (FICE)-technical review.

    Science.gov (United States)

    Negreanu, L; Preda, C M; Ionescu, D; Ferechide, D

    2015-01-01

    Background. A substantial advance in digestive endoscopy that has been made during the last decade is represented by digital chromoendoscopy, which was developed as a quicker and sometimes better alternative to the gold standard of dye spraying. Fujifilm developed a virtual coloration technique called Flexible spectral Imaging Color Enhancement (FICE). FICE provides a better detection of lesions of "minimal" esophagitis, of dysplasia in Barrett's esophagus and of squamous cell esophageal cancer. The use of FICE resulted in an improvement in the visualization of the early gastric cancer, being less invasive, and time consuming than the classic dye methods. Current evidence does not support FICE for screening purposes in colon cancer but it definitely improves characterization of colonic lesions. Its use in inflammatory bowel disease is still controversial and in video capsule endoscopy is considered a substantial progress. Conclusions. The use of FICE endoscopy in routine clinical practice can increase the diagnostic yield and can provide a better characterization of lesions. Future studies to validate its use, the good choice of channels, and the "perfect indications" and to provide common definitions and classifications are necessary.

  16. MHD Coal-Fired Flow Facility. Quarterly technical progress report, January-March 1980

    Energy Technology Data Exchange (ETDEWEB)

    Altstatt, M. C.; Attig, R.C. Baucum, W.E.

    1980-05-30

    The University of Tennessee Space Institute (UTSI) reports on significant activity, task status, planned research, testing, development, and conclusions for the Magnetohydrodynamics (MHD) Coal-Fired Flow Facility (CFFF) and the Research and Development Laboratory. Although slowed by incessant rain during several days, work on the CFFF Bid Packages progressed to nearly 100 percent completion, excluding later punchlist items. On the quench system, the cyclone separator was delivered to UTSI, and under Downstream Components, the secondary combustor was received and the radiant slagging furnace was emplaced at the CFFF. Water quality analysis of Woods Reservoir provided the expected favorable results, quite similar to last year's. Generator experiments describing local current distribution are reported along with behavior under conditions of imposed leakage. Also, during the Quarter, the shelter for the cold flow modeling facility was constructed and circuits installation begun. A jet turbine combustor was tested for use as a vitiation burner. Samples taken from the exhaust duct, besides other applications, show that the refractories used are performing well in alleviating heat loss while exhibiting acceptable degredation. A new resistive power take-off network was designed and implemented.

  17. Solvent Refined Coal (SRC) process. Quarterly technical progress report, January 1979-March 1979

    Energy Technology Data Exchange (ETDEWEB)

    1980-02-01

    This report summarizes the progress of the Solvent Refined Coal (SRC) Project by the Pittsburg and Midway Coal Mining Co. for the Department of Energy for the period January 1, 1979 to March 31, 1979. Activities included the operation and modification of the Solvent Refined Coal Pilot Plant at Fort Lewis, Washington; the Process Development Unit P-99 at Harmarville, Pennsylvania; and research at Merriam Laboratory in Merriam, Kansas. The Pilot Plant processed Powhatan No. 5 Coal in the SRC-II mode of operation studying the effect of coal particle size and system temperature on coal slurry blending and the effect of carbon monoxide concentration in the reaction feed gas on process yields. January and February were spent completing installation of a fourth High Pressure Separator on Process Development Unit P-99 to better simulate operating conditions for the proposed Demonstration Plant. During March, one run was completed at P-99 feeding Pittsburgh Seam Coal from the Powhatan No. 5 Mine. Merriam investigations included a study of the effect of iron containing additives on SRC-I operation, the addition of carbon monoxide to the feed gas, utilization of a hydrogenated solvent (Cresap process solvent) in the SRC-I mode under both normal and short residence time operating conditions, and development of a simulated distillation technique to determine the entire boiling range distribution of product oils.

  18. Enthalpy and phase behavior of coal derived liquid mixtures. Technical progress report, October-December 1985

    Energy Technology Data Exchange (ETDEWEB)

    Yesavage, V.F.; Kidnay, A.J.

    1986-01-31

    On July 15, 1984, work was initiated on a program to study the enthalpy and phase behavior of coal derived liquid model compound mixtures. During the sixth quarter, preliminary enthalpy measurements for the 1/3:2/3, 1/2:1/2, 2/3:1/3 m-cresol tetralin binary mixtures have been completed and are included in a section at the end of this report. Vapor liquid equilibria measurements for the m-cresol/tetralin system are in progress for four isotherms. Tetralin vapor pressures are reported in this report from both the VLE apparatus and the calorimeter. In addition, ongoing research into the modeling of polar systems has led to an approach for modifying the Soave equation of state. This equation of state introduces a polar parameter which appears to be related to the expected strength of polar interactions for different compounds. The appendix contains the paper on this work titled ''Approach for extending Van de Waals equations of state for polar, hydrogen bonding fluids applied to the Soave equation of state''. This article has been processed separately for inclusion in the Energy Data Base.

  19. Methyl chloride via oxyhydrochlorination of methane. Quarterly technical progress report No. 16, July 1995--September 1995

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-03-01

    Continuous progress is being made toward the contract objectives in our attempt to produce {open_quotes}Methyl Chloride via Oxyhydrochlorination of Methane.{close_quotes} Specifically, gains have been achieved in Task 1.0 Catalyst Development and Separation Unit Operation Development and Task 4.0 PDU Startup. Catalyst development continued forward to examine the copper, lanthanum, and lithium loadings as well as support surface area in four factor, two level, fully crossed design experiments carried out at five temperatures between 290{degrees}C and 310{degrees}C. Eight of the sixteen runs have been completed. Evaluation of these runs as a three factor, two level, fully crossed experiment has yielded some useful information. The choice of the Cu/La/Li metals system has been confirmed, and the high Cu, low La, low Li system hasn`t proven itself to be the most active at this point. Chemical feeds were brought on-line to the PDU. Small amounts of methyl chloride were made before the system was shut down due to equipment failure. Glass-lined equipment was found to be failing due to chemical etching. Replacement equipment with other materials of construction have been ordered. In addition, the FTIR windows clouded soon after chemical feeds were started. This materials problem is also being investigated.

  20. Great Basin paleoenvironmental studies project; Technical progress report: Fourth quarter, March--May, 1994

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1994-07-01

    Examination of the paleoenvironmental and geomorphic records to determine the local and regional impact of past climates will advance the assessment of Yucca Mountain`s suitability as a high-level nuclear waste repository. Paleobotanical studies will reconstruct the response of vegetation to climate change at the community and the organismal levels in order to identify periods of mesic climate at Yucca Mountain and the adjacent region during the last 20,000 to 50,000 years. Constructing a history of Great Basin vertebrates, particularly mammals, will provide empirical evidence of past environmental and climatic conditions within the Great Basin. The objective of the geomorphology component of the program is to document the responses of surficial processes and landforms to the climatic changes documented by studies of packrat middens, pollens, and faunal distributions. The goal of the transportation component is to compare the results from three models (FESWMS-2DH, DAMBRK, and FLO-2D) that have been suggested as appropriate for evaluating flood flows on alluvial fans with the results obtained from the traditional one-dimensional, stochastic model used in previous research for the Yucca Mountain Project. Progress on all these tasks is described.

  1. The crossroads of breast cancer progression: insights into the modulation of major signaling pathways

    Directory of Open Access Journals (Sweden)

    Velloso FJ

    2017-11-01

    Full Text Available Fernando J Velloso,1,* Arthur FR Bianco,2,* Jessica O Farias,3 Nadia EC Torres,4 Pault YM Ferruzo,3 Valesca Anschau,5 Henrique C Jesus-Ferreira,1 Ted Hung-Tse Chang,6 Mari Cleide Sogayar,1 Luiz F Zerbini,6 Ricardo G Correa7 1Cell and Molecular Therapy Center (NUCEL-NETCEM, School of Medicine, 2Department of Pharmacology, Biomedical Sciences Institute, 3Department of Biochemistry, Institute of Chemistry, 4Departament of Immunology, Biomedical Sciences Institute, 5Department of Genetics and Evolutionary Biology, Institute of Biosciences, University of São Paulo, São Paulo, Brazil; 6Cancer Genomics Group, International Center for Genetic Engineering and Biotechnology (ICGEB, Cape Town, South Africa; 7Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA *These authors contributed equally to this work Abstract: Cancer is the disease with highest public health impact in developed countries. Particularly, breast cancer has the highest incidence in women worldwide and the fifth highest mortality in the globe, imposing a significant social and economic burden to society. The disease has a complex heterogeneous etiology, being associated with several risk factors that range from lifestyle to age and family history. Breast cancer is usually classified according to the site of tumor occurrence and gene expression profiling. Although mutations in a few key genes, such as BRCA1 and BRCA2, are associated with high breast cancer risk, the large majority of breast cancer cases are related to mutated genes of low penetrance, which are frequently altered in the whole population. Therefore, understanding the molecular basis of breast cancer, including the several deregulated genes and related pathways linked to this pathology, is essential to ensure advances in early tumor detection and prevention. In this review, we outline key cellular pathways whose deregulation has been associated with breast cancer, leading to alterations in cell

  2. Serum 5-LOX: a progressive protein marker for breast cancer and new approach for therapeutic target.

    Science.gov (United States)

    Kumar, Rahul; Singh, Abhay Kumar; Kumar, Manoj; Shekhar, Shashank; Rai, Nitish; Kaur, Punit; Parshad, Rajinder; Dey, Sharmistha

    2016-09-01

    Lipoxygenase (LOX) pathway has emerged to have a role in carcinogenesis. There is an evidence that both 12-LOX and 5-LOX have procarcinogenic role. We have previously reported the elevated level of serum 12-LOX in breast cancer patients. This study evaluated the serum level of 5-LOX in breast cancer patients and its in vitro inhibition assessment with peptide inhibitor YWCS. The level of 5-LOX was determined by surface plasmon resonance (SPR). The peptide inhibitor of 5-LOX was designed by molecular modeling and kinetic assay was performed by spectrophotometry. The siRNA mediated 5-LOX gene silencing was performed to investigate the effect on proliferation of MDA-MB-231, breast cancer cell line. The serum 5-LOX level in breast cancer (5.69±1.97ng/µl) was almost 2-fold elevated compared to control (3.53±1.0ng/µl) (P breast cancer and a promising therapeutic target for the same. © The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

  3. Progress in nonviral gene therapy for breast cancer and what comes next?

    Science.gov (United States)

    Bottai, Giulia; Truffi, Marta; Corsi, Fabio; Santarpia, Libero

    2017-05-01

    The possibility of correcting defective genes and modulating gene expression through gene therapy has emerged as a promising treatment strategy for breast cancer. Furthermore, the relevance of tumor immune microenvironment in supporting the oncogenic process has paved the way for novel immunomodulatory applications of gene therapy. Areas covered: In this review, the authors describe the most relevant delivery systems, focusing on nonviral vectors, along with the description of the major approaches used to modify target cells, including gene transfer, RNA interference (RNAi), and epigenetic regulation. Furthermore, they highlight innovative therapeutic strategies and the application of gene therapy in clinical trials for breast cancer. Expert opinion: Gene therapy has the potential to impact breast cancer research. Further efforts are required to increase the clinical application of RNAi-based therapeutics, especially in combination with conventional treatments. Innovative strategies, including genome editing and stem cell-based systems, may contribute to translate gene therapy into clinical practice. Immune-based approaches have emerged as an attractive therapeutic opportunity for selected breast cancer patients. However, several challenges need to be addressed before considering gene therapy as an actual option for the treatment of breast cancer.

  4. Technical success, technique efficacy and complications of minimally-invasive imaging-guided percutaneous ablation procedures of breast cancer: A systematic review and meta-analysis.

    Science.gov (United States)

    Mauri, Giovanni; Sconfienza, Luca Maria; Pescatori, Lorenzo Carlo; Fedeli, Maria Paola; Alì, Marco; Di Leo, Giovanni; Sardanelli, Francesco

    2017-08-01

    To systematically review studies concerning imaging-guided minimally-invasive breast cancer treatments. An online database search was performed for English-language articles evaluating percutaneous breast cancer ablation. Pooled data and 95% confidence intervals (CIs) were calculated. Technical success, technique efficacy, minor and major complications were analysed, including ablation technique subgroup analysis and effect of tumour size on outcome. Forty-five studies were analysed, including 1,156 patients and 1,168 lesions. Radiofrequency (n=577; 50%), microwaves (n=78; 7%), laser (n=227; 19%), cryoablation (n=156; 13%) and high-intensity focused ultrasound (HIFU, n=129; 11%) were used. Pooled technical success was 96% (95%CI 94-97%) [laser=98% (95-99%); HIFU=96% (90-98%); radiofrequency=96% (93-97%); cryoablation=95% (90-98%); microwave=93% (81-98%)]. Pooled technique efficacy was 75% (67-81%) [radiofrequency=82% (74-88); cryoablation=75% (51-90); laser=59% (35-79); HIFU=49% (26-74)]. Major complications pooled rate was 6% (4-8). Minor complications pooled rate was 8% (5-13%). Differences between techniques were not significant for technical success (p=0.449), major complications (p=0.181) or minor complications (p=0.762), but significant for technique efficacy (p=0.009). Tumour size did not impact on variables (p>0.142). Imaging-guided percutaneous ablation techniques of breast cancer have a high rate of technical success, while technique efficacy remains suboptimal. Complication rates are relatively low. • Imaging-guided ablation techniques for breast cancer are 96% technically successful. • Overall technique efficacy rate is 75% but largely inhomogeneous among studies. • Overall major and minor complication rates are low (6-8%).

  5. Solvent refined coal (SRC) process. Quarterly technical progress report, January 1980-March 1980. [In process streams

    Energy Technology Data Exchange (ETDEWEB)

    1981-01-01

    This report summarizes the progress of the Solvent Refined Coal (SRC) project at the SRC Pilot Plant in Fort Lewis, Wahsington, and the Process Development Unit (P-99) in Harmarville, Pennsylvania. After the remaining runs of the slurry preheater survey test program were completed January 14, the Fort Lewis Pilot Plant was shut down to inspect Slurry Preheater B and to insulate the coil for future testing at higher rates of heat flux. Radiographic inspection of the coil showed that the welds at the pressure taps and the immersion thermowells did not meet design specifications. Slurry Preheater A was used during the first 12 days of February while weld repairs and modifications to Slurry Preheater B were completed. Two attempts to complete a material balance run on Powhatan No. 6 Mine coal were attempted but neither was successful. Slurry Preheater B was in service the remainder of the quarter. The start of a series of runs at higher heat flux was delayed because of plugging in both the slurry and the hydrogen flow metering systems. Three baseline runs and three slurry runs of the high heat flux program were completed before the plant was shut down March 12 for repair of the Inert Gas Unit. Attempts to complete a fourth slurry run at high heat flux were unsuccessful because of problems with the coal feed handling and the vortex mix systems. Process Development Unit (P-99) completed three of the four runs designed to study the effect of dissolver L/D ratio. The fourth was under way at the end of the period. SRC yield correlations have been developed that include coal properties as independent variables. A preliminary ranking of coals according to their reactivity in PDU P-99 has been made. Techniques for studying coking phenomenona are now in place.

  6. Technical Progress Report on Single Pass Flow Through Tests of Ceramic Waste Forms for Plutonium Immobilization

    Energy Technology Data Exchange (ETDEWEB)

    Zhao, P; Roberts, S; Bourcier, W

    2000-12-01

    This report updates work on measurements of the dissolution rates of single-phase and multi-phase ceramic waste forms in flow-through reactors at Lawrence Livermore National Laboratory. Previous results were reported in Bourcier (1999). Two types of tests are in progress: (1) tests of baseline pyrochlore-based multiphase ceramics; and (2) tests of single-phase pyrochlore, zirconolite, and brannerite (the three phases that will contain most of the actinides). Tests of the multi-phase material are all being run at 25 C. The single-phase tests are being run at 25, 50, and 75 C. All tests are being performed at ambient pressure. The as-made bulk compositions of the ceramics are given in Table 1. The single pass flow-through test procedure [Knauss, 1986 No.140] allows the powdered ceramic to react with pH buffer solutions traveling upward vertically through the powder. Gentle rocking during the course of the experiment keeps the powder suspended and avoids clumping, and allows the system to behave as a continuously stirred reactor. For each test, a cell is loaded with approximately one gram of the appropriate size fraction of powdered ceramic and reacted with a buffer solution of the desired pH. The buffer solution compositions are given in Table 2. All the ceramics tested were cold pressed and sintered at 1350 C in air, except brannerite, which was sintered at 1350 C in a CO/CO{sub 2} gas mixture. They were then crushed, sieved, rinsed repeatedly in alcohol and distilled water, and the desired particle size fraction collected for the single pass flow-through tests (SPFT). The surface area of the ceramics measured by BET ranged from 0.1-0.35 m{sup 2}/g. The measured surface area values, average particle size, and sample weights for each ceramic test are given in the Appendices.

  7. Improved methods for water shutoff. Final technical progress report, October 1, 1997--September 30, 1998

    Energy Technology Data Exchange (ETDEWEB)

    Seright, R.S.; Liang, J.T.; Schrader, R.; Hagstrom, J. II; Liu, J.; Wavrik, K.

    1998-10-01

    In the United States, more than 20 billion barrels of salt water are produced each year during oilfield operations. A tremendous economic incentive exists to reduce water production if that can be accomplished without significantly sacrificing hydrocarbon production. This three-year research project had three objectives. The first objective was to identify chemical blocking agents that will (a) during placement, flow readily through fractures without penetrating significantly into porous rock and with screening out or developing excessive pressure gradients and (b) at a predictable and controllable time, become immobile and resistant breakdown upon exposure to moderate to high pressure gradients. The second objective was to identify schemes that optimize placement of the above blocking agents. The third objective was to explain why gels and other chemical blocking agents reduce permeability to one phase (e.g., water) more than that to another phase (e.g., oil or gas). The authors also wanted to identify conditions that maximize this phenomenon. This project consisted of three tasks, each of which addressed one of the above objectives. This report describes work performed during the third and final period of the project. During this three-year project, they: (1) Developed a procedure and software for sizing gelant treatments in hydraulically fractured production wells; (2) Developed a method (based on interwell tracer results) to determine the potential for applying gel treatments in naturally fractured reservoirs; (3) Characterized gel properties during extrusion through fractures; (4) Developed a method to predict gel placement in naturally fractured reservoirs; (5) Made progress in elucidating the mechanism for why some gels can reduce permeability to water more than that to oil; (6) Demonstrated the limitations of using water/oil ratio diagnostic plots to distinguish between channeling and coning; and (7) Proposed a philosophy for diagnosing and attacking water

  8. Nuclear Physics Laboratory, University of Colorado technical progress report, 1976 and proposal for continuation of contract

    Energy Technology Data Exchange (ETDEWEB)

    1976-11-01

    This report summarizes the work carried out at the Nuclear Physics Laboratory of the University of Colorado during the period November 1, 1975 to November 1, 1976. The low energy nuclear physics section is dominated by light-ion reaction studies which span a wide range. These include both two-neutron and two-proton transfer reactions, charge exchange and inelastic scattering, as well as single nucleon transfer reactions. The nuclei studied vary widely in their mass and characteristics. These reaction studies have been aided by the multi-use scattering chamber which now allows the energy-loss-spectrometer beam preparation system (beam swinger) to shift from charged particle studies to neutron time-of-flight studies with a minimum loss of time. The intermediate energy section reflects the increase in activity accompanying the arrival of LAMPF data and the initiation of (p,d) studies at the Indiana separated-sector cyclotron. The nucleon removal results provided by the ..pi.. beam at EPICS previous to completion of the spectrometer have shown that nuclear effects dominate this process, so that the widely used free interaction picture is inadequate. The section entitled ''Other Activities'' reveals continuing activities in new applications of nuclear techniques to problems in medicine and biology. Reactions important to astrophysics continue to be investigated and our trace-element program remains at a high level of activity. The theoretical section reports new progress in understanding magnitudes of two-step reactions by inclusion of finite-range effects. A new finite-range program which is fast and economical has been completed. Intermediate energy results include calculations of ..pi..-..gamma.. angular correlations, low energy ..pi..-nucleus interactions, as well as (p,d) and nucleon scattering calculations for intermediate energies.

  9. Advanced thermally stable jet fuels: Technical progress report, October 1994--December 1994

    Energy Technology Data Exchange (ETDEWEB)

    Schobert, H.H.; Eser, S.; Song, C.; Hatcher, P.G.; Boehman, A.; Coleman, M.M.

    1995-02-01

    There are five tasks within this project on thermally stable coal-based jet fuels. Progress on each of the tasks is described. Task 1, Investigation of the quantitative degradation chemistry of fuels, has 5 subtasks which are described: Literature review on thermal stability of jet fuels; Pyrolytic and catalytic reactions of potential endothermic fuels: cis- and trans-decalin; Use of site specific {sup 13}C-labeling to examine the thermal stressing of 1-phenylhexane: A case study for the determination of reaction kinetics in complex fuel mixtures versus model compound studies; Estimation of critical temperatures of jet fuels; and Surface effects on deposit formation in a flow reactor system. Under Task 2, Investigation of incipient deposition, the subtask reported is Uncertainty analysis on growth and deposition of particles during heating of coal-derived aviation gas turbine fuels; under Task 3, Characterization of solid gums, sediments, and carbonaceous deposits, is subtask, Studies of surface chemistry of PX-21 activated carbon during thermal degradation of jet A-1 fuel and n-dodecane; under Task 4, Coal-based fuel stabilization studies, is subtask, Exploratory screening and development potential of jet fuel thermal stabilizers over 400 C; and under Task 5, Exploratory studies on the direct conversion of coal to high quality jet fuels, are 4 subtasks: Novel approaches to low-severity coal liquefaction and coal/resid co-processing using water and dispersed catalysts; Shape-selective naphthalene hydrogenation for production of thermally stable jet fuels; Design of a batch mode and a continuous mode three-phase reactor system for the liquefaction of coal and upgrading of coal liquids; and Exploratory studies on coal liquids upgrading using mesopores molecular sieve catalysts. 136 refs., 69 figs., 24 tabs.

  10. Advanced thermally stable jet fuels. Technical progress report, April 1994--June 1994

    Energy Technology Data Exchange (ETDEWEB)

    Schobert, H.H.; Eser, S.; Song, C. [and others

    1994-07-01

    Research continued on coal-based, thermally stable, jet fuels. Significant progress has been made on the detection of polycyclic aromatic hydrocarbons present in highly stressed fuels, using high-performance liquid chromatography (HPLC) with diode-array detection. Gas chromatography is not able to detect compounds with {>=}6 fused aromatic rings, but such compounds can be identified using the HPLC method. The concentration of such compounds is low in comparison to aromatics of 1-3 rings, but the role of the large compounds in the formation of solid deposits may be crucial in determining the thermal stability of a fuel. The unusual properties of fluid fuels in the near-critical region appear to have significant effects on their thermal decomposition reactions. This issue has been investigated in the present reporting period using n-tetradecane as a model compound for fuel decomposition. Temperature-programmed retention indices are very useful for gas chromatographic and gas chromatography/mass spectrometric analysis of coal and petroleum derived jet fuels. We have demonstrated this in the identification of components in two JP-8 fuels and their liquid chromatographic fractions. The role of activated carbon surfaces as catalysts in the thermal stressing of jet fuel was investigated using n-dodecane and n-octane as model compounds. In some cases the reactions were spiked with addition of 5% decalin to test the ability of the carbon to catalyze the transformation of decalin to naphthalene. We have previously shown that benzyl alcohol and 1,4-benzenedimethanol are effective stabilizers at temperatures {>=}400{degrees}C for jet fuels and the model compound dodecane. The addition of ethanol to hydrocarbon/benzyl alcohol mixtures has a significant effect on the thermal stabilization of jet fuels above 400{degrees}C. Ethanol appears to function by reducing the benzaldehyde formed during the degradation of the benzyl alcohol. This reduction regenerates the benzyl alcohol.

  11. Directional backlight liquid crystal autostereoscopic display: technical challenges, research progress, and prospect (Conference Presentation)

    Science.gov (United States)

    Fan, Hang; Li, Kunyang; Zhou, Yangui; Liang, Haowen; Wang, Jiahui; Zhou, Jianying

    2016-09-01

    Recent upsurge on virtual and augmented realities (VR and AR) has re-ignited the interest to the immerse display technology. The VR/AR technology based on stereoscopic display is believed in its early stage as glasses-free, or autostereoscopic display, will be ultimately adopted for the viewing convenience, visual comfort and for the multi-viewer purposes. On the other hand, autostereoscopic display has not yet received positive market response for the past years neither with stereoscopic displays using shutter or polarized glasses. We shall present the analysis on the real-world applications, rigid user demand, the drawbacks to the existing barrier- and lenticular lens-based LCD autostereoscopy. We shall emphasize the emerging autostereoscopic display, and notably on directional backlight LCD technology using a hybrid spatial- and temporal-control scenario. We report the numerical simulation of a display system using Monte-Carlo ray-tracing method with the human retina as the real image receiver. The system performance is optimized using newly developed figure of merit for system design. The reduced crosstalk in an autostereoscopic system, the enhanced display quality, including the high resolution received by the retina, the display homogeneity without Moiré- and defect-pattern, will be highlighted. Recent research progress including a novel scheme for diffraction-free backlight illumination, the expanded viewing zone for autostereoscopic display, and the novel Fresnel lens array to achieve a near perfect display in 2D/3D mode will be introduced. The experimental demonstration will be presented to the autostereoscopic display with the highest resolution, low crosstalk, Moiré- and defect- pattern free.

  12. Enthalpy measurement of coal-derived liquids. Technical progress report, February 1983-April 1983

    Energy Technology Data Exchange (ETDEWEB)

    Kidnay, A.J.; Yesavage, V.F.

    1983-05-31

    This quarter's work has concentrated on two primary areas. The first was the completion of experimental measurements of the associated factor. The second area was a look at current equation of state application. The work has progressed smoothly so far and should in future emphasize the computational work. The significant systems looked at this quarter were the C/sub 2/-C/sub 6/ alcohols, cresol, quinoline, and cresol-quinoline mixtures. The alcohols and cresols are important because the hydroxyl hydrogen bonding which is believed to be the primary association mechanism in coal liquids. Quinoline is significant because it is an excellent model for nitrogen containing constituents of coal liquids. The cresol-quinoline system, which was measured for range of system compositions, was studied because enthalpy data for a similar range of compositions was available. The results for most of these systems were reasonable and make important additions to previous data. The results for the quinoline-cresol mixture systems were curious and very different from anything previous to these measurements. The causes of these results are currently not well understood. Clearly they are due to complex interaction phenomena occurring in these systems. Since this behavior is not generally seen in complex mixtures, it is felt that the behavior is due to the fact that the cresol-quinoline system is a simple binary system which allows complex composition dependent solute-solute-solvent interactions to occur. This effect would also probably occur in ternary, quartenary, and maybe even higher systems. This behavior would tend to washout in coal liquids which have hundreds of components. As a result, it is felt that pure component systems are more valid models for coal liquid associations and that binary, etc., systems are too great a complexity to be currently understood.

  13. Lattice-based model of ductal carcinoma in situ suggests rules for breast cancer progression to an invasive state.

    Directory of Open Access Journals (Sweden)

    Eline Boghaert

    2014-12-01

    Full Text Available Ductal carcinoma in situ (DCIS is a heterogeneous group of non-invasive lesions of the breast that result from abnormal proliferation of mammary epithelial cells. Pathologists characterize DCIS by four tissue morphologies (micropapillary, cribriform, solid, and comedo, but the underlying mechanisms that distinguish the development and progression of these morphologies are not well understood. Here we explored the conditions leading to the emergence of the different morphologies of DCIS using a two-dimensional multi-cell lattice-based model that incorporates cell proliferation, apoptosis, necrosis, adhesion, and contractility. We found that the relative rates of cell proliferation and apoptosis governed which of the four morphologies emerged. High proliferation and low apoptosis favored the emergence of solid and comedo morphologies. In contrast, low proliferation and high apoptosis led to the micropapillary morphology, whereas high proliferation and high apoptosis led to the cribriform morphology. The natural progression between morphologies cannot be investigated in vivo since lesions are usually surgically removed upon detection; however, our model suggests probable transitions between these morphologies during breast cancer progression. Importantly, cribriform and comedo appear to be the ultimate morphologies of DCIS. Motivated by previous experimental studies demonstrating that tumor cells behave differently depending on where they are located within the mammary duct in vivo or in engineered tissues, we examined the effects of tissue geometry on the progression of DCIS. In agreement with our previous experimental work, we found that cells are more likely to invade from the end of ducts and that this preferential invasion is regulated by cell adhesion and contractility. This model provides additional insight into tumor cell behavior and allows the exploration of phenotypic transitions not easily monitored in vivo.

  14. Final Technical Progress Report Long term risk from actinides in the environment: Modes of mobility

    Energy Technology Data Exchange (ETDEWEB)

    Thomas B. Kirchner

    2002-03-22

    The key source of uncertainty in assessing actinide mobility is the relative importance of transport by: (1) wind erosion, (2) water erosion, and (3) vertical migration. Each of these three processes depends on several environmental factors and they compete with one another. A scientific assessment of the long-term risks associated with actinides in surface soils depends on better quantifying each of these three modes of mobility. The objective from our EMSP study was to quantify the mobility of soil actinides by wind erosion, water erosion, and vertical migration at three semiarid sites where actinide mobility is a key technical, social and legal issue. This EMSP project was the first to evaluate all three factors at a site. The approach has been to investigate both short- and long-term issues based on field and lab studies and model comparisons. Our results demonstrate the importance of incorporating threshold responses into a modeling framework that accounts for environmental factors and natural disturbances that trigger large changes in actinide mobility. The study measured erosional losses of sediment and fallout cesium (an actinide analogue) from field plots located near WIPP in 1998. The results highlight the large effect of burning as a disturbance on contaminant transport and mobility via runoff and erosion. The results show that runoff, erosion, and actinide transport are (1) strongly site specific-differences in radionuclide transport between WIPP and Rocky Flats differed by a factor of twelve because of soil and vegetation differences, and (2) are strongly impacted by disturbances such as fire, which can increase runoff, erosion, and actinide transport by more than an order of magnitude. In addition, a laboratory experiment using soil columns was conducted to investigate the vertical transport of contaminants in sandy soils. Nine columns of soil collected from the vicinity of the WIPP site were prepared. The column consisted of a piece of PVC pipe 20 cm

  15. Savannah River Ecology Laboratory Annual Technical Progress Report of Ecological Research, June 30, 2001

    Energy Technology Data Exchange (ETDEWEB)

    Bertsch, Paul M.; Janecek, Laura; Rosier, Brenda

    2001-06-30

    The Savannah River Ecology Laboratory (SREL) is a research unit of the University of Georgia (UGA) and has been conducting ecological research on the Savannah River Site (SRS) in South Carolina for 50 years. The overall mission of the Laboratory is to acquire and communicate knowledge of ecological processes and principles. SREL conducts fundamental and applied ecological research, as well as education and outreach programs, under a Cooperative Agreement with the U.S. Department of Energy (DOE) SRS near Aiken, South Carolina. The Laboratory's research mission during the 2001 fiscal year was fulfilled with the publication of one book and 83 journal articles and book chapters by faculty, technical staff, students, and visiting scientists. An additional 77 journal articles have been submitted or are in press. Other noteworthy events took place as faculty members and graduate students received awards. These are described in the section Special Accomplishments of Faculty, Staff, Students, and Administration on page 54. Notable scientific accomplishments include work conducted on contaminant transport, global reptile decline, phytoremediation, and radioecology. Dr. Domy Adriano authored the second edition of his book ''Trace Elements in Terrestrial Environments: Biogeochemistry, Bioavailability, and Risks of Metals'', which was recently published by Springer-Verlag. The book provides a comprehensive treatment of many important aspects of trace elements in the environment. The first edition of the book, published in 1986, has become a widely acclaimed and cited reference. International attention was focused on the problem of reptile species decline with the publication of an article on this topic in the journal ''Bioscience'' in August, 2000. The article's authors included Dr. Whit Gibbons and a number of other SREL herpetologists who researched the growing worldwide problem of decline of reptile species. Factors related

  16. High MicroRNA-370 Expression Correlates with Tumor Progression and Poor Prognosis in Breast Cancer

    OpenAIRE

    Sim, Jongmin; Ahn, Hyein; Abdul, Rehman; Kim, Hyunsung; Yi, Ki-jong; Chung, Yu-Min; Chung, Min Sung; Paik, Seung Sam; Song, Young Soo; Jang, Kiseok

    2015-01-01

    Purpose Deregulation of microRNA-370 (miR-370) has been reported in various cancers, in which it can act as either an oncogene or a tumor suppressor gene. However, the clinicopathologic significance of miR-370 expression in breast cancer has not been studied. Methods The expression of miR-370 was determined with quantitative real-time polymerase chain reaction in 60 formalin-fixed, paraffin-embedded primary breast cancer tissues. Additionally, the protein expression levels of previously known...

  17. Old Drug Scaffold, New Activity: Thalidomide-Correlated Compounds Exert Different Effects on Breast Cancer Cell Growth and Progression.

    Science.gov (United States)

    Iacopetta, Domenico; Carocci, Alessia; Sinicropi, Maria Stefania; Catalano, Alessia; Lentini, Giovanni; Ceramella, Jessica; Curcio, Rosita; Caroleo, Maria Cristina

    2017-03-07

    Thalidomide was first used for relief of morning sickness in pregnant women and then withdrawn from the market because of its dramatic effects on normal fetal development. Over the last decades, it has been used successfully for the treatment of several pathologies, including cancer. Many analogues with improved activity have been synthesized and tested. Herein we report some effects on the growth and progression of MCF-7 and MDA-MB-231 breast cancer cells by a small series of thalidomide-correlated compounds, which are very effective at inducing cancer cell death by triggering TNFα-mediated apoptosis. The most active compounds are able to drastically reduce the migration of breast cancer cells by regulation of the two major proteins involved in epithelial-mesenchymal transition (EMT): vimentin and E-cadherin. Moreover, these compounds diminish the intracellular biosynthesis of vascular endothelial growth factor (VEGF), which is primarily involved in the promotion of angiogenesis, sustaining tumor progression. The multiple features of these compounds that act on various key points of the tumorigenesis process make them good candidates for preclinical studies. © 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

  18. The estrogen receptor negative-progesterone receptor positive breast carcinoma is a biological entity and not a technical artifact.

    Science.gov (United States)

    Ng, Char Hong; Pathy, Nirmala Bhoo; Taib, Nur Aishah; Mun, Kein Seong; Rhodes, Anthony; Yip, Cheng Har

    2012-01-01

    The ER-/PR+ breast tumor may be the result of a false ER negative result. The aim of this study was to investigate whether there is a difference in patient and tumor characteristics of the ER-/PR+ phenotype in an Asian setting. A total of 2629 breast cancer patients were categorized on the basis of their age, ethnicity, tumor hormonal receptor phenotype, grade and histological type. There were 1230 (46.8%) ER+/PR+, 306 (11.6%) ER+/PR-, 122 (4.6%) ER-/PR+ and 972 (37%) ER-/PR-. ER-/PR+ tumors were 2.5 times more likely to be younger than 50 years at diagnosis (OR: 2.52; 95% CI: 1.72-3.67). Compared to ER+/PR+ tumors, the ER-/ PR+ phenotype was twice more likely to be associated with grade 3 tumors (OR:2.02; 95%CI: 1.00-4.10). In contrast, compared to ER-/PR- tumors, the ER-/PR+ phenotype was 90% less likely to be associated with a grade 3 tumor (OR: 0.12; 95%CI:0.05-0.26), and more likely to have invasive lobular than invasive ductal histology (OR: 3.66; 95%CI: 1.47-9.11). These results show that the ER-/PR+ phenotype occurs in a younger age group and is associated with intermediate histopathological characteristics compared to ER+/PR+ and ER-/PR- tumors. This may imply that it is a distinct entity and not a technical artifact.

  19. I-NERI QUARTERLY TECHNICAL PROGRESS REPORT - JANUARY 1 - MARCH 31, 2005

    Energy Technology Data Exchange (ETDEWEB)

    Chang Oh

    2005-03-01

    codes. The three categories of experiments were performed in the facility; (1) upper pool cooling trip test, (2) LOFC experiment, (3) emissivity measurement experiment. (C) Prof. NO continued Task 3. (Prof NO) The experimental work of air ingress is going on without any concern: Geometry and size effect test has been completed. The conversion factor for internal surface area was obtained through this experiment. Burn-off test was performed and the uniformity of internal reaction was confirmed. (D) INEEL engineers continued to extend the diffusion model for multiple chemical species and made some calculations. (E) Prof. Lee and Martin at University of Michigan continued to analyze the effect of the stochastic fuel on the neutronic analysis and have initiated fuel depletion calculations for the VHTGR core. Progress during the past quarter includes: Further analysis of stochastic fuel geometry; Preliminary Monte Carlo depletion of full-core VHTGR; and Installation of MCNP5 on Unix cluster.

  20. PAR Genes: Molecular Probes to Pathological Assessment in Breast Cancer Progression

    Directory of Open Access Journals (Sweden)

    Beatrice Uziely

    2011-01-01

    Full Text Available Taking the issue of tumor categorization a step forward and establish molecular imprints to accompany histopathological assessment is a challenging task. This is important since often patients with similar clinical and pathological tumors may respond differently to a given treatment. Protease-activated receptor-1 (PAR1, a G protein-coupled receptor (GPCR, is the first member of the mammalian PAR family consisting of four genes. PAR1 and PAR2 play a central role in breast cancer. The release of N-terminal peptides during activation and the exposure of a cryptic internal ligand in PARs, endow these receptors with the opportunity to serve as a “mirror-image” index reflecting the level of cell surface PAR1&2-in body fluids. It is possible to use the levels of PAR-released peptide in patients and accordingly determine the choice of treatment. We have both identified PAR1 C-tail as a scaffold site for the immobilization of signaling partners, and the critical minimal binding site. This binding region may be used for future therapeutic modalities in breast cancer, since abrogation of the binding inhibits PAR1 induced breast cancer. Altogether, both PAR1 and PAR2 may serve as molecular probes for breast cancer diagnosis and valuable targets for therapy.

  1. Progressive APOBEC3B mRNA expression in distant breast cancer metastases

    NARCIS (Netherlands)

    Sieuwerts, Anieta M; Schrijver, Willemijne A M E; Dalm, Simone U; de Weerd, Vanja; Moelans, CB; ter Hoeve, Natalie; van Diest, Paul J; Martens, John W M; van Deurzen, Carolien H M

    2017-01-01

    BACKGROUND: APOBEC3B was recently identified as a gain-of-function enzymatic source of mutagenesis, which may offer novel therapeutic options with molecules that specifically target this enzyme. In primary breast cancer, APOBEC3B mRNA is deregulated in a substantial proportion of cases and its

  2. Progressive APOBEC3B mRNA expression in distant breast cancer metastases

    NARCIS (Netherlands)

    A.M. Sieuwerts (Anieta); W.A.M.E. Schrijver (Willemijne); S.U. Dalm (Simone); V. de Weerd (Vanja); C.B. Moelans (Cathy); N. Ter Hoeve (Natalie); P.J. van Diest (Paul); J.W.M. Martens (John); C.H.M. van Deurzen (Carolien)

    2017-01-01

    markdownabstract__Background:__ APOBEC3B was recently identified as a gain-of-function enzymatic source of mutagenesis, which may offer novel therapeutic options with molecules that specifically target this enzyme. In primary breast cancer, APOBEC3B mRNA is deregulated in a substantial proportion of

  3. Evaluation of Genomic Instability as an Early Event in the Progression of Breast Cancer

    Science.gov (United States)

    2008-04-01

    University of New Mexico Health Sciences Center 915 Camino de Salud , NE Albuquerque, New Mexico 87131-5221 9...Pathol 1999;189:496–503. 39. Kurose K, Hoshaw-Woodard S, Adeyinka A, Lemeshow S, Watson PH , Eng C. Genetic model of multi-step breast carcinogenesis

  4. Translational control of TWIST1 expression in MCF-10A cell lines recapitulating breast cancer progression

    DEFF Research Database (Denmark)

    Nairismägi, Maarja-Liisa; Vislovukh, Andrii; Meng, Q

    2012-01-01

    TWIST1 is a highly conserved basic helix-loop-helix transcription factor that promotes epithelial–mesenchymal transition (EMT). Its misregulation has been observed in various types of tumors. Using the MCF-10A-series of cell lines that recapitulate the early stages of breast cancer formation...

  5. Unraveling the microenvironmental influences on the normal mammary gland and induction and progression of breast cancer

    Energy Technology Data Exchange (ETDEWEB)

    Weigelt, Britta; Bissell, Mina J.

    2008-06-26

    The normal mammary gland and invasive breast cancer are both complex 'organs' composed of multiple cell types as well as extracellular matrix (ECM) in three-dimensional (3D) space. Conventionally, both normal and malignant breast cells are studied in vitro as two-dimensional (2D) monolayers of epithelial cells, which results in the loss of structure and tissue function. Many laboratories are now investigating regulation of signaling function in normal mammary gland using 3D cultures. However, it is important also to assay malignant breast cells ex vivo in a physiologically relevant environment to more closely mimic tumor architecture, signal transduction regulation and tumor behavior in vivo. Here we present the potential of these 3D models for drug testing, target validation and guidance of patient selection for clinical trials. We argue also that in order to get full insight into the biology of the normal and malignant breast, and to create in vivo-like models for therapeutic approaches in humans, we need to continue to create more complex heterotypic models to approach the full context the cells encounter in the human body.

  6. Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.

    Science.gov (United States)

    Caffarel, María M; Andradas, Clara; Mira, Emilia; Pérez-Gómez, Eduardo; Cerutti, Camilla; Moreno-Bueno, Gema; Flores, Juana M; García-Real, Isabel; Palacios, José; Mañes, Santos; Guzmán, Manuel; Sánchez, Cristina

    2010-07-22

    ErbB2-positive breast cancer is characterized by highly aggressive phenotypes and reduced responsiveness to standard therapies. Although specific ErbB2-targeted therapies have been designed, only a small percentage of patients respond to these treatments and most of them eventually relapse. The existence of this population of particularly aggressive and non-responding or relapsing patients urges the search for novel therapies. The purpose of this study was to determine whether cannabinoids might constitute a new therapeutic tool for the treatment of ErbB2-positive breast tumors. We analyzed their antitumor potential in a well established and clinically relevant model of ErbB2-driven metastatic breast cancer: the MMTV-neu mouse. We also analyzed the expression of cannabinoid targets in a series of 87 human breast tumors. Our results show that both Delta9-tetrahydrocannabinol, the most abundant and potent cannabinoid in marijuana, and JWH-133, a non-psychotropic CB2 receptor-selective agonist, reduce tumor growth, tumor number, and the amount/severity of lung metastases in MMTV-neu mice. Histological analyses of the tumors revealed that cannabinoids inhibit cancer cell proliferation, induce cancer cell apoptosis, and impair tumor angiogenesis. Cannabinoid antitumoral action relies, at least partially, on the inhibition of the pro-tumorigenic Akt pathway. We also found that 91% of ErbB2-positive tumors express the non-psychotropic cannabinoid receptor CB2. Taken together, these results provide a strong preclinical evidence for the use of cannabinoid-based therapies for the management of ErbB2-positive breast cancer.

  7. Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

    Directory of Open Access Journals (Sweden)

    Flores Juana M

    2010-07-01

    Full Text Available Abstract Background ErbB2-positive breast cancer is characterized by highly aggressive phenotypes and reduced responsiveness to standard therapies. Although specific ErbB2-targeted therapies have been designed, only a small percentage of patients respond to these treatments and most of them eventually relapse. The existence of this population of particularly aggressive and non-responding or relapsing patients urges the search for novel therapies. The purpose of this study was to determine whether cannabinoids might constitute a new therapeutic tool for the treatment of ErbB2-positive breast tumors. We analyzed their antitumor potential in a well established and clinically relevant model of ErbB2-driven metastatic breast cancer: the MMTV-neu mouse. We also analyzed the expression of cannabinoid targets in a series of 87 human breast tumors. Results Our results show that both Δ9-tetrahydrocannabinol, the most abundant and potent cannabinoid in marijuana, and JWH-133, a non-psychotropic CB2 receptor-selective agonist, reduce tumor growth, tumor number, and the amount/severity of lung metastases in MMTV-neu mice. Histological analyses of the tumors revealed that cannabinoids inhibit cancer cell proliferation, induce cancer cell apoptosis, and impair tumor angiogenesis. Cannabinoid antitumoral action relies, at least partially, on the inhibition of the pro-tumorigenic Akt pathway. We also found that 91% of ErbB2-positive tumors express the non-psychotropic cannabinoid receptor CB2. Conclusions Taken together, these results provide a strong preclinical evidence for the use of cannabinoid-based therapies for the management of ErbB2-positive breast cancer.

  8. The Development of Early Literacy Measures for Use in a Progress Monitoring Assessment System: Letter Names, Letter Sounds and Phoneme Segmenting. Technical Report # 39

    Science.gov (United States)

    Alonzo, Julie; Tindal, Gerald

    2007-01-01

    In this technical report, the authors describe the development alternate forms of three types of early literacy measures as part of a comprehensive progress monitoring literacy assessment system developed in 2006 for use with students in Kindergarten through fourth grade. They begin with a brief overview of the two conceptual frameworks underlying…

  9. Retrospective study of the effect of disease progression on patient reported outcomes in HER-2 negative metastatic breast cancer patients

    Directory of Open Access Journals (Sweden)

    Yu Elaine

    2011-06-01

    Full Text Available Abstract Background This retrospective study evaluated the impact of disease progression and of specific sites of metastasis on patient reported outcomes (PROs that assess symptom burden and health related quality of life (HRQoL in women with metastatic breast cancer (mBC. Methods HER-2 negative mBC patients (n = 102 were enrolled from 7 U.S. community oncology practices. Demographic, disease and treatment characteristics were abstracted from electronic medical records and linked to archived Patient Care Monitor (PCM assessments. The PCM is a self-report measure of symptom burden and HRQoL administered as part of routine care in participating practices. Linear mixed models were used to examine change in PCM scores over time. Results Mean age was 57 years, with 72% of patients Caucasian, and 25% African American. Median time from mBC diagnosis to first disease progression was 8.8 months. Metastasis to bone (60%, lung (28% and liver (26% predominated at initial metastatic diagnosis. Results showed that PCM items assessing fatigue, physical pain and trouble sleeping were sensitive to either general effects of disease progression or to effects associated with specific sites of metastasis. Progression of disease was also associated with modest but significant worsening of General Physical Symptoms, Treatment Side Effects, Acute Distress and Impaired Performance index scores. In addition, there were marked detrimental effects of liver metastasis on Treatment Side Effects, and of brain metastasis on Acute Distress. Conclusions Disease progression has a detrimental impact on cancer-related symptoms. Delaying disease progression may have a positive impact on patients' HRQoL.

  10. Elevated expression of LSD1 (Lysine-specific demethylase 1 during tumour progression from pre-invasive to invasive ductal carcinoma of the breast

    Directory of Open Access Journals (Sweden)

    Serce Nuran

    2012-08-01

    Full Text Available Abstract Background Lysine-specific demethylase1 (LSD1 is a nuclear protein which belongs to the aminooxidase-enzymes playing an important role in controlling gene expression. It has also been found highly expressed in several human malignancies including breast carcinoma. Our aim was to detect LSD1 expression also in pre-invasive neoplasias of the breast. In the current study we therefore analysed LSD1 protein expression in ductal carcinoma in situ (DCIS in comparison to invasive ductal breast cancer (IDC. Methods Using immunohistochemistry we systematically analysed LSD1 expression in low grade DCIS (n = 27, intermediate grade DCIS (n = 30, high grade DCIS (n = 31 and in invasive ductal breast cancer (n = 32. SPSS version 18.0 was used for statistical analysis. Results LSD1 was differentially expressed in DCIS and invasive ductal breast cancer. Interestingly, LSD1 was significantly overexpressed in high grade DCIS versus low grade DCIS. Differences in LSD1 expression levels were also statistically significant between low/intermediate DCIS and invasive ductal breast carcinoma. Conclusions LSD1 is also expressed in pre-invasive neoplasias of the breast. Additionally, there is a gradual increase of LSD1 expression within tumour progression from pre-invasive DCIS to invasive ductal breast carcinoma. Therefore upregulation of LSD1 may be an early tumour promoting event.

  11. Re-Appraisal of Estrogen Receptor Negative/Progesterone Receptor Positive (ER-/PR+) Breast Cancer Phenotype: True Subtype or Technical Artefact?

    Science.gov (United States)

    Foley, Niamh M; Coll, J M; Lowery, A J; Hynes, S O; Kerin, M J; Sheehan, M; Brodie, C; Sweeney, K J

    2017-09-11

    Expression of the ER and PR receptors is routinely quantified in breast cancer as a predictive marker of response to hormonal therapy. Accurate determination of ER and PR status is critical to the optimal selection of patients for targeted therapy. The existence of an ER-/PR+ subtype is controversial, with debate centred on whether this represents a true phenotype or a technical artefact on immunohistochemistry (IHC). The aim of this study was to investigate the true incidence and clinico-pathological features of ER-/PR+ breast cancers in a tertiary referral symptomatic breast unit. Clinico-pathological data were collected on invasive breast cancers diagnosed between 1995 and 2005. IHC for ER and PR receptors was repeated on all cases which were ER-/PR+, with the same paraffin block used for the initial diagnostic testing. Concordance between the diagnostic and repeat IHC was determined using validated testing. Complete data, including ER and PR status were available for 697 patients diagnosed during the study period. On diagnostic IHC, the immunophenotype of the breast tumours was: ER+/PR+ in 396 (57%), ER-/PR- in 157 (23%), ER+/PR- in 88 (12%) and ER-/PR+ in 56 (8.6%) patients. On repeat IHC of 48/56 ER-/PR+ tumours 45.8% were ER+/PR+, 6% were ER+/PR- and 43.7% were ER-/PR- None of the cases were confirmed to be ER-/PR+. The ER-/PR+ phenotypic breast cancer is likely to be the result of technical artefact. Prompt reassessment of patients originally assigned to this subtype who re-present with symptoms should be considered to ensure appropriate clinical management.

  12. CCN5/WISP-2 expression in breast adenocarcinoma is associated with less frequent progression of the disease and suppresses the invasive phenotypes of tumor cells.

    Science.gov (United States)

    Banerjee, Snigdha; Dhar, Gopal; Haque, Inamul; Kambhampati, Suman; Mehta, Smita; Sengupta, Krishanu; Tawfik, Ossama; Phillips, Teresa A; Banerjee, Sushanta K

    2008-09-15

    Although previous in vitro studies predicted that CCN5/WISP-2 may act as an anti-invasive gene in breast cancer, the distribution pattern of CCN5 in breast cancer samples is conflicting. Thus, we systematically investigated the CCN5 expression profile in noninvasive and invasive breast tumor samples and its functional relevance in breast cancer progression. The studies showed that CCN5 expression is biphasic, such that in normal samples CCN5 expression is undetectable, whereas its expression is markedly increased in noninvasive breast lesions, including atypical ductal hyperplasia and ductal carcinoma in situ. Further, CCN5 mRNA and protein levels are significantly reduced as the cancer progresses from a noninvasive to invasive type. Additionally, we showed that CCN5 mRNA and protein level was almost undetectable in poorly differentiated cancers compared with the moderately or well-differentiated samples and its expression inversely correlated with lymph node positivity. The result was further supported by evaluating the RNA expression profile in microdissected sections using real-time PCR analysis. Therefore, our data suggest a protective function of CCN5 in noninvasive breast tumor cells. This hypothesis was further supported by our in vitro studies illuminating that CCN5 is a negative regulator of migration and invasion of breast cancer cells, and these events could be regulated by CCN5 through the modulation of the expression of genes essential for an invasive front. These include Snail-E-cadherin signaling and matrix metalloproteinase (MMP)-9 and MMP-2. Collectively, these studies suggest that the protective effect of CCN5 in breast cancer progression may have important therapeutic implications.

  13. Notch3 overexpression causes arrest of cell cycle progression by inducing Cdh1 expression in human breast cancer cells.

    Science.gov (United States)

    Chen, Chun-Fa; Dou, Xiao-Wei; Liang, Yuan-Ke; Lin, Hao-Yu; Bai, Jing-Wen; Zhang, Xi-Xun; Wei, Xiao-Long; Li, Yao-Chen; Zhang, Guo-Jun

    2016-01-01

    Uncontrolled cell proliferation, genomic instability and cancer are closely related to the abnormal activation of the cell cycle. Therefore, blocking the cell cycle of cancer cells has become one of the key goals for treating malignancies. Unfortunately, the factors affecting cell cycle progression remain largely unknown. In this study, we have explored the effects of Notch3 on the cell cycle in breast cancer cell lines by 3 methods: overexpressing the intra-cellular domain of Notch3 (N3ICD), knocking-down Notch3 by RNA interference, and using X-ray radiation exposure. The results revealed that overexpression of Notch3 arrested the cell cycle at the G0/G1 phase, and inhibited the proliferation and colony-formation rate in the breast cancer cell line, MDA-MB-231. Furthermore, overexpressing N3ICD upregulated Cdh1 expression and resulted in p27(Kip) accumulation by accelerating Skp2 degradation. Conversely, silencing of Notch3 in the breast cancer cell line, MCF-7, caused a decrease in expression levels of Cdh1 and p27(Kip) at both the protein and mRNA levels, while the expression of Skp2 only increased at the protein level. Correspondingly, there was an increase in the percentage of cells in the G0/G1 phase and an elevated proliferative ability and colony-formation rate, which may be caused by alterations of the Cdh1/Skp2/p27 axis. These results were also supported by exposing MDA-MB-231 cells or MCF-7 treated with siN3 to X-irradiation at various doses. Overall, our data showed that overexpression of N3ICD upregulated the expression of Cdh1 and caused p27(Kip) accumulation by accelerating Skp2 degradation, which in turn led to cell cycle arrest at the G0/G1 phase, in the context of proliferating breast cancer cell lines. These findings help to illuminate the precision therapy targeted to cell cycle progression, required for cancer treatment.

  14. Modeling the impacts of climate change and technical progress on the wheat yield in inland China: An autoregressive distributed lag approach.

    Science.gov (United States)

    Zhai, Shiyan; Song, Genxin; Qin, Yaochen; Ye, Xinyue; Lee, Jay

    2017-01-01

    This study aims to evaluate the impacts of climate change and technical progress on the wheat yield per unit area from 1970 to 2014 in Henan, the largest agricultural province in China, using an autoregressive distributed lag approach. The bounded F-test for cointegration among the model variables yielded evidence of a long-run relationship among climate change, technical progress, and the wheat yield per unit area. In the long run, agricultural machinery and fertilizer use both had significantly positive impacts on the per unit area wheat yield. A 1% increase in the aggregate quantity of fertilizer use increased the wheat yield by 0.19%. Additionally, a 1% increase in machine use increased the wheat yield by 0.21%. In contrast, precipitation during the wheat growth period (from emergence to maturity, consisting of the period from last October to June) led to a decrease in the wheat yield per unit area. In the short run, the coefficient of the aggregate quantity of fertilizer used was negative. Land size had a significantly positive impact on the per unit area wheat yield in the short run. There was no significant short-run or long-run impact of temperature on the wheat yield per unit area in Henan Province. The results of our analysis suggest that climate change had a weak impact on the wheat yield, while technical progress played an important role in increasing the wheat yield per unit area. The results of this study have implications for national and local agriculture policies under climate change. To design well-targeted agriculture adaptation policies for the future and to reduce the adverse effects of climate change on the wheat yield, climate change and technical progress factors should be considered simultaneously. In addition, adaptive measures associated with technical progress should be given more attention.

  15. Fundamental characterization of alternate fuel effects in continuous combustion systems. Summary technical progress report, August 15, 1978-January 31, 1980

    Energy Technology Data Exchange (ETDEWEB)

    Blazowski, W.S.; Edelman, R.B.; Wong, E.

    1980-02-27

    The overall objective of this contract is to assist in the development of fuel-flexible combustion systems for gas turbines as well as Rankine and Stirling cycle engines. The primary emphasis of the program is on liquid hydrocarbons produced from non-petroleum resources. Fuel-flexible combustion systems will provide for more rapid transition of these alternative fuels into important future energy utilization centers (especially utility power generation with the combined cycle gas turbine). The specific technical objectives of the program are: (a) develop an improved understanding of relationships between alternative fuel properties and continuous combustion system effects, and (b) provide analytical modeling/correlation capabilities to be used as design aids for development of fuel-tolerant combustion systems. This is the second major report of the program. Key experimental findings during this reporting period concern stirred combustor soot production during operation at controlled temperature conditions, soot production as a function of combustor residence time, an improved measurement technique for total hydrocarbons and initial stirred combustor results of fuel nitrogen conversion. While the results to be presented concern a stirred combustor which utilizes premixed fuel vapor/oxidant mixtures, a new combustor which combusts liquid fuel injected into the reactor as a spray has been developed and will be described. Analytical program progress includes the development of new quasiglobal models of soot formation and assessment of needs for other submodel development.

  16. Distribution of marine birds on Georges Bank and adjacent waters. Technical progress report, 1 January--31 August 1978

    Energy Technology Data Exchange (ETDEWEB)

    Powers, K.D.

    1978-10-01

    The work accomplished during the period covered in this technical progress report demonstrates the importance, interest, and necessity of a distribution study of marine birds in the Georges Bank area on a national and international scale. Cooperation was extended by the U.S. National Marine Fisheries Service, U.S. Fish and Wildlife Service, U.S. Coast Guard, and by the Canadian Wildlife Service, Halifax, N.S., AltantNIRO, Kaliningrad, USSR, and Federal Republic of Germany. Two sampling methods, fixed-area and total bird counts, were effectively employed, which allow comparable data bases with marine bird distribution information being collected in the North Pacific, Bering and Chukchi Seas (Outer Continental Shelf Energy Assessment Program), and in the North Atlantic and Canadian Arctic (CWS and The Seabird Group). A marine bird data retrieval bank is being developed for MBO seabird data at the USFWS Migratory Bird and Habitat Research Laboratory. A food habits bibliography and prey item/bird species summary table for marine birds in the western North Atlantic has been prepared from existing literature. Unpublished NMFS data on zooplankton/ichthyoplankton, and ground fish is being made available for possible correlations in distribution of selected prey items with bird species.

  17. Hot gas cleanup test facility for gasification and pressurized combustion. Quarterly technical progress report, January 1--March 31, 1992

    Energy Technology Data Exchange (ETDEWEB)

    1992-12-01

    This quarterly technical progress report summarizes work completed during the Sixth Quarter of the First Budget Period, January 1 through March 31, 1992, under the Department of Energy (DOE) Cooperative Agreement No. DE-FC21-90MC25140 entitled ``Hot Gas Cleanup Test Facility for Gasification and Pressurized Combustion.`` The objective of this project is to evaluate hot gas particle control technologies using coal-derived gas streams. The major emphasis during this reporting period was expanding the test facility to address system integration issues of hot particulate removal in advanced power generation systems. The conceptual design of the facility was extended to include additional modules for the expansion of the test facility, which is referred to as the Power Systems Development Facility (PSOF). A letter agreement was negotiated between Southern Company Services (SCS) and Foster Wheeler (FW) for the conceptual design of the Advanced Pressurized Fluid-Bed Combustion (APFBC)/Topping Combustor/Gas Turbine System to be added to the facility. The expanded conceptual design also included modifications to the existing conceptual design for the Hot Gas Cleanup Test Facility (HGCTF), facility layout and balance of plant design for the PSOF. Southern Research Institute (SRI) began investigating the sampling requirements for the expanded facility and assisted SCS in contacting Particulate Control Device (PCD) vendors for additional information. SCS also contacted the Electric Power Research Institute (EPRI) and two molten carbonate fuel cell vendors for input on the fuel cell module for the PSDF.

  18. Next generation sequencing for profiling expression of miRNAs: technical progress and applications in drug development.

    Science.gov (United States)

    Liu, Jie; Jennings, Steven F; Tong, Weida; Hong, Huixiao

    2011-10-01

    miRNAs are non-coding RNAs that play a regulatory role in expression of genes and are associated with diseases. Quantitatively measuring expression levels of miRNAs can help in understanding the mechanisms of human diseases and discovering new drug targets. There are three major methods that have been used to measure the expression levels of miRNAs: real-time reverse transcription PCR (qRT-PCR), microarray, and the newly introduced next-generation sequencing (NGS). NGS is not only suitable for profiling of known miRNAs as qRT-PCR and microarray can do too but it also is able to detect unknown miRNAs which the other two methods are incapable of doing. Profiling of miRNAs by NGS has progressed rapidly and is a promising field for applications in drug development. This paper reviews the technical advancement of NGS for profiling miRNAs, including comparative analyses between different platforms and software packages for analyzing NGS data. Examples and future perspectives of applications of NGS profiling miRNAs in drug development will be discussed.

  19. Feed-in tariffs versus quotas: how to promote renewable s and stimulate technical progress for cost decrease?

    Energy Technology Data Exchange (ETDEWEB)

    Menanteau, Ph.; Finon, D.; Lamy, M.L

    2002-07-01

    Incentive schemes for the development of renewable energy sources may focus on quantities (defining national targets and setting up bidding systems, or quota systems providing for green certificate trading), or they may focus on prices (feed-in tariffs). Whatever the system chosen, the role of the public authorities is quite specific: to stimulate technical progress and speed up the technological learning processes so that ultimately renewable energy technologies will be able to compete with conventional technologies, once the environmental costs have been internalized. A comparison of instruments must thus take into account the characteristics of the innovation process and adoption conditions (uncertainties regarding cost curves, learning effects) which means also looking at dynamic efficiency criteria. The paper concludes that a system of feed-in tariffs is more efficient than a bidding system, but highlights the theoretical interest of green certificate trading which must be confirmed through practice, given the influence of market structures and rules on the performance of this type of approach. (author)

  20. Developments in breeding of Agaricus bisporus var. bisporus: progress made and technical and legal hurdles to take.

    Science.gov (United States)

    Sonnenberg, Anton S M; Baars, Johan J P; Gao, Wei; Visser, Richard G F

    2017-03-01

    True breeding of button mushrooms has hardly been done in the last decades, despite this species being one of the most cultivated mushrooms worldwide. Research done in the last 20 years has identified and characterised new germplasm and improved our understanding of the genetic base for some traits. A substantial collection of wild-collected strains is now available and partly characterised for a number of important traits such as disease resistance and yield. Most of the variations found in a number of important agronomic traits have a considerable heritability and are thus useful for breeding. Genetic marker technology has also developed considerably for this mushrooms in the last decade and used to identify quantitative trait loci (QTL) for important agronomic traits. This progress has, except for one example, not resulted so far into new commercially varieties. One of the reasons lies in the typical life cycle of the button mushroom Agaricus bisporus var. bisporus which hampers breeding. Joint investment is needed to solve technical problems in breeding. Special attention is needed for the protection of new varieties. Due to its typical life cycle, it is very easy to generate so called "look-a-likes" from protected cultivars by screening fertile single spore cultures. A consensus has been reached within the mushroom (breeding) industry to consider this method as the generation of essentially derived varieties as defined in plant breeding.

  1. The Role of Myoepithelial Maspin in Breast Carcinoma Progression Diagnosis and Screening

    Science.gov (United States)

    2003-08-01

    of metastasis in a human melanoma/SCID model: implications for the direct autocrine and paracrine epigenetic regulation of the metastatic process...I.B. Owens, W.A. Nelson-Rees, J.L. Riggs , and M.B. Gardner. 1977. Two syngeneic cell lines from human breast tissue: the aneuploid mammary...SCID model: implications for the direct autocrine and paracrine epigenetic regulation of the metastatic process. Int. J. Cancer 66, 151-158. References

  2. The Role of Adipose-Derived Stem Cells in Breast Cancer Progression and Metastasis

    Directory of Open Access Journals (Sweden)

    Riccardo Schweizer

    2015-01-01

    Full Text Available Conventional breast cancer extirpation involves resection of parts of or the whole gland, resulting in asymmetry and disfiguration. Given the unsatisfactory aesthetic outcomes, patients often desire postmastectomy reconstructive procedures. Autologous fat grafting has been proposed for reconstructive purposes for decades to restore form and anatomy after mastectomy. Fat has the inherent advantage of being autologous tissue and the most natural-appearing filler, but given its inconsistent engraftment and retention rates, it lacks reliability. Implementation of autologous fat grafts with cellular adjuncts, such as multipotent adipose-derived stem cells (ADSCs, has shown promising results. However, it is pertinent and critical to question whether these cells could promote any residual tumor cells to proliferate, differentiate, or metastasize or even induce de novo carcinogenesis. Thus far, preclinical and clinical study findings are discordant. A trend towards potential promotion of both breast cancer growth and invasion by ADSCs found in basic science studies was indeed not confirmed in clinical trials. Whether experimental findings eventually correlate with or will be predictive of clinical outcomes remains unclear. Herein, we aimed to concisely review current experimental findings on the interaction of mesenchymal stem cells and breast cancer, mainly focusing on ADSCs as a promising tool for regenerative medicine, and discuss the implications in clinical translation.

  3. AZU-1: A Candidate Breast Tumor Suppressor and Biomarker for Tumor Progression

    Energy Technology Data Exchange (ETDEWEB)

    Chen, Huei-Mei; Schmeichel, Karen L; Mian, I. Saira; Lelie`vre, Sophie; Petersen, Ole W; Bissell, Mina J

    2000-02-04

    To identify genes misregulated in the final stages of breast carcinogenesis, we performed differential display to compare the gene expression patterns of the human tumorigenic mammary epithelial cells, HMT-3522-T4-2, with those of their immediate premalignant progenitors, HMT-3522-S2. We identified a novel gene, called anti-zuai-1 (AZU-1), that was abundantly expressed in non- and premalignant cells and tissues but was appreciably reduced in breast tumor cell types and in primary tumors. The AZU-1 gene encodes an acidic 571-amino-acid protein containing at least two structurally distinct domains with potential protein-binding functions: an N-terminal serine and proline-rich domain with a predicted immunoglobulin-like fold and a C-terminal coiled-coil domain. In HMT-3522 cells, the bulk of AZU-1 protein resided in a detergent-extractable cytoplasmic pool and was present at much lower levels in tumorigenic T4-2 cells than in their nonmalignant counterparts. Reversion of the tumorigenic phenotype of T4-2 cells, by means described previously, was accompanied by the up-regulation of AZU-1. In addition, reexpression of AZU-1 in T4-2 cells, using viral vectors, was sufficient to reduce their malignant phenotype substantially, both in culture and in vivo. These results indicate that AZU-1 is a candidate breast tumor suppressor that may exert its effects by promoting correct tissue morphogenesis.

  4. Protective Effect of Perindopril on Tumor Progression and Angiogenesis in Animal Model of Breast Cancer.

    Science.gov (United States)

    Patel, Snehal S; Nakka, Surender

    2017-01-01

    Studies have shown that the renin angiotensin system via angiogenesis is involved in tumor development. Therefore, objective of the present study was to examine the effect of perindopril on tumor growth and angiogenesis in animal models of breast cancer. In the present study, the effect of perindopril on tumor development of mammary gland cancer induced by 7,12-dimethylbenz[a]anthracene, mouse tumor xenograft and corneal micropocket model has been investigated. Anti-angiogenic effect by chick yolk sac membrane assay has also been studied. In the present study, it has been found that perindopril produced a significant inhibition of tumor growth, in DMBA induced breast cancer. Treatment also produced significant suppression of cancer biomarkers such as lactate dehydrogenase, gamma glutamyl transferase and inflammatory markers such as C-reactive protein, erythrocyte sedimentation rate. Histopathological analysis also showed that perindopril was able to inhibit tumor development by the inhibition of hyperplastic lesions. Perindopril produced significant inhibition of tumor growth, in a mouse xenograft model and caused inhibition of neovascularization in the corneal micropocket model. In chick yolk sac membrane assay, perindopril showed inhibition of vascular growth and reduced blood vessel formation. Therefore, perindopril is widely used in clinical practice, may represent a neo-adjuvant therapy for treatment of breast cancer. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

  5. Efficacy of trastuzumab in routine clinical practice and after progression for metastatic breast cancer patients: the observational Hermine study.

    Science.gov (United States)

    Extra, Jean-Marc; Antoine, Eric C; Vincent-Salomon, Anne; Delozier, Thierry; Kerbrat, Pierre; Bethune-Volters, Anne; Guastalla, Jean-Paul; Spielmann, Marc; Mauriac, Louis; Misset, Jean-Louis; Serin, Daniel; Campone, Mario; Hebert, Christophe; Remblier, Céline; Bergougnoux, Loïc; Campana, Frank; Namer, Moïse

    2010-01-01

    The Hermine study observed the use of trastuzumab for metastatic breast cancer (MBC) in routine practice, including patients who received trastuzumab treatment beyond progression (TBP). The study observed 623 patients for > or = 2 years. Treatment was given according to oncologists' normal clinical practices. Endpoints included duration of treatment, efficacy, and cardiac safety. The TBP subanalysis compared overall survival (OS) in 177 patients who received first-line trastuzumab and either continued trastuzumab for > or = 30 days following progression or stopped at or before progression. The median treatment duration was 13.3 months. In the first-, second-, and third-line or beyond treatment groups, the median time to progression (TTP) were 10.3 months, 9.0 months, and 6.3 months, and the median OS times were 30.3 months, 27.1 months, and 23.2 months, respectively. Heart failure was observed in 2.6% of patients, although no cardiac-associated deaths occurred. In the TBP subanalysis, the median OS duration from treatment initiation and time of disease progression were longer in patients who continued receiving trastuzumab TBP (>27.8 months and 21.3 months, respectively) than in those who stopped (16.8 months and 4.6 months, respectively). However, the groups were not completely comparable, because patients who continued trastuzumab TBP had better prognoses at treatment initiation. The median TTP was longer in patients who continued trastuzumab TBP (10.2 months) than in those who stopped (7.1 months). The Hermine findings confirm that the pivotal trials of first-line trastuzumab treatment in MBC patients are applicable in clinical practice. The subanalysis suggests that trastuzumab TBP offers a survival benefit to MBC patients treated with first-line trastuzumab.

  6. Final Technical Progress Report

    Energy Technology Data Exchange (ETDEWEB)

    J.Y. Hwang; R.C. Greenlund

    2002-12-31

    Michigan Technological University has demonstrated major inroads in establishing the viability of utilizing aluminum smelting by-product waste materials in lightweight concrete product applications. The research identified key elements of producing various forms of lightweight concrete products through utilizing various procedures and mixture components with the by-product materials. A process was developed through pilot plant testing that results in additional aluminum recovery at finer sizes, a clean returnable salt product through spray drying technology, and a low-salt-content oxide product with enough aluminum metal content that it can be used to form lightweight cementitious mixtures. Having three distinct products aids in generating favorable process economics. Revenue projections from aluminum recovery and salt recovery are enough to cover processing costs and create a cost-free oxide product to market for lightweight concrete applications. This supply side commercialization strategy offers aluminum by-product recyclers a potentially no cost product, which has been demonstrated through this project to create desirable and marketable lightweight concrete products of various forms. Environmental benefits to the public are tremendous. At best, all dross and salt cake materials have the potential to be completely recycled and utilized. At worst, disposal sites would see a reduced amount of material: a post processed oxide product with little salt and no hydrogen sulfide or ammonia gas generating capability, which, if isolated from high alkali conditions, would pose no reactivity concerns. The US aluminum industry has historically, along with the steel industry, been a leader in recycling metal. The findings from this project, increased metal recovery, improved salt recycling, and demonstrated end uses for oxide residues, will go a long way in helping the aluminum industry obtain 100% material utilization and zero discharge.

  7. Estrogen receptor (ER)α-regulated lipocalin 2 expression in adipose tissue links obesity with breast cancer progression.

    Science.gov (United States)

    Drew, Brian G; Hamidi, Habib; Zhou, Zhenqi; Villanueva, Claudio J; Krum, Susan A; Calkin, Anna C; Parks, Brian W; Ribas, Vicent; Kalajian, Nareg Y; Phun, Jennifer; Daraei, Pedram; Christofk, Heather R; Hewitt, Sylvia C; Korach, Kenneth S; Tontonoz, Peter; Lusis, Aldons J; Slamon, Dennis J; Hurvitz, Sara A; Hevener, Andrea L

    2015-02-27

    Obesity is associated with increased breast cancer (BrCA) incidence. Considering that inactivation of estrogen receptor (ER)α promotes obesity and metabolic dysfunction in women and female mice, understanding the mechanisms and tissue-specific sites of ERα action to combat metabolic-related disease, including BrCA, is of clinical importance. To study the role of ERα in adipose tissue we generated fat-specific ERα knock-out (FERKO) mice. Herein we show that ERα deletion increased adipocyte size, fat pad weight, and tissue expression and circulating levels of the secreted glycoprotein, lipocalin 2 (Lcn2), an adipokine previously associated with BrCA development. Chromatin immunoprecipitation and luciferase reporter studies showed that ERα binds the Lcn2 promoter to repress its expression. Because adipocytes constitute an important cell type of the breast microenvironment, we examined the impact of adipocyte ERα deletion on cancer cell behavior. Conditioned medium from ERα-null adipocytes and medium containing pure Lcn2 increased proliferation and migration of a subset of BrCA cells in culture. The proliferative and promigratory effects of ERα-deficient adipocyte-conditioned medium on BrCA cells was reversed by Lcn2 deletion. BrCA cell responsiveness to exogenous Lcn2 was heightened in cell types where endogenous Lcn2 expression was minimal, but components of the Lcn2 signaling pathway were enriched, i.e. SLC22A17 and 3-hydroxybutyrate dehydrogenase (BDH2). In breast tumor biopsies from women diagnosed with BrCA we found that BDH2 expression was positively associated with adiposity and circulating Lcn2 levels. Collectively these data suggest that reduction of ERα expression in adipose tissue promotes adiposity and is linked with the progression and severity of BrCA via increased adipocyte-specific Lcn2 production and enhanced tumor cell Lcn2 sensitivity. © 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

  8. Adipose Progenitor Cell Secretion of GM-CSF and MMP9 Promotes a Stromal and Immunological Microenvironment That Supports Breast Cancer Progression.

    Science.gov (United States)

    Reggiani, Francesca; Labanca, Valentina; Mancuso, Patrizia; Rabascio, Cristina; Talarico, Giovanna; Orecchioni, Stefania; Manconi, Andrea; Bertolini, Francesco

    2017-09-15

    A cell population with progenitor-like phenotype (CD45-CD34+) resident in human white adipose tissue (WAT) is known to promote the progression of local and metastatic breast cancer and angiogenesis. However, the molecular mechanisms of the interaction have not been elucidated. In this study, we identified two proteins that were significantly upregulated in WAT-derived progenitors after coculture with breast cancer: granulocyte macrophage colony-stimulating factor (GM-CSF) and matrix metallopeptidase 9 (MMP9). These proteins were released by WAT progenitors in xenograft and transgenic breast cancer models. GM-CSF was identified as an upstream modulator. Breast cancer-derived GM-CSF induced GM-CSF and MMP9 release from WAT progenitors, and GM-CSF knockdown in breast cancer cells neutralized the protumorigenic activity of WAT progenitors in preclinical models. GM-CSF neutralization in diet-induced obese mice significantly reduced immunosuppression, intratumor vascularization, and local and metastatic breast cancer progression. Similarly, MMP9 inhibition reduced neoplastic angiogenesis and significantly decreased local and metastatic tumor growth. Combined GM-CSF neutralization and MMP9 inhibition synergistically reduced angiogenesis and tumor progression. High-dose metformin inhibited GM-CSF and MMP9 release from WAT progenitors in in vitro and xenograft models. In obese syngeneic mice, metformin treatment mimicked the effects observed with GM-CSF neutralization and MMP9 inhibition, suggesting these proteins as new targets for metformin. These findings support the hypothesis that GM-CSF and MMP9 promote the protumorigenic effect of WAT progenitors on local and metastatic breast cancer. Cancer Res; 77(18); 5169-82. ©2017 AACR. ©2017 American Association for Cancer Research.

  9. SATB1 is Correlated with Progression and Metastasis of Breast Cancers: A Meta-Analysis

    Directory of Open Access Journals (Sweden)

    Zhongya Pan

    2016-05-01

    Full Text Available Background/Aims: Several researches have evaluated the significance of SATB1 (Special AT-rich sequence binding protein 1 expression in breast cancers (BCs, but the results have been disputed, especially in the aspects of clinicopathological features and prognosis. Therefore, our study aimed to use a meta-analysis to summarize the clinical and prognostic relevance of SATB1 gene expression in BCs. Methods: A literature search of PubMed, EMBASE, Cochrane library, Chinese Wanfang and CNKI was performed to identify eligible studies. Ten studies total, comprising 5,185 patients (1,699 SATB1-positive and 3,486 SATB1-negative, were enrolled in our study, which was performed using Revman5.3 Software and Stata11.0 Software. Results: This meta-analysis showed that the expression of SATB1 was significantly higher in breast cancer than in normal tissues (OR = 12.28; 95%CI = 6.01-25.09, and was statistically related to several clinicopathological parameters, including lymph node metastasis (OR = 1.55, 95%CI = 1.01-2.39 and Tumor Node Metastasis(TNM stage (OR = 0.35, 95%CI = 0.22-0.56. However, the level of SATB1 was not statistically associated with the age (OR = 1.13, 95%CI = 0.87-1.46, tumour size (OR = 0.72, 95%CI = 0.44-1.19, estrogen receptor (OR = 0.78, 95%CI = 0.55-1.09, progesterone receptor (OR = 0.64, 95%CI = 0.32-1.29, HER2 status (OR=1.98, 95%CI = 0.74-5.30, and histological type (OR = 0.49, 95%CI = 0.22-1.11. Conclusion: High expression of SATB1 was significantly correlated with tumourigenesis and metastasis of BCs, indicating poor prognosis for patients. SATB1 could serve as a potential marker for detection and prognosis evaluation of breast cancers.

  10. Index to Nuclear Safety: a technical progress review by chronology, permuted title, and author, Volume 18 (1) through Volume 22 (6)

    Energy Technology Data Exchange (ETDEWEB)

    Cottrell, W.B.; Passiakos, M.

    1982-06-01

    This index to Nuclear Safety covers articles published in Nuclear Safety, Volume 18, Number 1 (January-February 1977) through Volume 22, Number 6 (November-December 1981). The index is divided into three section: a chronological list of articles (including abstracts), a permuted-title (KWIC) index, and an author index. Nuclear Safety, a bimonthly technical progress review prepared by the Nuclear Safety Information Center, covers all safety aspects of nuclear power reactors and associated facilities. Over 300 technical articles published in Nuclear Safety in the last 5 years are listed in this index.

  11. Index to Nuclear Safety: a technical progress review by chronology, permuted title, and author. Vol. 11(1)--Vol. 18(6)

    Energy Technology Data Exchange (ETDEWEB)

    Cottrell, W.B.; Klein, A.

    1978-04-11

    This index to Nuclear Safety covers articles published in Nuclear Safety, Vol. 11, No. 1 (January-February 1970), through Vol. 18, No. 6 (November-December 1977). It is divided into three sections: a chronological list of articles (including abstracts) followed by a permuted-title (KWIC) index and an author index. Nuclear Safety, a bimonthly technical progress review prepared by the Nuclear Safety Information Center (NSIC), covers all safety aspects of nuclear power reactors and associated facilities. Over 450 technical articles published in Nuclear Safety in the last eight years are listed in this index.

  12. Index to Nuclear Safety. A technical progress review by chronology, permuted title, and author. Vol 11, No. 1 through Vol. 16, No. 6

    Energy Technology Data Exchange (ETDEWEB)

    Cottrell, W.B.; Klein, A.

    1976-04-01

    This index to Nuclear Safety covers articles in Nuclear Safety Vol. 11, No. 1 (Jan.-Feb. 1970) through Vol. 16, No. 6 (Nov.-Dec. 1975). Included in the index is a chronological list of articles (including abstract) followed by both a KWIC index and an Author Index. Nuclear Safety is a bimonthly technical progress review prepared by the Nuclear Safety Information Center and covers all safety aspects of nuclear power reactors and associated facilities. The index lists over 300 technical articles in the last six years of publication.

  13. ANX7 as a Bio-Marker in Prostate and Breast Cancer Progression

    Directory of Open Access Journals (Sweden)

    Meera Srivastava

    2001-01-01

    Full Text Available The ANX7 gene codes for a Ca2+-activated GTPase, which has been implicated in both exocytotic secretion in cells and control of growth. In this review, we summarize information regarding increased tumor frequency in the Anx7 knockout mice, ANX7 growth suppression of human cancer cell lines, and ANX7 expression in human tumor tissue micro-arrays. The loss of ANX7 is significant in metastatic and hormone refractory prostate cancer compared to benign prostatic hyperplasia. In addition, ANX7 expression has prognostic value for predicting survival of breast cancer patients.

  14. Haploinsufficiency in the prometastasis Kiss1 Receptor Gpr54 delays breast tumor initiation, progression and lung metastasis

    Science.gov (United States)

    Cho, Sung-Gook; Wang, Ying; Rodriguez, Melissa; Tan, Kunrong; Zhang, Wenzheng; Luo, Jian; Li, Dali; Liu, Mingyao

    2016-01-01

    Activation of KISS1 receptor (KISS1R or GPR54) by its ligands (kisspeptins) regulates a diverse function both in normal physiology and pathophysiology. In cancer, KISS1-induced KISS1R signaling is known to inhibit tumor angiogenesis and metastasis. However, roles of KISS1 and KISS1R in earlier stages of tumor progression and metastasis in vivo are still unknown. In this study, we demonstrate a critical role for Kiss1r in early stages of tumor progression using mouse tumor models. PyMT/Kiss1r mice with different Kiss1r genotypes were obtained by crossing MMTV-PyMT transgenic mouse with Kiss1r heterozygous mouse (Kiss1r+/−). Kiss1r heterozygosity attenuated breast tumor initiation, growth, latency, multiplicity and metastasis in MMTV-PyMT/Kiss1r+/− mouse models. To confirm the effects of Kiss1r in tumor progression and limit any effect of endogenous hormones, we isolated primary tumor cells from PyMT/Kiss1r+/+ or PyMT/Kiss1r+/− mice and performed in vitro and in vivo tumorigenesis assays. Kiss1r heterozygosity inhibited PyMT-induced in vitro tumorigeneity and in vivo tumor growth in NOD.SCID/NCr mice. To understand the underlying mechanism, we showed that activation of KISS1R by kisspeptin-10 led to RhoA activation and RhoA-dependent gene expression through Gαq-p63RhoGEF signaling pathway. Furthermore, anchorage-independent growth was tightly linked to the dosage-dependent regulation of RhoA by KISS1R. When MCF10A cells overexpressing H-RasV12 were subjected to in vitro tumorigenesis assays, knockdown of KISS1R or inactivation of RhoA in MCF10A cells reduced Ras-induced anchorage-independent growth, similar to our data obtained from PyMT-Kiss1r+/− mouse models. Altogether, we conclude that Kiss1r haploinsufficiency delays breast tumor initiation, progression and metastasis through its downstream Gαq-p63RhoGEF-RhoA signaling pathway. PMID:21852382

  15. Progression from normal breast pathology to breast cancer is associated with increasing prevalence of mouse mammary tumor virus-like sequences in men and women

    National Research Council Canada - National Science Library

    Ford, Caroline E; Faedo, Margaret; Crouch, Roger; Lawson, James S; Rawlinson, William D

    2004-01-01

    ...% of normal breast tissue samples from Australian women studied by our group. Screening of a larger and more diverse cohort of female breast cancer samples has now shown a correlation of MMTV-like sequences with the severity (grade) of breast cancer...

  16. Analysis of different HER-2 mutations in breast cancer progression and drug resistance.

    Science.gov (United States)

    Sun, Zijia; Shi, Yaqin; Shen, Yan; Cao, Lulu; Zhang, Wenwen; Guan, Xiaoxiang

    2015-12-01

    Studies over the last two decades have identified that amplified human epidermal growth factor receptor (HER-2; c-erbB-2, neu) and its overexpression have been frequently implicated in the carcinogenesis and prognosis in a variety of solid tumours, especially breast cancer. Lots of painstaking efforts were invested on the HER-2 targeted agents, and significantly improved outcome and prolonged the survival of patients. However, some patients classified as 'HER-2-positive' would be still resistant to the anti-HER-2 therapy. Various mechanisms of drug resistance have been illustrated and the alteration of HER-2 was considered as a crucial mechanism. However, systematic researches in regard to the HER-2 mutations and variants are still inadequate. Notably, the alterations of HER-2 play an important role in drug resistance, but also have a potential association with the cancer risk. In this review, we summarize the possible mutations and focus on HER-2 variants' role in breast cancer tumourigenesis. Additionally, the alteration of HER-2, as a potential mechanism of resistance to trastuzumab, is discussed here. We hope that HER-2 related activating mutations could potentially offer more therapeutic opportunities to a broader range of patients than previously classified as HER-2 overexpressed. © 2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.

  17. Botanical inventory of the Rocky Flats AEC site: mapping methods and preliminary maps. Technical progress report, July 31, 1975--April 28, 1976

    Energy Technology Data Exchange (ETDEWEB)

    Webber, P.J.; Clark, S.V.

    1976-01-01

    This Technical Progress Report represents a small but important part of the overall progress and research effort of this contract. It outlines the methods used to produce one 1:12,000 colored vegetation map of the Rocky Flats site and its surrounding area and six black and white 1:500 vegetation maps of intensively studied experimental plots. These maps are already being used by various researchers and it is appropriate that the mapping methods be detailed prior to the final contract report so that their use may be optimised. (auth)

  18. Analysis of Changes in SUMO-2/3 Modification during Breast Cancer Progression and Metastasis

    DEFF Research Database (Denmark)

    Subramonian, Divya; Raghunayakula, Sarita; Olsen, Jesper V

    2014-01-01

    SUMOylation is an essential posttranslational modification and regulates many cellular processes. Dysregulation of SUMOylation plays a critical role in metastasis, yet how its perturbation affects this lethal process of cancer is not well understood. We found that SUMO-2/3 modification is greatly...... up-regulated in metastatic breast cancer cells compared with nonmetastatic control cells. To identify proteins differentially modified by SUMO-2/3 between metastatic and nonmetastatic cells, we established a method in which endogenous SUMO-2/3 conjugates are labeled by stable isotope labeling...... in metastatic cells. Targets with altered SUMOylation are involved in cell cycle, migration, inflammation, glycolysis, gene expression, and SUMO/ubiquitin pathways, suggesting that perturbations of SUMO-2/3 modification might contribute to metastasis by affecting these processes. Consistent with this, up...

  19. Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results.

    Science.gov (United States)

    Loibl, Sibylle; Turner, Nicholas C; Ro, Jungsil; Cristofanilli, Massimo; Iwata, Hiroji; Im, Seock-Ah; Masuda, Norikazu; Loi, Sherene; André, Fabrice; Harbeck, Nadia; Verma, Sunil; Folkerd, Elizabeth; Puyana Theall, Kathy; Hoffman, Justin; Zhang, Ke; Bartlett, Cynthia Huang; Dowsett, Mitchell

    2017-09-01

    The efficacy and safety of palbociclib, a cyclin-dependent kinase 4/6 inhibitor, combined with fulvestrant and goserelin was assessed in premenopausal women with advanced breast cancer (ABC) who had progressed on prior endocrine therapy (ET). One hundred eight premenopausal endocrine-refractory women ≥18 years with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) ABC were among 521 women randomized 2:1 (347:174) to fulvestrant (500 mg) ± goserelin with either palbociclib (125 mg/day orally, 3 weeks on, 1 week off) or placebo. This analysis assessed whether the overall tolerable safety profile and significant progression-free survival (PFS) improvement extended to premenopausal women. Potential drug-drug interactions (DDIs) and ovarian suppression with goserelin were assessed via plasma pharmacokinetics and biochemical analyses, respectively. (ClinicalTrials.gov identifier: NCT01942135) RESULTS: Median PFS for premenopausal women in the palbociclib (n = 72) versus placebo arm (n = 36) was 9.5 versus 5.6 months, respectively (hazard ratio, 0.50, 95% confidence interval: 0.29-0.87), and consistent with the significant PFS improvement in the same arms for postmenopausal women. Any-grade and grade ≤3 neutropenia, leukopenia, and infections were among the most frequent adverse events reported in the palbociclib arm with concurrent goserelin administration. Hormone concentrations were similar between treatment arms and confirmed sustained ovarian suppression. Clinically relevant DDIs were not observed. Palbociclib combined with fulvestrant and goserelin was an effective and well-tolerated treatment for premenopausal women with prior endocrine-resistant HR+/HER2- ABC. Inclusion of both premenopausal and postmenopausal women in pivotal combination ET trials facilitates access to novel drugs for young women and should be considered as a new standard for clinical trial design. PALOMA-3, the first registrational study

  20. The SMRT coregulator enhances growth of estrogen receptor-α-positive breast cancer cells by promotion of cell cycle progression and inhibition of apoptosis.

    Science.gov (United States)

    Blackmore, Julia K; Karmakar, Sudipan; Gu, Guowei; Chaubal, Vaishali; Wang, Liguo; Li, Wei; Smith, Carolyn L

    2014-09-01

    The SMRT coregulator functions as a dual coactivator and corepressor for estrogen receptor-α (ERα) in a gene-specific manner, and in several studies its elevated expression correlates with poor outcome for breast cancer patients. A specific role of SMRT in breast cancer progression has not been elucidated, but SMRT knock-down limits estradiol-dependent growth of MCF-7 breast cancer cells. In this study, small-interfering RNA (siRNA) and short-hairpin RNA (shRNA) approaches were used to determine the effects of SMRT depletion on growth of ERα-positive MCF-7 and ZR-75-1 breast cancer cells, as well as the ERα-negative MDA-MB-231 breast cancer line. Depletion of SMRT inhibited growth of ERα-positive cells grown in monolayer but had no effect on growth of the ERα-negative cells. Reduced SMRT levels also negatively impacted the anchorage-independent growth of MCF-7 cells as assessed by soft agar colony formation assays. The observed growth inhibitions were due to a loss of estradiol-induced progression through the G1/S transition of the cell cycle and increased apoptosis in SMRT-depleted compared with control cells. Gene expression analyses indicated that SMRT inhibits apoptosis by a coordinated regulation of genes involved in apoptosis. Functioning as a dual coactivator for anti-apoptotic genes and corepressor for pro-apoptotic genes, SMRT can limit apoptosis. Together these data indicate that SMRT promotes breast cancer progression through multiple pathways leading to increased proliferation and decreased apoptosis.

  1. Validation of claims algorithms for progression to metastatic cancer in patients with breast, non-small cell lung, and colorectal cancer

    Directory of Open Access Journals (Sweden)

    Beth L. Nordstrom

    2016-02-01

    Full Text Available Background: Validated algorithms for identifying progression to metastatic cancer could permit the use of administrative claims databases for research in this area.Objective: To identify simple algorithms that could accurately detect cancer progression to metastatic breast, non-small cell lung, and colorectal cancer using medical and pharmacy claims data.Methods: Adults with stage I–III breast, non-small cell lung cancer (NSCLC, or colorectal cancer (CRC in the Geisinger Health System from 2004–2011 were selected. Evidence of progression was extracted via manual chart review as the reference standard. In addition to secondary malignancy diagnosis (ICD-9 code for metastases, diagnoses, procedures, and treatments were selected with clinician input as indicators of cancer progression. Random forests models provided variable importance scores. In addition to codes for secondary malignancy, several more complex algorithms were constructed and performance measures calculated.Results: Among those with breast cancer (17/502 [3.4%] progressed, the performance of a secondary malignancy code was suboptimal (sensitivity: 64.7%; specificity: 86.0%; positive predictive value [PPV]: 13.9; negative predictive value [NPV]: 98.6%; requiring malignancy at another site or initiation of immunotherapy increased PPV and specificity but decreased sensitivity. For NSCLC (61/236 [25.8%] progressed codes for secondary malignancy alone (PPV: 47.4%; NPV: 84.8%; sensitivity: 60.7%; specificity: 76.6% performed similarly or better than more complex algorithms. For CRC (33/276 [12.0%] progressed, secondary malignancy codes had good specificity (92.7% and NPV (92.3% but low sensitivity (42.4% and PPV (43.8%; an algorithm with change in chemotherapy increased sensitivity but decreased other metrics.Conclusions: Selected algorithms performed similarly to the presence of a secondary tumor diagnosis code, with low sensitivity/PPV and higher specificity/NPV. Accurate

  2. Novel CXCR3/CXCR7-Directed Biological Antagonist for Inhibition of Breast Cancer Progression

    Science.gov (United States)

    2012-09-01

    to regulate cell functions including: proliferation, survival, membrane trafficking and cytoskeletal structures (Cantrell, 2001). Src activity is...the role of CXCR4 in BrCa progression. 4 Figure 2. CXCR7 (G protein-independent) cell-signaling pathways. The GPCR , CXCR7 is hypothesized to...transcriptional and/or -translational modification of chemokine receptors may occur, which would not doubt effect their function . Receptor expression

  3. Homocysteine Is an Oncometabolite in Breast Cancer, Which Promotes Tumor Progression and Metastasis

    Science.gov (United States)

    2014-09-01

    to public health. Plasma homocysteine levels are also increased when dietary intake of three vitamins , folic acid, vitamin B12, and pyridoxine, is...low. Therefore, the nutritional status of individuals in terms of these three vitamins will also have an impact on the growth, progression, and...patients to take vitamin supplements to improve their nutritional status of folic acid, vitamin B12, and pyridoxine so as to reduce the homocysteine

  4. Technical Note: Skin thickness measurements using high-resolution flat-panel cone-beam dedicated breast CT

    Energy Technology Data Exchange (ETDEWEB)

    Shi Linxi; Vedantham, Srinivasan; Karellas, Andrew [Department of Radiology, University of Massachusetts Medical School, Worcester, Massachusetts 01655 (United States); O' Connell, Avice M. [Department of Radiology, University of Rochester Medical Center, Rochester, New York 14642 (United States)

    2013-03-15

    Purpose: To determine the mean and range of location-averaged breast skin thickness using high-resolution dedicated breast CT for use in Monte Carlo-based estimation of normalized glandular dose coefficients. Methods: This study retrospectively analyzed image data from a clinical study investigating dedicated breast CT. An algorithm similar to that described by Huang et al.['The effect of skin thickness determined using breast CT on mammographic dosimetry,' Med. Phys. 35(4), 1199-1206 (2008)] was used to determine the skin thickness in 137 dedicated breast CT volumes from 136 women. The location-averaged mean breast skin thickness for each breast was estimated and the study population mean and range were determined. Pathology results were available for 132 women, and were used to investigate if the distribution of location-averaged mean breast skin thickness varied with pathology. The effect of surface fitting to account for breast curvature was also studied. Results: The study mean ({+-} interbreast SD) for breast skin thickness was 1.44 {+-} 0.25 mm (range: 0.87-2.34 mm), which was in excellent agreement with Huang et al. Based on pathology, pair-wise statistical analysis (Mann-Whitney test) indicated that at the 0.05 significance level, there were no significant difference in the location-averaged mean breast skin thickness distributions between the groups: benign vs malignant (p= 0.223), benign vs hyperplasia (p= 0.651), hyperplasia vs malignant (p= 0.229), and malignant vs nonmalignant (p= 0.172). Conclusions: Considering this study used a different clinical prototype system, and the study participants were from a different geographical location, the observed agreement between the two studies suggests that the choice of 1.45 mm thick skin layer comprising the epidermis and the dermis for breast dosimetry is appropriate. While some benign and malignant conditions could cause skin thickening, in this study cohort the location-averaged mean breast skin

  5. Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women.

    Science.gov (United States)

    Colak, Dilek; Nofal, Asmaa; Albakheet, Albandary; Nirmal, Maimoona; Jeprel, Hatim; Eldali, Abdelmoneim; Al-Tweigeri, Taher; Tulbah, Asma; Ajarim, Dahish; Malik, Osama Al; Inan, Mehmet S; Kaya, Namik; Park, Ben H; Bin Amer, Suad M

    2013-01-01

    Breast cancer in young women is more aggressive with a poorer prognosis and overall survival compared to older women diagnosed with the disease. Despite recent research, the underlying biology and molecular alterations that drive the aggressive nature of breast tumors associated with breast cancer in young women have yet to be elucidated. In this study, we performed transcriptomic profile and network analyses of breast tumors arising in Middle Eastern women to identify age-specific gene signatures. Moreover, we studied molecular alterations associated with cancer progression in young women using cross-species comparative genomics approach coupled with copy number alterations (CNA) associated with breast cancers from independent studies. We identified 63 genes specific to tumors in young women that showed alterations distinct from two age cohorts of older women. The network analyses revealed potential critical regulatory roles for Myc, PI3K/Akt, NF-κB, and IL-1 in disease characteristics of breast tumors arising in young women. Cross-species comparative genomics analysis of progression from pre-invasive ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) revealed 16 genes with concomitant genomic alterations, CCNB2, UBE2C, TOP2A, CEP55, TPX2, BIRC5, KIAA0101, SHCBP1, UBE2T, PTTG1, NUSAP1, DEPDC1, HELLS, CCNB1, KIF4A, and RRM2, that may be involved in tumorigenesis and in the processes of invasion and progression of disease. Array findings were validated using qRT-PCR, immunohistochemistry, and extensive in silico analyses of independently performed microarray datasets. To our knowledge, this study provides the first comprehensive genomic analysis of breast cancer in Middle Eastern women in age-specific cohorts and potential markers for cancer progression in young women. Our data demonstrate that cancer appearing in young women contain distinct biological characteristics and deregulated signaling pathways. Moreover, our integrative genomic and cross

  6. Abrogation of junctional adhesion molecule-A expression induces cell apoptosis and reduces breast cancer progression.

    Directory of Open Access Journals (Sweden)

    Masato Murakami

    Full Text Available Intercellular junctions promote homotypic cell to cell adhesion and transfer intracellular signals which control cell growth and apoptosis. Junctional adhesion molecule-A (JAM-A is a transmembrane immunoglobulin located at tight junctions of normal epithelial cells of mammary ducts and glands. In the present paper we show that JAM-A acts as a survival factor for mammary carcinoma cells. JAM-A null mice expressing Polyoma Middle T under MMTV promoter develop significantly smaller mammary tumors than JAM-A positive mice. Angiogenesis and inflammatory or immune infiltrate were not statistically modified in absence of JAM-A but tumor cell apoptosis was significantly increased. Tumor cells isolated from JAM-A null mice or 4T1 cells incubated with JAM-A blocking antibodies showed reduced growth and increased apoptosis which paralleled altered junctional architecture and adhesive function. In a breast cancer clinical data set, tissue microarray data show that JAM-A expression correlates with poor prognosis. Gene expression analysis of mouse tumor samples showed a correlation between genes enriched in human G3 tumors and genes over expressed in JAM-A +/+ mammary tumors. Conversely, genes enriched in G1 human tumors correlate with genes overexpressed in JAM-A-/- tumors. We conclude that down regulation of JAM-A reduces tumor aggressive behavior by increasing cell susceptibility to apoptosis. JAM-A may be considered a negative prognostic factor and a potential therapeutic target.

  7. In Vivo Investigation of Breast Cancer Progression by Use of an Internal Control

    Directory of Open Access Journals (Sweden)

    John Baeten

    2009-03-01

    Full Text Available Optical imaging of breast cancer has been considered for detecting functional and molecular characteristics of diseases in clinical and preclinical settings. Applied to laboratory research, photonic investigations offer a highly versatile tool for preclinical imaging and drug discovery. A particular advantage of the optical method is the availability of multiple spectral bands for performing imaging. Herein, we capitalize on this feature to demonstrate how it is possible to use different wavelengths to offer internal controls and significantly improve the observation accuracy in molecular imaging applications. In particular, we show the independent in vivo detection of cysteine proteases along with tumor permeability and interstitial volume measurements using a dual-wavelength approach. To generate results with a view toward clinically geared studies, a transgenic Her2/neu mouse model that spontaneously developed mammary tumors was used. In vivo findings were validated against conventional ex vivo tests such as histology and Western blot analyses. By correcting for biodistribution parameters, the dual-wavelength method increases the accuracy of molecular observations by separating true molecular target from probe biodistribution. As such, the method is highly appropriate for molecular imaging studies where often probe delivery and target presence are not independently assessed. On the basis of these findings, we propose the dual-wavelength/normalization approach as an essential method for drug discovery and preclinical imaging studies.

  8. Mammography with and without radiolucent positioning sheets : Comparison of projected breast area, pain experience, radiation dose and technical image quality

    NARCIS (Netherlands)

    Timmers, Janine; ten Voorde, Marloes; van Engen, Ruben E.; van Landsveld-Verhoeven, Cary; Pijnappel, Ruud; Droogh-de Greve, Kitty; den Heeten, Gerard J.; Broeders, Mireille J. M.

    2015-01-01

    Purpose: To compare projected breast area, image quality, pain experience and radiation dose between mammography performed with and without radiolucent positioning sheets. Methods: 184 women screened in the Dutch breast screening programme (May-June 2012) provided written informed consent to have

  9. Technical reliability of geological disposal for high-level radioactive wastes in Japan. The second progress report. Part 1. Geological environment of Japan

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1999-11-01

    Based on the Advisory Committee Report on Nuclear Fuel Cycle Backend Policy submitted to the Japanese Government in 1997, JNC documents the progress of research and development program in the form of the second progress report (the first one published in 1992). It summarizes an evaluation of the technical reliability and safety of the geological disposal concept for high-level radioactive wastes (HLW) in Japan. The present document, the part 1 of the progress report, describes first in detail the role of geological environment in high-level radioactive wastes disposal, the features of Japanese geological environment, and programs to proceed the investigation in geological environment. The following chapter summarizes scientific basis for possible existence of stable geological environment, stable for a long period needed for the HLW disposal in Japan including such natural phenomena as volcano and faults. The results of the investigation of the characteristics of bed-rocks and groundwater are presented. These are important for multiple barrier system construction of deep geological disposal. The report furthermore describes the present status of technical and methodological progress in investigating geological environment and finally on the results of natural analog study in Tono uranium deposits area. (Ohno, S.)

  10. The rs4646 and rs12592697 Polymorphisms in CYP19A1 Are Associated with Disease Progression among Patients with Breast Cancer from Different Racial/ethnic Backgrounds.

    Directory of Open Access Journals (Sweden)

    Reina Armamento-Villareal

    2016-12-01

    Full Text Available Given the racial/ethnic disparities in breast cancer, we evaluated the association between CYP19A1 single nucleotide polymorphisms (SNPs on disease progression in women with breast cancer from different racial/ethnic backgrounds. This is a cross-sectional analysis of data from 327 women with breast cancer in the Expanded Breast Cancer Registry program of the University of New Mexico. Stored DNA samples were analyzed for CYP19A1 SNPs using a custom designed microarray panel. Genotype-phenotype correlations were analyzed. Of the 384 SNPs, 2 were associated with clinically significant outcomes, the rs4646 and rs12592697. The T allele for the rs4646 was associated with advanced stage of the disease at the time of presentation (odds ratio OR:1.8, confidence intervals CI: 1.05-3.13, p<0.05 and a more progressive disease (OR: 2.1 CI: 1.1-4.0, p=0.04. For the rs12592697, the variant T allele was more frequent in Hispanic women and associated with a more progressive disease (OR: 2.05 CI: 1.0-4.0, p=0.04. However, further analysis according to menopausal status showed that the association between these 2 SNPs with disease progression or the stage at diagnosis are confined only to postmenopausal women. The odds ratios of disease progression among postmenopausal women carrying the T allele for the rs4646 and rs12592697 are 3.05 (1.21, 7.74, p=0.02 and 3.80 (1.24, 11.6, p=0.02, respectively. Regardless, differences in disease progression among the different genotypes for both SNPs disappeared after adjustment for treatment. In summary, the rs4646 and the rs12592697 SNPs in CYP19A1 are associated with differences in disease progression in postmenopausal women. However, treatment appears to mitigate the differences in genetic risk.ClinicalTrials.govs Identifier: NCT00322894(https://clinicaltrials.gov/ct2/show/NCT00322894?term=new+mexico+breast+cancer+registry&rank=1

  11. Great Plains Coal Gasification Project: Quarterly technical progress report, April-June 1988 (Fourth fiscal quarter, 1987-1988)

    Energy Technology Data Exchange (ETDEWEB)

    1988-07-29

    This progress report describes the operation of the Great Plains Gasification Plant, including lignite coal production, SNG production, gas quality, by-products, and certain problems encountered. (LTN)

  12. Technical reliability of geological disposal for high-level radioactive wastes in Japan. The second progress report. Introductory part and summaries

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1999-11-01

    Based on the Advisory Committee Report on Nuclear Fuel Cycle Backend Policy submitted to the Japanese Government in 1997, JNC documents the progress of research and development program in the form of the second progress report (the first one published in 1992). It summarizes an evaluation of the technical reliability and safety of the geological disposal concept for high-level radioactive wastes (HLW) in Japan and comprises seven chapters. Chapter I briefly describes the importance of HLW management in promoting nuclear energy utilization. According to the long-term program, the HLW separated from spent fuels at reprocessing plants is to be vitrified and stored for a period of 30 to 50 years to allow cooling, then be disposed of in a deep geological formation. Chapter II mainly explains the concepts of geological disposal in Japan. Chapters III to V are devoted to discussions on three important technical elements (the geological environment of Japan, engineering technology and safety assessment of the geological disposal system) which are necessary for reliable realization of the geological disposal concept. Chapter VI demonstrates the technical ground for site selection and for setup of safety standards of the disposal. Chapter VII summarizes together with plans for future research and development. (Ohno, S.)

  13. SPACE-R Thermionic Space Nuclear Power System: Design and Technology Demonstration Program. Semiannual technical progress report for period ending March 1993

    Energy Technology Data Exchange (ETDEWEB)

    1993-05-01

    This Semiannual Technical Progress Report summarizes the technical progress and accomplishments for the Thermionic Space Nuclear Power System (TI-SNPS) Design and Technology Demonstration Program of the Prime Contractor, Space Power Incorporated (SPI), its subcontractors and supporting National Laboratories during the first half of the Government Fiscal Year (GFY) 1993. SPI`s subcontractors and supporting National Laboratories include: Babcock & Wilcox for the reactor core and externals; Space Systems/Loral for the spacecraft integration; Thermocore for the radiator heat pipes and the heat exchanger; INERTEK of CIS for the TFE, core elements and nuclear tests; Argonne National Laboratories for nuclear safety, physics and control verification; and Oak Ridge National laboratories for materials testing. Parametric trade studies are near completion. However, technical input from INERTEK has yet to be provided to determine some of the baseline design configurations. The INERTEK subcontract is expected to be initiated soon. The Point Design task has been initiated. The thermionic fuel element (TFE) is undergoing several design iterations. The reactor core vessel analysis and design has also been started.

  14. Epithelial to Mesenchymal Transition Promotes Breast Cancer Progression via a Fibronectin-dependent STAT3 Signaling Pathway*

    Science.gov (United States)

    Balanis, Nikolas; Wendt, Michael K.; Schiemann, Barbara J.; Wang, Zhenghe; Schiemann, William P.; Carlin, Cathleen R.

    2013-01-01

    We previously established that overexpression of the EGF receptor (EGFR) is sufficient to induce tumor formation by otherwise nontransformed mammary epithelial cells, and that the initiation of epithelial-mesenchymal transition (EMT) is capable of increasing the invasion and metastasis of these cells. Using this breast cancer (BC) model, we find that in addition to EGF, adhesion to fibronectin (FN) activates signal transducer and activator of transcription 3 (STAT3) through EGFR-dependent and -independent mechanisms. Importantly, EMT facilitated a signaling switch from SRC-dependent EGFR:STAT3 signaling in pre-EMT cells to EGFR-independent FN:JAK2:STAT3 signaling in their post-EMT counterparts, thereby sensitizing these cells to JAK2 inhibition. Accordingly, human metastatic BC cells that failed to activate STAT3 downstream of EGFR did display robust STAT3 activity upon adhesion to FN. Furthermore, FN enhanced outgrowth in three-dimensional organotypic cultures via a mechanism that is dependent upon β1 integrin, Janus kinase 2 (JAK2), and STAT3 but not EGFR. Collectively, our data demonstrate that matrix-initiated signaling is sufficient to drive STAT3 activation, a reaction that is facilitated by EMT during BC metastatic progression. PMID:23653350

  15. Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway.

    Science.gov (United States)

    Balanis, Nikolas; Wendt, Michael K; Schiemann, Barbara J; Wang, Zhenghe; Schiemann, William P; Carlin, Cathleen R

    2013-06-21

    We previously established that overexpression of the EGF receptor (EGFR) is sufficient to induce tumor formation by otherwise nontransformed mammary epithelial cells, and that the initiation of epithelial-mesenchymal transition (EMT) is capable of increasing the invasion and metastasis of these cells. Using this breast cancer (BC) model, we find that in addition to EGF, adhesion to fibronectin (FN) activates signal transducer and activator of transcription 3 (STAT3) through EGFR-dependent and -independent mechanisms. Importantly, EMT facilitated a signaling switch from SRC-dependent EGFR:STAT3 signaling in pre-EMT cells to EGFR-independent FN:JAK2:STAT3 signaling in their post-EMT counterparts, thereby sensitizing these cells to JAK2 inhibition. Accordingly, human metastatic BC cells that failed to activate STAT3 downstream of EGFR did display robust STAT3 activity upon adhesion to FN. Furthermore, FN enhanced outgrowth in three-dimensional organotypic cultures via a mechanism that is dependent upon β1 integrin, Janus kinase 2 (JAK2), and STAT3 but not EGFR. Collectively, our data demonstrate that matrix-initiated signaling is sufficient to drive STAT3 activation, a reaction that is facilitated by EMT during BC metastatic progression.

  16. Correlations of differentially expressed gap junction connexins Cx26, Cx30, Cx32, Cx43 and Cx46 with breast cancer progression and prognosis.

    Directory of Open Access Journals (Sweden)

    Ivett Teleki

    Full Text Available Connexins and their cell membrane channels contribute to the control of cell proliferation and compartmental functions in breast glands and their deregulation is linked to breast carcinogenesis. Our aim was to correlate connexin expression with tumor progression and prognosis in primary breast cancers.Meta-analysis of connexin isotype expression data of 1809 and 1899 breast cancers from the Affymetrix and Illumina array platforms, respectively, was performed. Expressed connexins were also monitored at the protein level in tissue microarrays of 127 patients equally representing all tumor grades, using immunofluorescence and multilayer, multichannel digital microscopy. Prognostic correlations were plotted in Kaplan-Meier curves and tested using the log-rank test and cox-regression analysis in univariate and multivariate models.The expression of GJA1/Cx43, GJA3/Cx46 and GJB2/Cx26 and, for the first time, GJA6/Cx30 and GJB1/Cx32 was revealed both in normal human mammary glands and breast carcinomas. Within their subfamilies these connexins can form homo- and heterocellular epithelial channels. In cancer, the array datasets cross-validated each other's prognostic results. In line with the significant correlations found at mRNA level, elevated Cx43 protein levels were linked with significantly improved breast cancer outcome, offering Cx43 protein detection as an independent prognostic marker stronger than vascular invasion or necrosis. As a contrary, elevated Cx30 mRNA and protein levels were associated with a reduced disease outcome offering Cx30 protein detection as an independent prognostic marker outperforming mitotic index and necrosis. Elevated versus low Cx43 protein levels allowed the stratification of grade 2 tumors into good and poor relapse free survival subgroups, respectively. Also, elevated versus low Cx30 levels stratified grade 3 patients into poor and good overall survival subgroups, respectively.Differential expression of Cx43 and Cx

  17. ATIP3, a novel prognostic marker of breast cancer patient survival, limits cancer cell migration and slows metastatic progression by regulating microtubule dynamics.

    Science.gov (United States)

    Molina, Angie; Velot, Lauriane; Ghouinem, Lydia; Abdelkarim, Mohamed; Bouchet, Benjamin Pierre; Luissint, Anny-Claude; Bouhlel, Imène; Morel, Marina; Sapharikas, Elène; Di Tommaso, Anne; Honoré, Stéphane; Braguer, Diane; Gruel, Nadège; Vincent-Salomon, Anne; Delattre, Olivier; Sigal-Zafrani, Brigitte; André, Fabrice; Terris, Benoit; Akhmanova, Anna; Di Benedetto, Mélanie; Nahmias, Clara; Rodrigues-Ferreira, Sylvie

    2013-05-01

    Metastasis, a fatal complication of breast cancer, does not fully benefit from available therapies. In this study, we investigated whether ATIP3, the major product of 8p22 MTUS1 gene, may be a novel biomarker and therapeutic target for metastatic breast tumors. We show that ATIP3 is a prognostic marker for overall survival among patients with breast cancer. Notably, among metastatic tumors, low ATIP3 levels associate with decreased survival of the patients. By using a well-defined experimental mouse model of cancer metastasis, we show that ATIP3 expression delays the time-course of metastatic progression and limits the number and size of metastases in vivo. In functional studies, ATIP3 silencing increases breast cancer cell migration, whereas ATIP3 expression significantly reduces cell motility and directionality. We report here that ATIP3 is a potent microtubule-stabilizing protein whose depletion increases microtubule dynamics. Our data support the notion that by decreasing microtubule dynamics, ATIP3 controls the ability of microtubule tips to reach the cell cortex during migration, a mechanism that may account for reduced cancer cell motility and metastasis. Of interest, we identify a functional ATIP3 domain that associates with microtubules and recapitulates the effects of ATIP3 on microtubule dynamics, cell proliferation, and migration. Our study is a major step toward the development of new personalized treatments against metastatic breast tumors that have lost ATIP3 expression.

  18. Materials compatibility and lubricants research on CFC-refrigerant substitutes. Technical progress report, 1 April 1995--30 June 1995

    Energy Technology Data Exchange (ETDEWEB)

    Szymurski, S.R.; Hourahan, G.C.; Godwin, D.S.; Amrane, K.

    1995-08-01

    The Materials Compatibility and Lubricants Research (MCLR) program supports critical research to accelerate the introduction of CFC and HCFC refrigerant substitutes. The MCLR program addresses refrigerant and lubricant properties and materials compatibility. The primary elements of the work include data collection and dissemination, materials compatibility testing, and methods development. The work is guided by an Advisory Committee consisting of technical experts from the refrigeration and air-conditioning industry and government agencies. The AirConditioning and Refrigeration Technology Institute, Inc., (ARTI) manages and contracts multiple research projects and a data collection and dissemination effort. Detailed results from these projects are reported in technical reports prepared by each subcontractor.

  19. Effects of progressive muscle relaxation, guided imagery and deep diaphragmatic breathing on quality of life in elderly with breast or prostate cancer.

    Science.gov (United States)

    Shahriari, Mohsen; Dehghan, Mojtaba; Pahlavanzadeh, Saeid; Hazini, Abdolrahim

    2017-01-01

    Due to the increasing number of elderly and an increase in the number of cases of cancer by age, cancer is a common problem in the elderly. For elderly patients with cancer, the disease and its treatment can have long-term negative effects on their quality of life (QoL). The purpose of this study was to evaluate the effect of progressive muscle relaxation, body image and deep diaphragmatic breathing on the QoL in the elderly with cancer. This study was a randomized controlled trial in which 50 elderly patients with breast or prostate cancer were randomized into study and control groups. Progressive muscle relaxation, guided imagery, and deep diaphragmatic breathing were given to the study group, but not to the control group. The effect of the progressive muscle relaxation, guided imagery and deep diaphragmatic breathing was measured at three different time points. European Organization for Research and Treatment of Cancer and QoL Questionnaire-Core questionnaires was completed before, after and 6 weeks after the intervention for the patients in both groups simultaneously. The data were analyzed by SPSS. There was statistically significant improvement in QoL (P progressive muscle relaxation, guided imagery and deep diaphragmatic breathing intervention. The findings indicated that concurrent application of progressive muscle relaxation, guided imagery, and deep diaphragmatic breathing would improve QoL in the elderly with breast or prostate cancer.

  20. Mammography with and without radiolucent positioning sheets: Comparison of projected breast area, pain experience, radiation dose and technical image quality.

    Science.gov (United States)

    Timmers, Janine; Voorde, Marloes Ten; Engen, Ruben E van; Landsveld-Verhoeven, Cary van; Pijnappel, Ruud; Greve, Kitty Droogh-de; Heeten, Gerard J den; Broeders, Mireille J M

    2015-10-01

    To compare projected breast area, image quality, pain experience and radiation dose between mammography performed with and without radiolucent positioning sheets. 184 women screened in the Dutch breast screening programme (May-June 2012) provided written informed consent to have one additional image taken with positioning sheets. 5 cases were excluded (missing data). Pain was scored using the Numeric Rating Scale. Radiation dose was estimated using the Dance model and projected breast area using computer software. Two radiologists and two radiographers assessed image quality. With positioning sheets significantly more pectoral muscle, lateral and medial breast tissue was projected (CC-views) and more and deeper depicted pectoral muscle (MLO-views). In contrast, visibility of white and darker areas was better on images without positioning sheets, radiologists were therefore better able to detect abnormalities (MLO-views). Women experienced more pain with positioning sheets (MLO-views only, mean difference NRS 0.98; SD 1.71; p=0,00). Mammograms with positioning sheets showed more breast tissue. Increased breast thickness after compression with sheets resulted in less visibility of white and darker areas and thus reduced detection of abnormalities. Also, women experienced more pain (MLO-views) due to the sheet material. A practical consideration is the fact that more subcutaneous fat tissue and skin are being pulled forward leading to folds in the nipple area. On balance, improvement to the current design is required before implementation in screening practice can be considered. Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

  1. POC-scale testing of an advanced fine coal dewatering equipment/technique. Quarterly technical progress report 6, January--March 1996

    Energy Technology Data Exchange (ETDEWEB)

    Tao, D.; Groppo, J.G.; Parekh, B.K.

    1996-05-03

    Froth flotation technique is an effective and efficient process for recovering of ultra-fine clean coal. Economical dewatering of an ultra-fine clean coal product to a 20% level moisture will be an important step in successful implementation of the advanced cleaning processes. This project is a step in the Department of Energy`s program to show that ultra-clean coal could be effectively dewatered to 20% or lower moisture using either conventional or advanced dewatering techniques. The cost-sharing contract effort is for 36 months beginning September 30, 1994. This report discusses technical progress made during the quarter from January 1- March 31, 1996.

  2. Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells.

    Science.gov (United States)

    Katdare, Meena; Osborne, Michael; Telang, Nitin T

    2002-10-01

    In the multistep progressive pathogenesis of human breast cancer, comedo ductal carcinoma in situ (DCIS) represents a preinvasive precursor lesion for therapy resistant invasive cancer. Human tissue derived cell culture models exhibiting molecular similarities to clinical DCIS facilitate an important preclinical mechanistic approach for evaluation of preventive efficacy of natural and synthetic chemopreventive compounds. Natural phytochemicals present in fresh fruits, vegetables and grain products are likely to offer protection against cancer. The clinical efficacy of these natural phytochemicals, however, depends on extrapolation, and is therefore equivocal. The present study determined whether the natural soy isoflavone genistein (GEN) inhibited aberrant proliferation in 184-B5/HER cells (a model for human comedo DCIS) and identified possible mechanisms responsible for its efficacy. Human reduction mammoplasty derived HER-2/neu oncogene expressing preneoplastic 184-B5/HER cells represented the experimental system. Flow cytometry and cellular epifluorescence based assays were utilized to quantitate the alterations in cell cycle progression, cellular apoptosis, and in the status of cell cycle regulatory and apoptosis-associated gene product expression. The 184-B5/HER cells exhibited specific immunofluorescence to p185HER, p53, EGFR, but not to ERalpha, thus resembling comedo DCIS. Treatment of 184-B5/HER cells with GEN resulted in a dose-dependent decrease in the viable cell population, increase in the G0/G1:S + G2/M ratio and enhancement of sub G0/G1 (apoptotic population). Exposure to the maximum cytostatic 10 microM dose of GEN down-regulated HER-2/neu mediated signal transduction as evidenced by a 73.9% decrease (p=0.001) in p185HER specific, and a 89.8% decrease (p=0.001) in phosphotyrosine specific immunofluorescence. The increase in G0/G1:S + G2/M ratio in response to the treatment with 10 microM GEN was associated with a 85.5% decrease (p=0.001) in

  3. Changes in arm tissue composition with slowly progressive weight-lifting among women with breast cancer-related lymphedema.

    Science.gov (United States)

    Zhang, Xiaochen; Brown, Justin C; Paskett, Electra D; Zemel, Babette S; Cheville, Andrea L; Schmitz, Kathryn H

    2017-07-01

    Studies in breast cancer-related lymphedema (BRCL) have exclusively examined total arm volume, but not the specific tissue composition that contributes to total volume. We evaluated baseline differences in arm tissue composition [fat mass, lean mass, bone mineral content (BMC), and bone mineral density (BMD)] between the affected and unaffected arms in women with BRCL. We compared changes in arm tissue composition and self-reported lymphedema symptoms after 1 year of weight-lifting versus control. We utilized data from physical activity and lymphedema trial that included 141 women with BRCL. Arm tissue composition was quantified using dual-energy X-ray absorptiometry. The severity of lymphedema was quantified using self-report survey. Weight-lifting was performed at community fitness facilities. At baseline, the affected arm had more fat (∆ = 89.7 g; P composition of the affected arm was improved: lean mass (71.2 g; P = 0.01) and BMD (14.0 mg/cm 2 ; P = 0.02) increased, arm fat percentage decreased (-1.5%; P = 0.003). Composition of the unaffected arm was only improved in lean mass (65.2 g; P = 0·04). Increases in lean mass were associated with less severe BCRL symptoms. Among women with BRCL, slowly progressive weight-lifting could improve arm tissue composition. Changes in arm tissue composition predict changes in symptom burden. Investigating the combined effects of exercise and weight loss on arm tissue composition and BCRL symptoms may provide additional insight into the benefits of lifestyle modification on lymphedema biology.

  4. Markers of progression in early-stage invasive breast cancer: a predictive immunohistochemical panel algorithm for distant recurrence risk stratification.

    Science.gov (United States)

    Aleskandarany, Mohammed A; Soria, D; Green, A R; Nolan, C; Diez-Rodriguez, Maria; Ellis, I O; Rakha, E A

    2015-06-01

    Accurate distant metastasis (DM) prediction is critical for risk stratification and effective treatment decisions in breast cancer (BC). Many prognostic markers/models based on tissue marker studies are continually emerging using conventional statistical approaches analysing complex/dimensional data association with DM/poor prognosis. However, few of them have fulfilled satisfactory evidences for clinical application. This study aimed at building DM risk assessment algorithm for BC patients. A well-characterised series of early invasive primary operable BC (n = 1902), with immunohistochemical expression of a panel of biomarkers (n = 31) formed the material of this study. Decision tree algorithm was computed using WEKA software, utilising quantitative biomarkers' expression and the absence/presence of distant metastases. Fifteen biomarkers were significantly associated with DM, with six temporal subgroups characterised based on time to development of DM ranging from 15 years of follow-up. Of these 15 biomarkers, 10 had a significant expression pattern where Ki67LI, HER2, p53, N-cadherin, P-cadherin, PIK3CA and TOMM34 showed significantly higher expressions with earlier development of DM. In contrast, higher expressions of ER, PR and BCL2 were associated with delayed occurrence of DM. DM prediction algorithm was built utilising cases informative for the 15 significant markers. Four risk groups of patients were characterised. Three markers p53, HER2 and BCL2 predicted the probability of DM, based on software-generated cut-offs, with a precision rate of 81.1 % for positive predictive value and 77.3 %, for the negative predictive value. This algorithm reiterates the reported prognostic values of these three markers and underscores their central biological role in BC progression. Further independent validation of this pruned panel of biomarkers is therefore warranted.

  5. Development and process evaluation of improved Fischer-Tropsch slurry catalysts. Quarterly technical progress report, 1 October-31 December 1987

    Energy Technology Data Exchange (ETDEWEB)

    Withers, H.P. [Air Products and Chemicals, Inc., Allentown, PA (United States); Bukur, D.B.; Rosynek, M.P. [Texas A and M Univ., College Station, TX (United States)

    1987-12-31

    The objective of this contract is to develop a consistent technical data base on the use of iron-based catalysts in Fischer-Tropsch (FT) synthesis reactions. This data base will be developed to allow the unambiguous comparison of the performance of these catalysts with each other and with state-of-the-art iron catalyst compositions. Particular attention will be devoted to generating reproducible kinetic and selectivity data and to developing reproducible improved catalyst compositions.

  6. P38 delta MAPK promotes breast cancer progression and lung metastasis by enhancing cell proliferation and cell detachment.

    Science.gov (United States)

    Wada, M; Canals, D; Adada, M; Coant, N; Salama, M F; Helke, K L; Arthur, J S; Shroyer, K R; Kitatani, K; Obeid, L M; Hannun, Y A

    2017-11-23

    The protein p38 mitogen-activated protein kinase (MAPK) delta isoform (p38δ) is a poorly studied member of the MAPK family. Data analysis from The Cancer Genome Atlas database revealed that p38δ is highly expressed in all types of human breast cancers. Using a human breast cancer tissue array, we confirmed elevation in cancer tissue. The breast cancer mouse model, MMTV-PyMT (PyMT), developed breast tumors with lung metastasis; however, mice deleted in p38δ (PyMT/p38δ -/- ) exhibited delayed primary tumor formation and highly reduced lung metastatic burden. At the cellular level, we demonstrate that targeting of p38δ in breast cancer cells, MCF-7 and MDA-MB-231 resulted in a reduced rate of cell proliferation. In addition, cells lacking p38δ also displayed an increased cell-matrix adhesion and reduced cell detachment. This effect on cell adhesion was molecularly supported by the regulation of the focal adhesion kinase by p38δ in the human breast cell lines. These studies define a previously unappreciated role for p38δ in breast cancer development and evolution by regulating tumor growth and altering metastatic properties. This study proposes MAPK p38δ protein as a key factor in breast cancer. Lack of p38δ resulted in reduced primary tumor size and blocked the metastatic potential to the lungs.

  7. Technical Note: Validation of two methods to determine contact area between breast and compression paddle in mammography.

    Science.gov (United States)

    Branderhorst, Woutjan; de Groot, Jerry E; van Lier, Monique G J T B; Highnam, Ralph P; den Heeten, Gerard J; Grimbergen, Cornelis A

    2017-08-01

    To assess the accuracy of two methods of determining the contact area between the compression paddle and the breast in mammography. An accurate method to determine the contact area is essential to accurately calculate the average compression pressure applied by the paddle. For a set of 300 breast compressions, we measured the contact areas between breast and paddle, both capacitively using a transparent foil with indium-tin-oxide (ITO) coating attached to the paddle, and retrospectively from the obtained mammograms using image processing software (Volpara Enterprise, algorithm version 1.5.2). A gold standard was obtained from video images of the compressed breast. During each compression, the breast was illuminated from the sides in order to create a dark shadow on the video image where the breast was in contact with the compression paddle. We manually segmented the shadows captured at the time of x-ray exposure and measured their areas. We found a strong correlation between the manual segmentations and the capacitive measurements [r = 0.989, 95% CI (0.987, 0.992)] and between the manual segmentations and the image processing software [r = 0.978, 95% CI (0.972, 0.982)]. Bland-Altman analysis showed a bias of -0.0038 dm2 for the capacitive measurement (SD 0.0658, 95% limits of agreement [-0.1329, 0.1252]) and -0.0035 dm2 for the image processing software [SD 0.0962, 95% limits of agreement (-0.1921, 0.1850)]. The size of the contact area between the paddle and the breast can be determined accurately and precisely, both in real-time using the capacitive method, and retrospectively using image processing software. This result is beneficial for scientific research, data analysis and quality control systems that depend on one of these two methods for determining the average pressure on the breast during mammographic compression. © 2017 Sigmascreening B.V. Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine.

  8. A systematic assessment of the state of hazardous waste clean-up technologies. Quarterly technical progress report, April 1--June 30, 1993

    Energy Technology Data Exchange (ETDEWEB)

    Berg, M.T.; Reed, B.E.; Gabr, M.

    1993-07-01

    West Virginia University (WVU) and the US DOE Morgantown Energy Technology Center (METC) entered into a Cooperative Agreement on August 29, 1992 entitled ``Decontamination Systems Information and Research Programs.`` Stipulated within the Agreement is the requirement that WVU submit to METC a series of Technical Progress Report for Year 1 of the Agreement. This report reflects the progress and/or efforts performed on the following nine technical projects encompassed by the Year 1 Agreement for the period of April 1 through June 30, 1993: Systematic assessment of the state of hazardous waste clean-up technologies; site remediation technologies -- drain-enhanced soil flushing (DESF) for organic contaminants removal; site remediation technologies -- in situ bioremediation of organic contaminants; excavation systems for hazardous waste sites; chemical destruction of polychlorinated biphenyls; development of organic sensors -- monolayer and multilayer self-assembled films for chemical sensors; Winfield lock and dam remediation; Assessments of Technologies for hazardous waste site remediation -- non-treatment technologies and pilot scale test facility implementation; and remediation of hazardous sites with stream reforming.

  9. Development of a low noise 10K J-T refrigeration system. Technical progress report, 31 Aug-15 Oct 90

    Energy Technology Data Exchange (ETDEWEB)

    Little, W.A.

    1990-10-15

    This report summarizes work done on the development of a low noise, Joule-Thomson, microminiature refrigeration system. Progress has been made on the development of the pneumatic compressor drive system which will be used to operate the compressor to determine the compressor lifetime and refrigerator system performance. Work on the refrigerator itself also has progressed well with operation down to 20K now being achieved, and reliably reproduced. Work is underway on the heat exchanger section of the third stage of the refrigerator, the helium stage.

  10. Silicon ribbon growth by a capillary action shaping technique. Annual report (Quarterly technical progress report No. 9)

    Energy Technology Data Exchange (ETDEWEB)

    Schwuttke, G.H.; Ciszek, T.F.; Kran, A.

    1977-10-01

    Progress on the technological and economical assessment of ribbon growth of silicon by a capillary action shaping technique is reported. Progress in scale-up of the process from 50 mm to 100 mm ribbon widths is presented, the use of vitreous carbon as a crucible material is analyzed, and preliminary tests of CVD Si/sub 3/N/sub 4/ as a potential die material are reported. Diffusion length measurements by SEM, equipment and procedure for defect display under MOS structure in silicon ribbon for lifetime interpretation, and an assessment of ribbon technology are discussed. (WHK)

  11. Main research accomplishments since the grant was last reviewed competitively. [Final technical progress report, November 1, 1992--July 31, 1993

    Energy Technology Data Exchange (ETDEWEB)

    Prakash, L.

    1993-11-01

    This project deals with the characterization of DNA repair genes and their encoded proteins involved in the incision step of excision repair and in postreplication repair and mutagenesis following exposure to UV light in eukaryotes: the yeast Saccharomyces cerevisiae and humans. Summarized in this report is progress in achieving the goals of this project.

  12. Fulvestrant in women with advanced breast cancer after progression on prior aromatase inhibitor therapy: North Central Cancer Treatment Group Trial N0032.

    Science.gov (United States)

    Ingle, James N; Suman, Vera J; Rowland, Kendrith M; Mirchandani, Deepu; Bernath, Albert M; Camoriano, John K; Fishkin, Paul A S; Nikcevich, Daniel A; Perez, Edith A

    2006-03-01

    Fulvestrant is an antiestrogen that leads to estrogen receptor degradation and has demonstrated efficacy in breast cancer patients who have had disease recurrence or progression after tamoxifen. This study was designed to examine the efficacy and toxicity of fulvestrant in patients with disease progression on a third-generation aromatase inhibitor (AI). A one-stage phase II trial was conducted in postmenopausal women with measurable disease by Response Evaluation Criteria in Solid Tumors criteria who experienced disease progression after treatment with a third-generation AI and, at most, one additional hormonal agent. Tumors must have been estrogen receptor and/or progesterone receptor positive. The primary end point was objective response rate, and secondary end points were time to disease progression, survival, duration of response, and toxicity. Eighty patients were enrolled, and three were ineligible. Characteristics of the 77 eligible patients included median age of 68 years, performance score of 0 or 1 in 91% of patients, visceral dominant disease in 88% of patients, two prior hormonal treatments in 73% of patients, and prior chemotherapy for metastatic disease in 32% of patients. Eleven patients (14.3%) achieved a partial response, and 16 patients (20.8%) had stable disease for at least 6 months, for a clinical benefit rate of 35%. Antitumor activity seemed to be higher in women with prior treatment with AI alone compared with women whose prior treatment also included tamoxifen. Median time to progression was 3 months, and median survival time was 20.2 months. Fulvestrant was well tolerated. Fulvestrant is a well-tolerated treatment and has efficacy against breast cancers that have progressed after therapy with a third-generation AI.

  13. Omega-3 fatty acids reduce obesity-induced tumor progression independent of GPR120 in a mouse model of postmenopausal breast cancer.

    Science.gov (United States)

    Chung, H; Lee, Y S; Mayoral, R; Oh, D Y; Siu, J T; Webster, N J; Sears, D D; Olefsky, J M; Ellies, L G

    2015-07-01

    Obesity and inflammation are both risk factors for a variety of cancers, including breast cancer in postmenopausal women. Intake of omega-3 polyunsaturated fatty acids (ω-3 PUFAs) decreases the risk of breast cancer, and also reduces obesity-associated inflammation and insulin resistance, but whether the two effects are related is currently unknown. We tested this hypothesis in a postmenopausal breast cancer model using ovariectomized, immune-competent female mice orthotopically injected with Py230 mammary tumor cells. Obesity, whether triggered genetically or by high-fat diet (HFD) feeding, increased inflammation in the mammary fat pad and promoted mammary tumorigenesis. The presence of tumor cells in the mammary fat pad further enhanced the local inflammatory milieu. Tumor necrosis factor-alpha (TNF-α) was the most highly upregulated cytokine in the obese mammary fat pad, and we observed that TNF-α dose-dependently stimulated Py230 cell growth in vitro. An ω-3 PUFA-enriched HFD (referred to as fish oil diet, FOD) reduced inflammation in the obese mammary fat pad in the absence of tumor cells and inhibited Py230 tumor growth in vivo. Although some anti-inflammatory effects of ω-3 PUFAs were previously shown to be mediated by the G-protein-coupled receptor 120 (GPR120), the FOD reduced Py230 tumor burden in GPR120-deficient mice to a similar degree as observed in wild-type mice, indicating that the effect of FOD to reduce tumor growth does not require GPR120 in the host mouse. Instead, in vitro studies demonstrated that ω-3 PUFAs act directly on tumor cells to activate c-Jun N-terminal kinase, inhibit proliferation and induce apoptosis. Our results show that obesity promotes mammary tumor progression in this model of postmenopausal breast cancer and that ω-3 PUFAs, independent of GPR120, inhibit mammary tumor progression in obese mice.

  14. MiR-340 Inhibits Triple-Negative Breast Cancer Progression by Reversing EZH2 Mediated miRNAs Dysregulated Expressions.

    Science.gov (United States)

    Shi, Zhendong; Li, Yang; Qian, Xiaomin; Hu, Yunhui; Liu, Jingjing; Zhang, Sheng; Zhang, Jin

    2017-01-01

    The anti-tumor efficacy of miR-340 has been recently characterized in cancers. However, the underlying mechanisms of miR-340 inhibited cell growth and invasion in triple-negative breast cancer (TNBC) have not been well elucidated. In this study, we found that miR-340 expression was negatively correlated with EZH2 (Enhancer of zeste homolog 2) expression in TNBC tissues and cell lines. Subsequent luciferase reporter assay confirmed that EZH2 was a novel molecule target of miR-340. Upregulated miR-340 levels by mimics transfection significantly inhibited the MDA-MB-231 and MDA-MB-468 breast cancer cells proliferation, invasion and migration, and induced more cell apoptosis. Meanwhile, miR-340 inhibited the tumor growth in an orthotopic MDA-MB-231 breast cancer mouse model. Furthermore, we found the reduced EZH2 expression by miR-340 mimics transfection decreased the DNMT1, H3K27me3, β-catenin and P-STAT3 expressions, which ultimately resulted in miR-21 activity blockage and miR-200a/b expression upregulation. The results of rescue experiments further confirmed that miR-340 inhibited triple-negative breast cancer progression through targeting EZH2. Taken together, our results identified miR-340 as a tumor suppressor in TNBC, moreover, an EZH2 medicated regulatory loop was established. Post-transcriptional suppression of EZH2 expression not only blocked STAT3 mediated miR-21 trans-activation, but also reversed the miR-200a/b silencing via reducing DNMT1 and H3K27me3 expressions. MiR-21 inhibition and miR-200a/b expression triggered by miR-340 ultimately cooperated in the TNBC progression.

  15. Technical progress report of biological research on the Volcanic Island Surtsey and its environs for the period 1965--1978

    Energy Technology Data Exchange (ETDEWEB)

    Fridriksson, S.

    1978-01-01

    Progress is reported on the following research projects: changes in shoreline and surface of the island due to volcanic activity; colonization of microorganisms, algae, lichens, and vascular plants; introduction of insects and other arthropods by wind, water, and man; transport of invertebrates to the island by flotsam of the sea; species and nesting habits of birds on the island; behavior of seals on beaches of the island; and future trends of Surtsey ecosystems. (HLW)

  16. Research proposal and annual report No. 16. Part B. Technical progress, September 1, 1975--August 31, 1976

    Energy Technology Data Exchange (ETDEWEB)

    1976-06-01

    Progress is reported on the following research projects: RNA synthesis in yeast; regulation of nitrogen metabolism; biological toxicity of intracellular radioisotope decay; the mechanism of energy conversion in chloroplasts; promoting vibrations in spin-orbital coupling in vibrationally deficient molecules; electronic excitation and hydrogen bonding; macromolecular biophysics; the synthesis and maturation of RNA; electronic response properties of biomolecular systems; chromosome structure and function and chromosome damage; DNA replication and chromosome structure; and influence of phospholipids on the dynamic properties of rhodopsin. (HLW)

  17. Podoplanin increases the migration of human fibroblasts and affects the endothelial cell network formation: A possible role for cancer-associated fibroblasts in breast cancer progression.

    Science.gov (United States)

    Suchanski, Jaroslaw; Tejchman, Anna; Zacharski, Maciej; Piotrowska, Aleksandra; Grzegrzolka, Jedrzej; Chodaczek, Grzegorz; Nowinska, Katarzyna; Rys, Janusz; Dziegiel, Piotr; Kieda, Claudine; Ugorski, Maciej

    2017-01-01

    In our previous studies we showed that in breast cancer podoplanin-positive cancer-associated fibroblasts correlated positively with tumor size, grade of malignancy, lymph node metastasis, lymphovascular invasion and poor patients' outcome. Therefore, the present study was undertaken to assess if podoplanin expressed by fibroblasts can affect malignancy-associated properties of breast cancer cells. Human fibroblastic cell lines (MSU1.1 and Hs 578Bst) overexpressing podoplanin and control fibroblasts were co-cultured with breast cancer MDA-MB-231 and MCF7 cells and the impact of podoplanin expressed by fibroblasts on migration and invasiveness of breast cancer cells were studied in vitro. Migratory and invasive properties of breast cancer cells were not affected by the presence of podoplanin on the surface of fibroblasts. However, ectopic expression of podoplanin highly increases the migration of MSU1.1 and Hs 578Bst fibroblasts. The present study also revealed for the first time, that podoplanin expression affects the formation of pseudo tubes by endothelial cells. When human HSkMEC cells were co-cultured with podoplanin-rich fibroblasts the endothelial cell capillary-like network was characterized by significantly lower numbers of nodes and meshes than in co-cultures of endothelial cells with podoplanin-negative fibroblasts. The question remains as to how our experimental data can be correlated with previous clinical data showing an association between the presence of podoplanin-positive cancer-associated fibroblasts and progression of breast cancer. Therefore, we propose that expression of podoplanin by fibroblasts facilitates their movement into the tumor stroma, which creates a favorable microenvironment for tumor progression by increasing the number of cancer-associated fibroblasts, which produce numerous factors affecting proliferation, survival and invasion of cancer cells. In accordance with this, the present study revealed for the first time, that such

  18. Podoplanin increases the migration of human fibroblasts and affects the endothelial cell network formation: A possible role for cancer-associated fibroblasts in breast cancer progression.

    Directory of Open Access Journals (Sweden)

    Jaroslaw Suchanski

    Full Text Available In our previous studies we showed that in breast cancer podoplanin-positive cancer-associated fibroblasts correlated positively with tumor size, grade of malignancy, lymph node metastasis, lymphovascular invasion and poor patients' outcome. Therefore, the present study was undertaken to assess if podoplanin expressed by fibroblasts can affect malignancy-associated properties of breast cancer cells. Human fibroblastic cell lines (MSU1.1 and Hs 578Bst overexpressing podoplanin and control fibroblasts were co-cultured with breast cancer MDA-MB-231 and MCF7 cells and the impact of podoplanin expressed by fibroblasts on migration and invasiveness of breast cancer cells were studied in vitro. Migratory and invasive properties of breast cancer cells were not affected by the presence of podoplanin on the surface of fibroblasts. However, ectopic expression of podoplanin highly increases the migration of MSU1.1 and Hs 578Bst fibroblasts. The present study also revealed for the first time, that podoplanin expression affects the formation of pseudo tubes by endothelial cells. When human HSkMEC cells were co-cultured with podoplanin-rich fibroblasts the endothelial cell capillary-like network was characterized by significantly lower numbers of nodes and meshes than in co-cultures of endothelial cells with podoplanin-negative fibroblasts. The question remains as to how our experimental data can be correlated with previous clinical data showing an association between the presence of podoplanin-positive cancer-associated fibroblasts and progression of breast cancer. Therefore, we propose that expression of podoplanin by fibroblasts facilitates their movement into the tumor stroma, which creates a favorable microenvironment for tumor progression by increasing the number of cancer-associated fibroblasts, which produce numerous factors affecting proliferation, survival and invasion of cancer cells. In accordance with this, the present study revealed for the first

  19. Technical Note: Multipurpose CT, ultrasound, and MRI breast phantom for use in radiotherapy and minimally invasive interventions.

    Science.gov (United States)

    Ruschin, Mark; Davidson, Sean R H; Phounsy, William; Yoo, Tae Sun; Chin, Lee; Pignol, Jean-Philippe; Ravi, Ananth; McCann, Claire

    2016-05-01

    To develop a multipurpose gel-based breast phantom consisting of a simulated tumor with realistic imaging properties in CT, ultrasound and MRI, or a postsurgical cavity on CT. Applications for the phantom include: deformable image registration (DIR) quality assurance (QA), autosegmentation validation, and localization testing and training for minimally invasive image-guided procedures such as those involving catheter or needle insertion. A thermoplastic mask of a typical breast patient lying supine was generated and then filled to make an array of phantoms. The background simulated breast tissue consisted of 32.4 g each of ballistic gelatin (BG) powder and Metamusil™ (MM) dissolved in 800 ml of water. Simulated tumors were added using the following recipe: 12 g of barium sulfate (1.4% v/v) plus 0.000 14 g copper sulfate plus 0.7 g of MM plus 7.2 g of BG all dissolved in 75 ml of water. The phantom was evaluated quantitatively in CT by comparing Hounsfield units (HUs) with actual breast tissue. For ultrasound and MRI, the phantoms were assessed based on subjective image quality and signal-difference to noise (SDNR) ratio, respectively. The stiffness of the phantom was evaluated based on ultrasound elastography measurements to yield an average Young's modulus. In addition, subjective tactile assessment of phantom was performed under needle insertion. The simulated breast tissue had a mean background value of 24 HU on CT imaging, which more closely resembles fibroglandular tissue (40 HU) as opposed to adipose (-100 HU). The tumor had a mean CT number of 45 HU, which yielded a qualitatively realistic image contrast relative to the background either as an intact tumor or postsurgical cavity. The tumor appeared qualitatively realistic on ultrasound images, exhibiting hypoechoic characteristics compared to background. On MRI, the tumor exhibited a SDNR of 3.7. The average Young's modulus was computed to be 15.8 ± 0.7 kPa (1 SD). We have developed a process to

  20. Technical Note: Multipurpose CT, ultrasound, and MRI breast phantom for use in radiotherapy and minimally invasive interventions

    Energy Technology Data Exchange (ETDEWEB)

    Ruschin, Mark, E-mail: Mark.Ruschin@sunnybrook.ca; Chin, Lee; Ravi, Ananth; McCann, Claire [Department of Medical Physics, Sunnybrook Odette Cancer Centre, Toronto, Ontario M4N 3M5, Canada and Department of Radiation Oncology, University of Toronto, Toronto, Ontario M4N 3M5 (Canada); Davidson, Sean R. H. [Techna Institute, University Health Network, Toronto, Ontario M5G 1P5 (Canada); Phounsy, William [Department of Physics, Ryerson University, Toronto, Ontario M5B 2K3 (Canada); Yoo, Tae Sun [Institute of Health Policy, University of Toronto, Toronto, Ontario M5T 3M6 (Canada); Pignol, Jean-Philippe [Department of Radiation Oncology, Erasmus MC Cancer Institute, 3075 EA Rotterdam (Netherlands)

    2016-05-15

    Purpose: To develop a multipurpose gel-based breast phantom consisting of a simulated tumor with realistic imaging properties in CT, ultrasound and MRI, or a postsurgical cavity on CT. Applications for the phantom include: deformable image registration (DIR) quality assurance (QA), autosegmentation validation, and localization testing and training for minimally invasive image-guided procedures such as those involving catheter or needle insertion. Methods: A thermoplastic mask of a typical breast patient lying supine was generated and then filled to make an array of phantoms. The background simulated breast tissue consisted of 32.4 g each of ballistic gelatin (BG) powder and Metamusil™ (MM) dissolved in 800 ml of water. Simulated tumors were added using the following recipe: 12 g of barium sulfate (1.4% v/v) plus 0.000 14 g copper sulfate plus 0.7 g of MM plus 7.2 g of BG all dissolved in 75 ml of water. The phantom was evaluated quantitatively in CT by comparing Hounsfield units (HUs) with actual breast tissue. For ultrasound and MRI, the phantoms were assessed based on subjective image quality and signal-difference to noise (SDNR) ratio, respectively. The stiffness of the phantom was evaluated based on ultrasound elastography measurements to yield an average Young’s modulus. In addition, subjective tactile assessment of phantom was performed under needle insertion. Results: The simulated breast tissue had a mean background value of 24 HU on CT imaging, which more closely resembles fibroglandular tissue (40 HU) as opposed to adipose (−100 HU). The tumor had a mean CT number of 45 HU, which yielded a qualitatively realistic image contrast relative to the background either as an intact tumor or postsurgical cavity. The tumor appeared qualitatively realistic on ultrasound images, exhibiting hypoechoic characteristics compared to background. On MRI, the tumor exhibited a SDNR of 3.7. The average Young’s modulus was computed to be 15.8 ± 0.7 kPa (1 SD

  1. Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression

    National Research Council Canada - National Science Library

    Wendt, M K; Smith, J A; Schiemann, W P

    2010-01-01

    Transforming growth factor-β (TGF-β) and epidermal growth factor (EGF) have critical roles in regulating the metastasis of aggressive breast cancers, yet the impact of epithelial-mesenchymal transition (EMT) induced by TGF-β...

  2. Technical reliability of geological disposal for high-level radioactive wastes in Japan. The second progress report. Part 3. Safety assessment for geological disposal systems

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1999-11-01

    Based on the Advisory Committee Report on Nuclear Fuel Cycle Backend Policy submitted to the Japanese Government in 1997, JNC documents the progress of research and development program in the form of the second progress report (the first one published in 1992). It summarizes an evaluation of the technical reliability and safety of the geological disposal concept for high-level radioactive wastes (HLW) in Japan. The present document, the part 3 of the progress report, concerns safety assessment for geological disposal systems definitely introduced in part 1 and 2 of this series and consists of 9 chapters. Chapter I concerns the methodology for safety assessment while Chapter II deals with diversity and uncertainty about the scenario, the adequate model and the required data of the systems above. Chapter III summarizes the components of the geological disposal system. Chapter IV refers to the relationship between radioactive wastes and human life through groundwater, i.e. nuclide migration. In Chapter V is made a reference case which characterizes the geological environmental data using artificial barrier specifications. (Ohno. S.)

  3. Technical reliability of geological disposal for high-level radioactive wastes in Japan. The second progress report. Part 2. Engineering technology for geological disposal

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1999-11-01

    Based on the Advisory Committee Report on Nuclear Fuel Cycle Backend Policy submitted to the Japanese Government in 1997, JNC documents the progress of research and development program in the form of the second progress report (the first one published in 1992). It summarizes an evaluation of the technical reliability and safety of the deep geological disposal concept for high-level radioactive wastes (HLW) in Japan. The present document, part 2 of the progress report, concerns engineering aspect with reference to Japanese geological disposal plan, according to which the vitrified HLW will be disposed of into a deep, stable rock mass with thick containers and surrounding buffer materials at the depth of several hundred meters. It discusses on multi-barrier systems consisting of a series of engineered and natural barriers that will isolate radioactive nuclides effectively and retard their migrations to the biosphere environment. Performance of repository components, including specifications of containers for vitrified HLW and their overpacks under design as well as buffer material such as Japanese bentonite to be placed in between are described referring also to such possible problems as corrosion arising from the supposed system. It also presents plans and designs for underground disposal facilities, and the presumed management of the underground facilities. (Ohno, S.)

  4. Synthesis of oxygenate products for high volume fuels applications. Quarterly technical progress report, November 1, 1994--January 31, 1995

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1995-03-08

    The objective of this project is to develop high yield syntheses of oxygenate products that are liquid at room temperature using as starting materials dimethy ether (DME) or methanol. The identified products include: Dimethyl Carbonate (DMC), 1,1-Dimethoxyethane (DMOE), C{sub 2}{sup +} Alcohols/Ethers (C{sub 2}AE). The technical strategy is outlined below: (A) Synthesis of DMC via oxidative carbonylation of DME instead of methanol. Since this synthesis would not co-produce water as a byproduct, there is a potential for very high DME conversions in contrast to the low (ca 20%) conversions obtained in conventional plants. Technical emphasis will be placed on development of a supported copper catalyst with a capability for cleavage of DME into its chemisorbed organic moieties. (B) Synthesis of 1,1-dimethoxymethane (DMOE) from acetylene/CO/H{sub 2} process streams obtained from commercial methane oxidative pyrolysis processes. In the overall processing scheme the syngas would be converted to DME. The wet acetylene stream would be partially condensed to retain an equivalent of water and then condensed with DME to produce EMOE. (C) Direct conversion of DME or DME/methanol to ethanol/propanol or their methyl ethers. Under the influence of functionalized alcohol condensation catalysts developed exclusively at Amoco it should be possible to achieve direct conversion of dimethyl ether (or methanol) to ethanol/propanol and/or the methyl ethers of these alcohols. Although this reaction is not currently known, a combination of key catalyst components from identified systems should result in a DME conversion catalyst to C{sub 2}+ oxygenates. (D) Reaction of DME or acetylene with synthesis gas (CO/H{sub 2}) or methanol. A variety of catalysts will be tested for conversion of acetylene/CO/H{sub 2} or acetylene/methanol to propylene and conversion of DME/CO/H{sub 2} or DME/methanol to dimenthyoxymethane (DMM) and/or other oxygenates.

  5. Direct probing of chromatography columns by laser-induced fluorescence. Technical progress report, September 1, 1989--February 28, 1993

    Energy Technology Data Exchange (ETDEWEB)

    McGuffin, V.L.

    1992-12-07

    This report summarizes the progress and accomplishments of this research project from September 1, 1989 to February 28, 1993. During this period, we have accomplished all of the primary scientific objectives of the research proposal: (1) constructed and evaluated a laser-induced fluorescence detection system that allows direct examination of the chromatographic column, (2) examined nonequilibrium processes that occur upon solute injection and elution, (3) examined solute retention in liquid chromatography as a function of temperature and pressure, (4) examined solute zone dispersion in liquid chromatography as a function of temperature and pressure, and (5) developed appropriate theoretical models to describe these phenomena. In each of these studies, substantial knowledge has been gained of the fundamental processes that are responsible for chromatographic separations. In addition to these primary research objectives, we have made significant progress in three related areas: (1) examined pyrene as a fluorescent polarity probe insupercritical fluids and liquids as a function of temperature and pressure, (2) developed methods for the class-selective identification of polynuclear aromatic hydrocarbons in coal-derived fluids by microcolumn liquid chromatography with fluorescence quenching detection, and (3) developed methods for the determination of saturated and unsaturated (including omega-3) fatty acids in fish oil extracts by microcolumn liquid chromatography with laser-induced fluorescence detection. In these studies, the advanced separation and detection techniques developed in our laboratory are applied to practical problems of environmental and biomedical significance.

  6. Environmental assessment of Oklahoma abandoned drilling and production sites and associated public education outreach activities. Quarterly technical progress report, October--December 1995

    Energy Technology Data Exchange (ETDEWEB)

    Terry, M.

    1996-01-29

    Oklahoma oil producers and royalty owners are taking part in the nation`s first oil industry funded environmental cleanup and education program. The program is administered by the Oklahoma Energy Resources Board (OERB), a state agency which was created by the Oklahoma Independent Energy Education and Marketing Act. The purpose of this project will be accomplished through two primary objectives: (1) Conduct environmental assessment of abandoned oil and gas drilling and production sites where no responsible owner can be found and transfer environmental technology to oil and gas operators; and (2) Provide a comprehensive public education/outreach program to increase public awareness of the importance of the Oklahoma oil (and gas) industry. Technical progress is reported for these tasks.

  7. The main technical progress directions in air-jet engine design branch, which are worked out by the “Single theory of continuous flow propulsions”

    Directory of Open Access Journals (Sweden)

    Борис Шамшадович Мамедов

    2016-03-01

    Full Text Available The main technical progress directions in air-jet engine design branch, which are worked out by the “Single theory of continuous flow propulsions” are highlighted. They are connected with providing the fly security by air-jet engines gas-dynamic work steady increasing with full elimination zone of rigid (spring stroke in the cross section B-B of the air-jet engines, with bypass turbojet engine’s thrust increasing with simultaneously fuel consumption lowering, with inlet and outlet decibel characteristic and radial dementias lowering, with high pressure compressor’s last working wheels blades increasing, with regulating law air-jet engine’s introduction to provide maximum thrust with the purpose of flying (thrust efficiency increasing

  8. POC-scale testing of an advanced fine coal dewatering equipment/technique. Quarterly technical progress report 2, January 1995--March 1995

    Energy Technology Data Exchange (ETDEWEB)

    Groppo, J.G.; Parekh, B.K.

    1995-05-05

    Froth flotation technique is an effective and efficient process for recovering of ultra-fine (minus 74 {mu}m) clean coal. Economical dewatering of an ultra-fine clean coal product to a 20 percent level moisture will be an important step in successful implementation of the advanced cleaning processes. This project is a step in the Department of Energy`s program to show that ultra-clean coal could be effectively dewatered to 20 percent or lower moisture using either conventional or advanced dewatering techniques. The cost-sharing contract effort is for 36 months beginning September 30, 1994. This report discusses technical progress made during the quarter from January 1 to March 31, 1995.

  9. POC-scale testing of an advanced fine coal dewatering equipment/technique. Quarterly technical progress report, April 1996--June 1996

    Energy Technology Data Exchange (ETDEWEB)

    Tao, D.; Groppo, J.G.; Parekh, B.K.

    1996-07-31

    Froth flotation technique is an effective and efficient process for recovering of ultra-fine (minus 74 {mu}m) clean coal. Economical dewatering of an ultra-fine clean coal product to a 20 percent level moisture will be an important step in successful implementation of the advanced cleaning processes. This project is a step in the Department of Energy`s program to show that ultra-clean coal could be effectively dewatered to 20 percent or lower moisture using either conventional or advanced dewatering techniques. The cost sharing contract effort is for 36 months beginning September 30, 1994. This report discusses technical progress made during the quarter from April 1 - June 30, 1996.

  10. POC-scale testing of an advanced fine coal dewatering equipment/technique. Quarterly technical progress report, No. 4, July 1995--September 1995

    Energy Technology Data Exchange (ETDEWEB)

    Groppo, J.G.; Parekh, B.K.

    1995-11-06

    Froth flotation technique is an effective and efficient process for recovering of ultra-fine (minus 74 {mu}m) clean coal. Economical dewatering of an ultra-fine clean coal product to a 20 percent level moisture will be an important step in successful implementation of the advanced cleaning processes. This project is a step in the Department of Energy`s program to show that ultra-clean coal could be effectively dewatered to 20 percent or lower moisture using either conventional or advanced dewatering techniques. The cost-sharing contract effort is for 36 months beginning September 30, 1994. This report discusses technical progress made during the quarter from July 1 - September 29, 1995.

  11. Projects at the Western Environmental Technology Office. Quarterly technical progress report, July 1, 1995--September 30, 1995

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-01-01

    The goal of this project is to demonstrate the technical and economic feasibility of commercializing a biotechnology that uses plants to remediate soils, sediments, surface waters, and groundwaters contaminated by heavy metals and radionuclides. This technology, known as phytoremediation, is particularly suited to remediation of soils or water where low levels of contaminants are widespread. Project objectives are to provide an accurate estimate of the capability and rate of phytoremediation for removal of contaminants of concern from soils and groundwaters at Department of Energy (DOE) sites and to develop data suitable for engineering design and economic feasibility evaluations, including methods for destruction or final disposition of plants containing contaminants of concern. The bioremediation systems being evaluated could be less expensive than soil removal and treatment systems, given the areal extent and topography of sites under consideration and the investment of energy and money in soil-moving and -treating processes. In situ technology may receive regulatory acceptance more easily than ex situ treatments requiring excavation, processing, and replacement of surface soils. In addition, phytoremediation may be viable for cleanup of contaminated waters, either as the primary treatment or the final polishing stage, depending on the contaminant concentrations and process economics considerations.

  12. Advanced liquefaction using coal swelling and catalyst dispersion techniques. Quarterly technical progress report, January--March 1993

    Energy Technology Data Exchange (ETDEWEB)

    Curtis, C.W. [Auburn Univ., AL (United States); Gutterman, C. [Foster Wheeler Development Corp., Livingston, NJ (United States); Chander, S. [Pennsylvania State Univ., University Park, PA (United States)

    1993-09-01

    The overall objective of this project is to develop a new approach for the direct liquefaction of coal to produce an all-distillate product slate at a sizable cost reduction over current technology. The approach integrates coal selection, pretreatment, coal swelling with catalyst impregnation, liquefaction, product recovery with characterization, alternate bottoms processing, and carrying out a technical assessment including an economic evaluation. The primary coal of this program, Black Thunder subbituminous coal, can be effectively beneficiated to about 4 wt% ash using aqueous sulfurous acid pretreatment. This treated coal can be further beneficiated to about 2 wt% ash using commercially available procedures. All three coals used in this study (Black Thunder, Burning Star bituminous, and Martin Lake lignite) are effectively swelled by a number of solvents. The most effective solvents are those having hetero-functionality. In addition, a synergistic effect has been demonstrated, in which solvent blends are more effective for coal swelling than the pure solvents alone. Therefore, it will be necessary to use only low levels of swelling agents and yet promote the impregnation of catalyst precursors. The rate of the impregnation of catalyst precursors into swollen coal increases greatly as the effectiveness of the solvent to swell the coal increases.

  13. Exploratory research on solvent refined coal liquefaction. Quarterly technical progress report, January 1, 1980-March 31, 1980

    Energy Technology Data Exchange (ETDEWEB)

    1982-01-01

    This report summarizes the progress of the Exploratory Research on Solvent Refined Coal Liquefaction project by The Pittsburg and Midway Coal Mining Co.'s Merriam Laboratory for the period January 1, 1980 through March 31, 1980. A series of experiments was conducted with three western coals to study the relationship between coal properties and liquefaction behavior. All three coals were low in iron (0.2 to 0.4%, dry coal basis) and processing in both the SRC I and SRC II modes does not appear to be feasible at normal conditions without added catalyst. Adding 1 to 2% pyrite to the feed slurry increased oil yields considerably while reducing SRC and IOM yields and improved operability. Product quality was also generally improved by the catalyst. Operability and oil yields were generally found to be better at 450/sup 0/C than at 465/sup 0/C.

  14. Development of polycrystal GaAs solar cells. Quarterly technical progress report No. 1, January 15-April 30, 1979

    Energy Technology Data Exchange (ETDEWEB)

    Miller, D.L.; Cohen, M.J.; Harris, J.S. Jr.; Ballantyne, J.; Hoyte, A.; Stefanakos, E.

    1979-05-01

    The objective of this program is to develop a thin film GaAs solar cell technology with the potential of yielding cells with 12 to 15% efficiency and to develop thin film growth techniques which are compatible with the low cost production goal of $500/kW-peak. Progress is reported on a study of junction formation in large grain polycrystal GaAs; characterization of the electronic properties of polycrystal GaAs grown by MBE on low cost foreign substrates; optimizing the structure of AlGaAs-GaAs heterojunction Schottky barrier solar cells; and a variety of grain boundary measurements, including Scanning Light Microscopy (SLM), Deep Level Transient Spectroscopy (DLTS), SIMS, and temperature dependent resistivity.

  15. Superconducting fault current limiter. First quarterly technical progress report, August 8-November 7, 1978. [230 kV

    Energy Technology Data Exchange (ETDEWEB)

    1979-01-01

    The purpose of this project is to investigate the suitability of using a superconducting fault current limiter (SCFCL) in conjunction with other superconducting apparatus or transmission lines. Literature search, consultation, analysis and experimentation are to be carried out to derive a set of operational parameters for a SCFCL and to answer key questions as to the feasibility of a superconducting element to meet these performance objectives. During the first quarter year of effort, substantial progress has been made on several of these program tasks. A comprehensive search of the literature on SCFCL devices and applications was initiated; the references which were obtained to date are evaluated within a framework into which additional references can be added as they are received. Consultation with key researchers has occurred to supplement and update the literature search. Device analyses have also been started in order to determine to what extent the various proposed SCFCL devices meet the requirements of the power system.

  16. SIMS three year study on statistics and environmental factors in health. Technical progress report No. 1. [Hazards of air pollution

    Energy Technology Data Exchange (ETDEWEB)

    None

    1976-12-01

    Progress is reported for the activities of the Siam Institute for mathematics and society (SIMS), Columbia University, and Stanford University. The SIMS report is concerned with the use of animal experiments in establishing tolerance limits for human exposure to environmental toxicants; valid assessment of the health consequences of occupational and other specialized toxic exposures; mathematical theories for the kinetics of carcinogenesis; data coding, storage, access, and analysis, relationship between air pollution and respiratory diseases; and air pollution assessment. The Columbia University report is concerned with development of statistical methods and models for describing the effects of the environment, measured by pollution and weather variables, on respiratory diseases. The Stanford University report is concerned with spatial distribution of air pollutants, relation of pollutant concentrations to morbidity and mortality statistics, and other topics. (HLW)

  17. Theoretical research in intermediate-energy nuclear physics. [Technical progress report, April 1, 1993--March 31, 1994

    Energy Technology Data Exchange (ETDEWEB)

    Seki, R.

    1994-09-01

    This paper discusses progress that has been made on the following seven problems: (1) (e, e{prime}p) at high momentum transfer; (2) post,acceleration effects in two-nucleon interferometry of heavy-ion collisions; (3) pion-nucleus interactions above 0.5 GeV; (4) chiral symmetry breaking in nuclei and picnic atom anomaly; (5) atomic screening on nuclear astronomical reactions; (6) QCD related work (coherent pion production from skyrmion-antiskyrmion annihilation, QCD in 1 + 1 dimensions, and correlation functions in the QCD vacuum), and (7) kaonic hydrogen atom experiment. The problems deal with various topics mostly in intermediate-energy nuclear physics. We place priority on (1) and (2), and describe them somewhat in detail below. Other problems are our on-going projects, but we are placing lower priority on them in the second and third year.

  18. High resolution, low cost solar cell contact development. Quarterly technical progress and schedule report, September 28, 1980

    Energy Technology Data Exchange (ETDEWEB)

    Mardesich, N.

    1980-01-01

    The scope of the contract covers the development and evaluation of forming solar cell collector grid contacts by the MIDFILM process. This is a proprietary process developed by the Ferro Corporation which is a subcontractor for the program. The MIDFILM process attains line resolution characteristics of photoresist methods with processing related to screen printing. The surface to be processed is first coated with a thin layer of photoresist material. Upon exposure to ultraviolet light through a suitable mask, the resist in the non-pattern area cross-links and becomes hard. The unexposed pattern areas remain tacky. The conductor material is applied in the form of a dry mixture of metal and frit particles which adhere to the tacky pattern area. The assemblage is then fired to ash the photopolymer and sinter the fritted conductor powder. Effort was concentrated during this period on the establishment, optimization and identification of problem areas of the MIDFILM process. Progress is reported. (WHK)

  19. Enthalpy and phase behavior of coal derived liquid mixtures: Technical progress report for the period October-December 1986

    Energy Technology Data Exchange (ETDEWEB)

    Yesavage, V.F.; Kidnay, A.J.

    1987-01-01

    The objectives of this program are to study the enthalpy and phase behavior of a selected ternary model compound system, representative of interactions present in coal derived liquids. Measurements have been made in a Freon 11 reference fluid-boil-off calorimeter, and an equilibrium flash vaporization apparatus. During the tenth quarter, enthalpy measurements for the m-cresol/quinoline/tetralin ternary system have been initiated and are included in Appendix A. Vapor liquid equilibria measurements for the m-cresol/quinoline/tetralin ternary system have been completed for four isotherms: 250, 275, 300, 325/sup 0/C, at various pressures. These results and a summary of progress to date for the VLE apparatus are in Appendix B. Also, predictions for the ternary system using the binary interaction parameters generated from previously obtained binary data were completed, and these results are also presented in Appendix B.

  20. Low-rank coal research under the UND/DOE cooperative agreement. Quarterly technical progress report, April 1983-June 1983

    Energy Technology Data Exchange (ETDEWEB)

    Wiltsee, Jr., G. A.

    1983-01-01

    Progress reports are presented for the following tasks: (1) gasification wastewater treatment and reuse; (2) fine coal cleaning; (3) coal-water slurry preparation; (4) low-rank coal liquefaction; (5) combined flue gas cleanup/simultaneous SO/sub x/-NO/sub x/ control; (6) particulate control and hydrocarbons and trace element emissions from low-rank coals; (7) waste characterization; (8) combustion research and ash fowling; (9) fluidized-bed combustion of low-rank coals; (10) ash and slag characterization; (11) organic structure of coal; (12) distribution of inorganics in low-rank coals; (13) physical properties and moisture of low-rank coals; (14) supercritical solvent extraction; and (15) pyrolysis and devolatilization.

  1. AFCT/TFCT/ISFS Program. Technical progress report for the period January 1, 1978--March 31, 1978

    Energy Technology Data Exchange (ETDEWEB)

    Hill, O.F. (comp.)

    1978-04-01

    This is the ninth in a series of quarterly progress reports on Fuel Cycle Technologies/Thorium Fuel Cycle Technologies/International Spent Fuel Receipt and Storage (AFCT/TFCT/ISFS) program. This program provides information needed by industry to close the back end of the power reactor fuel cycle. Included in the program are activities supporting specific design studies, as well as activities for general fuel cycle technology. Studies were conducted in the following tasks: thorium resource price analyses; investigation of air cleaning processes for removing TBP from off-gas streams; study of iodine chemistry in process solutions; high-level waste treatment; electropolishing to decontaminate metallic waste from alternate and thorium converter fuel cycles; U.S. scale transport, dispersion and removal model comparison; safety criticality experiments; and criticality research in support of thorium fuel cycle technology program. (21 figs., 7 tables) (DLC)

  2. Quantitatively characterizing the microstructural features of breast ductal carcinoma tissues in different progression stages by Mueller matrix microscope.

    Science.gov (United States)

    Dong, Yang; Qi, Ji; He, Honghui; He, Chao; Liu, Shaoxiong; Wu, Jian; Elson, Daniel S; Ma, Hui

    2017-08-01

    Polarization imaging has been recognized as a potentially powerful technique for probing the microstructural information and optical properties of complex biological specimens. Recently, we have reported a Mueller matrix microscope by adding the polarization state generator and analyzer (PSG and PSA) to a commercial transmission-light microscope, and applied it to differentiate human liver and cervical cancerous tissues with fibrosis. In this paper, we apply the Mueller matrix microscope for quantitative detection of human breast ductal carcinoma samples at different stages. The Mueller matrix polar decomposition and transformation parameters of the breast ductal tissues in different regions and at different stages are calculated and analyzed. For more quantitative comparisons, several widely-used image texture feature parameters are also calculated to characterize the difference in the polarimetric images. The experimental results indicate that the Mueller matrix microscope and the polarization parameters can facilitate the quantitative detection of breast ductal carcinoma tissues at different stages.

  3. Quantification of the N-glycosylated secretome by super-SILAC during breast cancer progression and in human blood Samples

    DEFF Research Database (Denmark)

    Boersema, P.J.; Geiger, T.; Wiśniewski, J.R.

    2013-01-01

    that are representative of different stages of breast cancer development by specifically capturing N-glycosylated peptides using the N-glyco FASP technology. For accurate quantification we developed a super-SILAC mix from several labeled breast cancer cell lines and used it as an internal standard for all samples....... In total, 1398 unique N-glycosylation sites were identified and quantified. Enriching for N-glycosylated peptides focused the analysis on classically secreted and membrane proteins. N-glycosylated secretome profiles correctly clustered the different cell lines to their respective cancer stage, suggesting...... that biologically relevant differences were detected. Five different profiles of glycoprotein dynamics during cancer development were detected, and they contained several proteins with known roles in breast cancer. We then used the super-SILAC mix in plasma, which led to the quantification of a large number...

  4. Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13.

    Science.gov (United States)

    Sendon-Lago, Juan; Seoane, Samuel; Eiro, Noemi; Bermudez, Maria A; Macia, Manuel; Garcia-Caballero, Tomas; Vizoso, Francisco J; Perez-Fernandez, Roman

    2014-12-20

    The POU class 1 homeobox 1 transcription factor (POU1F1, also known as Pit-1) is expressed in the mammary gland and its overexpression induces profound phenotypic changes in proteins involved in cell proliferation, apoptosis, and invasion. Patients with breast cancer and elevated expression of Pit-1 show a positive correlation with the occurrence of distant metastasis. In this study we evaluate the relationship between Pit-1 and two collagenases: matrix metalloproteinase-1 (MMP-1) and matrix metalloproteinase-13 (MMP-13), which have been related to metastasis in breast cancer. We began by transfecting the MCF-7 and MDA-MB-231 human breast adenocarcinoma cell lines with the Pit-1 overexpression vector (pRSV-hPit-1). Afterward, the mRNA, protein, and transcriptional regulation of both MMP-1 and MMP-13 were evaluated by real-time PCR, Western blot, chromatin immunoprecipitation (ChIP), and luciferase reporter assays. We also evaluated Pit-1 overexpression with MMP-1 and MMP-13 knockdown in a severe combined immunodeficiency (SCID) mouse tumor xenograft model. Finally, by immunohistochemistry we correlated Pit-1 with MMP-1 and MMP-13 protein expression in 110 human breast tumors samples. Our data show that Pit-1 increases mRNA and protein of both MMP-1 and MMP-13 through direct transcriptional regulation. In SCID mice, knockdown of MMP-13 completely blocked lung metastasis in Pit-1-overexpressing MCF-7 cells injected into the mammary fat pad. In breast cancer patients, expression of Pit-1 was found to be positively correlated with the presence of both MMP-1 and MMP-13. Our data indicates that Pit-1 regulates MMP-1 and MMP-13, and that inhibition of MMP-13 blocked invasiveness to lung in Pit-1-overexpressed breast cancer cells.

  5. Design, fabrication and operation of a biomass fermentation facility. Technical progress report No. 2, January 1-March 31, 1979

    Energy Technology Data Exchange (ETDEWEB)

    O' Neil, D.J.; Colcord, A.R.; Bery, M.K.

    1979-04-01

    The conceptual design for a three oven-dry ton per day biomass fermentation facility is presented. Based on a detailed evaluation of emerging technologies and improved modifications of current technology, a mainstream process and optional unit operation and sub-systems have been selected which offer the greatest probability of success for an economic and technically feasible process for production of ethanol from lignocellulosic biomass (hardwoods, wheat straw, corn stover, etc.). The design is intentionally flexible as stipulated in the contractual objectives. Recommendations of equipment is premised on its versatility for multi-functional application, thus enabling investigation to assess a number of process configurations while adhering to a cost-effective capital investment in the process development unit. A specific criterion in selection has been to facilitate the generation of engineering data based on the application of the results of research contractors of the US Department of Energy. The design for a total system includes the facility for evaluation of three pretreatment options, for isolation of by-product streams, for evaluation of acid and enzymatic hydrolysis, sugar concentration, alternative fermentation technologies and alcohol recovery for production of absolute ethanol. In order to maintain capital costs for the PDU within reasonable limits monitoring of by-product streams will be undertaken and, for unit operation with high potential (such as membrane concentration of ethanol) but which are in early stages of development smaller-scale equipment and/or plumbing taps for late addition of full-scale (i.e., PDU-scale) equipment is recommended. The rationale, and process economics, upon which the recommendations are based is detailed, as is a study of biomass feedstock availability.

  6. Coal-fired combustion system for industrial process heating applications. Quarterly technical progress report, April 1995--June 1995

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1995-08-01

    PETC has implemented a number of advanced combustion research projects that will lead to the establishment of a broad, commercially acceptable engineering data base for the advancement of coal as the fuel of choice for boilers, furnaces, and process heaters. This includes new installations and those existing installations that were originally designed for oil or gas firing. The data generated by these projects must be sufficient for private-sector decisions on the feasibility of using coal as the fuel of choice. This work should also provide incentives for the private sector to continue and expand the development, demonstration, and application of these combustion systems. Vortec Corporation`s Coal-Fired Combustion System for Industrial Process Heating Applications is being developed under contract DE-AC22-91PC91161 as part of this DOE development program. The current contract represents the third phase of a three-phase development program. Phase I of the program addressed the technical and economic feasibility of the process, and was initiated in 1987 and completed 1989. Phase II was initiated in 1989 and completed in 1990. During Phase II of the development, design improvements were made to critical components and the test program addressed the performance of the process using several different feedstocks. Phase III of the program was initiated September 1991 and is scheduled for completion in 1994. The Phase III research effort is being focused on the development of a process heater system to be used for producing value-added vitrified glass products from boiler/incinerator ashes and selected industrial wastes.

  7. Candidate pathways linking inducible nitric oxide synthase to a basal-like transcription pattern and tumor progression in human breast cancer.

    Science.gov (United States)

    Ambs, Stefan; Glynn, Sharon A

    2011-02-15

    Inducible nitric oxide synthase (NOS2) is an inflammation responsive enzyme (EC 1.14.13.39) that is induced during acute and chronic inflammation and tissue injury as part of the host defense and wound healing process. NOS2 up-regulation leads to increased nitric oxide (NO) production, the means by which this enzyme can initiate NO-dependent signal transduction, influence the redox state of cells and induce modifications of proteins, lipids, and DNA. Aberrant expression of NOS2 has been observed in many types of human tumors. In breast cancer, increased NOS2 is associated with markers of poor outcome and decreased survival. Growth factor and cytokine signaling, tissue remodeling, NF-kB activation, and hypoxia are candidate mechanisms that induce NOS2 in tumor epithelial and tumor-infiltrating cells. NOS2 induction will trigger the release of variable amounts of NO into the tumor microenvironment and can activate oncogenic pathways, including the Akt, epidermal growth factor receptor and c-Myc signaling pathways, and stimulate tumor microvascularization. Constitutively increased NO levels may also select for mutant p53 cells to overcome the tumor suppressor function of NO-activated wild-type p53. More recent findings suggest that NO induces stem cell-like tumor characteristics in breast cancer. In this review, we will discuss the effects of NO in tumor biology and disease progression with an emphasis on breast cancer, and will examine the mechanisms that link increased NO to a basal-like transcription pattern in human breast tumors and poor disease outcome.

  8. Management of dry flue gas desulfurization by-products in underground mines. Technical progress report, 1 January--31 March 1994

    Energy Technology Data Exchange (ETDEWEB)

    Chugh, Y.P.; Esling, S.; Ghafoori, N.; Honaker, R.; Paul, B.; Sevim, H.; Thomasson, E.

    1994-04-01

    Southern Illinois University at Carbondale will develop and demonstrate several technologies for the handling and transport of dry coal combustion residues and for the underground placement in abandoned coal mines and assess associated environmental impacts. Although parts of the Residue Characterization portion of the program were delayed because residue samples were not obtained, other parts of the program are proceeding on schedule. The delays in obtaining residue samples were primarily caused by adverse weather conditions, the shut-down of one unit at the City Water, Light, and Power Company Plant for routing maintenance and problems due to conflicting schedules of utility and program personnel. However, by the end of the quarter most residue samples had been obtained, and the residue characterization studies were under way. Progress is described for five studies: environmental assessment and geotechnical stability and subsidence impacts; residue characterization; physico-chemical characterization of residues; identification and assessment of handling/transportation systems for FGD residues; and residue handling and transport.

  9. Molluscs and echinoderms aquaculture: biological aspects, current status, technical progress and future perspectives for the most promising species in Italy

    Directory of Open Access Journals (Sweden)

    Antonio Pais

    2012-10-01

    Full Text Available Shellfish aquaculture is a widespread activity in the Italian peninsula. However, only two bivalve species are mainly cultured along the coastline of that country: the Mediterranean mussel Mytilus galloprovincialis and the Manila clam Venerupis philippinarum (Ruditapes philippinarum. By contrast, just a few other mollusc species of commercial interest are scarcely reared at a small-scale level. After analysing the current status of Italian shellfish production, this paper reports and discusses the potential for culturing several different invertebrate species [i.e., the European flat oyster Ostrea edulis, the grooved carpet shell Venerupis decussata (Ruditapes decussatus, the razor clams Ensis minor and Solen marginatus, the cephalopod Octopus vulgaris, and the purple sea urchin Paracentrotus lividus] in this country. In addition, a detailed overview of the progress made in aquacultural techniques for these species in the Mediterranean basin is presented, highlighting the most relevant bottlenecks and the way forward to shift from the experimental to the aquaculture phase. Finally, an outlook of the main economic and environmental benefits arising from these shellfish culture practices is also given.

  10. Identification of sulfur heterocycles in coal liquids and shale oils. Technical progress report, August 1, 1980-May 1, 1981

    Energy Technology Data Exchange (ETDEWEB)

    Lee, M. L.; Castle, R. N.

    1981-01-01

    The sulfur heterocycle separation scheme which was described in the last progress report was evaluated for quantitative recovery of individual components. The results indicate that recoveries can range from 10% to approx. 30% depending on the structure of the compound. During this period, 23 unsubstituted sulfur-containing heterocyclic ring systems were synthesized in oder to confirm GC/MS identifications and for biological testing. The four possible 3-ring heterocycles and the thirteen possible 4-ring heterocycles were tested for mutagenic activity in the histidine reversion (Ames assay) system. One of the 3-ring isomers, naphtho(1,2-b)-thiophene, and six of the 4-ring isomers induced mutations in Salmonella test strains. One of these compounds, phenanthro(3,4-b)thiophene, displayed approximately the same mutagenic activity as benzo(a)pyrene. A two-step adsorption chromatographic procedure was developed in order to fractionate synthetic fuels into various chemical-type classes for studying the relative concentrations and mutagenic activities of the various types. An SRC-II Heavy Distillate was fractionated into aliphatic hydrocarbons, polycyclic aromatic hydrocarbons, sulfur heterocycles, indoles and carbazoles, azaarenes, and amino polycyclic aromatic hydrocarbons. It was found that the amino-PAH fraction contained most of the mutagenic activity. A survey was made for compounds containing both nitrogen and sulfur heteroatoms in their structures. A number of these compounds were detected by GC using nitrogen- and sulfur-selective detection.

  11. Development of molten carbonate fuel cell power plant. Quarterly technical progress report, May 1-July 31, 1980

    Energy Technology Data Exchange (ETDEWEB)

    Peterson, J. R.

    1980-09-04

    The major objective of this program for development of a molten carbonate fuel cell power plant is to establish and demonstrate readiness for fabrication and test of full-scale prototype stacks. This will be accomplished by a heavy emphasis upon resolution of remaining technology problems, including materials, processes and contaminant effects research, development and testing of cell components to 10,000 hours endurance life and scaleup of laboratory hardware to commercial size. A detailed design for a prototype stack will be defined and a tenth-size of full-scale cells will be tested. Component and manufacturing processes will be developed based upon commercial cost goals. Coal-fired utility central station and industrial cogeneration power plant requirements will be defined and plant options evaluated, leading to selection of a single reference design. Cell and stack design and development will be guided by requirements based upon the reference plant design. The specific program objectives derived from the contract work statement are as follows: (1) to define a reference power plant design for a coal-fired molten carbonate power plant; (2) to develop and verify cell and stack design based upon the requirements of the reference power plant design; (3) to establish and demonstrate readiness to fabricate and test full-length stacks of full-scale cells, hereafter called prototype stacks; and (4) to quantify contaminant effects and establish a program to verify performance of molten carbonate fuel cells operating on products of coal gasification. Progress is reported.

  12. The impact of loco-regional recurrences on metastatic progression in early-stage breast cancer : a multistate model

    NARCIS (Netherlands)

    de Bock, G. H.; Putter, H.; Bonnema, J.; van der Hage, J. A.; Bartelink, H.; van de Velde, C. J.

    To study whether the effects of prognostic factors associated with the occurrence of distant metastases (DM) at primary diagnosis change after the incidence of loco-regional recurrences (LRR) among women treated for invasive stage I or II breast cancer. The study population consisted of 3,601 women,

  13. Insulin-Like Growth Factor-1 Inscribes a Gene Expression Profile for Angiogenic Factors and Cancer Progression in Breast Epithelial Cells

    Directory of Open Access Journals (Sweden)

    J.S. Oh

    2002-01-01

    Full Text Available Activation of the insulin-like growth factor-1 receptor (IGF-11R by IGF-1 is associated with the risk and progression of many types of cancer, although despite this it remains unclear how activated IGF-1 R contributes to cancer progression. In this study, gene expression changes elicited by IGF-1 were profiled in breast epithelial cells. We noted that many genes are functionally linked to cancer progression and angiogenesis. To validate some of the changes observed, the RNA and/or protein was confirmed for c-fos, cytochrome P4501Al, cytochrome P450 1131, interleukin-1 beta, fas ligand, vascular endothelial growth factor, and urokinase plasminogen activator. Nuclear proteins were also temporally monitored to address how gene expression changes were regulated. We found that IGF-1 stimulated the nuclear translocation of phosphorylated AKT, hypoxic-inducible factor-1 alpha, and phosphorylated cAMP-responsive element-binding protein, which correlated with temporal changes in gene expression. Next, the promoter regions of IGF-1-regulated genes were searched in silico. The promoters of genes that clustered together had similar regulatory regions. In summary, IGF-1 inscribes a gene expression profile relevant to cancer progression, and this study provides insight into the mechanism(s whereby some of these changes occur.

  14. Progressive resistance training and stretching following surgery for breast cancer: study protocol for a randomised controlled trial

    Directory of Open Access Journals (Sweden)

    Ward Leigh C

    2006-12-01

    Full Text Available Abstract Background Currently 1 in 11 women over the age of 60 in Australia are diagnosed with breast cancer. Following treatment, most breast cancer patients are left with shoulder and arm impairments which can impact significantly on quality of life and interfere substantially with activities of daily living. The primary aim of the proposed study is to determine whether upper limb impairments can be prevented by undertaking an exercise program of prolonged stretching and resistance training, commencing soon after surgery. Methods/design We will recruit 180 women who have had surgery for early stage breast cancer to a multicenter single-blind randomized controlled trial. At 4 weeks post surgery, women will be randomly assigned to either an exercise group or a usual care (control group. Women allocated to the exercise group will perform exercises daily, and will be supervised once a week for 8 weeks. At the end of the 8 weeks, women will be given a home-based training program to continue indefinitely. Women in the usual care group will receive the same care as is now typically provided, i.e. a visit by the physiotherapist and occupational therapist while an inpatient, and receipt of pamphlets. All subjects will be assessed at baseline, 8 weeks, and 6 months later. The primary measure is arm symptoms, derived from a breast cancer specific questionnaire (BR23. In addition, range of motion, strength, swelling, pain and quality of life will be assessed. Discussion This study will determine whether exercise commencing soon after surgery can prevent secondary problems associated with treatment of breast cancer, and will thus provide the basis for successful rehabilitation and reduction in ongoing problems and health care use. Additionally, it will identify whether strengthening exercises reduce the incidence of arm swelling. Trial Registration The protocol for this study is registered with the Australian Clinical Trials Registry (ACTRN012606000050550.

  15. Imaging Guided Breast Interventions.

    Science.gov (United States)

    Masroor, Imrana; Afzal, Shaista; Sufian, Saira Naz

    2016-06-01

    Breast imaging is a developing field, with new and upcoming innovations, decreasing the morbidity and mortality related to breast pathologies with main emphasis on breast cancer. Breast imaging has an essential role in the detection and management of breast disease. It includes a multimodality approach, i.e. mammography, ultrasound, magnetic resonance imaging, nuclear medicine techniques and interventional procedures, done for the diagnosis and definitive management of breast abnormalities. The range of methods to perform biopsy of a suspicious breast lesion found on imaging has also increased markedly from the 1990s with hi-technological progress in surgical as well as percutaneous breast biopsy methods. The image guided percutaneous breast biopsy procedures cause minimal breast scarring, save time, and relieve the patient of the anxiety of going to the operation theatre. The aim of this review was to describe and discuss the different image guided breast biopsy techniques presently employed along with the indications, contraindication, merits and demerits of each method.

  16. Vinorelbine-based salvage therapy in HER2-positive metastatic breast cancer patients progressing during trastuzumab-containing regimens: a retrospective study

    Directory of Open Access Journals (Sweden)

    Viale Giuseppe

    2008-07-01

    Full Text Available Abstract Background The vinka-alkaloyd vinorelbine is a potentially valuable treatment in patients with HER2-positive, trastuzumab-resistant advanced breast cancer. We sought to document the clinical activity of vinorelbine-based salvage treatments in this clinical setting. Methods We analyzed a cohort of 424 consecutive women receiving trastuzumab-based therapy for HER2-positive advanced breast cancer. Of these, 299 were identified as progressing during the initial trastuzumab-based treatment, and 77 received vinorelbine-based therapy as first salvage treatment. Central review of pathological specimens revealed that 70 patients had HER2-amplification detected by FISH. For these patients we determined overall response rate (ORR = complete-CR + partial-PR and clinical benefit (CB = CR+PR+ Stable disease lasting at least 6 months, time to progression (TTP and overall survival (OS from the initiation of vinorelbine-based salvage therapy. Results In 60 patients who were evaluable for tumor response, ORR and CB rates were 28% (95% C.I. 18%-41% and 50% (95% C.I. 38%-62%, respectively. Median follow-up from the initiation of salvage therapy was 15 months (range 1–63 months. Median TTP and OS were 7.1 months (95% C.I. 6.6–7.7 months and 21 months (95% C.I. 14.3–27.7 months, respectively. No differences in clinical outcomes were observed according to whether vinorelbine was administered as a single agent or in combination with other cytostatics, or whether trastuzumab was stopped or continued beyond disease progression. Conclusion our findings suggests that vinorelbine-based combinations are active and should be further evaluated in studies conducted in trastuzumab-resistant patients, including those evaluating newer HER2-targeting agents.

  17. Progressive resistance versus relaxation training for breast cancer patients during adjuvant chemotherapy: design and rationale of a randomized controlled trial (BEATE study).

    Science.gov (United States)

    Schmidt, Martina E; Wiskemann, Joachim; Krakowski-Roosen, Holger; Knicker, Axel J; Habermann, Nina; Schneeweiss, Andreas; Ulrich, Cornelia M; Steindorf, Karen

    2013-01-01

    Cancer-related fatigue is a common severe symptom in breast cancer patients, especially during chemotherapy. Exercise appears to be promising in prevention or treatment of fatigue. Resistance training as an accompanying treatment to chemotherapy has been minimally investigated, yet might counteract muscle degradation and inflammation caused by many chemotherapeutics, and thus forestall or reduce fatigue. Previous exercise trials mostly compared the intervention with 'usual care'. Therefore, it is unclear to what extent the observed effects on fatigue are based on physical adaptations by exercise itself, or rather on psycho-social factors linked to the group support or attention by the trainer. The BEATE study is a randomized, controlled intervention trial comparing a 12-week supervised progressive resistance training program with a supervised group-based progressive muscle relaxation training in 100 patients with breast cancer under adjuvant chemotherapy. The primary endpoint is cancer-related fatigue; secondary endpoints include quality of life, depression, and cognitive capacity. In addition, isokinetic and isometric muscle strength, cardiorespiratory fitness, and body composition are measured, and biomarkers, such as inflammatory parameters, cortisol, and oxidative stress are analyzed in blood, saliva and urine. Safety of the resistance training during chemotherapy is monitored. Strengths of the BEATE study include the investigation of progressive resistance training parallel with chemotherapy, the choice of a control group that enables an evaluation of the physiological effects of exercise beyond potential psycho-social effects, and the comprehensive and high-quality assessment of physiological factors and biomarkers potentially related to fatigue. Copyright © 2012 Elsevier Inc. All rights reserved.

  18. Randomized controlled trial to evaluate the effects of combined progressive exercise on metabolic syndrome in breast cancer survivors: rationale, design, and methods

    Science.gov (United States)

    2014-01-01

    Background Metabolic syndrome (MetS) is increasingly present in breast cancer survivors, possibly worsened by cancer-related treatments, such as chemotherapy. MetS greatly increases risk of cardiovascular disease and diabetes, co-morbidities that could impair the survivorship experience, and possibly lead to cancer recurrence. Exercise has been shown to positively influence quality of life (QOL), physical function, muscular strength and endurance, reduce fatigue, and improve emotional well-being; however, the impact on MetS components (visceral adiposity, hyperglycemia, low serum high-density lipoprotein cholesterol, hypertriglyceridemia, and hypertension) remains largely unknown. In this trial, we aim to assess the effects of combined (aerobic and resistance) exercise on components of MetS, as well as on physical fitness and QOL, in breast cancer survivors soon after completing cancer-related treatments. Methods/Design This study is a prospective randomized controlled trial (RCT) investigating the effects of a 16-week supervised progressive aerobic and resistance exercise training intervention on MetS in 100 breast cancer survivors. Main inclusion criteria are histologically-confirmed breast cancer stage I-III, completion of chemotherapy and/or radiation within 6 months prior to initiation of the study, sedentary, and free from musculoskeletal disorders. The primary endpoint is MetS; secondary endpoints include: muscle strength, shoulder function, cardiorespiratory fitness, body composition, bone mineral density, and QOL. Participants randomized to the Exercise group participate in 3 supervised weekly exercise sessions for 16 weeks. Participants randomized to the Control group are offered the same intervention after the 16-week period of observation. Discussion This is the one of few RCTs examining the effects of exercise on MetS in breast cancer survivors. Results will contribute a better understanding of metabolic disease-related effects of resistance and

  19. A 3D in vitro model of the human breast duct: a method to unravel myoepithelial-luminal interactions in the progression of breast cancer.

    Science.gov (United States)

    Carter, Edward P; Gopsill, James A; Gomm, Jennifer J; Jones, J Louise; Grose, Richard P

    2017-04-21

    3D modelling fulfils a critical role in research, allowing for complex cell behaviour and interactions to be studied in physiomimetic conditions. With tissue banks becoming established for a number of cancers, researchers now have access to primary patient cells, providing the perfect building blocks to recreate and interrogate intricate cellular systems in the laboratory. The ducts of the human breast are composed of an inner layer of luminal cells supported by an outer layer of myoepithelial cells. In early-stage ductal carcinoma in situ, cancerous luminal cells are confined to the ductal space by an intact myoepithelial layer. Understanding the relationship between myoepithelial and luminal cells in the development of cancer is critical for the development of new therapies and prognostic markers. This requires the generation of new models that allows for the manipulation of these two cell types in a physiological setting. Using access to the Breast Cancer Now Tissue Bank, we isolated pure populations of myoepithelial and luminal cells from human reduction mammoplasty specimens and placed them into 2D culture. These cells were infected with lentiviral particles encoding either fluorescent proteins, to facilitate cell tracking, or an inducible human epidermal growth factor receptor 2 (HER2) expression construct. Myoepithelial and luminal cells were then recombined in collagen gels, and the resulting cellular structures were analysed by confocal microscopy. RESULTS: Myoepithelial and luminal cells isolated from reduction mammoplasty specimens can be grown separately in 2D culture and retain their differentiated state. When recombined in collagen gels, these cells reform into physiologically reflective bilayer structures. Inducible expression of HER2 in the luminal compartment, once the bilayer has formed, leads to robust luminal filling, recapitulating ductal carcinoma in situ, and can be blocked with anti-HER2 therapies. This model allows for the interaction

  20. The SDF1-CXCR4 Axis Functions through p38-MAPK Signaling to Drive Breast Cancer Progression and Metastasis

    Science.gov (United States)

    2008-09-01

    hormone-independent, endocrine therapy resistant and metastatic phenotype. Our preliminary evidence demonstrates that over expression of CXCR4 in... AER signal pathway, growth factor mediated signaling, and other kinase networks could be responsible for this resistance. It has been shown that...and PI3K/AKT have been implicated in development of endocrine therapy resistance in breast carcinoma. More recently, our lab became interested in

  1. Features of formation spirituality pictures of the world in youth in in the era of information-highlytechnological scientific and technical progress

    Directory of Open Access Journals (Sweden)

    N. V. Polishchuk

    2016-06-01

    Full Text Available In clause necessity of formation of a spiritual picture of the world, anthropocosmos at young generation at the present stage of development much crisis world and, including, the Ukrainian society is proved. In the article the necessity of formation of anthropocosmos-spiritual picture of the world at young generation at the present stage of development bagalicious the world and, in particular, of the Ukrainian society. The proposed definition of new terms: anthropocosmos is a spiritual picture of the world, anthropocosmic spirituality, anthropocosmic worldview and other anthropocentric concepts and definitions in contemporary philosophical and pedagogical discourse. The presented model of the formation of anthropocosmos-spiritual worldview of the young generation in the information and high-tech scientific and technical progress and the author’s interpretation of its philosophical, educational, pedagogical and spiritual essence. It is proved, that having generated in consciousness of the young man a anthropocosmos-spiritual picture of the world, will allow it in conditions of inevitable crash in the near future of a human civilization, if it will not solve present global-civilizational crises and will not avoid geocosmic accidents, to understand sense space-ekzoplanete lives which will be esclusivi, and, therefore, crisis-free, conflict-free, comprehensive and meaningful, anthropocosmos-highly spiritual (divine M. Berdyaev, and, therefore, progressive and virtually eternal as the life of society, which is composed of such anthropocosmos educated individuals. Solved zagalnoosvitnioi sense anthropocosmos spiritual world picture, which is to solve the problem of the choice of life strategies of mankind, the search for new ways of civilization development, in particular, resettlement anthropocosmos-conscious part of humanity for exoplanets space with the aim of preserving the gene pool of humanity and creation of human cosmically

  2. Progress in the establishment and strengthening of national immunization technical advisory groups: analysis from the 2013 WHO/UNICEF joint reporting form, data for 2012.

    Science.gov (United States)

    Duclos, Philippe; Dumolard, Laure; Abeysinghe, Nihal; Adjagba, Alex; Janusz, Cara Bess; Mihigo, Richard; Mosina, Liudmila; Takashima, Yashohiro; Oztürk, Murat Hakan

    2013-11-04

    The majority of industrialized and some developing countries have established National Immunization Technical Advisory Groups (NITAGs). To enable systematic global monitoring of the existence and functionality of NITAGs, in 2011, WHO and UNICEF included related questions in the WHO/UNICEF Joint Reporting Form (JRF) that provides an official means to globally collect indicators of immunization program performance. These questions relate to six basic process indicators. According to the analysis of the 2013 JRF, data for 2012, notable progress was achieved between 2010 and 2012 and by the end of 2012, 99 countries (52%) reported the existence of a NITAG with a formal legislative or administrative basis (with a high of 86% in the Eastern Mediterranean Region - EMR), among the countries that reported data in the NITAG section of the JRF. There were 63 (33%) countries with a NITAG that met six process indicators (47% increase over the 43 reported in 2010) including a total of 38 developing countries. 11% of low income countries reported a NITAG that meets all six process criteria, versus 29% of middle income countries and 57% of the high income ones. Countries with smaller populations reported the existence of a NITAG that meets all six process criteria less frequently than more populated countries (23% for less populated countries versus 43% for more populated ones). However, progress needs to be accelerated to reach the Global Vaccine Action Plan (GVAP) target of ensuring all countries have support from a NITAG. The GVAP represents a major opportunity to boost the institutionalization of NITAGs. A special approach needs to be explored to allow small countries to benefit from sub-regional or other countries advisory groups. Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.

  3. A Randomized Controlled Trial for the Effectiveness of Progressive Muscle Relaxation and Guided Imagery as Anxiety Reducing Interventions in Breast and Prostate Cancer Patients Undergoing Chemotherapy

    Directory of Open Access Journals (Sweden)

    Andreas Charalambous

    2015-01-01

    Full Text Available Objective. To test the effectiveness of guided imagery (GI and progressive muscle relaxation (PMR as stress reducing interventions in patients with prostate and breast cancer who undergo chemotherapy. Methods. Patients were randomly assigned to either the control group or the intervention group (PMR and GI. Patients were observed for a total duration of 3 weeks and assessed with the SAS and BECK-II questionnaires for anxiety and depression, respectively, in addiotion to two biological markers (saliva cortisol and saliva amylase (trial registration number: NCT01275872. Results. 256 patients were registered and 236 were randomly assigned. In total 104 were randomised to the control group and 104 to the intervention group. Intervention’s mean anxiety score and depression score changes were significantly different compared to the control’s (b=-29.4, p<0.001; b=-29.4, p<0.001, resp.. Intervention group’s cortisol levels before the intervention (0.30±0.25 gradually decreased up to week 3 (0.16±0.18, whilst the control group’s cortisol levels before the intervention (0.21±0.22 gradually increased up to week 3 (0.44±0.35. The same interaction appears for the Amylase levels (p<0.001. Conclusions. The findings showed that patients with prostate and breast cancer undergoing chemotherapy treatment can benefit from PMR and GI sessions to reduce their anxiety and depression.

  4. A Randomized Controlled Trial for the Effectiveness of Progressive Muscle Relaxation and Guided Imagery as Anxiety Reducing Interventions in Breast and Prostate Cancer Patients Undergoing Chemotherapy.

    Science.gov (United States)

    Charalambous, Andreas; Giannakopoulou, Margarita; Bozas, Evangelos; Paikousis, Lefkios

    2015-01-01

    Objective. To test the effectiveness of guided imagery (GI) and progressive muscle relaxation (PMR) as stress reducing interventions in patients with prostate and breast cancer who undergo chemotherapy. Methods. Patients were randomly assigned to either the control group or the intervention group (PMR and GI). Patients were observed for a total duration of 3 weeks and assessed with the SAS and BECK-II questionnaires for anxiety and depression, respectively, in addiotion to two biological markers (saliva cortisol and saliva amylase) (trial registration number: NCT01275872). Results. 256 patients were registered and 236 were randomly assigned. In total 104 were randomised to the control group and 104 to the intervention group. Intervention's mean anxiety score and depression score changes were significantly different compared to the control's (b = -29.4, p < 0.001; b = -29.4, p < 0.001, resp.). Intervention group's cortisol levels before the intervention (0.30 ± 0.25) gradually decreased up to week 3 (0.16 ± 0.18), whilst the control group's cortisol levels before the intervention (0.21 ± 0.22) gradually increased up to week 3 (0.44 ± 0.35). The same interaction appears for the Amylase levels (p < 0.001). Conclusions. The findings showed that patients with prostate and breast cancer undergoing chemotherapy treatment can benefit from PMR and GI sessions to reduce their anxiety and depression.

  5. Comparison of multi-state Markov models for cancer progression with different procedures for parameters estimation. An application to breast cancer

    Directory of Open Access Journals (Sweden)

    Leonardo Ventura

    2013-10-01

    Full Text Available Background: the knowledge of sojourn time (the duration of the preclinical screen-detectable period and screening test sensitivity is crucial for understanding the disease progression and the effectiveness of screening programmes. For this purpose a model of the natural history of the disease is needed. The aim of this work is to provide an illustration of the application of multistate Markov models for breast cancer progression to the data of the Florentine screening programme, in order to estimate the sojourn time and sensitivity for breast cancer screening.Methods: three different multi-state Markov models of increasing complexity were used with three different estimation procedures based on non-linear least squares, maximum likelihood, and on a Bayesian approach. All the models produced estimates for screening sensitivity and mean sojourn time. The data used in our application seem to lead to a non-identifiability problem, since the estimation procedures for both the Maximum Likelihood and Non-Linear Least Squares gave estimates that changed with the parameters’ initial values or difficultly converged. In order to take this problem into account we used the Bayesian Approach by incorporating prior information on all the parameters.Results: the mean sojourn time varied between 2-7 years and 3-5 years for women aged 50-59 and 60-69, respectively. When the model complexity was increased a higher variability in estimates was observed among the estimation procedures. The results of the screening sensitivity estimates were highly variable, both among estimation techniques and models - varying between 63% and 100%, and between 77% and 100% for women aged 50-59 and 60-69, respectively.Conclusions: results are in accord with the literature; those obtained through the Bayesian Approach seem to be more reliable. 

  6. Immunohistochemical analysis of aldehyde dehydrogenase isoforms and their association with estrogen-receptor status and disease progression in breast cancer

    Directory of Open Access Journals (Sweden)

    Opdenaker LM

    2014-12-01

    Full Text Available Lynn M Opdenaker,1,2 Kimberly M Arnold,1,3 Ryan T Pohlig,3,4 Jayasree S Padmanabhan,1 Daniel C Flynn,1,3 Jennifer Sims-Mourtada1–3 1Center for Translational Cancer Research, Helen F Graham Cancer Center, Christiana Care Health Services, Inc., Newark, Delaware, USA; 2Department of Biological Sciences, 3Department of Medical Laboratory Sciences, 4Biostatistics Core Facility, University of Delaware, Newark, Delaware, USA Abstract: In many types of tumors, especially breast tumors, aldehyde dehydrogenase (ALDH activity has been used to identify cancer stem-like cells within the tumor. The presence and quantity of these cells are believed to predict the response of tumors to chemotherapy. Therefore, identification and eradication of these cells would be necessary to cure the patient. However, there are 19 different ALDH isoforms that could contribute to the enzyme activity. ALDH1A1 and ALDH1A3 are among the isoforms mostly responsible for the increased ALDH activity observed in these stem-like cells, although the main isoforms vary in different tissues and tumor types. In the study reported here, we attempted to determine if ALDH1A1 or ALDH1A3, specifically, correlate with tumor stage, grade, and hormone-receptor status in breast-cancer patients. While there was no significant correlation between ALDH1A1 and any of the parameters tested, we were able to identify a positive correlation between ALDH1A3 and tumor stage in triple-negative cancers. In addition, ALDH1A3 was negatively correlated with estrogen-receptor status. Our data suggest that ALDH1A3 could be utilized as a marker to identify stem-like cells within triple-negative tumors. Keywords: breast tumor, ALDH, ALDH1A1, ALDH1A3, stem-like cells, triple-negative cancer

  7. IRIS Final Technical Progress Report

    Energy Technology Data Exchange (ETDEWEB)

    M. D. Carelli

    2003-11-03

    OAK-B135 This NERI project, originally started as the Secure Transportable Autonomous Light Water Reactor (STAR-LW) and currently known as the International Reactor Innovative and Secure (IRIS) project, had the objective of investigating a novel type of water-cooled reactor to satisfy the Generation IV goals: fuel cycle sustainability, enhanced reliability and safety, and improved economics. The research objectives over the three-year (1999-2002) program were as follows: First year: Assess various design alternatives and establish main characteristics of a point design; Second year: Perform feasibility and engineering assessment of the selected design solutions; Third year: Complete reactor design and performance evaluation, including cost assessment These objectives were fully attained and actually they served to launch IRIS as a full fledged project for eventual commercial deployment. The program did not terminate in 2002 at the end of the NERI program, and has just entered in its fifth year. This has been made possible by the IRIS project participants which have grown from the original four member, two-countries team to the current twenty members, nine countries consortium. All the consortium members work under their own funding and it is estimated that the value of their in-kind contributions over the life of the project has been of the order of $30M. Currently, approximately 100 people worldwide are involved in the project. A very important constituency of the IRIS project is the academia: 7 universities from four countries are members of the consortium and five more US universities are associated via parallel NERI programs. To date, 97 students have worked or are working on IRIS; 59 IRIS-related graduate theses have been prepared or are in preparation, and 41 of these students have already graduated with M.S. (33) or Ph.D. (8) degrees. This ''final'' report (final only as far as the NERI program is concerned) summarizes the work performed in the first four years of IRIS, from October 1999 to October 2003. It provides a panoramic of the project status and design effort, with emphasis on the current status, since two previous reports have very extensively documented the work performed, from inception to early 2002.

  8. Tryptophan hydroxylase 1 and 5-HT7 receptor preferentially expressed in triple-negative breast cancer promote cancer progression through autocrine serotonin signaling.

    Science.gov (United States)

    Gautam, Jaya; Banskota, Suhrid; Regmi, Sushil Chandra; Ahn, Subi; Jeon, Yong Hyun; Jeong, Hyunyoung; Kim, Seung Joo; Nam, Tae-Gyu; Jeong, Byeong-Seon; Kim, Jung-Ae

    2016-11-21

    Triple-negative breast cancer (TNBC) has a high risk of relapse and there are few chemotherapy options. Although 5-hydroxytryptamine (5-HT, serotonin) signaling pathways have been suggested as potential targets for anti-cancer drug development, the mechanism responsible for the action of 5-HT in TNBC remains unknown. Quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting were used to measure mRNA and protein levels, respectively. Cell proliferation was measured using CellTiter 96 Aqueous One Solution. siRNA transfection was used to assess involvement of genes in cancer invasion, which were identified by Matrigel transwell invasion assay. Levels of 5-HT and vascular endothelial growth factor (VEGF) were measured using ELISA kits. Chick chorioallantoic membrane (CAM) assay and mouse tumor model were used to investigate the in vivo effects of SB269970, a 5-HT7 receptor antagonist, and BJ-1113, a novel synthetic compound. TNBC cell lines (MDA-MB-231, HCC-1395, and Hs578T) expressed higher levels of tryptophan hydroxylase 1 (TPH1) than hormone-responsive breast cancer cell lines (MCF-7 and T47D). In MDA-MB-231 cells, 5-HT promoted invasion and proliferation via 5-HT7 receptor, and interestingly, the stimulatory effect of 5-HT on MDA-MB-231 cell invasion was stronger than its effect on proliferation. Likewise, downstream signaling pathways of 5-HT7 differed during invasion and proliferation, that is, Gα-activated cAMP and Gβγ-activated kinase signaling during invasion, and Gβγ-activated PI3K/Akt signaling during proliferation. Also, 5-HT increased the protein expressions of TPH1 and VEGF in MDA-MB-231 cells. These results provide insight of the stimulatory effect of 5-HT on breast cancer progression; 5-HT was found to act more strongly during the first stage of metastasis (during invasion and migration) than during the later proliferative phase after local invasion. Interestingly, these actions of 5-HT were inhibited by BJ-1113, a 6-amino-2

  9. Progression of Luminal Breast Tumors Is Promoted by Ménage à Trois between the Inflammatory Cytokine TNFα and the Hormonal and Growth-Supporting Arms of the Tumor Microenvironment

    Directory of Open Access Journals (Sweden)

    Polina Weitzenfeld

    2013-01-01

    Full Text Available Breast cancer progression is strongly linked to inflammatory processes, aggravating disease course. The impacts of the inflammatory cytokine TNFα on breast malignancy are not fully substantiated, and they may be affected by cooperativity between TNFα and other protumoral mediators. Here, we show that together with representatives of other important arms of the tumor microenvironment, estrogen (hormonal and EGF (growth-supporting, TNFα potently induced metastasis-related properties and functions in luminal breast tumor cells, representing the most common type of breast cancer. Jointly, TNFα + Estrogen + EGF had a stronger effect on breast cancer cells than each element alone, leading to the following: (1 extensive cell spreading and formation of FAK/paxillin-enriched cellular protrusions; (2 elevated proportion of tumor cells coexpressing high levels of CD44 and β1 and VLA6; (3 EMT and cell migration; (4 resistance to chemotherapy; (5 release of protumoral factors (CXCL8, CCL2, MMPs. Importantly, the tumor cells used in this study are known to be nonmetastatic under all conditions; nevertheless, they have acquired high metastasizing abilities in vivo in mice, following a brief stimulation by TNFα + Estrogen + EGF. These dramatic findings indicate that TNFα can turn into a strong prometastatic factor, suggesting a paradigm shift in which clinically approved inhibitors of TNFα would be applied in breast cancer therapy.

  10. Destabilization of mitochondrial functions as a target against breast cancer progression: Role of TPP(+)-linked-polyhydroxybenzoates.

    Science.gov (United States)

    Sandoval-Acuña, Cristian; Fuentes-Retamal, Sebastián; Guzmán-Rivera, Daniela; Peredo-Silva, Liliana; Madrid-Rojas, Matías; Rebolledo, Solange; Castro-Castillo, Vicente; Pavani, Mario; Catalán, Mabel; Maya, Juan Diego; Jara, José A; Parra, Eduardo; Calaf, Gloria M; Speisky, Hernán; Ferreira, Jorge

    2016-10-15

    Mitochondrion is an accepted molecular target in cancer treatment since it exhibits a higher transmembrane potential in cancer cells, making it susceptible to be targeted by lipophilic-delocalized cations of triphenylphosphonium (TPP(+)). Thus, we evaluated five TPP(+)-linked decyl polyhydroxybenzoates as potential cytotoxic agents in several human breast cancer cell lines that differ in estrogen receptor and HER2/neu expression, and in metabolic profile. Results showed that all cell lines tested were sensitive to the cytotoxic action of these compounds. The mechanism underlying the cytotoxicity would be triggered by their weak uncoupling effect on the oxidative phosphorylation system, while having a wider and safer therapeutic range than other uncouplers and a significant lowering in transmembrane potential. Noteworthy, while the TPP(+)-derivatives alone led to almost negligible losses of ATP, when these were added in the presence of an AMP-activated protein kinase inhibitor, the levels of ATP fell greatly. Overall, data presented suggest that decyl polyhydroxybenzoates-TPP(+) and its derivatives warrant future investigation as potential anti-tumor agents. Copyright © 2016 Elsevier Inc. All rights reserved.

  11. Development of a new technic for breast attenuation correction in myocardial perfusion scintigraphy using computational methods; Desenvolvimento de uma nova tecnica para correcao da atenuacao por tecidos moles em cintilografia de perfusao miocardica utilizando metodos computacionais

    Energy Technology Data Exchange (ETDEWEB)

    Oliveira, Anderson de

    2015-07-01

    Introduction: One of the limitations of nuclear medicine studies are false-positive results that lead to unnecessary exams and procedures associated to morbidity and costs to the individual and society. One of the most frequent causes for reducing the specificity of myocardial perfusion imaging (MPI) is photon attenuation, especially by breast in women. Objective: To develop a new technique to compensate the photon attenuation by women breasts in myocardial perfusion imaging with {sup 99m}Tc-sestamibi, using computational methods. Materials and methods: A procedure was proposed which integrates Monte Carlo simulation, computational methods and experimental techniques. Initially, were obtained the chest attenuation correction percentages using a phantom Jaszczak and breast attenuation percentages by Monte Carlo simulation method, using the EGS4 program. The percentages of attenuation correction were linked to individual patients' characteristics by an artificial neural network and a multivariate analysis. A preliminary technical validation was done by comparing the results of the MPI and catheterism (CAT), before and after applying the technique to 4 patients. The t test for parametric data, Wilcoxon, Mann-Whitney and X{sup 2} for the others were used. Probability values less than 0.05 were considered statistically significant. Results: Each increment of 1 cm in the thickness of breast was associated to an average increment of 6% on photon attenuation, while the maximum increase related to breast composition was about 2%. The average chest attenuation percentage per unit was 2.9%. Both, the artificial neural network and linear regression, showed an error less than 3% as predictive models for percentage of female attenuation. The anatomical-functional correlation between MPI and CAT was maintained after the use of the technique. Conclusion: Results suggest that the proposed technique is promising and could be a possible alternative to other conventional methods

  12. Second-Line Treatment of Her2-Positive Metastatic Breast Cancer: Trastuzumab beyond Progression or Lapatinib? A Population Based Cohort Study.

    Directory of Open Access Journals (Sweden)

    Ariel Hammerman

    Full Text Available The relative efficacy of lapatinib vs. continuing trastuzumab beyond progression (TBP in HER2-positive metastatic breast cancer (MBC patients, who progressed on first-line trastuzumab, is still unclear. The objective of this population based cohort study was to compare outcomes of lapatinib vs. TBP in daily practice.All HER2-positive MBC patients who began second-line anti HER2 therapy between 1st January 2010 and 30th August 2013 were selected from Clalit Health Services' (CHS electronic database. Available data on patient and disease characteristics and treatments were analyzed. The primary endpoint was overall survival (OS. Outcomes were compared using the Kaplan-Meier (log-rank method and Cox proportional hazards model.64 patients received second-line lapatinib and 93 TBP. The two treatment groups were similar in age and co-morbidity rates, but differed in proportion of prior adjuvant trastuzumab (lapatinib: 29.7%, TBP: 16.1%, P = 0.043 and rates of prior brain metastases (lapatinib: 32.8%, TBP: 10.8%, P = 0.01. Lapatinib median OS was 13.0 months (95% CI: 9.5-16.5 vs. 31.0 for TBP (95% CI: 20.6-41.4, P<0.001. On multivariate analysis, longer OS was preserved for TBP, after controlling for differences in age, adjuvant trastuzumab, duration of first-line trastuzumab therapy, brain metastases, visceral metastases and hormonal treatment [Hazard Ratio (HR = 0.63, 95% CI: 0.40-0.99, P = 0.045].In this comparative cohort study, OS of HER2-positive MBC patients treated with TBP was significantly longer than with lapatinib. These results might be especially relevant in settings where ado-trastuzumab-emtansine (TDM-1, the current preferred agent in this setting, is not available yet for patients.

  13. Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: Implications for post-progression and conditional survival.

    Science.gov (United States)

    Carbognin, Luisa; Sperduti, Isabella; Ciccarese, Mariangela; Fabi, Alessandra; Petrucelli, Luciana; Vari, Sabrina; Forcignanò, Rosa Chiara; Nortilli, Rolando; Vicentini, Cecilia; Pilotto, Sara; Merler, Sara; Zampiva, Ilaria; Brunelli, Matteo; Manfrin, Erminia; Giannarelli, Diana; Tortora, Giampaolo; Bria, Emilio

    2016-10-01

    The aim of this analysis was to develop and validate a prognostic model for advanced breast cancer (ABC) with luminal subtype based on the combination of clinical, pathological and therapeutic predictors to provide a practical tool to evaluate patients' prognosis. Clinical and pathological data were retrospectively correlated to progression-free and overall survival (PFS/OS) using a Cox model. Significant treatment variables were adjusted with the propensity score analysis. A continuous score to identify risk classes was derived according to model ratios. The performance of the risk-class model was tested for post-progression survival (PPS) and conditional survival (CS) as well. Data from 335 patients (3 institutions) were gathered (median follow-up 58 months). At multivariate analysis Ki67, Performance Status (PS) and number of metastatic sites were significant predictors for PFS, whereas Ki67, PS, brain metastases, PFS after 1st-line therapy, number of chemotherapy lines, hormonal therapy and maintenance were significant predictors for OS. The hormonal maintenance resulted to be prognostic after adjustment with propensity score analysis. A two-class model significantly differentiated low-risk and high-risk patients for 2-year PFS (31.5% and 11.0%, p model separated low risk, intermediate-risk, and high-risk patients for 2-year PFS (40.8%, 24.4%, and 11.0%, p models equally discriminate the luminal ABC prognosis in terms of PPS and CS. A risk stratification model including 'easy-to-obtain' clinical, pathological and therapeutic parameters accurately separates luminal ABC patients into different risk classes. Copyright © 2016 Elsevier Ltd. All rights reserved.

  14. Beta blockers and improved progression-free survival in patients with advanced HER2 negative breast cancer: a retrospective analysis of the ROSE/TRIO-012 study.

    Science.gov (United States)

    Spera, G; Fresco, R; Fung, H; Dyck, J R B; Pituskin, E; Paterson, I; Mackey, J R

    2017-08-01

    Recent retrospective studies suggest that beta-adrenergic blocking drugs (BB) are associated with improved outcomes in patients with a range of cancers. Although limited and discordant data suggest that BB may increase overall survival (OS) in localized breast cancer (BC), there is no information on the effects of BB in women with advanced BC. To explore the association between BB use and BC outcomes, we retrospectively reviewed ROSE/TRIO-012, a double-blinded, multinational phase III trial that randomized 1144 patients with HER2-negative advanced BC to first-line docetaxel in combination with ramucirumab or placebo. We compared progression-free survival (PFS), OS, overall response rate, and clinical benefit rate in patients who received BB to those who did not. 153/1144 (13%) patients received BB; 62% prior to enrolment and 38% began after enrolment. Median PFS in BB treated patients was longer than in patients who did not receive them (10.3 versus 8.3 months; HR 0.81; 95% CI 0.66-0.99; P = 0.038). Patients treated with BB only after enrolment had even higher median PFS (15.5 versus 8.3 months, P < 0.001). In the TNBC subset, median PFS was 13.0 months with BB, compared to 5.2 months without BB (HR 0.52; 95% CI 0.34-0.79; P = 0.002). The benefit of BB intake in PFS was independent of treatment-emergent hypertension (P = 0.476) but associated with treatment arm (P = 0.037). The test for interactions between BB and treatment arm was not significant (P = 0.276). No differences were seen in OS, overall response rate, or clinical benefit rate. A validation dataset analysis had consistent but less substantial improved outcomes for women with node positive operable breast cancer receiving BB in the BCIRG-005 trial. In this exploratory analysis, BB intake was associated with significant improvement in PFS, particularly in patients with TNBC and patients not previously exposed to BB. NCT00703326.

  15. TECHNICAL COORDINATION

    CERN Multimedia

    A. Ball and W. Zeuner

    2011-01-01

    In this report we will review the main achievements of the Technical Stop and the progress of several centrally-managed projects to support CMS operation and maintenance and prepare the way for upgrades. Overview of the extended Technical Stop  The principal objectives of the extended Technical Stop affecting the detector itself were the installation of the TOTEM T1 telescopes on both ends, the readjustment of the alignment link-disk in YE-2, the replacement of the light-guide sleeves for all PMs of both HFs, and some repairs on TOTEM T2 and CASTOR. The most significant tasks were, however, concentrated on the supporting infrastructure. A detailed line-by-line leak search was performed in the C6F14 cooling system of the Tracker, followed by the installation of variable-frequency drives on the pump motors of the SS1 and SS2 tracker cooling plants to reduce pressure transients during start-up. In the electrical system, larger harmonic filters were installed in ...

  16. MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression.

    Science.gov (United States)

    Christenson, Jessica L; Butterfield, Kiel T; Spoelstra, Nicole S; Norris, John D; Josan, Jatinder S; Pollock, Julie A; McDonnell, Donald P; Katzenellenbogen, Benita S; Katzenellenbogen, John A; Richer, Jennifer K

    2017-04-01

    Triple-negative breast cancer (TNBC) has a faster rate of metastasis compared to other breast cancer subtypes, and no effective targeted therapies are currently FDA-approved. Recent data indicate that the androgen receptor (AR) promotes tumor survival and may serve as a potential therapeutic target in TNBC. Studies of AR in disease progression and the systemic effects of anti-androgens have been hindered by the lack of an AR-positive (AR+) immunocompetent preclinical model. In this study, we identified the transgenic MMTV-PyMT (mouse mammary tumor virus-polyoma middle tumor-antigen) mouse mammary gland carcinoma model of breast cancer and Met-1 cells derived from this model as tools to study the role of AR in breast cancer progression. AR protein expression was examined in late-stage primary tumors and lung metastases from MMTV-PyMT mice as well as in Met-1 cells by immunohistochemistry (IHC). Sensitivity of Met-1 cells to the AR agonist dihydrotestosterone (DHT) and anti-androgen therapy was examined using cell viability, migration/invasion, and anchorage-independent growth assays. Late-stage primary tumors and lung metastases from MMTV-PyMT mice and Met-1 cells expressed abundant nuclear AR protein, while negative for estrogen and progesterone receptors. Met-1 sensitivity to DHT and AR antagonists demonstrated a reliance on AR for survival, and AR antagonists inhibited invasion and anchorage-independent growth. These data suggest that the MMTV-PyMT model and Met-1 cells may serve as valuable tools for mechanistic studies of the role of AR in disease progression and how anti-androgens affect the tumor microenvironment.

  17. Increased oil production and reserves utilizing secondary/tertiary recovery techniques on small reservoirs in the Paradox basin, Utah. Final technical progress report, October 1--December 31, 1995

    Energy Technology Data Exchange (ETDEWEB)

    Allison, M.L.

    1996-01-15

    The primary objective of this project is to enhance domestic petroleum production by demonstration and technology transfer of an advanced oil recovery technology in the Paradox basin, southeastern Utah. If this project can demonstrate technical and economic feasibility, the technique can be applied to approximately 100 additional small fields in the Paradox basin alone, and result in increased recovery of 150 to 200 million barrels of oil. This project is designed to characterize five shallow-shelf carbonate reservoirs in the Pennsylvanian (Desmoinesian) Paradox Formation and choose the best candidate for a pilot demonstration project for either a waterflood or carbon dioxide-(CO{sub 2}) flood project. The field demonstration, monitoring of field performance, and associated validation activities will take place in the Paradox basin within the Navajo Nation. The results of this project will be transferred to industry and other researchers through a petroleum extension service, creation of digital databases for distribution, technical workshops and seminars, field trips, technical presentations at national and regional professional meeting, and publication in newsletters and various technical or trade journals. Five activities continued this quarter as part of the geological and reservoir characterization of carbonate mound buildups in the Paradox basin: (1) regional facies evaluation, (2) evaluation of outcrop analogues, (3) field-scale geologic analysis, (4) reservoir analysis, and (5) technology transfer.

  18. A clinical randomized controlled trial of music therapy and progressive muscle relaxation training in female breast cancer patients after radical mastectomy: results on depression, anxiety and length of hospital stay.

    Science.gov (United States)

    Zhou, Kaina; Li, Xiaomei; Li, Jin; Liu, Miao; Dang, Shaonong; Wang, Duolao; Xin, Xia

    2015-02-01

    To examine effects of music therapy and progressive muscle relaxation training on depression, anxiety and length of hospital stay in Chinese female breast cancer patients after radical mastectomy. A total of 170 patients were randomly allocated to the intervention group (n = 85) receiving music therapy and progressive muscle relaxation training plus routine nursing care and the control group (n = 85) receiving routine nursing care. Music therapy and progressive muscle relaxation training were performed twice a day within 48 h after radical mastectomy, once in the early morning (6a.m.-8a.m.) and once in the evening (9p.m.-11p.m.), for 30 min per session until discharged from the hospital. A general linear model with univariate analysis showed that the intervention group patients had significant improvement in depression and anxiety in the effects of group (F = 20.31, P Music therapy and progressive muscle relaxation training can reduce depression, anxiety and length of hospital stay in female breast cancer patients after radical mastectomy. Copyright © 2014 Elsevier Ltd. All rights reserved.

  19. Association of germline variation in CCNE1 and CDK2 with breast cancer risk, progression and survival among Chinese Han women.

    Directory of Open Access Journals (Sweden)

    Ji-Yuan Han

    Full Text Available BACKGROUND: Somatic alterations of cyclin-dependent kinase 2 (CDK2-cyclin E complex have been shown to contribute to breast cancer (BC development and progression. This study aimed to explore the effects of single nucleotide polymorphisms (SNPs in CDK2 and CCNE1 (a gene encoding G1/S specific cyclin E1 protein, formerly called cyclin E on BC risk, progression and survival in a Chinese Han population. METHODOLOGY/PRINCIPAL FINDINGS: We herein genotyped 6 haplotype-tagging SNPs (htSNPs of CCNE1 and 2 htSNPs of CDK2 in 1207 BC cases and 1207 age-matched controls among Chinese Han women, and then reconstructed haplotype blocks according to our genotyping data and linkage disequilibrium status of these htSNPs. For CCNE1, the minor allele homozygotes of three htSNPs were associated with BC risk (rs3218035: adjusted odds ratio [aOR] = 3.35, 95% confidence interval [CI] = 1.69-6.67; rs3218038: aOR = 1.81, 95% CI = 1.22-2.70; rs3218042: aOR = 2.64, 95% CI = 1.31-5.34, and these three loci showed a dose-dependent manner in increasing BC risk (P(trend = 0.0001. Moreover, the 5-SNP haplotype CCGTC, which carried none of minor alleles of the 3 at-risk SNPs, was associated with a favorable event-free survival (hazard ratio [HR] = 0.53, 95% CI = 0.32-0.90. Stratified analysis suggested that the minor-allele homozygote carriers of rs3218038 had a worse event-free survival among patients with aggressive tumours (in tumour size>2 cm group: HR = 2.06, 95% CI = 1.06-3.99; in positive lymph node metastasis group: HR = 2.41, 95% CI = 1.15-5.03; in stage II-IV group: HR = 2.03, 95% CI = 1.09-3.79. For CDK2, no significant association was found. CONCLUSIONS/SIGNIFICANCE: This study indicates that genetic variants in CCNE1 may contribute to BC risk and survival in Chinese Han population. They may become molecular markers for individual evaluation of BC susceptibility and prognosis. Nevertheless, further validation studies are needed.

  20. The development of coal-based technologies for Department of Defense facilities. Volume 2, Appendices. Semiannual technical progress report, September 28, 1994--March 27, 1995

    Energy Technology Data Exchange (ETDEWEB)

    Miller, B.G.; Bartley, D.A.; Hatcher, P. [Pennsylvania State Univ., University Park, PA (United States). Energy and Fuels Research Center] [and others

    1996-10-15

    This semiannual progress report contains the following appendices: description of the 1,000 lb steam/h watertube research boiler; the Pennsylvania CGE model; Phase II, subtask 3.9 coal market analysis; the CGE model; and sector definition.

  1. Technical aspects of contrast-enhanced magnetic resonance imaging of the breast: literature review; Aspectos tecnicos da ressonancia magnetica de mama com meio de contraste: revisao da literatura

    Energy Technology Data Exchange (ETDEWEB)

    Leopoldino, Denise de Deus; Gracio, Tatiana Schiller [Hospital Sao Luiz, Sao Paulo, SP (Brazil). Setor de Tomografia e Ressonancia Magnetica]. E-mail: leopoldinod@yahoo.com; D' Ippolito, Giuseppe; Bezerra, Alexandre Sergio de Araujo; Gracio, Tatiana Schiller [Hospital Sao Luiz, Sao Paulo, SP (Brazil). Setor de Diagnostico por Imagem

    2005-07-15

    With the advances in surface coil technology and the development of new imaging protocols in addition to the increase of the use of contrast agents, contrast enhanced magnetic resonance imaging (MRI) has emerged as a promising modality for detection, diagnosis and staging of breast cancer. Despite these advances, there are some unresolved issues, including no defined standard technique for contrast-enhanced breast MRI and no standard criteria of interpretation for the evaluation of such studies. In this article, we review the literature and discuss the general requirements and recommendations for contrast agent-enhanced breast MRI, including image interpretation criteria, MR equipment, dedicated radiofrequency coils, use of paramagnetic contrast agents, fat-suppression techniques, planes of acquisition, pulse sequence specifications and artifact sources. (author)

  2. Cellular Mechanisms of Zinc Dysregulation: A Perspective on Zinc Homeostasis as an Etiological Factor in the Development and Progression of Breast Cancer

    Directory of Open Access Journals (Sweden)

    Samina Alam

    2012-07-01

    Full Text Available Worldwide, breast cancer is the most commonly diagnosed cancer among women and is the leading cause of female cancer deaths. Zinc (Zn functions as an antioxidant and plays a role in maintaining genomic stability. Zn deficiency results in oxidative DNA damage and increased cancer risk. Studies suggest an inverse association between dietary and plasma Zn levels and the risk for developing breast cancer. In contrast, breast tumor biopsies display significantly higher Zn levels compared with normal tissue. Zn accumulation in tumor tissue also correlates with increased levels of Zn importing proteins. Further, aberrant expression of Zn transporters in tumors correlates with malignancy, suggesting that altered metal homeostasis in the breast could contribute to malignant transformation and the severity of cancer. However, studies have yet to link dysregulated Zn transport and abnormal Zn-dependent functions in breast cancer development. Herein, we summarize studies that address the multi-modal role of Zn dyshomeostasis in breast cancer with respect to the role of Zn in modulating oxidative stress, DNA damage response/repair pathways and cell proliferation/apoptosis, and the relationship to aberrant regulation of Zn transporters. We also compare Zn dysregulation in breast tissue to that of prostate, pancreatic and ovarian cancer where possible.

  3. Progesterone Receptor Scaffolding Function in Breast Cancer

    Science.gov (United States)

    2012-10-01

    response. PR are expressed in multiple human tissues including the uterus, mammary gland , brain, pancreas, thymus , bone, ovary, testes, and in the...ABSTRACT Progesterone receptors (PR) are critical mediators of mammary gland development and contribute to breast cancer progression. Progestin...receptors (PR) are critical for massive breast epithelial cell expansion during mammary gland development and contribute to breast cancer progression

  4. Development and process evaluation of improved Fischer-Tropsch slurry catalysts. Sixth quarterly technical progress report, 1 January--31 March 1988

    Energy Technology Data Exchange (ETDEWEB)

    Withers, H.P. [Air Products and Chemicals, Inc., Allentown, PA (United States); Bukur, D.B.; Rosynek, M.P. [Texas A and M Univ., College Station, TX (United States)

    1988-12-31

    The objective of this contract is to develop a consistent technical data base on the use of iron-based catalysts in Fischer-Tropsch (FT) synthesis reactions. This data base will be developed to allow the unambiguous comparison of the performance of these catalysts with each other and with state-of-the-art iron catalyst comparisons. Particular attention will be devoted to generating reproducible kinetic and selectivity data and to developing reproducible improved catalyst compositions.

  5. Development and testing of a high efficiency advanced coal combustor: Phase 3 industrial boiler retrofit. Quarterly technical progress report No. 11, April 1, 1994--June 30, 1994

    Energy Technology Data Exchange (ETDEWEB)

    Patel, R.; Borio, R. [ABB Combustion Engineering, Windsor, CT (United States). Power Plant Labs.; Scaroni, A.W.; Miller, B.G. [Pennsylvania State Univ., (United States); McGowan, J.G. [Univ. of Massachusetts (United States)

    1994-09-23

    The objective of this project is to retrofit the previously developed High Efficiency Advanced Coal Combustor (HEACC) to a standard gas/oil designed industrial boiler to assess the technical and economic viability of displacing premium fuels with microfine coal. This report documents the technical aspects of this project during the tenth quarter of the program. The four hundred hours ``Proof-of-Concept System Test`` under Task 3 was completed during this quarter. The primary objectives were to obtain steady state operation consistently on coal only and increase carbon conversion efficiency from {approximately}95% to the project goal of 98%. This was to be obtained without increasing NO{sub x} emission above the project goal level of 0.6 lbs/MBtu ({approximately}425 ppM). The testing was also designed to show that consistent, reliable operation could be achieved as another prerequisite to the demonstration. The data were gathered and analyzed for both economic and technical analysis prior to committing to the long term demonstration. The Economic Evaluation was completed and work started on commercialization plan. During this reporting period, activities included sample analysis, data reduction and interpretation from all the testing during March and April. Following preliminary conclusions are drawn based on results evaluated: coal handling/preparation system can be designed to meet technical requirements for retrofitting microfine coal combustion; boiler thermal performance met requirement; NO{sub x} Emission can meet target of 0.6 lb/MBtu; combustion efficiencies of 95% could be met on a daily average basis, somewhat below target of 98%; economic playback very sensitive to fuel differential cost, unit size, and annual operating hours; and continuous long term demonstration needed to quantify ash effect and how to best handle.

  6. Research and development of methods/utilities and rules for managing cooperation for performance improvement in government offices. Second Technical progress report, September 1, 1992--January 31, 1993

    Energy Technology Data Exchange (ETDEWEB)

    Kurstedt, H.A.

    1993-03-01

    Purpose is to help managers approach their responsibilities proactively, so that they can anticipate problems and take actions to alleviate or eliminate those problems. Continuous performance improvement, the philosophy behind total quality management, requires working cooperatively to do a little better each day. The most effective tools are working through a closed set of 9 methods: setting expectations, charting, defining indicators and standards, collecting and logging data, converting data to information, organizing and presenting information, reviewing status and progress, self-management, and appraising. In addition, there are 8 rules: focus on what you can do, supply physical evidence of progress, pay attention to detail, inspect (don`t expect), review progress routinely and frequently, face ``success/fail`` squarely, communicate crisply, and conduct honest, open appraisals. Scope and plans of the draft research plan (study areas) are described.

  7. Breast lump

    Science.gov (United States)

    ... removed with surgery. Breast infections are treated with antibiotics. If you are diagnosed with breast cancer , you will discuss your options carefully and thoroughly with your provider. Alternative Names Breast mass Images Female breast Breast lumps ...

  8. Breast lift

    Science.gov (United States)

    Mastopexy; Breast lift with reduction; Breast lift with augmentation ... enlargement with implants) when they have a breast lift. ... it for medical reasons. Women usually have breast lifts to lift sagging, loose breasts. Pregnancy, breastfeeding, and ...

  9. A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers.

    LENUS (Irish Health Repository)

    Hennessy, Bryan T

    2010-12-01

    INTRODUCTION: The lack of large panels of validated antibodies, tissue handling variability, and intratumoral heterogeneity potentially hamper comprehensive study of the functional proteome in non-microdissected solid tumors. The purpose of this study was to address these concerns and to demonstrate clinical utility for the functional analysis of proteins in non-microdissected breast tumors using reverse phase protein arrays (RPPA). METHODS: Herein, 82 antibodies that recognize kinase and steroid signaling proteins and effectors were validated for RPPA. Intraslide and interslide coefficients of variability were <15%. Multiple sites in non-microdissected breast tumors were analyzed using RPPA after intervals of up to 24 h on the benchtop at room temperature following surgical resection. RESULTS: Twenty-one of 82 total and phosphoproteins demonstrated time-dependent instability at room temperature with most variability occurring at later time points between 6 and 24 h. However, the 82-protein functional proteomic "fingerprint" was robust in most tumors even when maintained at room temperature for 24 h before freezing. In repeat samples from each tumor, intratumoral protein levels were markedly less variable than intertumoral levels. Indeed, an independent analysis of prognostic biomarkers in tissue from multiple tumor sites accurately and reproducibly predicted patient outcomes. Significant correlations were observed between RPPA and immunohistochemistry. However, RPPA demonstrated a superior dynamic range. Classification of 128 breast cancers using RPPA identified six subgroups with markedly different patient outcomes that demonstrated a significant correlation with breast cancer subtypes identified by transcriptional profiling. CONCLUSION: Thus, the robustness of RPPA and stability of the functional proteomic "fingerprint" facilitate the study of the functional proteome in non-microdissected breast tumors.

  10. Targeting mrtl to Reverse Myc in Breast Oncogenesis

    Science.gov (United States)

    2011-06-01

    fibrocystic changes, stromal fibrosis, focal microcalcifications , no malignancy, history of cancer contralateral breast , BRCA 1 / 2 positive. 36-10...in development and progression of human breast cancer . 15. SUBJECT TERMS Myc, mrtl, breast cancer , metastasis, polymorphism 16. SECURITY...relationship between mrtl and Myc and to elucidate the possible involvement of mrtl in development and progression of human breast cancer . Our experimental

  11. TECHNICAL COORDINATION

    CERN Multimedia

    Austin Ball

    Summary of progress since last CMS week. Ten years of construction work have been completed. CMS is closed, in very close to the ideal low luminosity configuration, and performed well in the first tests with LHC beam. Behind this encouraging news is the story of a summer of intense commitment by many teams (from the collaboration and 3 CERN departments) working together, against the clock and despite many minor setbacks, to ensure that the experiment was ready to play a leading role in the excitement of September 10. Following beampipe bakeout and refill with pure neon, a magnificent effort by the ECAL group and the pt 5 technical crew made it possible to install and commission all 4 ECAL endcap Dees before the end of August. In the shadow of this activity, the barrel and forward pixel trackers and part of the beam monitoring were installed within the vac tank. The pt 5 technical teams then succeeded in safely removing the 20t installation tables and their support blocks from beneath the already installed ...

  12. Coagulation factor VIIa-mediated protease-activated receptor 2 activation leads to β-catenin accumulation via the AKT/GSK3β pathway and contributes to breast cancer progression.

    Science.gov (United States)

    Roy, Abhishek; Ansari, Shabbir A; Das, Kaushik; Prasad, Ramesh; Bhattacharya, Anindita; Mallik, Suman; Mukherjee, Ashis; Sen, Prosenjit

    2017-08-18

    Cell migration and invasion are very characteristic features of cancer cells that promote metastasis, which is one of the most common causes of mortality among cancer patients. Emerging evidence has shown that coagulation factors can directly mediate cancer-associated complications either by enhancing thrombus formation or by initiating various signaling events leading to metastatic cancer progression. It is well established that, apart from its distinct role in blood coagulation, coagulation factor FVIIa enhances aggressive behaviors of breast cancer cells, but the underlying signaling mechanisms still remain elusive. To this end, we investigated FVIIa's role in the migration and invasiveness of the breast cancer cell line MDA-MB-231. Consistent with previous observations, we observed that FVIIa increased the migratory and invasive potential of these cells. We also provide molecular evidence that protease-activated receptor 2 activation followed by PI3K-AKT activation and GSK3β inactivation is involved in these processes and that β-catenin, a well known tumor-regulatory protein, contributes to this signaling pathway. The pivotal role of β-catenin was further indicated by the up-regulation of its downstream targets cyclin D1, c-Myc, COX-2, MMP-7, MMP-14, and Claudin-1. β-Catenin knockdown almost completely attenuated the FVIIa-induced enhancement of breast cancer migration and invasion. These findings provide a new perspective to counteract the invasive behavior of breast cancer, indicating that blocking PI3K-AKT pathway-dependent β-catenin accumulation may represent a potential therapeutic approach to control breast cancer. © 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

  13. Synthesis of 6-Methyl-9-n-propyldibenzothiophene-4-ol. Quarterly technical progress report No. 4, April 25--July 25, 1991

    Energy Technology Data Exchange (ETDEWEB)

    Eisenbraun, E.J.

    1991-07-25

    The material covered in this report is divided into two parts: further cyclization experiments on 1,4-diethyl-2-[(2`- methoxyphenyl)thio]benzene and its sulfone both by chemical and photochemical means, and progress toward synthesis of modified target molecule, 9-isopropyl-4-methoxy-6-methyldibenzo-thiophene. 8 refs, figs.

  14. GPHS-RTGs in support of the Cassini Mission. Semi-annual technical progress report, April 3, 1995--October 1, 1995

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1995-10-24

    This document is the April-October 1995 Progress Report on the Cassini RTG Program. Nine tasks are summarized; (1) Spacecraft integration and liason, (2) Engineering support, (3) Safety, (4) Unicouple fabrication, (5) ETG fabrication, assembly, and test, (6) Ground support equipment, (7) RTG shipping and launch support, (8) Design, reviews, and mission applications, and (9) Project management, QA, contract changes, and material acquisitions.

  15. Development of automated welding process for field fabrication of thick walled pressure vessels. Technical progress report, second quarter, FY 1980, ending March 28, 1980

    Energy Technology Data Exchange (ETDEWEB)

    Schneider, U.A.

    1980-01-01

    Progress on a metallurgical contract is reported: (1) specifications of 2 1/4 chromium-1 molybdenum low alloy steel plate for a coal gasification project; (2) methods of welding and analyses of helium-argon mixtures for welding; and (3) tensile properties of welded joints. (LTN)

  16. Materials testing and requirement for the ERDA nuclear-powered artificial heart. Technical progress report, July 15, 1975--May 30, 1976. [BIOMER and AVCOTHANE

    Energy Technology Data Exchange (ETDEWEB)

    Andrade, J. D.; Hufferd, W. L.; Lyman, D. J.

    1976-01-01

    The two materials currently being used for the artificial heart fabrication are BIOMER and AVCOTHANE. BIOMER is a polyether urethane polymer. AVCOTHANE is a proprietary polyurethane/polydimethylsiloxane polymer blend. Research progress on the chemical degradation, mechanical strength, and blood compatibility is reported. (TFD)

  17. A "Fear" Studies Perspective and Critique: Analyzing English and Stengel's Progressive Study of Fear and Learning in "Education Theory." Technical Paper No. 37

    Science.gov (United States)

    Fisher, R. Michael

    2011-01-01

    The author critiques the progressive approach of two contemporary educational philosophers (English and Stengel) on the topic of fear and learning. Using a postmodern integral approach, this article examines the tendency of reductionism, individualism, and psychologism as part of a hegemonic liberalism and modernism in discourses on fear and…

  18. Production and screening of carbon products precursors from coal. Quarterly technical progress report No. 5, January 1,1996--March 31, 1996

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-04-01

    Individual quarterly reports of four industrial participants of this project are included in this report. The technical emphasis continues to be the supply of coal-based feedstocks to the industrial participants. There have been several iterations of samples and feedback to meet feedstock characteristics for a wide variety of carbon products. Technology transfer and marketing of the Carbon Products Consortium (CPC) is a continual effort. Interest in the program and positive results from the research continue to grow. In several aspects, the program is ahead of schedule.

  19. Evaluation and capacity building to improve precollege science and mathematics achievement in the US: 10 CFR, Part 605. Technical progress report, June--December 1992

    Energy Technology Data Exchange (ETDEWEB)

    1992-12-31

    The National Center for Improving Science Education has undertaken activities to achieve evaluation goals for DOE`s Precollege programs: develop means to determine program quality; develop means for determining the contribution of DOE precollege programs to both teacher enhancement and student achievement; provide evaluation designs and instruments and reports of program quality and impact; and strengthen both DOE`s and the Labs` capacity to do both short- and long-term planning as well as deliver effective programs and evaluation. Appendices include evaluation/technical assistance report, profiling teacher research participation and teacher development programs, teacher surveys, impact assessment design, and teacher research participation programs anecdotes for 8 labs.

  20. TECHNICAL COORDINATION

    CERN Multimedia

    Austin Ball

    2013-01-01

      Since the last report, much visible progress has been made, as the LS1 programme approaches the halfway point. From early October, technical and safety shift-crew have been present around the clock, allowing detectors to stay switched on overnight, ensuring that safety systems are operational and instructions for non-expert shift-crew are clear. LS1 progress Throughout the summer, whilst the solenoid vacuum tank and YB0 surfaces were accessible, an extensive installation programme took place to prepare for Tracker colder operation and the PLT installation, in 2014, the Phase 1 Pixel Tracker installation, in 2016–’17, and the HCAL Phase 1 upgrade completion, ending in LS2. This included pipework for N2 or dry air to flush the Tracker bulkhead region, many sensors to monitor temperature and dew point in the Tracker and its service channels, heating wires outside the Tracker cooling bundles, supports for the new vacuum-jacketed, concentric, CO2 Pixel cooling lines, the PLT cool...

  1. Implantes mamarios y mastopexía: colgajos mamarios laterales y mediales, una opción técnica Breast Implants and Mastopexy: lateral and Medial Breast Flaps, a Technical Option

    Directory of Open Access Journals (Sweden)

    R. Goulart Jr.

    2012-12-01

    Full Text Available La mastopexia asociada al uso de implantes mamarios es actualmente una de las prácticas más desafiantes en Cirugía Plástica; en ella, el cirujano tiene que utilizar al máximo sus capacidades y conocimientos para decidir con exactitud la mejor relación entre el tamaño ideal del implante y el exceso de piel a retirar. El objetivo de este artículo es presentar una técnica a base de colgajos mamarios laterales y mediales (CMLM para cirugía de mastopexia con implantes mamarios en busca de una mejor definición de la mama y de una mayor duración del resultado final. Esta técnica se crea en base a la circulación mamaria y en los excedentes de tejido al final de la cirugía utilizando la marcación en T. Los resultados inmediatos han sido muy satisfactorios en términos de definición de la forma mamaria, de la solidez de la nueva estructura glandular y de la protección del implante mamario. La duración a largo plazo aún debe ser evaluada. Creemos que se trata de una técnica fácil de ejecutar, que permite un resultado estético satisfactorio, proporciona una percepción de mayor seguridad en el posicionamiento del implante, aunque somos conscientes de que su sostenibilidad y duración a largo plazo aún necesitan tiempo para una mejor evaluación.The breast implant associated with mastopexy actually is one of most difficult plastic surgeries. In fact, it is a surgery where the surgeon has to use his higher capabilities and skills in order to decide with precision the best relationship between ideal sizes of the breast implant and skin excess. The purpose in this paper is to present a breast lateral and medial flaps technique for augmentation mastopexy surgery looking for a better breast design and resistance on the final result. The technique was created on breast circulation basis, skin excess and better definition and resistance about the aesthetical breast results in the augmentation mastopexy surgery utilizing the T scar technique

  2. A charge distribution analysis instrument for catalysis and material science applications. Third quarterly technical progress report, April 1, 1994--June 30, 1994

    Energy Technology Data Exchange (ETDEWEB)

    Freund, F.

    1994-08-05

    Key component in the CDA instrument is the differential capacitive force sensor. The CDA instrument has four basic components: OEM analytical balance, flexure point and capacitor plates, gas confinement tower and high-voltage bias electrodes, and the furnace. Phyton is in position to purchase an OEM analytical balance; negotations are underway for obtaining the feedback control circuitry for the differential capacitive force sensor. Progress with the differential capacitive force sensor is reviewed.

  3. Enthalpy measurement of coal-derived liquids. Quarterly technical progress report, July-September, 1978. [148 to 459/sup 0/F; 100 to 300 psia

    Energy Technology Data Exchange (ETDEWEB)

    Kidnay, A.J.; Yesavage, V.F.

    1978-12-01

    Experimental measurements were completed on a naphtha sample (1046) furnished by the Pittsburg and Midway Coal Mining Company. A total of 38 measurements were made in the temperature region 148 to 459/sup 0/F, and at pressures of 100 and 300 psia. Additional analytical work was also completed on the SRC-I naphtha whose enthalpy measurements were reported in previous progress reports. Comparisons are given between the experimental SRC-I naphtha enthalpies and the available petroleum enthalpy correlations.

  4. Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression.

    Science.gov (United States)

    Sisirak, Vanja; Faget, Julien; Gobert, Michael; Goutagny, Nadège; Vey, Nelly; Treilleux, Isabelle; Renaudineau, Sarah; Poyet, Gaelle; Labidi-Galy, Sana Intidhar; Goddard-Leon, Sophie; Durand, Isabelle; Le Mercier, Isabelle; Bajard, Agathe; Bachelot, Thomas; Puisieux, Alain; Puisieux, Isabelle; Blay, Jean-Yves; Ménétrier-Caux, Christine; Caux, Christophe; Bendriss-Vermare, Nathalie

    2012-10-15

    Infiltration and dysfunction of immune cells have been documented in many types of cancers. We previously reported that plasmacytoid dendritic cells (pDC) within primary breast tumors correlate with an unfavorable prognosis for patients. The role of pDC in cancer remains unclear but they have been shown to mediate immune tolerance in other pathophysiologic contexts. We postulated that pDC may interfere with antitumor immune response and favor tolerance in breast cancer. The present study was designed to decipher the mechanistic basis for the deleterious impact of pDC on the clinical outcome. Using fresh human breast tumor biopsies (N = 60 patients), we observed through multiparametric flow cytometry increased tumor-associated (TA) pDC (TApDC) rates in aggressive breast tumors, i.e., those with high mitotic index and the so-called triple-negative breast tumors (TNBT). Furthermore, TApDC expressed a partially activated phenotype and produced very low amounts of IFN-α following toll-like receptor activation in vitro compared with patients' blood pDC. Within breast tumors, TApDC colocalized and strongly correlated with TA regulatory T cells (TATreg), especially in TNBT. Of most importance, the selective suppression of IFN-α production endowed TApDC with the unique capacity to sustain FoxP3(+) Treg expansion, a capacity that was reverted by the addition of exogenous IFN-α. These findings indicate that IFN-α-deficient TApDC accumulating in aggressive tumors are involved in the expansion of TATreg in vivo, contributing to tumor immune tolerance and poor clinical outcome. Thus, targeting pDC to restore their IFN-α production may represent an attractive therapeutic strategy to overcome immune tolerance in breast cancer.

  5. Breast Pain

    Science.gov (United States)

    ... result in the development of breast cysts. Breast trauma, prior breast surgery or other factors localized to the breast can lead to breast pain. Breast pain may also start outside the breast — in the chest wall, muscles, joints or heart, for example — and ...

  6. Development and testing of a high efficiency advanced coal combustor: Phase 3, industrial boiler retrofit. Quarterly technical progress report number 12, July 1, 1994--September 30, 1994

    Energy Technology Data Exchange (ETDEWEB)

    Patel, R.L.; Borio, R. [ABB/Combustion Engineering, Windsor, CT (United States). Power Plant Labs.; Scaroni, A.W.; Miller, B.G. [Pennsylvania State Univ., University Park, PA (United States); McGowan, J.G. [Univ. of Massachusetts, Amherst, MA (United States)

    1994-11-18

    The objective of this project is to retrofit the previously developed High Efficiency Advanced Coal Combustor (HEACC) to a standard gas/oil designed industrial boiler to assess the technical and economic viability of displacing premium fuels with microfine coal. During this reporting period, data reduction/evaluation and interpretation from the long term four hundred hours Proof-of-Concept System Test under Task 3 were completed. Cumulatively, a total of approximately 563 hours of coal testing was performed with 160 hrs on 100% coal and over 400 hours with co-firing coal and gas. The primary objectives of this testing were to: (1) obtain steady state operation consistently on 100% coal; (2) increase carbon conversion efficiency from 95% to the project goal of 98%; and (3) maintain NOx emissions at or below 0.6 lbs/MBtu. The following specific conclusions are based on results of coal-fired testing at Penn State and the initial economic evaluation of the HEACC system: a coal handling/preparation system can be designed to meet the technical requirements for retrofitting microfine coal combustion to a gas/oil-designed boiler; the boiler thermal performance requirements were met; the NOx emission target of was met; combustion efficiencies of 95% could be met on a daily average basis, somewhat below the target of 98%; the economic playback is very sensitive to fuel differential cost, unit size, and annual operating hours; continuous long term demonstration is needed to quantify ash effects and how to best handle ashes. The following modifications are recommended prior to the 1,000 hour demonstration phase testing: (1) coal feeding improvements--improved raw coal/storage and transport, installation of gravimetric feeder, and redesign/installation of surge bin bottom; (2) burner modification--minor modification to the tip of the existing HEACC burner to prevent change of flame shapes for no apparent reason.

  7. Anticancer effects of the flavonoid diosmetin on cell cycle progression and proliferation of MDA-MB 468 breast cancer cells due to CYP1 activation.

    Science.gov (United States)

    Androutsopoulos, Vasilis P; Mahale, Sachin; Arroo, Randolph R J; Potter, Gerry

    2009-06-01

    Flavonoids constitute a large class of polyphenolic compounds with cancer preventative properties. We have examined the ability of the natural flavone diosmetin to inhibit proliferation of breast adenocarcinoma MDA-MB 468 and normal breast MCF-10A cells and found that this compound is selective for the cancer cells with slight toxicity in the normal breast cells. Diosmetin was metabolised to the structurally similar flavone luteolin in MDA-MB 468 cells, whereas no metabolism was seen in MCF-10A cells. Diosmetin caused G1 arrest at 10 microM in MDA-MB 468 cells after 48-h treatment whereas this effect was not observed in MCF-10A cells. We suggest that diosmetin exerts cytostatic effects in MDA-MB 468 cells, due to CYP1A1 and CYP1B1 catalyzed conversion to the flavone luteolin.

  8. Development of molten carbonate fuel cell power plant technology. Quarterly technical progress report No. 9, October 1, 1981-December 31, 1981

    Energy Technology Data Exchange (ETDEWEB)

    1981-01-01

    The overall objective of this 29-month program is to develop and verify the design of a prototype molten carbonate fuel cell stack which meets the requirements of a 1990's-competitive coal-fired electrical utility central station or industrial cogeneration power plants. During this quarter, activity continued in three of the four task areas: Task 2-cell and stack design, development and verification; Task 3 - preparation for fabrication and testing of the full-scale prototype stack; and Task 4 - development of the capability to operate stacks on coal-derived gas. Progress is reported. (WHK)

  9. Nuclear Energy Research Initiative (NERI) Program Continuous Fiber Wound Ceramic Composite (CFCC) for Commercial Water Reactor Fuel-Technical Progress Report

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2000-07-11

    This project began on August 1, 1999. As of July 1, 2000, the progress has been in materials production, test planning, testing facility design & instruction, and calibration. One new subcontractor was added to provide a solution to the CFCC material permeability issue (Northwestern University). This is in addition to the three subcontracts that were previously in place (McDermott Technologies Inc. for continuous fiber reinforced ceramic tubing fabrication, Swales Aerospace for LOCA testing of tubes, and Massachusetts Institute of Technology for In Reactor testing of tubes).

  10. Preliminary study of the behavioral and biological effects of high intensity 60 HZ electric fields. Interim technical progress report No. 4

    Energy Technology Data Exchange (ETDEWEB)

    Feldstone, C.; Spiegel, R.J.; Winters, W.; Polonis, J.J.

    1980-03-01

    Progress is reported in studies of the effects of high intensity 60 Hz electric fields on baboon behavior - both individual performance (operant conditioning) and natural (social) behavior. The result of the study should be either a clear indication of the electric field intensity which produces deleterious effects in the baboon or an indication that the highest field intensity of practical interest (analogous to the highest intensity that can be encountered by man under power lines) produces no deleterious effects. The generalization of results to man will be futher aided by the development of models relating the physical effects of electric fields on man to the physical effects on the baboon. (LCL)

  11. Evaluation of using cyclocranes to support drilling & production of oil & gas in wetland areas. Sixth quarterly technical progress report, incorporating milestone schedule/status, October 1993--December 1993

    Energy Technology Data Exchange (ETDEWEB)

    Eggington, W.J.

    1994-04-01

    This report is a progress report on a planned program falling under wetlands area research related to drilling, production, and transportation of oil and gas resources. Specifically the planned program addresses an evaluation of using cyclocraft to transport drill rigs, mud, pipes and other materials and equipment in a cost effective and environmentally safe manner to support oil and gas drilling and production operations in wetland areas. During this period, task 5, subscale tests, and task 7, environmental impacts, were completed. Work was continued on task 10, technology transfer, and the preparation of the final report as part of task 11.

  12. Fibroadenoma - breast

    Science.gov (United States)

    ... fibroadenoma; Breast lump - noncancerous; Breast lump - benign References Hacker NF, Friedlander ML. Breast disease: a gynecologic perspective. In: Hacker NF, Gambone JC, Hobel CJ, eds. Hacker and ...

  13. The Clinicopathological Factors Associated with Disease Progression in Luminal A Breast Cancer and Characteristics of Metastasis: A Retrospective Study from A Single Center in China.

    Science.gov (United States)

    Ye, Jingming; Wang, Wenjun; Xin, Ling; Owen, Sioned; Xu, Ling; Duan, Xuening; Cheng, Yuanjia; Zhang, Hong; Zhang, Shuang; Li, Ting; Liu, Yinhua

    2017-08-01

    This study investigated the clinicopathological factors associated with outcomes in patients with Luminal A breast cancer. Retrospective analysis of the association of clinicopathological factors and breast cancer outcome in 421 patients with newly-diagnosed Luminal-A breast cancer that were enrolled from January 2008 to December 2014. Clinicopathological data were analyzed to validate the relationship with disease-free survival (DFS) and overall survival (OS). Kaplan-Meier curves and log-rank tests were used to analyze the value of clinicopathological factors (tumor size, node status and lymphovascular invasion), and subsequent Cox regression analysis revealed significant prognostic factors. With a median of 61 months follow-up, the 5-year DFS and 5-year OS rate were 98.3% and 99.3%. Cox multivariate regression analysis showed that clinical anatomic stage, tumor size, status of lymph nodes, lymphovascular invasion and systemic treatment are strong prognostic factors for clinical outcome in patients with Luminal-A breast cancer. Of all 413 patients with stage I-III breast cancer, 14 presented with metastasis (3.4%) during the follow up. Bone (6/14, 42.9%) was the most common site of metastasis followed by liver (5/14, 35.7%) and lung (4/14, 28.6%). The median survival time after metastasis was 20.4 months. Of all the sites of distant metastasis, liver metastasis was the only factor that affected survival time after metastasis (χ2=6.263, p=0.012). Patients with Luminal A breast cancer have excellent outcomes. Liver metastasis is an important factor compressing the survival time after distant metastasis presents. Copyright© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

  14. A Cohert Study of the Relationship Between c-erbB-2 and Cyclin D1 Overexpression, p53 Mutation and/or Protein Accumulation, and Risk of Progression from Benign Breast Disease to Breast Cancer; and Creation of a Bank of Benign Breast Tissue

    National Research Council Canada - National Science Library

    Kandel, Rita

    2000-01-01

    ... increase in risk to develop breast cancer. The purpose of this project is: 1) collect paraffm-embedded benign breast tissue from the remaining 4,336 cohort members who were not part of the case-control study. (2...

  15. Geothermal space/water heating for Mammoth Lakes Village, California. Quarterly technical progress report, 13 December 1976-12 March 1977

    Energy Technology Data Exchange (ETDEWEB)

    Sims, A.V.; Racine, W.C.

    1977-01-01

    During the second three months of this feasibility study to determine the technical, economic and environmental feasibility of heating Mammoth Lakes Village, California using geothermal energy, the following work was accomplished. A saturation survey of the number and types of space and water heaters currently in use in the Village was completed. Electric energy and ambient temperature metering equipment was installed. Peak heating demand for Mammoth Lakes was estimated for the years 1985, 1990 and 2000. Buildings were selected which are considered typical of Mammoth Lakes in terms of their heating systems to be used in estimating the cost of installing hydronic heating systems in Mammoth. Block diagrams and an order of magnitude cost comparison were prepared for high-temperature and low-temperature geothermal district heating systems. Models depicting a geothermal district heating system and a geothermal-electric power plant were designed, built and delivered to ERDA in Washington. Local input to the feasibility study was obtained from representatives of the State of California Departments of Transportation and Fish and Game, US Forest Service, and Mono County Planning Department.

  16. Undergraduate technical skills training guided by student tutors – Analysis of tutors' attitudes, tutees' acceptance and learning progress in an innovative teaching model

    Directory of Open Access Journals (Sweden)

    Jünger Jana

    2008-04-01

    Full Text Available Abstract Background Skills labs provide a sheltered learning environment. As close supervision and individual feedback were proven to be important in ensuring effective skills training, we implemented a cross-year peer tutor system in our skills lab of internal medicine that allowed intense training sessions with small learning groups (3–4 students taught by one student tutor. Methods The expectations, experiences and criticisms of peer tutors regarding the tutor system for undergraduate skills lab training were investigated in the context of a focus group. In addition, tutees' acceptance of this learning model and of their student tutors was evaluated by means of a pre/post web-based survey. Results 14 voluntary senior students were intensely prepared by consultants for their peer tutor activity. 127 students participated in the project, 66.9% of which responded to the web-based survey (23 topics with help of 6-point Likert scale + free comments. Acceptance was very high (5.69 ± 0.07, mean ± SEM, and self-confidence ratings increased significantly after the intervention for each of the trained skills (average 1.96 ± 0.08, all p Conclusion This study demonstrates that peer teaching in undergraduate technical clinical skills training is feasible and widely accepted among tutees, provided that the tutors receive sufficient training and supervision.

  17. Development of innovative techniques and principles that may be used as models to improve plant performance. Technical progress report, February 1, 1991--January 31, 1992

    Energy Technology Data Exchange (ETDEWEB)

    Hanna, W.W.; Burton, G.W.

    1991-09-01

    Methods and techniques for transferring germplasm from wild to cultivated species are being developed. The transferred germplasm is being shown to be valuable in plant breeding and in cultivar development. Forty cytoplasms from the wild grassy subspecies monodii (primary gene pool) of Pennisetum glaucum are being tested for cytoplasmic effects on morphological characteristics and forage yield. A`-genome chromosomes from P. purpureum (secondary gene pool) have been transferred to cultivated pearl millet. The A`-chromosome derived lines have been developed into excellent male pollinator lines to produce a new high quality, high yielding grain hybrid for the US. Significant progress is being made in transferring the genes controlling apomixis (to produce true-breeding hybrids) from the tertiary gene pool to cultivated pearl millet. Backcross-4 plants are more pearl millet-like and reproduce by apomixis. New genome combinations have been produced in the apomixis genes transfer program which demonstrate the impact of apomixis on speciation and evolution.

  18. Identification and validation of heavy metal and radionuclide hyperaccumulating terrestrial plant species, Quarterly technical progress report, December 20, 1995--March 20, 1995

    Energy Technology Data Exchange (ETDEWEB)

    Kochian, L.; Brady, D.; Last, M.; Ebbs, S.

    1995-12-01

    Although the period covered by this progress report began on December 20, 1994, which was the date that DOE approved the Interagency Agreement, the agreement was not approved by USDA until January 9, 1995 and the first scientists working on the project were not hired until February 1, 1995. The first goal of the research supported by the Interagency Agreement is to use hydroponic techniques to identify plant species and genotypes with potential for heavy metal hyperaccumulation for planting on a test site at Silverbow Creek and for radionuclide ({sup 90}Sr and {sup 137}Cs) accumulation on a test site at INEL, Idaho, later this year. The second goal of this research is to identify soil amendment procedures that will enhance the bioavailability of heavy metals and radionuclides in the soil without increasing the movement of the contaminants of concern (COC`s) into the groundwater. Our initial research covered in this report focuses on the first goal.

  19. A systematic review to establish the frequency of cyclooxygenase-2 expression in normal breast epithelium, ductal carcinoma in situ, microinvasive carcinoma of the breast and invasive breast cancer

    OpenAIRE

    Glover, J A; Hughes, C M; Cantwell, M M; Murray, L J

    2011-01-01

    Background: Epidemiological studies have suggested a protective effect of cyclooxygenase (COX)-inhibiting non-steroidal anti-inflammatory drugs in breast cancer risk and disease progression. We performed a systematic review to evaluate the frequency of COX-2 expression in normal breast epithelium, ductal carcinoma in situ of breast (DCIS), DCIS-adjoining invasive breast cancer, microinvasive carcinoma of the breast (MICB) and invasive breast cancer. Methods: Literature searches were carried o...

  20. Development & testing of industrial scale, coal fired combustion system, phase 3. Eighth quarterly technical progress report, 1 October, 1993--31 December, 1993

    Energy Technology Data Exchange (ETDEWEB)

    Zauderer, B.

    1994-01-31

    The primary objective of the present Phase 3 effort is to perform the final testing at a 20 MMBtu/hr commercial scale of an air cooled, slagging coal combustor for application to industrial steam boilers and power plants. The focus of the test effort will be on combustor durability, automatic control of the combustor`s operation, and optimum environmental control of emissions inside the combustor. In connection with the latter, the goal is to achieve 0.4 lb/MMBtu of SO{sub 2} emissions, 0.2 lb/MMBtu of NO{sub x} emissions, and 0.02 lb particulates/MMBtu. Meeting the particulate goal will require the use of a baghouse or electrostatic precipitator to augment the nominal slag retention in the combustor. The NO{sub x} emission goal will require a modest improvement over maximum reduction achieved to date in the combustor to a level of 0.26 lb/MMBtu. To reach the SO{sub 2} emissions goal may require a combination of sorbent injection inside the combustor and sorbent injection inside the boiler, especially in high (>3.5%) sulfur coals. Prior to the initiation of the project, SO{sub 2} levels as low as 0.6 lb/MMBtu, equal to 81% reduction in 2% sulfur coals, were measured with boiler injection of calcium hydrate. The final objective is to define suitable commercial power or steam generating systems to which the use of the air cooled combustor offers significant technical and economic benefits. In implementing this objective both simple steam generation and combined gas turbine-steam generation systems will be considered.

  1. Undergraduate technical skills training guided by student tutors – Analysis of tutors' attitudes, tutees' acceptance and learning progress in an innovative teaching model

    Science.gov (United States)

    Weyrich, Peter; Schrauth, Markus; Kraus, Bernd; Habermehl, Daniel; Netzhammer, Nicolai; Zipfel, Stephan; Jünger, Jana; Riessen, Reimer; Nikendei, Christoph

    2008-01-01

    Background Skills labs provide a sheltered learning environment. As close supervision and individual feedback were proven to be important in ensuring effective skills training, we implemented a cross-year peer tutor system in our skills lab of internal medicine that allowed intense training sessions with small learning groups (3–4 students) taught by one student tutor. Methods The expectations, experiences and criticisms of peer tutors regarding the tutor system for undergraduate skills lab training were investigated in the context of a focus group. In addition, tutees' acceptance of this learning model and of their student tutors was evaluated by means of a pre/post web-based survey. Results 14 voluntary senior students were intensely prepared by consultants for their peer tutor activity. 127 students participated in the project, 66.9% of which responded to the web-based survey (23 topics with help of 6-point Likert scale + free comments). Acceptance was very high (5.69 ± 0.07, mean ± SEM), and self-confidence ratings increased significantly after the intervention for each of the trained skills (average 1.96 ± 0.08, all p skills training to be provided by faculty staff only. Focus group analyses with tutors revealed 18 different topics, including profit in personal knowledge and personal satisfaction through teaching activities. The ratio of 1:4 tutor/tutees was regarded to be very beneficial for effective feedback, and the personalized online evaluation by tutees to be a strong motivator and helpful for further improvements. The tutors ascribed great importance to the continuous availability of a contact doctor in case of uncertainties. Conclusion This study demonstrates that peer teaching in undergraduate technical clinical skills training is feasible and widely accepted among tutees, provided that the tutors receive sufficient training and supervision. PMID:18400106

  2. Undergraduate technical skills training guided by student tutors--analysis of tutors' attitudes, tutees' acceptance and learning progress in an innovative teaching model.

    Science.gov (United States)

    Weyrich, Peter; Schrauth, Markus; Kraus, Bernd; Habermehl, Daniel; Netzhammer, Nicolai; Zipfel, Stephan; Jünger, Jana; Riessen, Reimer; Nikendei, Christoph

    2008-04-09

    Skills labs provide a sheltered learning environment. As close supervision and individual feedback were proven to be important in ensuring effective skills training, we implemented a cross-year peer tutor system in our skills lab of internal medicine that allowed intense training sessions with small learning groups (3-4 students) taught by one student tutor. The expectations, experiences and criticisms of peer tutors regarding the tutor system for undergraduate skills lab training were investigated in the context of a focus group. In addition, tutees' acceptance of this learning model and of their student tutors was evaluated by means of a pre/post web-based survey. 14 voluntary senior students were intensely prepared by consultants for their peer tutor activity. 127 students participated in the project, 66.9% of which responded to the web-based survey (23 topics with help of 6-point Likert scale + free comments). Acceptance was very high (5.69 +/- 0.07, mean +/- SEM), and self-confidence ratings increased significantly after the intervention for each of the trained skills (average 1.96 +/- 0.08, all p skills training to be provided by faculty staff only. Focus group analyses with tutors revealed 18 different topics, including profit in personal knowledge and personal satisfaction through teaching activities. The ratio of 1:4 tutor/tutees was regarded to be very beneficial for effective feedback, and the personalized online evaluation by tutees to be a strong motivator and helpful for further improvements. The tutors ascribed great importance to the continuous availability of a contact doctor in case of uncertainties. This study demonstrates that peer teaching in undergraduate technical clinical skills training is feasible and widely accepted among tutees, provided that the tutors receive sufficient training and supervision.

  3. Predictive value of quantitative HER2, HER3 and p95HER2 levels in HER2-positive advanced breast cancer patients treated with lapatinib following progression on trastuzumab.

    Science.gov (United States)

    Duchnowska, Renata; Sperinde, Jeff; Czartoryska-Arłukowicz, Bogumiła; Myśliwiec, Paulina; Winslow, John; Radecka, Barbara; Petropoulos, Christos; Demlova, Regina; Orlikowska, Marlena; Kowalczyk, Anna; Lang, Istvan; Ziółkowska, Barbara; Dębska-Szmich, Sylwia; Merdalska, Monika; Grela-Wojewoda, Aleksandra; Żawrocki, Anton; Biernat, Wojciech; Huang, Weidong; Jassem, Jacek

    2017-11-28

    Lapatinib is a HER1 and HER2 tyrosine kinase inhibitor (TKI) approved in second line treatment of advanced or metastatic breast cancer following progression on trastuzumab-containing therapy. Biomarkers for activity of lapatinib and other TKIs are lacking. Formalin-fixed, paraffin-embedded primary tumor samples were obtained from 189 HER2-positive patients treated with lapatinib plus capecitabine following progression on trastuzumab. The HERmark ® Breast Cancer Assay was used to quantify HER2 protein expression. HER3 and p95HER2 protein expression was quantified using the VeraTag ® technology. Overall survival (OS) was inversely correlated with HER2 (HR = 1.9/log; P = 0.009) for patients with tumors above the cut-off positivity level by the HERmark assay. OS was significantly shorter for those with above median HER2 levels (HR = 1.7; P = 0.015) and trended shorter for those below the cut-off level of positivity by the HERmark assay (HR = 1.7; P = 0.057) compared to cases with moderate HER2 overexpression. The relationship between HER2 protein expression and OS was best captured with a U-shaped parabolic function (P = 0.004), with the best prognosis at moderate levels of HER2 protein overexpression. In a multivariate model including HER2, increasing p95HER2 expression was associated with longer OS (HR = 0.35/log; P = 0.027). Continuous HER3 did not significantly correlate with OS. Patients with moderately overexpressed HER2 levels and high p95HER2 expression may have best outcomes while receiving lapatinib following progression on trastuzumab. Further study is warranted to explore the predictive utility of quantitative HER2 and p95HER2 in guiding HER2-directed therapies.

  4. Development of innovative techniques and principles that may be used as models to improve plant performance. Technical progress report, February 1, 1990--January 31, 1993

    Energy Technology Data Exchange (ETDEWEB)

    Hanna, W.W.; Burton, G.W.

    1992-06-01

    Methods and techniques for transferring germplasm from wild to cultivated species are being developed. The transferred germplasm is being shown to be valuable in plant breeding and in cultivar development. In the primary gene pool of the grassy Pennisetum glaucum subspecies monodii germplasm, some cytoplasms are being identified that appear to have significant effects on forage yields and morphological characteristics. One cytoplasm, A{sub 4}, is very stable for male sterility and fertility is not easily restored by other lines. It should be a valuable cytoplasm for producing commercial forage hybrids. Disease resistance and yield genes transferred from monodii to cultivated pearl millet lines are having a major impact on increasing production of animals grazing disease resistant Tifleaf 2 pearl millet. Genes controlling resistance to many of the world-wide diseases on pearl millet are being identified in the monodii germplasm. Valuable germplasm has been transferred from the secondary gene pool P. purpuroum) which is used as the pollinator of the first pearl millet grain hybrid in the US Production of 7-chromosome gametes in 42-chromosome interspecific hybrids appears to be genotype specific and makes possible transfer of germplasm from the secondary gene pool to cultivated diploid pearl millet. Significant progress has been made in transferring genes controlling apomixis from P. squamulatum (tertiary gene pool) to cultivated pearl millet. Highly apomictic BC{sub 4} plants have been recovered, one of which sets five times as much seed as the best BC{sub 3} plant.

  5. Plasma Science Committee (PLSC) and study on new opportunities in plasma science and technology. Technical progress report, July 15, 1991--May 31, 1992

    Energy Technology Data Exchange (ETDEWEB)

    1992-09-01

    The Plasma Science Committee (PLSC) of the National Research Council (NRC) is charged with monitoring the health of the field of plasma science in the United States. Accordingly, the Committee identifies and examines both broad and specific issues affecting the field. Regular meetings, teleconferences, briefings from agencies and the scientific community, the formation of study panels to prepare reports, and special symposia are among the mechanisms used by the PLSC to meet its charge. This progress report presents a review of PLSC activities from July 15, 1991 to May 31, 1992. The details of prior activities are discussed in earlier reports. This report also includes the status of activities associated with the PLSC study on opportunities in plasma science and technology. During the above period, the PLSC has continued to track and participate in, when requested, discussions on the health of the field. Much of the perspective of the PLSC has been presented in the recently-published report Research Briefing on Contemporary Problems in Plasma Science. That report has served as the basis for briefings to representatives of the federal government as well as the community-at-large. In keeping with its charge to identify and highlight specific areas for scientific and technological opportunities, the PLSC completed publication of the report Plasma Processing of Materials: Scientific and Technological Opportunities and launched a study on new opportunities in plasma science and technology.

  6. An exploration of sequence specific DNA-duplex/pyrene interactions for intercalated and surface-associated pyrene species. Technical progress report

    Energy Technology Data Exchange (ETDEWEB)

    Netzel, T.L.

    1994-01-07

    The use of both short (5-atom) and long (12-atom) covalent linking chains to attach, respectively, a pyrenesulfonate or a pyrenebutyrate moiety to a central region of a DNA duplex allows construction of DNA-duplex/pyrene assemblies of two types. Long linking chains permit pyrene to intercalate within the DNA duplex, while the short chains constrain pyrene to remain in the outer-surface region of the major-groove of the duplex. Electrochemical data suggest that reductive electron-transfer (ET) quenching of photoexcited pyrene (pyrene*) labels will be most exothermic for guanosine than for the other three DNA nucleosides and that oxidative ET quenching of pyrene* will be most exothermic for thymidine than for the other three DNA nucleosides. The study combines two effects, (1) differential DNA/pyrene geometries in covalent assemblies with different length linking chains and (2) differential ET quenching reactivities among the DNA nucleotides to explore sequence specific and duplex/pyrene association specific effects on DNA-base ionization reactions. This report describes progress in synthesizing target pyrene-labeled nucleosides and oligonucleotides, in commissioning our fluorescence lifetime measurement system, and in the photochemical behavior of pyrene-labeled nucleosides, single strands of DNA, and duplexes of DNA.

  7. Research and development of methods/utilities and rules for managing cooperation for performance improvement in government offices. First technical progress report, September 1, 1991--August 31, 1992

    Energy Technology Data Exchange (ETDEWEB)

    1992-03-01

    On September 1, 1991, Defense Programs (DP) within the US Department of Energy entered into a research grant with Management Systems Laboratories (MSL) of Virginia Polytechnic Institute and State University (Virginia Tech), to study Tools, Methods, and Rules for Managing Cooperation for Performance Improvement. Continuous performance improvement is a gradual, systematic process. The idea is to do a little better each day by knowing where you are, where you want to be, what you have to do to get there, whether or not you have done it, and how to resolve problems doing it. And, although many management decisions are made along direct lines of authority, much of the work of an organization can be achieved only through cooperation (people sharing information and coordinating effort). Therefore, continuous performance improvement requires working cooperatively to do a little better each day. We are researching the most effective configuration of tools working through what we believe is a closed set of nine methods. These methods are: setting expectations, charting, defining indicators and standards, collecting and logging data, converting data to information, organizing and presenting information, reviewing status and progress, self-management, and appraising. We believe that these methods form a closed set because they reflect the management activities of formulation (planning),execution (doing), and verification (evaluating). If these activities are carried out effectively through the methods, the manager can achieve visibility and control.

  8. Phase-equilibrium properties of coal-derived liquids. Technical progress report, July-December 1982. [300/sup 0/C; 40 to 1200 psia; M-cresol-quinoline

    Energy Technology Data Exchange (ETDEWEB)

    Yesavage, V.F.; Kidnay, A.J.

    1983-01-01

    On July 1, 1980, work was initiated on a program for experimental vapor liquid equilibrium measurements on coal-derived liquids. During the last six months, effort was devoted to data collection for the m-cresol-quinoline binary system, which is a system that should be of significance in coal-derived liquid studies. Major equipment difficulties were ecnountereed with this system including continued deterioration of the seal in the back pressure regulator (which eventually had to be replaced with a different model) and continued leakage from the cell at high temperatures across the graphoil gasket. A new cell using a quartz or sapphire window and a gold seal has been designed and will be constructed shortly to replace the existing cell. In addition, analysis of the samples was hampered due to lack of reproducibility of the capillary column gas-liquid chromatograph for this system. Although our progress is less than expected, our rate of expenditure has also been low, and we hope to attain our project objectives in a longer period of time.

  9. Development and testing of a high efficiency advanced coal combustor phase III industrial boiler retrofit. Quarterly technical progress report No. 9, 1 October 1993--31 December 1993

    Energy Technology Data Exchange (ETDEWEB)

    Jennings, P.; Borio, R. [ABB/Combustion Engineering, Windsor, CT (United States); Scaroni, A.W.; Miller, B.G. [Penn State Univ., University Park, PA (United States); McGowan, J.G. [Univ. of Massachusetts, Amherst, MA (United States)

    1994-03-01

    This report documents the technical aspects of this project during the ninth quarter of the program. During this quarter, the natural gas baseline testing at the Penn State demonstration boiler was completed, results were analyzed and are presented here. The burner operates in a stable manner over an 8/1 turndown, however due to baghouse temperature limitations (300{degrees}F for acid dewpoint), the burner is not operated for long periods of time below 75% load. Boiler efficiency averaged 83.1% at the 100 percent load rate while increasing to 83.7% at 75% load. NO{sub x} emissions ranged from a low of 0.17 Lbs/MBtu to a high of 0.24 Lbs/MBtu. After the baseline natural gas testing was completed, work continued on hardware optimization and testing with the goal of increasing carbon conversion efficiency on 100% coal firing from {approx}95% to 98%. Several coal handling and feeding problems were encountered during this quarter and no long term testing was conducted. While resolving these problems several shorter term (less than 6 hour) tests were conducted. These included, 100% coal firing tests, 100% natural gas firing tests, testing of air sparges on coal to simulate more primary air and a series of cofiring tests. For 100% coal firing, the carbon conversion efficiency (CCE) obtained this quarter did not exceed the 95-96% barrier previously reached. NO{sub x} emissions on coal only ranged from {approx} 0.42 to {approx} 0.78 Lbs/MBtu. The burner has not been optimized for low NO{sub x} yet, however, due to the short furnace residence time, meeting the goals of 98% CCE and <0.6 Lbs/MBtu NO{sub x} simultaneously will be difficult. Testing on 100% natural gas in the boiler after coal firing indicated no changes in efficiency due to firing in a `dirty` boiler. The co-firing tests showed that increased levels of natural gas firing proportionately decreased NO{sub x}, SO{sub 2}, and CO.

  10. Breast cancer stem cells

    Directory of Open Access Journals (Sweden)

    Thomas W Owens

    2013-08-01

    Full Text Available Cancer metastasis, resistance to therapies and disease recurrence are significant hurdles to successful treatment of breast cancer. Identifying mechanisms by which cancer spreads, survives treatment regimes and regenerates more aggressive tumours are critical to improving patient survival. Substantial evidence gathered over the last 10 years suggests that breast cancer progression and recurrence is supported by cancer stem cells (CSCs. Understanding how CSCs form and how they contribute to the pathology of breast cancer will greatly aid the pursuit of novel therapies targeted at eliminating these cells. This review will summarise what is currently known about the origins of breast CSCs, their role in disease progression and ways in which they may be targeted therapeutically.

  11. Adaptive harvest management for the Svalbard population of pink‐footed geese: 2016 progress summary: Technical Report from DCE – Danish Centre for Environment and Energy, No. 86

    Science.gov (United States)

    Johnson, Fred A.; Madsen, Jesper

    2016-01-01

    This document describes progress to date on the development of an adaptive harvest management strategy for maintaining the Svalbard population of pink‐footed geese (Anser brachyrhynchus) near their agreed target level (60,000) by providing for sustainable harvests in Norway and Denmark. This report provides an assessment of the most recent monitoring information (1991-2015) and its implications for the harvest management strategy. By combining varying hypotheses about survival and reproduction, a suite of nine models have been developed that represent a wide range of possibilities concerning the extent to which demographic rates are density dependent or independent. These results suggest that the pink‐footed goose population may have recently experienced a release from density‐dependent mechanisms, corresponding to the period of most rapid growth in population size. Beginning with the 2016 hunting season, harvest quotas will be prescribed on an annual basis rather than every three years because of the potential to better meet population management objectives. Based on updated model weights, the recent observations of population size (74,800), the proportion of the population comprised of one-year-old birds (0.138), and temperature days in Svalbard (20), the optimal harvest quota for the 2016 hunting season is 25,000. The large increase in quota compared to that during first three years of AHM reflects stakeholders’ desire to reduce population size to the goal of 60,000, recognizing that population size remains relatively high and above-average production is expected in 2016 due to a warm spring.

  12. Effects of low-temperature catalytic pretreatments on coal structure and reactivity in liquefaction. [Quarterly] technical progress report, April--June 1993

    Energy Technology Data Exchange (ETDEWEB)

    Song, C.; Huang, L.; Saini, A.K.; Schobert, H.H.; Hatcher, P.G.

    1993-07-01

    In this quarter, progress has been made in the following two aspects: (1) effects of drying and mild oxidation on conversion and product distribution during non-catalytic and catalytic liquefaction of a Montana subbituminous coal (DECS-9); and (2) effects of solvent and catalyst on conversion and structural changes of a Texas subbituminous coal (DECS-1). Influence of drying and mild oxidation on catalytic and non-catalytic liquefaction (at 350C for 30 min with 6.9 MPa (cold) H{sub 2} was studied using Wyodak subbituminous coal. For non-catalytic runs, fresh raw coal gave higher conversion and higher oil yield than both the vacuum- and air-dried coals, regardless of the solvent. Compared to the vacuum-dried coal, the coal dried in air in 100C for 2 h gave a better conversion in the presence of either a hydrogen donor tetralin or a non-donor 1-methylnaphthalene (1-MN) solvent. Catalytic runs were performed using in-situ generated molybdenum sulfide catalyst from ammonium tetrathiomolybdate (ATTM) precursor impregnated on either raw coal or predried coal samples. The solvent-free runs using ATTM loaded on the raw coal gave higher conversion and higher oil yield than loading ATTM on vacuum- or air-dried coal. In the presence of either tetralin or 1-MN, however, the runs using ATTM loaded on air-dried coal afford better conversions and oil yields as compared to the runs using vacuum-dried coal. Upon drying coal in air at 150C for 20 h, the conversion significantly decreased to a lower value than that of the vacuum-dried coal in the non-catalytic runs, and the same trend was observed in the runs of the dried coals loaded with ATTM. Physical, chemical, and surface chemical aspects of effects of drying and oxidation and the role of water are also discussed in the report.

  13. Effects of low-temperature catalytic pretreatments on coal structure and reactivity in liquefaction. Technical progress report, July--September 1993

    Energy Technology Data Exchange (ETDEWEB)

    Song, C.; Saini, A.K.; Huang, L.; Schobert, H.H.; Hatcher, P.G.

    1994-01-01

    In this quarter, progress has been made in the following two aspects: (1) spectroscopic and chemical reaction studies on the effects of drying and mild oxidation of a Wyodak subbituminous coal on its structure and pretreatment/liquefaction at 350{degrees}C; and (2) effects of dispersed catalyst and solvent on conversion and structural changes of a North Dakota lignite. Drying and oxidation of Wyodak subbituminous coal at 100-150{degrees}C have been shown to have significant effects on its structure and on its catalytic and non-catalytic low-severity liquefaction at 350{degrees}C for 30 min under 6.9 MPa H{sub 2}. Spectroscopic analyses using solid-state {sup 13}C NMR, Pyrolysis-GC-MS, and FT-IR revealed that oxidative drying at 100-150{degrees}C causes the transformation of phenolics and catechol into other related structures (presumably via condensation) and high-severity air drying at 150{degrees}C for 20 h leads to disappearance of catechol-like structure. Increasing air drying time or temperature increases oxidation to form more oxygen functional groups at the expense of aliphatic carbons. Such a clearly negative impact of severe oxidation is considered to arise from significantly increased oxygen functionality which enhances the cross-link formation in the early stage of coal liquefaction. Physical, chemical, and surface physicochemical aspects of drying and oxidation and the role of water are also discussed. A North Dakota lignite (DECS-1) coal was studied for its behaviors in non-catalytic and catalytic liquefaction. Reactions were carried out at temperatures between 250 and 450{degrees}C. Regardless the reaction solvents and the catalyst being used, the optimum temperature was found to be 400{degrees}C. The donor solvent has a significant effect over the conversion especially at temperatures higher than 350{degrees}C.

  14. Effects of low-temperature catalytic pretreatments on coal structure and reactivity in liquefaction. Technical progress report, October 1993--December 1993

    Energy Technology Data Exchange (ETDEWEB)

    Song, C.; Huang, L.; Wenzel, K.A.; Hatcher, P.G.; Schobert, H.H.

    1994-02-01

    In this quarter, progress has been made in the following two aspects: The influences of temperature, dispersed Mo catalyst, and solvent on the liquefaction conversion and composition of products from low-rank coals; and the hydrous pyrolysis of a lignite and spectroscopic characterization of its structural transformation during the hydrous pyrolysis. The analytical work described in this quarter also represents molecular-level characterization of products. The purpose of the first part of the work described in this quarter is to study the influences of temperature, solvent and dispersed Mo catalyst on the liquefaction conversion and chemical composition of the products. Many specialty chemicals, including one- to four-ring aromatics, could potentially be produced by liquefying coal. To achieve this goal, not only a high coal conversion but also a desirable product distribution is necessary. Therefore, it is of great importance to understand the structural changes of the coal during reaction and to investigate the conditions under which the aliphatics or aromatics can be removed from the macromolecular structure of coal. This quarterly report also describes the hydrous pyrolysis of Potapsco lignite and spectroscopic characterization of its structural transformation during the hydrous pyrolysis. This work has some implications both on the structural changes of low-rank coals during pretreatment and on the geochemical reactions during coalification stage. Vitrinite, a major component of most coals, is derived from degraded wood in ancient peat swamps. Organic geochemical studies conducted on a series of coalified wood samples derived mostly from gymnosperms have allowed the development of a chemical reaction series to characterize the major coalification reactions which lignin, the major coal-producing component of wood, undergoes.

  15. A protocol for evaluating progressive levels of simulation fidelity in the development of technical skills, integrated performance and woman centred clinical assessment skills in undergraduate midwifery students

    Science.gov (United States)

    2013-01-01

    Background Simulation as a pedagogical approach has been used in health professional education to address the need to safely develop effective clinical skills prior to undertaking clinical practice. However, evidence for the use of simulation in midwifery is largely anecdotal, and research evaluating the effectiveness of different levels of simulation fidelity are lacking. Woman centred care is a core premise of the midwifery profession and describes the behaviours of an individual midwife who demonstrates safe and effective care of the individual woman. Woman centred care occurs when the midwife modifies the care to ensure the needs of each individual woman are respected and addressed. However, a review of the literature demonstrates an absence of a valid and reliable tool to measure the development of woman centred care behaviours. This study aims to determine which level of fidelity in simulated learning experiences provides the most effective learning outcomes in the development of woman centred clinical assessment behaviors and skills in student midwives. Methods/Design Three-arm, randomised, intervention trial. In this research we plan to: a) trial three levels of simulation fidelity - low, medium and progressive, on student midwives performing the procedure of vaginal examination; b) measure clinical assessment skills using the Global Rating Scale (GRS) and Integrated Procedural Performance Instrument (IPPI); and c) pilot the newly developed Woman Centred Care Scale (WCCS) to measure clinical behaviors related to Woman-Centredness. Discussion This project aims to enhance knowledge in relation to the appropriate levels of fidelity in simulation that yield the best educational outcomes for the development of woman centred clinical assessment in student midwives. The outcomes of this project may contribute to improved woman centred clinical assessment for student midwives, and more broadly influence decision making regarding education resource allocation for

  16. Enthalpy and phase behavior of coal derived liquid mixtures: Technical progress report for the period January-March 1987. [M-cresol/quinoline/tetralin ternary mixture

    Energy Technology Data Exchange (ETDEWEB)

    Yesavage, V.F.; Kidnay, A.J.

    1987-04-30

    On July 15, 1984, work was initiated on a program to study the enthalpy and phase behavior of coal derived liquid model compound mixtures. The objectives of this program are to study the enthalpy and phase behavior of a selected ternary model compound system, representative of interactions present in coal derived liquids. Measurements will be made in a Freon 11 reference fluid boil-off calorimeter, and an equilibrium flash vaporization apparatus. These experimental systems have already been developed. Previous studies have indicated that existing data and correlations developed for petroleum fluids are not applicable to coal derived liquids. This is due to the presence of significant concentrations of polar associating heteroatomics in the predominantly aromatic coal liquids. Thus, the ternary system will include an aromatic, a basic nitrogen compound, and a cresol. It is presently planned to study the m-cresol/quinoline/tetralin ternary mixture. Measurements will be made over a wide range of temperature (200 to 750/sup 0/F) and pressure (20 to 1500 psia), for the three pure compounds, the three binary mixtures and selected compositions of the ternary. Both enthalpy and phase behavior measurements will be made. This set of data will be useful as a standard for fitting and evaluating thermodynamic correlations and equations of state that are applicable to associating fluid mixtures, and thus to coal derived liquids. In particular we will attempt to fit both the enthalpy and phase behavior data with a single equation of state using local composition mixing rules and common interaction parameters. During the eleventh quarter, enthalpy measurements have been obtained for the ternary mixtures of m-cresol/quinoline/tetralin with molar ratios 2/3:1/6:1/6 and 1/6:2/3:1/6 m-cresol:quinoline:tetralin. The results are presented in Appendix A. The project has progressed very will during this quarter, and the enthalpy measurements have been completed. 2 refs., 2 figs., 2 tabs.

  17. Interleukin-19 in Breast Cancer

    Directory of Open Access Journals (Sweden)

    Ying-Yin Chen

    2013-01-01

    Full Text Available Inflammatory cytokines within the tumor microenvironment are linked to progression in breast cancer. Interleukin- (IL- 19, part of the IL-10 family, contributes to a range of diseases and disorders, such as asthma, endotoxic shock, uremia, psoriasis, and rheumatoid arthritis. IL-19 is expressed in several types of tumor cells, especially in squamous cell carcinoma of the skin, tongue, esophagus, and lung and invasive duct carcinoma of the breast. In breast cancer, IL-19 expression is correlated with increased mitotic figures, advanced tumor stage, higher metastasis, and poor survival. The mechanisms of IL-19 in breast cancer have recently been explored both in vitro and in vivo. IL-19 has an autocrine effect in breast cancer cells. It directly promotes proliferation and migration and indirectly provides a microenvironment for tumor progression, which suggests that IL-19 is a prognostic marker in breast cancer and that antagonizing IL-19 may have therapeutic potential.

  18. Imbalance in leptin-adiponectin levels and leptin receptor expression as chief contributors to triple negative breast cancer progression in Northeast India.

    Science.gov (United States)

    Sultana, Rizwana; Kataki, Amal Ch; Borthakur, Bibhuti Bhusan; Basumatary, Tarun K; Bose, Sujoy

    2017-07-20

    Triple-Negative breast cancer (TNBC), accounts for a large percentage of breast cancer cases in India including Northeast India. TNBC has an unclear molecular aetiology and hence limited targeted therapies. Human breast is comprised of glandular, ductal, connective, and adipose tissues. Adipose tissue is composed of adipocytes. The adipocytes apart from being energy storage depots, are also active sources of adipocytokines and/or adipokines. The role of adipokines in breast cancer including TNBC has been sporadically documented. Two adipokines in particular, leptin and adiponectin, have come to be recognized for their influence on breast cancer risk and tumour biology. Therefore, the aim of this study was to understand the association of differential expression of critical adipokines and associated cellular mechanism in the susceptibility and severity of TNBC in northeast Indian population. We collected 68 TNBC and 63 controls cases and examined for serum leptin and adiponectin levels using enzyme linked immunosorbent assay (ELISA). Leptin Receptor (Ob-R) mRNA expression was determined by real-time polymerase chain reaction (RT-PCR) assay. Differential Ob-R mRNA expression and correlation with cancer stem cell (CSC) markers was evaluated, and correlated with severity. The serum leptin levels were significantly associated with TNBC severity, while the adiponectin levels were comparative. The serum leptin levels correlated inversely with the adiponetin levels. Serum leptin levels were unaffected with difference in parity. The difference in leptin levels in pre and post menopausal cases were found to be statistically non-significant. Higher leptin levels were also found to be associated obesity, mortality and recurrence. Obesity was found to be a factor for TNBC pathogenesis and severity. Increased Ob-R mRNA expression was associated with TNBC, significantly with TNBC severity, and was significantly higher in obese patients with higher grade TNBC cases. The Ob-R gene

  19. Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib.

    Directory of Open Access Journals (Sweden)

    Darrell C Bessette

    Full Text Available Basal-like and triple negative breast cancer (TNBC share common molecular features, poor prognosis and a propensity for metastasis to the brain. Amplification of epidermal growth factor receptor (EGFR occurs in ~50% of basal-like breast cancer, and mutations in the epidermal growth factor receptor (EGFR have been reported in up to ~ 10% of Asian TNBC patients. In non-small cell lung cancer several different mutations in the EGFR tyrosine kinase domain confer sensitivity to receptor tyrosine kinase inhibitors, but the tumourigenic potential of EGFR mutations in breast cells and their potential for targeted therapy is unknown.Constructs containing wild type, G719S or E746-A750 deletion mutant forms of EGFR were transfected into the MCF10A breast cells and their tumorigenic derivative, MCF10CA1a. The effects of EGFR over-expression and mutation on proliferation, migration, invasion, response to gefitinib, and tumour formation in vivo was investigated. Copy number analysis and whole exome sequencing of the MCF10A and MCF10CA1a cell lines were also performed.Mutant EGFR increased MCF10A and MCF10CA1a proliferation and MCF10A gefitinib sensitivity. The EGFR-E746-A750 deletion increased MCF10CA1a cell migration and invasion, and greatly increased MCF10CA1a xenograft tumour formation and growth. Compared to MCF10A cells, MCF10CA1a cells exhibited large regions of gain on chromosomes 3 and 9, deletion on chromosome 7, and mutations in many genes implicated in cancer.Mutant EGFR enhances the oncogenic prope